ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count,fold_enrichment,ci_lower,ci_upper
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,36/1379,98/9872,0.3673469387755102,2.6297672078258425,6.53332996476071,1.335259969925785e-8,1.1730755524901398e-5,1.0884677641039115e-5,SOCS3/STAT3/FOS/JAK3/VEGFA/CDKN1A/IL1B/OSM/BATF/IL13RA1/ITGAX/CEBPD/PIM1/BCL6/IL4R/BCL2L1/JUNB/HMOX1/HIF1A/CCL2/MMP2/IL18/CXCL8/MCL1/OPRM1/ZEB1/TNF/CCND1/FN1/RORA/TNFRSF1B/IL12B/PTGS2/ICAM1/STAT1/S1PR1,36,5.195868049903065,3.532465404293773,7.6425503726627015
R-HSA-6783783,Interleukin-10 signaling,21/1379,41/9872,0.5121951219512195,3.6667079361148947,6.894466737700684,1.5798997339934542e-8,1.1730755524901398e-5,1.0884677641039115e-5,STAT3/IL1B/PTAFR/CD86/CCL3/CCL2/IL18/FPR1/CXCL8/TNF/CSF1/IL10RA/TNFRSF1B/IL12B/IL1RN/CCL4/PTGS2/CSF3/ICAM1/CCR1/CCL3L1,21,7.244645289092485,4.269418173800194,12.293217302266115
R-HSA-500792,GPCR ligand binding,82/1379,348/9872,0.23563218390804597,1.6868462070632557,5.256196345074382,6.916612734929132e-7,3.4237233037899203e-4,3.1767880947446435e-4,CX3CR1/CD55/EDNRB/CXCL12/CYSLTR1/P2RY12/P2RY13/C3/DHH/PTAFR/LPAR5/CALCRL/PENK/ADGRE2/FFAR4/CALCR/GRM3/HRH2/P2RY6/CCL3/CCRL2/ADM/P2RY14/FZD5/GNB3/ADRB2/CCL2/LPAR4/ADORA1/ACKR3/CRH/NPFFR1/GNB4/CX3CL1/PTH2R/FPR1/CXCL8/F2R/OPRM1/WNT11/PTGDR/GPR17/PROK2/C3AR1/WNT7A/NTSR2/WNT2B/PDYN/OPRL1/GPR37L1/WNT5A/C5AR1/NLN/TACR1/WNT8B/ADGRE5/ADRB1/CCL4/ADM2/CRHBP/SMO/DRD1/LPAR6/GNG2/ADORA2A/GRM1/TAC1/HTR2C/NPY1R/EDN3/PLPPR5/CNR1/GPR132/S1PR1/GRM4/KEL/FZD2/NMUR2/WNT6/CMKLR1/CCR1/CCL3L1,82,3.3328540588299034,2.6041578162605066,4.265454308529427
R-HSA-1474244,Extracellular matrix organization,70/1379,298/9872,0.2348993288590604,1.6815998364732736,4.814187989158051,5.097031184262103e-6,0.0018922728271573055,0.0017557931105787086,A2M/TLL2/SGCZ/P3H2/NRXN1/P4HA1/JAM2/ITGB3/P4HA2/ADAMTS14/ADAM19/CD47/SPP1/ITGAX/COL9A1/VCAN/CTSS/COL4A1/ITGB4/DMD/ADAM9/ACAN/BMP2/PECAM1/ADAM12/TGFB3/NCAN/PDGFA/LAMA1/LOXL2/MMP2/COL5A3/LOXL3/ITGA4/MADCAM1/COL10A1/PLOD1/FBLN1/EMILIN2/COL5A2/COL4A2/COL12A1/BMP1/FN1/COL18A1/BMP7/ACTG1/SNTA1/SGCD/UTRN/ASPN/COL8A2/ACTA2/NID1/COL14A1/LAMA4/LTBP4/LAMA2/ICAM1/PDGFB/HAPLN1/ACTB/ITGB7/P3H3/KLKB1/COL3A1/COL8A1/TLL1/PLOD2/EFEMP1,70,3.32248833168671,2.546494551963767,4.33495084671652
R-HSA-2022870,Chondroitin sulfate biosynthesis,11/1379,20/9872,0.55,3.937345902828137,5.298342579782355,1.8949844558012905e-5,0.004321303602690987,0.0040096306332961205,CSGALNACT1/CHST9/VCAN/CSPG5/CHSY1/NCAN/CSGALNACT2/CHST3/CHST13/CHST7/CHSY3,11,7.779369108049312,3.719945244852278,16.268675944361963
R-HSA-449147,Signaling by Interleukins,88/1379,412/9872,0.21359223300970873,1.5290663700303442,4.420234840747684,1.932176335365687e-5,0.004321303602690987,0.0040096306332961205,CSF2RA/PTPN14/SOCS3/STAT3/PTPN13/INPP5D/FOS/JAK3/VEGFA/CDKN1A/CSF1R/IL1B/PTAFR/CD86/MEF2C/PTPN2/OSM/BATF/IL13RA1/IL1RAP/BLNK/ITGAX/CEBPD/PIM1/IL27/NFKBIA/NLRC5/BCL6/LIFR/IL4R/CCL3/SYK/BCL2L1/JUNB/HMOX1/CD4/TIFA/HIF1A/CCL2/HNRNPF/TNIP2/IL16/IL21R/DUSP3/MAP2K3/MMP2/IL18/FPR1/CXCL8/CSF3R/MCL1/OPRM1/ZEB1/TNF/LMNB1/PELI2/PTPN5/CCND1/CSF1/FN1/CASP1/IL10RA/RORA/UBC/TNFRSF1B/IL12B/IL1RN/CCL4/STX3/GSDMD/PTGS2/RPS27A/CNTFR/CSF3/ICAM1/STAT1/TXLNA/PIK3R3/IL33/CASP8/PIK3CD/S1PR1/NOD2/MAP3K8/PTPN20/CCR1/CCL3L1/DUSP6,88,3.0211142167181793,2.384677163367391,3.827407437226564
R-HSA-418038,Nucleotide-like (purinergic) receptors,9/1379,14/9872,0.6428571428571429,4.602092613695224,5.4344629560462705,2.0369781292146065e-5,0.004321303602690987,0.0040096306332961205,P2RY12/P2RY13/P2RY6/P2RY14/LPAR4/ADORA1/GPR17/LPAR6/ADORA2A,9,9.092769087330364,3.9286546576770935,21.044977703485955
R-HSA-71387,Metabolism of carbohydrates and carbohydrate derivatives,64/1379,278/9872,0.2302158273381295,1.6480715355199524,4.416493898277792,2.5266500700442894e-5,0.0046900941925197125,0.004351822291694704,HS3ST4/GPC5/PGK1/HPSE2/ALDH1A1/CSGALNACT1/GLCE/PYGL/HK2/SLC35D2/AKR1E2/PFKFB3/CHST9/VCAN/CSPG5/B3GAT1/ENO1/ACAN/B3GAT2/CHSY1/PFKL/HS3ST1/HAS1/NCAN/B3GALT5/PCK1/CSGALNACT2/ENO2/PYGM/NUP205/ST3GAL6/PGM2/B4GALT5/GYS1/GPC6/ST3GAL4/NUP188/HPSE/CHST3/PFKFB4/OMD/GPI/UBC/CHST13/OGN/FUT3/HKDC1/RPS27A/TPI1/CHST2/GPC2/CHST7/HK1/XYLB/PFKP/B3GAT3/CHSY3/SLC2A1/GALK1/GBE1/GLB1L3/PFKM/BPGM/B3GALT2,64,3.2562434461422884,2.4679759801564813,4.296282243343518
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,12/1379,25/9872,0.48,3.4362291515591004,4.914375282429781,4.688692974646454e-5,0.0068653608154790454,0.006370198339508823,ENTPD1/C3/IL1B/NT5E/NLRP3/HMOX1/IL18/CASP1/C3AR1/GSDMD/MEFV/TXN,12,6.789267585206671,3.40365698400684,13.542538087746799
R-HSA-9664424,Cell recruitment (pro-inflammatory response),12/1379,25/9872,0.48,3.4362291515591004,4.914375282429781,4.688692974646454e-5,0.0068653608154790454,0.006370198339508823,ENTPD1/C3/IL1B/NT5E/NLRP3/HMOX1/IL18/CASP1/C3AR1/GSDMD/MEFV/TXN,12,6.789267585206671,3.40365698400684,13.542538087746799
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,22/1379,66/9872,0.3333333333333333,2.3862702441382644,4.55308828749906,5.085452455910404e-5,0.0068653608154790454,0.006370198339508823,TLL2/P3H2/P4HA1/P4HA2/ADAMTS14/COL9A1/COL4A1/COL5A3/COL10A1/PLOD1/COL5A2/COL4A2/COL12A1/BMP1/COL18A1/COL8A2/COL14A1/P3H3/COL3A1/COL8A1/TLL1/PLOD2,22,4.714769156393522,2.9011300769132973,7.662203213490731
R-HSA-1474290,Collagen formation,26/1379,85/9872,0.3058823529411765,2.1897538710915843,4.438885495746934,5.8786422369226985e-5,0.007274819768191839,0.0067501251650279055,TLL2/P3H2/P4HA1/P4HA2/ADAMTS14/COL9A1/CTSS/COL4A1/ITGB4/LOXL2/COL5A3/LOXL3/COL10A1/PLOD1/COL5A2/COL4A2/COL12A1/BMP1/COL18A1/COL8A2/COL14A1/P3H3/COL3A1/COL8A1/TLL1/PLOD2,26,4.326494049396408,2.7790679222508503,6.7355499336992875
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),56/1379,247/9872,0.22672064777327935,1.6230502065393864,3.9957959177803204,1.235187572449625e-4,0.013237622680012696,0.012282862369758372,CX3CR1/EDNRB/CXCL12/CYSLTR1/P2RY12/P2RY13/C3/PTAFR/LPAR5/PENK/FFAR4/HRH2/P2RY6/CCL3/CCRL2/P2RY14/ADRB2/CCL2/LPAR4/ADORA1/ACKR3/NPFFR1/CX3CL1/FPR1/CXCL8/F2R/OPRM1/PTGDR/GPR17/PROK2/C3AR1/NTSR2/PDYN/OPRL1/GPR37L1/C5AR1/NLN/TACR1/ADRB1/CCL4/DRD1/LPAR6/ADORA2A/TAC1/HTR2C/NPY1R/EDN3/PLPPR5/CNR1/GPR132/S1PR1/KEL/NMUR2/CMKLR1/CCR1/CCL3L1,56,3.2068065517170514,2.3871206695190965,4.307954931414137
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,19/1379,56/9872,0.3392857142857143,2.4288822127835905,4.320711965971505,1.2479913637722408e-4,0.013237622680012696,0.012282862369758372,TLL2/COL9A1/CTSS/COL4A1/ITGB4/LOXL2/COL5A3/LOXL3/COL10A1/COL5A2/COL4A2/COL12A1/BMP1/COL18A1/COL8A2/COL14A1/COL3A1/COL8A1/TLL1,19,4.798961462757692,2.8438735957505106,8.098120519648385
R-HSA-417957,P2Y receptors,7/1379,11/9872,0.6363636363636364,4.555606829718505,4.7542470087039534,2.0150596542330065e-4,0.019949090576906765,0.01851026727993688,P2RY12/P2RY13/P2RY6/P2RY14/LPAR4/GPR17/LPAR6,7,9.000922934933087,3.483741496081739,23.25563299450492
R-HSA-156902,Peptide chain elongation,25/1379,87/9872,0.28735632183908044,2.0571295208088487,3.990612505425253,2.442685645316132e-4,0.02267117614559035,0.021036023090255374,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/EEF1A1/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,25,4.06445616930476,2.5965130293086873,6.362303506945184
R-HSA-5218859,Regulated Necrosis,19/1379,59/9872,0.3220338983050847,2.3053797273878143,4.05223027752363,2.7121531254163737e-4,0.022894150266553445,0.021242915257074932,IL1B/IRF1/CASP4/MLKL/FLOT1/TNFSF10/FLOT2/IL18/GSDME/CASP1/UBC/CHMP4C/TNFRSF10A/GSDMD/RPS27A/CASP8/CASP5/TRADD/TNFRSF10B,19,4.554946473125945,2.708311162489981,7.660691895523372
R-HSA-76002,"Platelet activation, signaling and aggregation",54/1379,243/9872,0.2222222222222222,1.5908468294255096,3.7576783261070976,2.775048517157993e-4,0.022894150266553445,0.021242915257074932,A2M/SRGN/ABCC4/MGLL/P2RY12/VEGFA/ITGB3/HABP4/IGF1/PROS1/PRKCD/LHFPL2/PLA2G4A/RAB27B/PIK3R5/SYK/GNB3/PECAM1/CD9/SERPINA1/TGFB3/PDGFA/APBB1IP/PIK3CG/GNB4/DAGLB/F2R/PDPN/CALU/PCDH7/TAGLN2/BCAR1/SCG3/GNA12/FLNA/FN1/WDR1/FCER1G/CD109/VAV3/RHOB/ARRB2/GAS6/RAPGEF3/VEGFD/GNG2/PDGFB/PIK3R3/PRKCH/ITPR1/CD63/GP1BA/SYTL4/MMRN1,54,3.1431794375956814,2.328786482647829,4.2423713167946735
R-HSA-202733,Cell surface interactions at the vascular wall,33/1379,129/9872,0.2558139534883721,1.831323675734017,3.829576946298152,3.115819407802449e-4,0.024352588529403352,0.02259616401558674,CD84/SELPLG/INPP5D/TREM1/L1CAM/JAM2/ITGB3/TNFRSF10D/MERTK/PROS1/CD47/ITGAX/ATP1B3/PECAM1/THBD/SLC16A3/ITGA4/PSG8/FN1/FCER1G/SLC7A11/TNFRSF10A/SLC7A8/SLC3A2/GAS6/ANGPT4/SELE/GYPC/CD244/PSG9/SELL/TNFRSF10B/CD58,33,3.618311213046191,2.459052182640863,5.32407409931238
R-HSA-3000171,Non-integrin membrane-ECM interactions,23/1379,79/9872,0.2911392405063291,2.0842107195638,3.8985356702246685,3.465388342439366e-4,0.025171434710648168,0.023355951115533194,SGCZ/NRXN1/ITGB3/COL4A1/ITGB4/DMD/PDGFA/LAMA1/COL5A3/COL10A1/COL5A2/COL4A2/FN1/ACTG1/SNTA1/SGCD/UTRN/ACTA2/LAMA4/LAMA2/PDGFB/ACTB/COL3A1,23,4.117962934065228,2.579956653668099,6.572830866063317
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,17/1379,51/9872,0.3333333333333333,2.3862702441382644,3.9993303679812757,3.559596827768428e-4,0.025171434710648168,0.023355951115533194,GPC5/CSGALNACT1/CHST9/VCAN/CSPG5/B3GAT1/B3GAT2/CHSY1/NCAN/CSGALNACT2/GPC6/CHST3/CHST13/GPC2/CHST7/B3GAT3/CHSY3,17,4.714769156393522,2.7157818467440027,8.18513763347025
R-HSA-1630316,Glycosaminoglycan metabolism,32/1379,125/9872,0.256,1.8326555474981872,3.7750008201495655,3.7640289293534596e-4,0.02540719527313585,0.023574707504897985,HS3ST4/GPC5/HPSE2/CSGALNACT1/GLCE/SLC35D2/CHST9/VCAN/CSPG5/B3GAT1/ACAN/B3GAT2/CHSY1/HS3ST1/HAS1/NCAN/CSGALNACT2/ST3GAL6/B4GALT5/GPC6/ST3GAL4/HPSE/CHST3/OMD/CHST13/OGN/CHST2/GPC2/CHST7/B3GAT3/CHSY3/GLB1L3,32,3.620942712110225,2.4463690721034776,5.359463653254347
R-HSA-9658195,Leishmania infection,38/1379,159/9872,0.2389937106918239,1.710910741080265,3.641405893631125,4.980783300714059e-4,0.03079319135907772,0.02857223993551851,CYSLTR1/WIPF3/ENTPD1/C3/IL1B/NT5E/DOCK1/DPEP2/CYFIP1/MYO10/NCKAP1L/FCGR2A/NLRP3/SYK/FCGR1A/GNB3/HMOX1/FGR/CD163/ADCY3/FCGR3A/GNB4/IL18/CASP1/BTK/C3AR1/ACTG1/WNT5A/VAV3/ADCY7/GSDMD/GNG2/ACTB/MEFV/ITPR1/NCKIPSD/TXN/PLK2,38,3.380400527225544,2.362901204664836,4.836049726458033
R-HSA-9824443,Parasitic Infection Pathways,38/1379,159/9872,0.2389937106918239,1.710910741080265,3.641405893631125,4.980783300714059e-4,0.03079319135907772,0.02857223993551851,CYSLTR1/WIPF3/ENTPD1/C3/IL1B/NT5E/DOCK1/DPEP2/CYFIP1/MYO10/NCKAP1L/FCGR2A/NLRP3/SYK/FCGR1A/GNB3/HMOX1/FGR/CD163/ADCY3/FCGR3A/GNB4/IL18/CASP1/BTK/C3AR1/ACTG1/WNT5A/VAV3/ADCY7/GSDMD/GNG2/ACTB/MEFV/ITPR1/NCKIPSD/TXN/PLK2,38,3.380400527225544,2.362901204664836,4.836049726458033
R-HSA-156842,Eukaryotic Translation Elongation,25/1379,91/9872,0.27472527472527475,1.9667062451688992,3.7329806431784265,5.184038949339684e-4,0.03079319135907772,0.02857223993551851,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/EEF1A1/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,25,3.8857987552693856,2.4877755639688113,6.0694510329398845
R-HSA-192823,Viral mRNA Translation,24/1379,87/9872,0.27586206896551724,1.9748443399764946,3.6799899514457524,6.231897032577168e-4,0.034647948470874865,0.03214897362989559,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,24,3.9018779225325697,2.475047022531141,6.151257403900707
R-HSA-5686938,Regulation of TLR by endogenous ligand,8/1379,16/9872,0.5,3.579405366207397,4.160651974381055,6.428111797505656e-4,0.034647948470874865,0.03214897362989559,TLR2/CD14/S100A9/TLR7/S100A8/GSDME/LY96/GSDMD,8,7.072153734590283,3.0213530235307577,16.55396044624778
R-HSA-425407,SLC-mediated transmembrane transport,51/1379,234/9872,0.21794871794871795,1.5602536211673268,3.4948721020158717,6.53294651302691e-4,0.034647948470874865,0.03214897362989559,SLC11A1/SLC1A2/SLC2A3/SLCO1C1/RUNX1/SLC4A7/SLC8A3/SLC8A1/SLC16A7/SLC14A1/SLC29A3/SLC35D2/EMB/SLC24A3/SLC40A1/SLC11A2/SLC4A5/AHCYL2/SLC7A3/SLC6A6/SLC6A15/SLC38A4/SLC4A4/SLC39A10/SLC22A4/SLC45A3/SLC16A3/SLC15A3/SLC7A1/SLC25A18/SLC27A1/SLCO2B1/SLC27A6/SLC30A10/SLC1A4/SLC39A14/HEPH/SLC1A6/SLC31A1/SLC7A11/SLC7A8/SLC3A2/SLC32A1/SLC6A20/SLC26A7/SLC4A10/SLC2A1/CP/RHCG/SLC12A5/SLC17A8,51,3.0827336791803797,2.2660584679747564,4.193734217831694
R-HSA-373080,Class B/2 (Secretin family receptors),23/1379,83/9872,0.27710843373493976,1.9837668294643402,3.626554462190705,7.489739391542852e-4,0.038344359715772554,0.03557878211444003,CD55/DHH/CALCRL/ADGRE2/CALCR/ADM/FZD5/GNB3/CRH/GNB4/PTH2R/WNT11/WNT7A/WNT2B/WNT5A/WNT8B/ADGRE5/ADM2/CRHBP/SMO/GNG2/FZD2/WNT6,23,3.919506889050036,2.461799438395962,6.240367925065608
R-HSA-114608,Platelet degranulation,29/1379,114/9872,0.2543859649122807,1.8211009757897283,3.553045213318525,7.746335296115668e-4,0.038344359715772554,0.03557878211444003,A2M/SRGN/ABCC4/VEGFA/ITGB3/HABP4/IGF1/PROS1/LHFPL2/RAB27B/PECAM1/CD9/SERPINA1/TGFB3/PDGFA/CALU/PCDH7/TAGLN2/SCG3/FLNA/FN1/WDR1/CD109/GAS6/VEGFD/PDGFB/CD63/SYTL4/MMRN1,29,3.5981133035634776,2.3848379796197805,5.428636853286174
R-HSA-383280,Nuclear Receptor transcription pathway,16/1379,50/9872,0.32,2.2908194343727337,3.6870810099155786,8.754539010211647e-4,0.041937065903755795,0.038912365244030724,NR2F1/HNF4G/ESRRB/RARB/RARA/NR4A3/NR2E1/AR/PPARG/RORA/ESRRG/RARG/PGR/RXRG/NR4A1/NR1I3,16,4.5261783901377814,2.570930510378604,7.968434283481804
R-HSA-2408557,Selenocysteine synthesis,24/1379,90/9872,0.26666666666666666,1.9090161953106115,3.4906892881852265,0.0010542633759336854,0.0472596221000873,0.04385103337162096,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,24,3.771815325114817,2.3964236176959757,5.93659265487003
R-HSA-72764,Eukaryotic Translation Termination,24/1379,90/9872,0.26666666666666666,1.9090161953106115,3.4906892881852265,0.0010542633759336854,0.0472596221000873,0.04385103337162096,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,24,3.771815325114817,2.3964236176959757,5.93659265487003
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),28/1379,111/9872,0.25225225225225223,1.805826130699227,3.440232752829528,0.0010897026574452076,0.0472596221000873,0.04385103337162096,VGF/SPARCL1/C3/IGF1/CHRDL1/PENK/FAM20C/SPP1/SCG2/VCAN/SERPINA1/MFGE8/MMP2/STC2/SHISA5/CALU/SCG3/CSF1/FN1/ENAM/IGFBP6/GAS6/IGFBP2/CST3/MEPE/CKAP4/CHGB/CP,28,3.5679334156491516,2.3488022553962686,5.419847000427079
R-HSA-112316,Neuronal System,78/1379,400/9872,0.195,1.3959680928208846,3.257628004453888,0.0011138631471401047,0.0472596221000873,0.04385103337162096,SLC1A2/GABRB1/CACNB4/GLUL/NRXN1/KCNQ3/KCNMB4/EPB41L2/HCN2/IL1RAP/CACNA1A/PPFIA2/PTPRF/SLITRK5/CAMK2G/LRRTM2/GNB3/KCNK10/NLGN4X/KCNMB2/KCNJ16/ADCY3/FLOT1/PLCB1/GRIN1/KCNH5/SYT1/KCNK2/GNB4/FLOT2/NCALD/KCNMA1/KCNC3/PPFIA4/CACNG3/RIMS1/RASGRF1/EPB41/KCNA2/GRIK4/TUBB4A/TUBA1A/ALDH5A1/GABRG3/CAMK4/CAMK2D/SLC1A6/DLGAP1/KCNN4/GABRA2/GABRG2/KCND2/GABRA4/GRIK2/KCNF1/KCNJ6/TSPOAP1/SLC32A1/ADCY7/KCNQ2/GNG2/GRM1/NAAA/PLCB2/KCNV1/KCNQ5/PPFIBP1/CACNG4/GRIA1/GRIA4/KCNAB1/KCNA5/GIT1/KCNJ3/GABRB3/GRIN2B/TUBA1B/CACNG2,78,2.7581399564902105,2.1508949280995013,3.5368236356898883
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,29/1379,119/9872,0.24369747899159663,1.7445841280674705,3.292685793862503,0.0016000485853679331,0.06600200414642725,0.061241625679725874,A2M/SRGN/ABCC4/VEGFA/ITGB3/HABP4/IGF1/PROS1/LHFPL2/RAB27B/PECAM1/CD9/SERPINA1/TGFB3/PDGFA/CALU/PCDH7/TAGLN2/SCG3/FLNA/FN1/WDR1/CD109/GAS6/VEGFD/PDGFB/CD63/SYTL4/MMRN1,29,3.446932072321314,2.2885789808803847,5.191579932551301
R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,25/1379,98/9872,0.25510204081632654,1.826227227656835,3.312138738729858,0.0016614770047657889,0.0666836041101945,0.061874065412188275,ATF3/RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,25,3.608241701321573,2.317930680702848,5.616823783189335
R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),24/1379,93/9872,0.25806451612903225,1.8474350277199465,3.3085127246560435,0.0017216731968615867,0.06728117624577516,0.06242853780309743,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,24,3.650143863014339,2.3226482662526893,5.7363615551644305
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,27/1379,109/9872,0.24770642201834864,1.7732833924330225,3.271089555761322,0.0017690100621727991,0.0673584600596566,0.062500247540734,TREM1/C3/SIGLEC8/LILRB1/SIGLEC9/FCGR1A/LILRB4/TREM2/FCGR3A/SIGLEC5/ITGA4/MADCAM1/LILRA4/CD300LF/CLEC2D/CD96/LILRA1/NECTIN2/KLRD1/ICAM1/LILRA2/ITGB7/COL3A1/SIGLEC10/PVR/SELL/TREML4,27,3.5036357951181216,2.2908858842095383,5.358391646412627
R-HSA-2408522,Selenoamino acid metabolism,26/1379,105/9872,0.24761904761904763,1.7726578956455679,3.2072546953687215,0.0021428539316211944,0.07761312410871887,0.07201529644395746,HNMT/NNMT/RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,26,3.5023999447494734,2.271953119562728,5.3992334909366635
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,26/1379,105/9872,0.24761904761904763,1.7726578956455679,3.2072546953687215,0.0021428539316211944,0.07761312410871887,0.07201529644395746,SLC1A2/SLC4A7/SLC8A3/SLC8A1/SLC24A3/SLC4A5/AHCYL2/SLC7A3/SLC6A6/SLC6A15/SLC38A4/SLC4A4/SLC15A3/SLC7A1/SLC25A18/SLC1A4/SLC1A6/SLC7A11/SLC7A8/SLC3A2/SLC32A1/SLC6A20/SLC26A7/SLC4A10/SLC12A5/SLC17A8,26,3.5023999447494734,2.271953119562728,5.3992334909366635
R-HSA-216083,Integrin cell surface interactions,21/1379,79/9872,0.26582278481012656,1.902975004819122,3.2468598604383088,0.002203732502748584,0.07791768491861065,0.07229789087964653,JAM2/ITGB3/CD47/SPP1/ITGAX/COL9A1/COL4A1/PECAM1/COL5A3/ITGA4/MADCAM1/COL10A1/COL5A2/COL4A2/FN1/COL18A1/COL8A2/ICAM1/ITGB7/COL3A1/COL8A1,21,3.759879200668252,2.3165742540357943,6.102412464866885
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),7/1379,15/9872,0.4666666666666667,3.34077834179357,3.655659090613888,0.0023543333261348744,0.0813066276583788,0.07544240695007469,PTGS1/TBXAS1/HPGDS/AKR1C3/CYP8B1/PTGS2/CBR1,7,6.600676818950929,2.6867855277645236,16.21600757410907
R-HSA-425410,Metal ion SLC transporters,9/1379,23/9872,0.391304347826087,2.801273764857963,3.48481493978801,0.002543152488701338,0.08583139649367015,0.07964082793564718,SLC11A1/SLC40A1/SLC11A2/SLC39A10/SLC30A10/SLC39A14/HEPH/SLC31A1/CP,9,5.534729009679351,2.5560927171138057,11.984395169035755
R-HSA-418990,Adherens junctions interactions,16/1379,55/9872,0.2909090909090909,2.0825631221570307,3.2439737022583013,0.0026768454636821974,0.08833590030151252,0.08196469501660811,CDH19/CTNNA1/ADAM19/CDH6/CADM2/CDH8/CDH10/CDH18/AFDN/CDH24/ACTG1/NECTIN2/ACTB/ANGPTL4/PVR/CDH7,16,4.114707627397983,2.351765452876498,7.199195327178
R-HSA-418594,G alpha (i) signalling events,51/1379,251/9872,0.20318725099601595,1.4545790731201373,2.9394653097123196,0.0032316767655928614,0.10339516522738079,0.09593781412910968,CX3CR1/RGS18/RGS1/CXCL12/P2RY12/RGS10/P2RY13/C3/LPAR5/RGS16/PENK/PRKCD/PDE4D/GRM3/PLA2G4A/P2RY14/CAMK2G/GNB3/ADCY3/ADORA1/PLCB1/ACKR3/GNB4/CX3CL1/FPR1/CXCL8/OPRM1/RGS22/GPR17/RGS9/CAMK4/CAMK2D/C3AR1/PDYN/OPRL1/GPR37L1/C5AR1/CCL4/ADCY7/GNG2/PDE4A/PLCB2/NPY1R/PLCB4/CNR1/GRM4/ITPR1/RGS7/NMUR2/CCL4L2/CCR1,51,2.8739429519052146,2.116411255467501,3.9026196205808685
R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,10/1379,28/9872,0.35714285714285715,2.556718118719569,3.3238034966844583,0.0032724395728531298,0.10339516522738079,0.09593781412910968,INPP5D/PLD4/PLCB1/PLCH2/ITPKC/PLCD4/PLCB2/PLCH1/PLCB4/PLCZ1,10,5.051538381850202,2.4487499826755994,10.420843370634254
R-HSA-6798695,Neutrophil degranulation,82/1379,441/9872,0.18594104308390022,1.3311167348254263,2.866511576984804,0.003411421194060485,0.10554084319124626,0.09792873559265734,SLC11A1/TLR2/SLC2A3/CD55/MVP/GLIPR1/CD93/SLC2A5/C3/CD14/PTAFR/PYGL/ATP8B4/CYFIP1/PLAUR/CD47/FRK/PRKCD/ITGAX/NCKAP1L/FCGR2A/CD59/CTSS/NFASC/ADA2/SIGLEC9/BIN2/IQGAP1/HVCN1/PECAM1/FGR/S100A9/FCAR/PFKL/CLEC5A/SERPINA1/CYBB/GCA/MGAM/SERPINB6/HSPA6/PTPRB/PGM2/MNDA/SIGLEC5/LRG1/FPR1/CD53/S100A8/GGH/HPSE/GPI/C3AR1/CR1/SERPINB1/FCER1G/TNFRSF1B/C5AR1/FCGR3B/ADGRG3/PLAC8/ARL8A/IQGAP2/ADGRE5/LTF/GSDMD/GRN/MGST1/EEF1A1/CST3/HSPA1A/HSPA1B/NFAM1/CD63/FTH1/IMPDH1/SELL/CKAP4/CHI3L1/FABP5/CD58/BST1,82,2.6300072845188356,2.064794625758916,3.3499401007399547
R-HSA-375276,Peptide ligand-binding receptors,32/1379,142/9872,0.22535211267605634,1.6132531227976998,2.9659216039133645,0.0036216389797587346,0.10945986136768346,0.10156509553804549,CX3CR1/EDNRB/CXCL12/C3/PENK/CCL3/CCRL2/CCL2/ACKR3/NPFFR1/CX3CL1/FPR1/CXCL8/F2R/OPRM1/PROK2/C3AR1/NTSR2/PDYN/OPRL1/GPR37L1/C5AR1/NLN/TACR1/CCL4/TAC1/NPY1R/EDN3/KEL/NMUR2/CCR1/CCL3L1,32,3.187449570519564,2.1636820133223886,4.695622878985193
R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,7/1379,16/9872,0.4375,3.1319796954314723,3.4389420311161936,0.00368551721776712,0.10945986136768346,0.10156509553804549,CD14/TNFSF10/LY96/TNFRSF10A/CASP8/TRADD/TNFRSF10B,7,6.188134517766497,2.541503245003616,15.067070595032318
R-HSA-1296071,Potassium Channels,24/1379,99/9872,0.24242424242424243,1.7354692684641926,2.963468568884778,0.004173663726667516,0.11919020450194734,0.11059364004469188,KCNQ3/KCNMB4/HCN2/GNB3/KCNK10/KCNMB2/KCNJ16/KCNH5/KCNK2/GNB4/KCNMA1/KCNC3/KCNA2/KCNN4/KCND2/KCNF1/KCNJ6/KCNQ2/GNG2/KCNV1/KCNQ5/KCNAB1/KCNA5/KCNJ3,24,3.4289230228316523,2.187950343251322,5.3737568280608885
R-HSA-72689,Formation of a pool of free 40S subunits,24/1379,99/9872,0.24242424242424243,1.7354692684641926,2.963468568884778,0.004173663726667516,0.11919020450194734,0.11059364004469188,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,24,3.4289230228316523,2.187950343251322,5.3737568280608885
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",19/1379,73/9872,0.2602739726027397,1.8632521084367268,2.9829113455572474,0.004507991079554816,0.12398818601416603,0.11504556830944063,SLC11A1/RUNX1/SLC16A7/SLC14A1/EMB/SLC40A1/SLC11A2/SLC6A6/SLC6A15/SLC39A10/SLC22A4/SLC16A3/SLC30A10/SLC39A14/HEPH/SLC31A1/SLC6A20/CP/RHCG,19,3.681395094718229,2.215669844977583,6.116737055449052
R-HSA-2672351,Stimuli-sensing channels,25/1379,105/9872,0.23809523809523808,1.704478745813046,2.9242473001697085,0.004508661309606038,0.12398818601416603,0.11504556830944063,TRPM1/RYR1/CLCA4/SGK1/TRPC5/BEST1/TRPC4AP/ANO2/SGK2/ANO3/TRPM6/MLKL/UNC80/TRDN/SLC9B2/TRPV4/CLCN2/CLCN5/UBC/SLC9C2/WNK2/RPS27A/TRPM3/TRPV5/RYR3,25,3.3676922545668013,2.169820614398199,5.226861172860023
R-HSA-8957275,Post-translational protein phosphorylation,24/1379,100/9872,0.24,1.7181145757795502,2.9082662249854874,0.004782731258024193,0.12475522132006293,0.11575728138079915,VGF/SPARCL1/C3/CHRDL1/PENK/FAM20C/SPP1/SCG2/VCAN/SERPINA1/MFGE8/STC2/SHISA5/CALU/SCG3/CSF1/FN1/ENAM/GAS6/CST3/MEPE/CKAP4/CHGB/CP,24,3.3946337926033356,2.167006900957085,5.317721222205149
R-HSA-2142753,Arachidonate metabolism,15/1379,53/9872,0.2830188679245283,2.026078509173998,3.0179847668198967,0.004785592324724193,0.12475522132006293,0.11575728138079915,LTC4S/DPEP2/PTGS1/TBXAS1/PLA2G4A/ALOX15B/HPGDS/SLC27A1/AKR1C3/CYP8B1/PTGR1/PTGS2/CBR1/CYP4F3/ALOX5AP,15,4.003105887503934,2.250713487530594,7.1199007938369725
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,16/1379,58/9872,0.27586206896551724,1.9748443399764946,3.000256542347442,0.004788584252689284,0.12475522132006293,0.11575728138079915,HS3ST4/GPC5/HPSE2/GLCE/SLC35D2/VCAN/CSPG5/B3GAT1/B3GAT2/HS3ST1/NCAN/GPC6/HPSE/GPC2/B3GAT3/GLB1L3,16,3.9018779225325697,2.237356440250602,6.804750038237894
R-HSA-5602498,MyD88 deficiency (TLR2/4),6/1379,13/9872,0.46153846153846156,3.304066491883751,3.3495186314259078,0.005233294708782254,0.13114023792574336,0.12168178021959813,TLR2/CD14/S100A9/S100A8/BTK/LY96,6,6.528141908852569,2.477444469329159,17.201853486410123
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,12/1379,39/9872,0.3076923076923077,2.2027109945891676,3.0323736351312593,0.005386905396276327,0.13114023792574336,0.12168178021959813,GPC5/VCAN/CSPG5/ACAN/CHSY1/NCAN/GPC6/CHST3/OMD/OGN/GPC2/B3GAT3,12,4.352094605901713,2.2735342791091107,8.330961900491225
R-HSA-5362517,Signaling by Retinoic Acid,12/1379,39/9872,0.3076923076923077,2.2027109945891676,3.0323736351312593,0.005386905396276327,0.13114023792574336,0.12168178021959813,PDK1/ALDH1A1/CYP26C1/DHRS9/RARB/RARA/PDK3/RDH10/AKR1C3/RARG/RXRG/FABP5,12,4.352094605901713,2.2735342791091107,8.330961900491225
R-HSA-9031628,NGF-stimulated transcription,12/1379,39/9872,0.3076923076923077,2.2027109945891676,3.0323736351312593,0.005386905396276327,0.13114023792574336,0.12168178021959813,FOS/VGF/SGK1/ID4/JUNB/EGR1/FOSL1/ID2/LYL1/ARC/EGR3/ASCL1,12,4.352094605901713,2.2735342791091107,8.330961900491225
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,17/1379,64/9872,0.265625,1.9015591007976795,2.9155876847737647,0.005628029628960623,0.1313537897737446,0.12187992969259732,ITGB3/LMNA/IQGAP1/CAMK2G/MARK3/APBB1IP/MPRIP/TRAK1/CAMK2D/FN1/CNKSR2/ACTG1/KIAA1549/ARRB2/ACTB/AGTRAP/KSR2,17,3.757081671501088,2.1947540429636585,6.431546501342127
R-HSA-352230,Amino acid transport across the plasma membrane,10/1379,30/9872,0.3333333333333333,2.3862702441382644,3.064072205718718,0.005761988675195134,0.1313537897737446,0.12187992969259732,SLC7A3/SLC6A6/SLC6A15/SLC38A4/SLC7A1/SLC1A4/SLC7A11/SLC7A8/SLC3A2/SLC6A20,10,4.714769156393522,2.300044227272766,9.664617721041541
R-HSA-445095,Interaction between L1 and Ankyrins,10/1379,30/9872,0.3333333333333333,2.3862702441382644,3.064072205718718,0.005761988675195134,0.1313537897737446,0.12187992969259732,L1CAM/KCNQ3/SCN1B/NFASC/SCN1A/SCN11A/ACTG1/ANK1/KCNQ2/ACTB,10,4.714769156393522,2.300044227272766,9.664617721041541
R-HSA-9616222,Transcriptional regulation of granulopoiesis,10/1379,30/9872,0.3333333333333333,2.3862702441382644,3.064072205718718,0.005761988675195134,0.1313537897737446,0.12187992969259732,STAT3/RUNX1/CDKN1A/CEBPA/FLI1/RARA/CSF3R/TAL1/CEBPE/TFDP2,10,4.714769156393522,2.300044227272766,9.664617721041541
R-HSA-446728,Cell junction organization,25/1379,107/9872,0.2336448598130841,1.6726193300034562,2.8187545231374354,0.005837946212166427,0.1313537897737446,0.12187992969259732,CDH19/CTNNA1/ARHGEF6/ADAM19/CDH6/PXN/CADM2/CLDN11/ITGB4/CDH8/CDH10/CDH18/CLDN7/AFDN/CDH24/CLDN14/PARD6G/FLNA/ACTG1/NECTIN2/ACTB/PARVA/ANGPTL4/PVR/CDH7,25,3.3047447357898516,2.130921588616548,5.12517111238296
R-HSA-877300,Interferon gamma signaling,22/1379,91/9872,0.24175824175824176,1.7307014957486313,2.8216374448833643,0.006145710278546012,0.1362146233379228,0.12639017682037282,SOCS3/GBP2/PTAFR/SMAD7/PTPN2/IRF1/PRKCD/IFNGR1/TRIM38/OAS1/CAMK2G/FCGR1A/IRF5/TRIM34/TRIM3/GBP1/CAMK2D/HLA-DRB5/ICAM1/STAT1/HLA-DQA2/IRF9,22,3.4195029046370595,2.139665422907586,5.46487314775209
R-HSA-9656223,Signaling by RAF1 mutants,12/1379,40/9872,0.3,2.1476432197244377,2.9305430320623986,0.006738142467962978,0.14714914066066212,0.1365360447455656,ITGB3/IQGAP1/CAMK2G/MARK3/APBB1IP/CAMK2D/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,12,4.24329224075417,2.2209095070350378,8.107277213866455
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,14/1379,50/9872,0.28,2.004467005076142,2.869147396516181,0.007000655778597196,0.15066628740893964,0.13979951814162822,EFNA1/EPHB2/EPHA6/EFNA5/EPHA4/MMP2/EPHB1/ACTG1/VAV3/EFNB1/ACTB/EPHA2/EPHB6/EPHB3,14,3.960406091370558,2.1840635230687195,7.181483616615263
R-HSA-425381,Bicarbonate transporters,5/1379,10/9872,0.5,3.579405366207397,3.288283451895757,0.007224075898315578,0.15209583887416842,0.14112596355575863,SLC4A7/SLC4A5/AHCYL2/SLC4A4/SLC4A10,5,7.072153734590283,2.413892368570977,20.71979641548324
R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,8/1379,22/9872,0.36363636363636365,2.6032039026962885,3.0332913983327763,0.0073613259253671025,0.15209583887416842,0.14112596355575863,ELOVL5/ACSL1/HACD4/ELOVL2/TECR/HACD1/ACSL6/ACSBG1,8,5.143384534247478,2.285676540371647,11.573993082518454
R-HSA-9013404,RAC2 GTPase cycle,21/1379,87/9872,0.2413793103448276,1.727988797479433,2.748122289507251,0.007464798894598333,0.15209583887416842,0.14112596355575863,ERBIN/ARHGAP26/TFRC/DOCK1/ARHGAP21/CYFIP1/ABR/NCKAP1L/IQGAP1/SLITRK5/CYBB/ARHGAP42/OPHN1/NCF2/DEF6/VAV3/PIK3R3/VANGL1/EPHA2/GIT1/DIAPH3,21,3.4141431822159984,2.1133364153532,5.515626184259862
R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,25/1379,109/9872,0.22935779816513763,1.6419290670676132,2.7154436360229384,0.007476765143309289,0.15209583887416842,0.14112596355575863,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/EIF4A1/RPL8/RPSA/RPS14,25,3.2441072177019645,2.0933942471669393,5.027352900290415
R-HSA-421270,Cell-cell junction organization,20/1379,82/9872,0.24390243902439024,1.7460513981499495,2.7334836206576485,0.007895858014687307,0.1559907712902991,0.1447399749204335,CDH19/CTNNA1/ADAM19/CDH6/CADM2/CLDN11/CDH8/CDH10/CDH18/CLDN7/AFDN/CDH24/CLDN14/PARD6G/ACTG1/NECTIN2/ACTB/ANGPTL4/PVR/CDH7,20,3.4498310900440408,2.109561808551811,5.641614529419536
R-HSA-2243919,Crosslinking of collagen fibrils,7/1379,18/9872,0.3888888888888889,2.783981951494642,3.052478241370483,0.007957893954854744,0.1559907712902991,0.1447399749204335,TLL2/COL4A1/LOXL2/LOXL3/COL4A2/BMP1/TLL1,7,5.500564015792442,2.2935267284928975,13.191999951843755
R-HSA-9913351,Formation of the dystrophin-glycoprotein complex (DGC),11/1379,36/9872,0.3055555555555556,2.187414390460076,2.8759176440447463,0.00802786260664139,0.1559907712902991,0.1447399749204335,SGCZ/DMD/LAMA1/ACTG1/SNTA1/SGCD/UTRN/ACTA2/LAMA4/LAMA2/ACTB,11,4.321871726694061,2.1951375162491735,8.509068376688104
R-HSA-5603041,IRAK4 deficiency (TLR2/4),6/1379,14/9872,0.42857142857142855,3.0680617424634824,3.1200766153274766,0.008088410363200694,0.1559907712902991,0.1447399749204335,TLR2/CD14/S100A9/S100A8/BTK/LY96,6,6.061846058220242,2.325823554969741,15.79912524105396
R-HSA-983712,Ion channel transport,37/1379,179/9872,0.20670391061452514,1.4797541737393707,2.610046939299976,0.008362231959476423,0.1564436634348564,0.14516020232941843,TRPM1/ATP1A2/RYR1/CLCA4/SGK1/ATP8B4/TRPC5/BEST1/TRPC4AP/ATP13A4/ATP1B3/ATP2B4/ANO2/SGK2/CAMK2G/ANO3/TRPM6/MLKL/UNC80/TRDN/SLC9B2/TRPV4/CLCN2/ATP2C2/FXYD6/CLCN5/ATP8B1/CAMK2D/UBC/SLC9C2/FXYD7/WNK2/RPS27A/TRPM3/TRPV5/RYR3/ATP13A5,37,2.9236836668138597,2.043562548972074,4.182855175093026
R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,25/1379,110/9872,0.22727272727272727,1.6270024391851803,2.664577266355935,0.00842794146450405,0.1564436634348564,0.14516020232941843,SRPRB/RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,25,3.214615333904674,2.075122459974372,4.979827429125643
R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,25/1379,110/9872,0.22727272727272727,1.6270024391851803,2.664577266355935,0.00842794146450405,0.1564436634348564,0.14516020232941843,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/EIF4A1/RPL8/RPSA/RPS14,25,3.214615333904674,2.075122459974372,4.979827429125643
R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,9/1379,27/9872,0.3333333333333333,2.3862702441382644,2.906391201928814,0.008671366975923344,0.15703634096641664,0.1457101331384295,GPC5/VCAN/CSPG5/B3GAT1/B3GAT2/NCAN/GPC6/GPC2/B3GAT3,9,4.714769156393522,2.2129385701563686,10.045036268905081
R-HSA-5620971,Pyroptosis,9/1379,27/9872,0.3333333333333333,2.3862702441382644,2.906391201928814,0.008671366975923344,0.15703634096641664,0.1457101331384295,IL1B/IRF1/CASP4/IL18/GSDME/CASP1/CHMP4C/GSDMD/CASP5,9,4.714769156393522,2.2129385701563686,10.045036268905081
R-HSA-4085001,Sialic acid metabolism,10/1379,32/9872,0.3125,2.2371283538796227,2.8243879347272216,0.009524178809272343,0.16570294787651083,0.15375166313687946,ST6GAL2/ST6GALNAC3/ST6GAL1/ST8SIA4/ST3GAL6/NEU4/ST3GAL4/ST8SIA3/ST8SIA6/NEU3,10,4.420096084118927,2.1683939488494532,9.010009183621781
R-HSA-5213460,RIPK1-mediated regulated necrosis,10/1379,32/9872,0.3125,2.2371283538796227,2.8243879347272216,0.009524178809272343,0.16570294787651083,0.15375166313687946,MLKL/FLOT1/TNFSF10/FLOT2/UBC/TNFRSF10A/RPS27A/CASP8/TRADD/TNFRSF10B,10,4.420096084118927,2.1683939488494532,9.010009183621781
R-HSA-5675482,Regulation of necroptotic cell death,10/1379,32/9872,0.3125,2.2371283538796227,2.8243879347272216,0.009524178809272343,0.16570294787651083,0.15375166313687946,MLKL/FLOT1/TNFSF10/FLOT2/UBC/TNFRSF10A/RPS27A/CASP8/TRADD/TNFRSF10B,10,4.420096084118927,2.1683939488494532,9.010009183621781
R-HSA-186797,Signaling by PDGF,15/1379,57/9872,0.2631578947368421,1.8838975611617874,2.6966610259938797,0.009853632769501335,0.16570294787651083,0.15375166313687946,STAT3/NCK2/SPP1/COL9A1/PDGFRA/COL4A1/PDGFA/COL5A3/COL5A2/BCAR1/COL4A2/PDGFRB/PDGFB/STAT1/COL3A1,15,3.722186176100149,2.1020682292467567,6.59097061493368
R-HSA-72613,Eukaryotic Translation Initiation,26/1379,117/9872,0.2222222222222222,1.5908468294255096,2.590516425836022,0.009865681012922572,0.16570294787651083,0.15375166313687946,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/EIF4EBP1/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/EIF4A1/RPL8/RPSA/RPS14,26,3.143179437595681,2.0478352199884053,4.824400362144488
R-HSA-72737,Cap-dependent Translation Initiation,26/1379,117/9872,0.2222222222222222,1.5908468294255096,2.590516425836022,0.009865681012922572,0.16570294787651083,0.15375166313687946,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/EIF4EBP1/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/EIF4A1/RPL8/RPSA/RPS14,26,3.143179437595681,2.0478352199884053,4.824400362144488
R-HSA-449836,Other interleukin signaling,8/1379,23/9872,0.34782608695652173,2.490021124318189,2.882653362262897,0.009931018424922198,0.16570294787651083,0.15375166313687946,CSF1R/CD4/IL16/CSF3R/CSF1/STX3/CSF3/TXLNA,8,4.919759119714979,2.196585909360676,11.018931557775213
R-HSA-9013149,RAC1 GTPase cycle,37/1379,182/9872,0.2032967032967033,1.4553626214249853,2.4984078226185193,0.01091557746653301,0.17095604402852854,0.15862588100892708,ERBIN/WIPF3/ARHGAP26/ARHGAP31/PREX2/TFRC/ARHGEF6/DOCK1/ARHGAP21/ARHGAP15/CYFIP1/ABR/NCKAP1L/IQGAP1/GMIP/ARHGEF10/CYBB/ARHGAP42/SRGAP2/ARHGDIB/NGEF/ARHGAP4/DOCK8/OPHN1/NCF2/DEF6/VAV3/IQGAP2/PAK5/PIK3R3/VANGL1/PLEKHG2/EPHA2/GIT1/PLEKHG4/ARHGAP20/DIAPH3,37,2.8754910788993455,2.0108710049539997,4.111874369096524
R-HSA-3928664,Ephrin signaling,7/1379,19/9872,0.3684210526315789,2.6374565856265026,2.8786873563931814,0.011106976503603615,0.17095604402852854,0.15862588100892708,NCK2/EPHB2/EPHB1/EFNB1/EPHB6/GIT1/EPHB3,7,5.211060646540208,2.1868620869890565,12.417405388059084
R-HSA-5260271,Diseases of Immune System,9/1379,28/9872,0.32142857142857145,2.301046306847612,2.777909636977448,0.01122875364053559,0.17095604402852854,0.15862588100892708,TLR2/CD14/NFKBIA/S100A9/TLR7/S100A8/TLR10/BTK/LY96,9,4.546384543665182,2.1411011136486873,9.653730170479534
R-HSA-5602358,Diseases associated with the TLR signaling cascade,9/1379,28/9872,0.32142857142857145,2.301046306847612,2.777909636977448,0.01122875364053559,0.17095604402852854,0.15862588100892708,TLR2/CD14/NFKBIA/S100A9/TLR7/S100A8/TLR10/BTK/LY96,9,4.546384543665182,2.1411011136486873,9.653730170479534
R-HSA-3000178,ECM proteoglycans,18/1379,74/9872,0.24324324324324326,1.7413323403171121,2.579242852751069,0.011698584583799724,0.17095604402852854,0.15862588100892708,ITGB3/ITGAX/COL9A1/VCAN/COL4A1/ACAN/TGFB3/NCAN/LAMA1/COL5A3/COL5A2/COL4A2/FN1/ASPN/LAMA4/LAMA2/HAPLN1/COL3A1,18,3.4405072222331103,2.0495581632305147,5.775434997941492
R-HSA-3371378,Regulation by c-FLIP,5/1379,11/9872,0.45454545454545453,3.2540048783703606,3.013858523678444,0.011736929354479047,0.17095604402852854,0.15862588100892708,TNFSF10/TNFRSF10A/CASP8/TRADD/TNFRSF10B,5,6.429230667809348,2.230664865049445,18.530352823297825
R-HSA-5218900,CASP8 activity is inhibited,5/1379,11/9872,0.45454545454545453,3.2540048783703606,3.013858523678444,0.011736929354479047,0.17095604402852854,0.15862588100892708,TNFSF10/TNFRSF10A/CASP8/TRADD/TNFRSF10B,5,6.429230667809348,2.230664865049445,18.530352823297825
R-HSA-69416,Dimerization of procaspase-8,5/1379,11/9872,0.45454545454545453,3.2540048783703606,3.013858523678444,0.011736929354479047,0.17095604402852854,0.15862588100892708,TNFSF10/TNFRSF10A/CASP8/TRADD/TNFRSF10B,5,6.429230667809348,2.230664865049445,18.530352823297825
R-HSA-9762292,Regulation of CDH11 function,5/1379,11/9872,0.45454545454545453,3.2540048783703606,3.013858523678444,0.011736929354479047,0.17095604402852854,0.15862588100892708,CTNNA1/ADAM19/CDH8/CDH24/ANGPTL4,5,6.429230667809348,2.230664865049445,18.530352823297825
R-HSA-927802,Nonsense-Mediated Decay (NMD),25/1379,113/9872,0.22123893805309736,1.583807684162565,2.5150030535157595,0.011889522762207323,0.17095604402852854,0.15862588100892708,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/SMG9/RPL19/RPL32/RPL8/RPSA/RPS14,25,3.129271563978001,2.022174012455747,4.842481636498442
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),25/1379,113/9872,0.22123893805309736,1.583807684162565,2.5150030535157595,0.011889522762207323,0.17095604402852854,0.15862588100892708,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/SMG9/RPL19/RPL32/RPL8/RPSA/RPS14,25,3.129271563978001,2.022174012455747,4.842481636498442
R-HSA-418457,cGMP effects,6/1379,15/9872,0.4,2.8635242929659173,2.910318076909757,0.011911128387911255,0.17095604402852854,0.15862588100892708,KCNMB4/KCNMB2/KCNMA1/PRKG1/ITPR1/PDE11A,6,5.6577229876722255,2.191700339586207,14.605020963439829
R-HSA-975577,N-Glycan antennae elongation,6/1379,15/9872,0.4,2.8635242929659173,2.910318076909757,0.011911128387911255,0.17095604402852854,0.15862588100892708,MGAT4C/ST6GAL1/B4GALT5/ST3GAL4/ST8SIA3/ST8SIA6,6,5.6577229876722255,2.191700339586207,14.605020963439829
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,10/1379,33/9872,0.30303030303030304,2.1693365855802402,2.7111476779404415,0.011994156989205654,0.17095604402852854,0.15862588100892708,ITGB3/IQGAP1/MARK3/APBB1IP/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,10,4.286153778539566,2.10807198603198,8.714652220140222
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,12/1379,43/9872,0.27906976744186046,1.997807646255291,2.642156480276688,0.01243316683843844,0.17095604402852854,0.15862588100892708,ITGB3/IQGAP1/CAMK2G/MARK3/APBB1IP/CAMK2D/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,12,3.94724859605039,2.0767241162657823,7.502571649737475
R-HSA-6802949,Signaling by RAS mutants,12/1379,43/9872,0.27906976744186046,1.997807646255291,2.642156480276688,0.01243316683843844,0.17095604402852854,0.15862588100892708,ITGB3/IQGAP1/CAMK2G/MARK3/APBB1IP/CAMK2D/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,12,3.94724859605039,2.0767241162657823,7.502571649737475
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,12/1379,43/9872,0.27906976744186046,1.997807646255291,2.642156480276688,0.01243316683843844,0.17095604402852854,0.15862588100892708,ITGB3/IQGAP1/CAMK2G/MARK3/APBB1IP/CAMK2D/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,12,3.94724859605039,2.0767241162657823,7.502571649737475
R-HSA-8948216,Collagen chain trimerization,12/1379,43/9872,0.27906976744186046,1.997807646255291,2.642156480276688,0.01243316683843844,0.17095604402852854,0.15862588100892708,COL9A1/COL4A1/COL5A3/COL10A1/COL5A2/COL4A2/COL12A1/COL18A1/COL8A2/COL14A1/COL3A1/COL8A1,12,3.94724859605039,2.0767241162657823,7.502571649737475
R-HSA-9649948,Signaling downstream of RAS mutants,12/1379,43/9872,0.27906976744186046,1.997807646255291,2.642156480276688,0.01243316683843844,0.17095604402852854,0.15862588100892708,ITGB3/IQGAP1/CAMK2G/MARK3/APBB1IP/CAMK2D/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,12,3.94724859605039,2.0767241162657823,7.502571649737475
R-HSA-6802957,Oncogenic MAPK signaling,19/1379,80/9872,0.2375,1.7002175489485134,2.5338122357007937,0.012635590565548747,0.17214543109944855,0.15972948382716862,ITGB3/LMNA/SPRED3/IQGAP1/CAMK2G/MARK3/APBB1IP/MPRIP/TRAK1/CAMK2D/FN1/CNKSR2/ACTG1/KIAA1549/ARRB2/ACTB/AGTRAP/KSR2/DUSP6,19,3.3592730239303843,2.031028874163684,5.55615697681949
R-HSA-6794362,Protein-protein interactions at synapses,20/1379,86/9872,0.23255813953488372,1.6648397052127426,2.4951445770615535,0.013476754344797275,0.18193618365476322,0.1688140807400922,NRXN1/EPB41L2/IL1RAP/PPFIA2/PTPRF/SLITRK5/LRRTM2/NLGN4X/FLOT1/GRIN1/SYT1/FLOT2/PPFIA4/EPB41/DLGAP1/GRM1/PPFIBP1/GRIA1/GRIA4/GRIN2B,20,3.289373830041992,2.0159133255253257,5.367284424763427
R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,10/1379,34/9872,0.29411764705882354,2.105532568357292,2.6018948265097896,0.0149178264045982,0.19628830354089702,0.18213105747654382,RPS3/RPS16/RPS3A/RPS6/RPS12/RPS27A/EEF1A1/RPS9/RPSA/RPS14,10,4.160090432111931,2.0510203948019723,8.437923117298
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,12/1379,44/9872,0.2727272727272727,1.952402927022216,2.5512124921808486,0.014980934266855421,0.19628830354089702,0.18213105747654382,BNIP3L/TNFRSF10D/BCL6/NDRG1/PMAIP1/TNFRSF10C/CASP10/CASP1/TNFRSF10A/BID/CASP2/TNFRSF10B,12,3.8575384006856086,2.032740583473239,7.3204631391470345
R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,7/1379,20/9872,0.35,2.5055837563451777,2.7157504725581703,0.015068597039503204,0.19628830354089702,0.18213105747654382,GPC5/VCAN/CSPG5/NCAN/GPC6/GPC2/B3GAT3,7,4.950507614213198,2.0896891907906454,11.727832898015944
R-HSA-9008059,Interleukin-37 signaling,7/1379,20/9872,0.35,2.5055837563451777,2.7157504725581703,0.015068597039503204,0.19628830354089702,0.18213105747654382,PTPN14/STAT3/PTPN13/PTPN2/PTPN5/CASP1/PTPN20,7,4.950507614213198,2.0896891907906454,11.727832898015944
R-HSA-1442490,Collagen degradation,14/1379,55/9872,0.2545454545454545,1.8222427318874017,2.4639060249909805,0.01665480249249178,0.21506418870739386,0.19955273650042785,COL9A1/COL4A1/ADAM9/MMP2/COL5A3/COL10A1/COL5A2/COL4A2/COL12A1/COL18A1/COL8A2/COL14A1/COL3A1/COL8A1,14,3.6003691739732346,1.9972557751030662,6.490234425897598
R-HSA-381771,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",6/1379,16/9872,0.375,2.6845540246555477,2.7172320878513325,0.01684649508999777,0.21544982137500865,0.19991055550585599,DPP4/FFAR4/GNB3/PAX6/TCF7L2/LEP,6,5.304115300942712,2.072211292108124,13.576626685145307
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,8/1379,25/9872,0.32,2.2908194343727337,2.6038482949363324,0.01697483441136432,0.21544982137500865,0.19991055550585599,SOCS3/STAT3/SYK/CSF3R/UBC/RPS27A/CSF3/STAT1,8,4.5261783901377814,2.037760032014652,10.053338223096008
R-HSA-2029481,FCGR activation,5/1379,12/9872,0.4166666666666667,2.982837805172831,2.769309549035056,0.01784043175364249,0.2223961946540018,0.20635592330468783,FCGR2A/SYK/FCGR1A/FGR/FCGR3A,5,5.893461445491903,2.0732663846610184,16.752737644554237
R-HSA-416476,G alpha (q) signalling events,37/1379,188/9872,0.19680851063829788,1.4089148781880179,2.280954350598439,0.017946429197464694,0.2223961946540018,0.20635592330468783,RGS18/RGS1/MGLL/EDNRB/CYSLTR1/PTAFR/LPAR5/RGS16/FFAR4/PRKCD/P2RY6/GNB3/LPAR4/PLCB1/NPFFR1/GNB4/DAGLB/RGS2/F2R/GPR17/BTK/PROK2/NTSR2/TACR1/LPAR6/GNG2/GRM1/TAC1/HTR2C/PLCB2/EDN3/PIK3R3/PLCB4/GPR132/PRKCH/ITPR1/NMUR2,37,2.7837200870195793,1.9485308712365255,3.976892353755097
R-HSA-1296072,Voltage gated Potassium channels,11/1379,40/9872,0.275,1.9686729514140684,2.4735368268854745,0.01827093316349375,0.2223961946540018,0.20635592330468783,KCNQ3/KCNH5/KCNC3/KCNA2/KCND2/KCNF1/KCNQ2/KCNV1/KCNQ5/KCNAB1/KCNA5,11,3.889684554024656,1.9913374799709196,7.597730712143747
R-HSA-380108,Chemokine receptors bind chemokines,11/1379,40/9872,0.275,1.9686729514140684,2.4735368268854745,0.01827093316349375,0.2223961946540018,0.20635592330468783,CX3CR1/CXCL12/CCL3/CCRL2/CCL2/ACKR3/CX3CL1/CXCL8/CCL4/CCR1/CCL3L1,11,3.889684554024656,1.9913374799709196,7.597730712143747
R-HSA-419037,NCAM1 interactions,11/1379,40/9872,0.275,1.9686729514140684,2.4735368268854745,0.01827093316349375,0.2223961946540018,0.20635592330468783,CACNB4/COL9A1/COL4A1/CACNA1D/NCAN/ST8SIA4/COL5A3/COL5A2/COL4A2/GDNF/COL3A1,11,3.889684554024656,1.9913374799709196,7.597730712143747
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),15/1379,61/9872,0.2459016393442623,1.7603632948560968,2.400278143710092,0.01843194698857838,0.2225320429108853,0.20648197353914508,FOS/VGF/SGK1/MEF2C/ID4/JUNB/EGR1/DUSP3/FOSL1/ID2/LYL1/ARC/EGR3/ASCL1/DUSP6,15,3.4781083940607953,1.9718645909044066,6.134923288666439
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",14/1379,56/9872,0.25,1.7897026831036984,2.3879349899659816,0.019437872444170712,0.23196120365089032,0.21523105835833098,NLRP1/NLRP3/CASP4/BCL2L1/HMOX1/CARD9/CASP1/UBC/RPS27A/MEFV/CASP8/NOD2/TXN/CASP2,14,3.536076867295141,1.9636694801521166,6.36758870971056
R-HSA-392154,Nitric oxide stimulates guanylate cyclase,7/1379,21/9872,0.3333333333333333,2.3862702441382644,2.562415402475643,0.019939912819392534,0.23196120365089032,0.21523105835833098,KCNMB4/GUCY1A1/KCNMB2/KCNMA1/PRKG1/ITPR1/PDE11A,7,4.714769156393522,2.000794096607736,11.110112847577923
R-HSA-622312,Inflammasomes,7/1379,21/9872,0.3333333333333333,2.3862702441382644,2.562415402475643,0.019939912819392534,0.23196120365089032,0.21523105835833098,NLRP1/NLRP3/BCL2L1/HMOX1/CASP1/MEFV/TXN,7,4.714769156393522,2.000794096607736,11.110112847577923
R-HSA-8849932,Synaptic adhesion-like molecules,7/1379,21/9872,0.3333333333333333,2.3862702441382644,2.562415402475643,0.019939912819392534,0.23196120365089032,0.21523105835833098,PTPRF/FLOT1/GRIN1/FLOT2/GRIA1/GRIA4/GRIN2B,7,4.714769156393522,2.000794096607736,11.110112847577923
R-HSA-70171,Glycolysis,16/1379,67/9872,0.23880597014925373,1.7095667420692044,2.348221180239289,0.019993962334891556,0.23196120365089032,0.21523105835833098,PGK1/HK2/PFKFB3/ENO1/PFKL/ENO2/NUP205/NUP188/PFKFB4/GPI/HKDC1/TPI1/HK1/PFKP/PFKM/BPGM,16,3.377745067267001,1.9524841165171785,5.843408221828765
R-HSA-2022854,Keratan sulfate biosynthesis,8/1379,26/9872,0.3076923076923077,2.2027109945891676,2.4742876439076578,0.021594401326330996,0.2466745074584733,0.22888316871390504,SLC35D2/ACAN/ST3GAL6/B4GALT5/ST3GAL4/OMD/OGN/CHST2,8,4.352094605901713,1.9666706327257166,9.630858946862798
R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,8/1379,26/9872,0.3076923076923077,2.2027109945891676,2.4742876439076578,0.021594401326330996,0.2466745074584733,0.22888316871390504,CD14/TNFSF10/LY96/TNFRSF10A/CASP8/DAPK1/TRADD/TNFRSF10B,8,4.352094605901713,1.9666706327257166,9.630858946862798
R-HSA-397795,G-protein beta:gamma signalling,9/1379,31/9872,0.2903225806451613,2.0783644061849404,2.4230307327305343,0.022275215800205188,0.25059617775230836,0.23252198949336994,ARHGEF6/PIK3R5/GNB3/PLCB1/PIK3CG/GNB4/BTK/GNG2/PLCB2,9,4.106411845891132,1.951124690306592,8.642511845527046
R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,9/1379,31/9872,0.2903225806451613,2.0783644061849404,2.4230307327305343,0.022275215800205188,0.25059617775230836,0.23252198949336994,STAT3/INPP5D/CSF1R/CSF1/UBC/RPS27A/STAT1/PIK3CD/GRAP2,9,4.106411845891132,1.951124690306592,8.642511845527046
R-HSA-5576891,Cardiac conduction,27/1379,131/9872,0.20610687022900764,1.4754800746198429,2.2074879691595557,0.02274321108243895,0.2539373568227206,0.23562218683745617,ATP1A2/RYR1/SLC8A3/SLC8A1/SCN1B/FGF11/NPPC/ATP1B3/ATP2B4/SCN1A/CAMK2G/KCNK10/SCN11A/TRDN/KCNK2/FGF14/FGF12/FXYD6/KCNE3/CAMK2D/KCND2/FXYD7/CACNG4/WWTR1/ITPR1/RYR3/KCNA5,27,2.915238944029582,1.9195922741998237,4.4273037639356705
R-HSA-1500931,Cell-Cell communication,29/1379,143/9872,0.20279720279720279,1.4517867918883147,2.1928028858455675,0.023039979714326465,0.2553311184759313,0.2369154237710396,CDH19/CTNNA1/ARHGEF6/NCK2/ADAM19/CD47/CDH6/PXN/CADM2/CLDN11/ITGB4/FYB1/IQGAP1/CDH8/CDH10/CDH18/CLDN7/AFDN/CDH24/CLDN14/PARD6G/FLNA/ACTG1/NECTIN2/ACTB/PARVA/ANGPTL4/PVR/CDH7,29,2.8684259902534017,1.9172249310992295,4.291550526021905
R-HSA-2682334,EPH-Ephrin signaling,20/1379,91/9872,0.21978021978021978,1.5733649961351193,2.2140753126866564,0.024391802427071143,0.2667758527714102,0.24753470939413502,EFNA1/NCK2/EPHB2/EPHA6/EFNA5/GRIN1/EPHA4/MMP2/NGEF/EPHB1/LIMK2/ACTG1/VAV3/EFNB1/ACTB/EPHA2/EPHB6/GIT1/GRIN2B/EPHB3,20,3.108639004215509,1.909942209910568,5.0596486157465925
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,15/1379,63/9872,0.23809523809523808,1.704478745813046,2.260257658227881,0.02443199729084969,0.2667758527714102,0.24753470939413502,ST6GAL2/ST6GALNAC3/ST6GAL1/PGM3/ST8SIA4/ST3GAL6/NEU4/ST3GAL4/ST8SIA3/GFPT2/NUDT14/HK1/ST8SIA6/NEU3/UAP1,15,3.3676922545668018,1.9126369892935797,5.9296934990565475
R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,5/1379,13/9872,0.38461538461538464,2.753388743236459,2.548975163820616,0.02571989240668011,0.27836708696038603,0.25828992864160577,DTX4/UBC/RPS27A/NLRP4/TRIM56,5,5.440118257377141,1.936603453634115,15.281851634991199
R-HSA-977443,GABA receptor activation,14/1379,58/9872,0.2413793103448276,1.727988797479433,2.2405147804889336,0.026038535610900103,0.27836708696038603,0.25828992864160577,GABRB1/GNB3/KCNJ16/ADCY3/GNB4/GABRG3/GABRA2/GABRG2/GABRA4/KCNJ6/ADCY7/GNG2/KCNJ3/GABRB3,14,3.414143182215998,1.899779517025111,6.135645512656566
R-HSA-1566948,Elastic fibre formation,11/1379,42/9872,0.2619047619047619,1.8749266203943507,2.2895580741879886,0.026055909149827382,0.27836708696038603,0.25828992864160577,ITGB3/BMP2/TGFB3/LOXL2/LOXL3/FBLN1/EMILIN2/FN1/BMP7/LTBP4/EFEMP1,11,3.7044614800234816,1.9030169201204419,7.211199602003135
R-HSA-5674135,MAP2K and MAPK activation,10/1379,37/9872,0.2702702702702703,1.9348137114634578,2.29546619166191,0.02685974800867641,0.2849051842348891,0.26435646724328893,ITGB3/IQGAP1/MARK3/APBB1IP/FN1/CNKSR2/ACTG1/ARRB2/ACTB/KSR2,10,3.822785802481234,1.8970253899617069,7.703476911264263
R-HSA-5673001,RAF/MAP kinase cascade,46/1379,250/9872,0.184,1.3172211747643219,2.0470650529236205,0.028495273010633204,0.300109790218371,0.2784644447250382,CSF2RA/FGF20/FGFR3/JAK3/RASAL2/ITGB3/RALGDS/SPRED3/RASA3/PDGFRA/BCL2L1/RASAL1/IQGAP1/DUSP1/CAMK2G/MARK3/PDGFA/RASGRP3/APBB1IP/GRIN1/FGF22/RASGRF1/RGL1/ABHD17C/RGL3/RASAL3/CAMK2D/KIT/FN1/GDNF/CNKSR2/UBC/ACTG1/SHC3/ARRB2/PDGFRB/NRG3/MET/RPS27A/PDGFB/ACTB/KSR2/AREG/GRIN2B/RGL2/DUSP6,46,2.6025525743292244,1.8914319073300117,3.5810329073431935
R-HSA-418555,G alpha (s) signalling events,25/1379,122/9872,0.20491803278688525,1.4669694123800807,2.091212608143492,0.029474504256859775,0.3066074721843339,0.2844934829624618,CALCRL/CALCR/PDE4D/PDE8B/HRH2/ADM/PDE7B/GNB3/ADRB2/ADCY3/CRH/GNB4/PTH2R/PDE3A/PTGDR/FN1/ARRB2/ADRB1/ADM2/ADCY7/DRD1/GNG2/ADORA2A/PDE4A/PDE11A,25,2.898423661717329,1.8784019723202192,4.472343963963194
R-HSA-9013026,RHOB GTPase cycle,16/1379,70/9872,0.22857142857142856,1.636299595980524,2.1527096884471137,0.029525163988121036,0.3066074721843339,0.2844934829624618,ERBIN/ARHGAP26/ARHGEF3/TFRC/ARHGAP21/ABR/RTKN/ARHGEF10/FLOT1/FLOT2/PCDH7/OPHN1/CAVIN1/RHOB/VANGL1/DIAPH3,16,3.2329845643841293,1.8730087386797798,5.580427350762619
R-HSA-8980692,RHOA GTPase cycle,29/1379,146/9872,0.19863013698630136,1.4219555564385549,2.0697035875408782,0.0297534709450871,0.3068326691212107,0.284702437625139,ERBIN/ARHGAP26/ARHGAP31/ARHGEF3/PREX2/TFRC/ARHGAP21/ABR/RTKN/IQGAP1/GMIP/ARHGEF10/ARHGAP42/FLOT1/TEX2/ARHGDIB/FLOT2/NGEF/PCDH7/ARHGAP4/OPHN1/CAVIN1/DEF6/VAV3/ARHGAP8/VANGL1/PLEKHG4/ARHGAP20/DIAPH3,29,2.8094857301797016,1.8791178768519128,4.200486922782551
R-HSA-446353,Cell-extracellular matrix interactions,6/1379,18/9872,0.3333333333333333,2.3862702441382644,2.371974533344436,0.030558811242088074,0.3129643772034537,0.29039189775603114,ARHGEF6/PXN/FLNA/ACTG1/ACTB/PARVA,6,4.714769156393522,1.8684970334269388,11.89675327303583
R-HSA-909733,Interferon alpha/beta signaling,15/1379,65/9872,0.23076923076923078,1.6520332459418754,2.125154347423246,0.031782701964762634,0.32326926313474325,0.29995354630046356,SOCS3/GBP2/IFNAR2/IRF1/OAS1/SAMHD1/ISG20/IRF5/EGR1/UBC/RPS27A/STAT1/RSAD2/IFITM2/IRF9,15,3.2640709544262845,1.8568676503539179,5.737705212053557
R-HSA-9820960,Respiratory syncytial virus (RSV) attachment and entry,7/1379,23/9872,0.30434782608695654,2.1787684837784154,2.280491784737784,0.03275693949171542,0.33091193976324756,0.3070449967393876,CX3CR1/GPC5/CD14/GPC6/IGF1R/LY96/GPC2,7,4.3047892297506065,1.8439356637216735,10.04981392635722
R-HSA-3295583,TRP channels,8/1379,28/9872,0.2857142857142857,2.045374494975655,2.232015777270438,0.03335844907036314,0.3347114653343869,0.31057048245451885,TRPM1/TRPC5/TRPC4AP/TRPM6/MLKL/TRPV4/TRPM3/TRPV5,8,4.041230705480162,1.838418120435743,8.883477285920558
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,14/1379,60/9872,0.23333333333333334,1.670389170896785,2.09872720787965,0.03416434850819374,0.34049703043401147,0.3159387650810711,WIPF3/DOCK1/CYFIP1/MYO10/NCKAP1L/FCGR2A/SYK/FCGR1A/FCGR3A/BTK/ACTG1/VAV3/ACTB/NCKIPSD,14,3.3003384094754646,1.8399207765278411,5.919947073815883
R-HSA-70326,Glucose metabolism,17/1379,77/9872,0.22077922077922077,1.5805166552084606,2.060582341375377,0.03463645041484474,0.34290085910696294,0.3181692181967142,PGK1/HK2/PFKFB3/ENO1/PFKL/PCK1/ENO2/NUP205/NUP188/PFKFB4/GPI/HKDC1/TPI1/HK1/PFKP/PFKM/BPGM,17,3.122769181507398,1.8416419823121217,5.295104832878242
R-HSA-9824878,"Regulation of TBK1, IKK (IKBKE)-mediated activation of IRF3, IRF7",5/1379,14/9872,0.35714285714285715,2.556718118719569,2.3486145017545454,0.03551516020861314,0.34927160867410934,0.32408047900365705,CD14/IKBKE/UBC/LY96/RPS27A,5,5.051538381850202,1.8168364014837752,14.04531525373758
R-HSA-8986944,Transcriptional Regulation by MECP2,14/1379,61/9872,0.22950819672131148,1.6430057418656903,2.029809485704338,0.03885059576935563,0.374481694948205,0.347472293948042,SLC2A3/SGK1/MEF2C/FKBP5/CAMK2G/CRH/OPRM1/RBFOX1/CAMK4/CAMK2D/PPARG/MOBP/MET/GRIN2B,14,3.2462345011234084,1.8113856117804017,5.817667076380362
R-HSA-1638074,Keratan sulfate/keratin metabolism,9/1379,34/9872,0.2647058823529412,1.8949793115215627,2.1063531795733264,0.03949764869612044,0.374481694948205,0.347472293948042,SLC35D2/ACAN/ST3GAL6/B4GALT5/ST3GAL4/OMD/OGN/CHST2/GLB1L3,9,3.744081388900738,1.7921503523402005,7.821969528621246
R-HSA-5576892,Phase 0 - rapid depolarisation,9/1379,34/9872,0.2647058823529412,1.8949793115215627,2.1063531795733264,0.03949764869612044,0.374481694948205,0.347472293948042,SCN1B/FGF11/SCN1A/CAMK2G/SCN11A/FGF14/FGF12/CAMK2D/CACNG4,9,3.744081388900738,1.7921503523402005,7.821969528621246
R-HSA-400508,"Incretin synthesis, secretion, and inactivation",6/1379,19/9872,0.3157894736842105,2.2606770733941453,2.2163000738648386,0.03953658112138865,0.374481694948205,0.347472293948042,DPP4/FFAR4/GNB3/PAX6/TCF7L2/LEP,6,4.466623411320179,1.7809647813057032,11.202200575761394
R-HSA-9020958,Interleukin-21 signaling,4/1379,10/9872,0.4,2.8635242929659173,2.3756623038183067,0.03959190192354041,0.374481694948205,0.347472293948042,STAT3/JAK3/IL21R/STAT1,4,5.657722987672226,1.7721339214357075,18.06287268588693
R-HSA-9692914,SARS-CoV-1-host interactions,19/1379,90/9872,0.2111111111111111,1.511304487954234,1.96344697521369,0.0404599888304564,0.374481694948205,0.347472293948042,RUNX1/NFKBIA/NLRP3/BCL2L1/TLR7/IKBKE/RPS3/CASP1/RPS16/UBC/RPS3A/RPS6/RPS12/RPS27A/EEF1A1/RPS9/SFN/RPSA/RPS14,19,2.986020465715897,1.815007331555101,4.912552179078343
R-HSA-186763,Downstream signal transduction,8/1379,29/9872,0.27586206896551724,1.9748443399764946,2.1183741971926877,0.04061469060504429,0.374481694948205,0.347472293948042,STAT3/NCK2/PDGFRA/PDGFA/BCAR1/PDGFRB/PDGFB/STAT1,8,3.9018779225325697,1.780373538931757,8.551380364528463
R-HSA-8874081,MET activates PTK2 signaling,8/1379,29/9872,0.27586206896551724,1.9748443399764946,2.1183741971926877,0.04061469060504429,0.374481694948205,0.347472293948042,LAMA1/COL5A3/COL5A2/FN1/MET/LAMA4/LAMA2/COL3A1,8,3.9018779225325697,1.780373538931757,8.551380364528463
R-HSA-210500,Glutamate Neurotransmitter Release Cycle,7/1379,24/9872,0.2916666666666667,2.0879864636209815,2.1502415018836514,0.040846547455393026,0.374481694948205,0.347472293948042,SLC1A2/PPFIA2/SYT1/PPFIA4/RIMS1/SLC1A6/TSPOAP1,7,4.125423011844331,1.7743903115040764,9.591528378121248
R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,7/1379,24/9872,0.2916666666666667,2.0879864636209815,2.1502415018836514,0.040846547455393026,0.374481694948205,0.347472293948042,MGAT4C/ST6GAL1/B4GALT5/ST3GAL4/ST8SIA3/FUT3/ST8SIA6,7,4.125423011844331,1.7743903115040764,9.591528378121248
R-HSA-5684996,MAPK1/MAPK3 signaling,46/1379,256/9872,0.1796875,1.2863488034807833,1.8704679671963054,0.040930675598358036,0.374481694948205,0.347472293948042,CSF2RA/FGF20/FGFR3/JAK3/RASAL2/ITGB3/RALGDS/SPRED3/RASA3/PDGFRA/BCL2L1/RASAL1/IQGAP1/DUSP1/CAMK2G/MARK3/PDGFA/RASGRP3/APBB1IP/GRIN1/FGF22/RASGRF1/RGL1/ABHD17C/RGL3/RASAL3/CAMK2D/KIT/FN1/GDNF/CNKSR2/UBC/ACTG1/SHC3/ARRB2/PDGFRB/NRG3/MET/RPS27A/PDGFB/ACTB/KSR2/AREG/GRIN2B/RGL2/DUSP6,46,2.541555248368383,1.848144857283622,3.4951281308127338
R-HSA-168273,Influenza Viral RNA Transcription and Replication,26/1379,132/9872,0.19696969696969696,1.4100687806271563,1.9111568922897832,0.04168893413421938,0.374481694948205,0.347472293948042,RPL9/NUP205/RPL18A/RPL37A/RPS3/RPL30/NUP188/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,26,2.785999956050717,1.823088143141633,4.2574988951105235
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,22/1379,108/9872,0.2037037037037037,1.458276260306717,1.9295564999741963,0.041692138840938434,0.374481694948205,0.347472293948042,TLR2/FOS/CD14/MEF2C/NFKBIA/NLRC5/S100A9/TIFA/TNIP2/DUSP3/MAP2K3/S100A8/PELI2/MAP3K1/BTK/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,22,2.8812478177960412,1.8157864896521831,4.571897100712888
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,22/1379,108/9872,0.2037037037037037,1.458276260306717,1.9295564999741963,0.041692138840938434,0.374481694948205,0.347472293948042,TLR2/FOS/CD14/MEF2C/NFKBIA/NLRC5/S100A9/TIFA/TNIP2/DUSP3/MAP2K3/S100A8/PELI2/MAP3K1/BTK/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,22,2.8812478177960412,1.8157864896521831,4.571897100712888
R-HSA-5578775,Ion homeostasis,13/1379,56/9872,0.23214285714285715,1.66186677716772,2.001379594764877,0.041861253442021566,0.374481694948205,0.347472293948042,ATP1A2/RYR1/SLC8A3/SLC8A1/ATP1B3/ATP2B4/CAMK2G/TRDN/FXYD6/CAMK2D/FXYD7/ITPR1/RYR3,13,3.283499948202631,1.7914583824922408,6.0182095298512355
R-HSA-112315,Transmission across Chemical Synapses,47/1379,263/9872,0.17870722433460076,1.279331195526598,1.850079388222687,0.04249093744252632,0.3778385754619855,0.3505870602727196,SLC1A2/GABRB1/CACNB4/GLUL/CACNA1A/PPFIA2/CAMK2G/GNB3/KCNJ16/ADCY3/PLCB1/GRIN1/SYT1/GNB4/NCALD/PPFIA4/CACNG3/RIMS1/RASGRF1/GRIK4/TUBB4A/TUBA1A/ALDH5A1/GABRG3/CAMK4/CAMK2D/SLC1A6/GABRA2/GABRG2/GABRA4/GRIK2/KCNJ6/TSPOAP1/SLC32A1/ADCY7/GNG2/NAAA/PLCB2/CACNG4/GRIA1/GRIA4/GIT1/KCNJ3/GABRB3/GRIN2B/TUBA1B/CACNG2,47,2.5276899279524208,1.84438506622813,3.464144493936083
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,18/1379,85/9872,0.21176470588235294,1.5159834492172504,1.9250968661900825,0.04405269916276608,0.38939439438516443,0.3613094185718096,WIPF3/DOCK1/PLD4/CYFIP1/MYO10/PRKCD/NCKAP1L/FCGR2A/SYK/FCGR1A/FGR/FCGR3A/BTK/ACTG1/VAV3/ACTB/ITPR1/NCKIPSD,18,2.9952651111205904,1.7960036810539823,4.995319987669104
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,22/1379,109/9872,0.2018348623853211,1.4448975790194996,1.881974756415363,0.04561241620029768,0.39843787092612964,0.3697006365708338,TLR2/FOS/CD14/MEF2C/NFKBIA/NLRC5/S100A9/TIFA/TNIP2/DUSP3/MAP2K3/S100A8/PELI2/MAP3K1/BTK/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,22,2.854814351577729,1.7997640672179362,4.5283518714607585
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,22/1379,109/9872,0.2018348623853211,1.4448975790194996,1.881974756415363,0.04561241620029768,0.39843787092612964,0.3697006365708338,TLR2/FOS/CD14/MEF2C/NFKBIA/NLRC5/S100A9/TIFA/TNIP2/DUSP3/MAP2K3/S100A8/PELI2/MAP3K1/BTK/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,22,2.854814351577729,1.7997640672179362,4.5283518714607585
R-HSA-2129379,Molecules associated with elastic fibres,9/1379,35/9872,0.2571428571428571,1.8408370454780896,2.0079212272681115,0.046821203423009446,0.4038276237739177,0.3747016548077676,ITGB3/BMP2/TGFB3/FBLN1/EMILIN2/FN1/BMP7/LTBP4/EFEMP1,9,3.6371076349321454,1.7447700584284835,7.581831132519936
R-HSA-2214320,Anchoring fibril formation,5/1379,15/9872,0.3333333333333333,2.3862702441382644,2.1649770632056264,0.047317176118964084,0.4038276237739177,0.3747016548077676,TLL2/COL4A1/COL4A2/BMP1/TLL1,5,4.714769156393522,1.7110169400268909,12.991717193478117
R-HSA-9037629,Lewis blood group biosynthesis,5/1379,15/9872,0.3333333333333333,2.3862702441382644,2.1649770632056264,0.047317176118964084,0.4038276237739177,0.3747016548077676,B3GALT5/ST3GAL6/ST3GAL4/FUT3/B3GALT2,5,4.714769156393522,1.7110169400268909,12.991717193478117
R-HSA-9706369,Negative regulation of FLT3,5/1379,15/9872,0.3333333333333333,2.3862702441382644,2.1649770632056264,0.047317176118964084,0.4038276237739177,0.3747016548077676,SOCS6/SLA/SH2B3/UBC/RPS27A,5,4.714769156393522,1.7110169400268909,12.991717193478117
R-HSA-3000157,Laminin interactions,8/1379,30/9872,0.26666666666666666,1.9090161953106115,2.0091978965694524,0.04884745163583102,0.41128749864190695,0.3816234880186115,COL4A1/ITGB4/LAMA1/COL4A2/COL18A1/NID1/LAMA4/LAMA2,8,3.7718153251148174,1.7258859645291402,8.243065381583493
R-HSA-9674555,Signaling by CSF3 (G-CSF),8/1379,30/9872,0.26666666666666666,1.9090161953106115,2.0091978965694524,0.04884745163583102,0.41128749864190695,0.3816234880186115,SOCS3/STAT3/SYK/CSF3R/UBC/RPS27A/CSF3/STAT1,8,3.7718153251148174,1.7258859645291402,8.243065381583493
R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",6/1379,20/9872,0.3,2.1476432197244377,2.0701024457521244,0.05002286001362525,0.41128749864190695,0.3816234880186115,GPC5/VCAN/CSPG5/NCAN/GPC6/GPC2,6,4.24329224075417,1.7012714263505035,10.583572239891936
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,6/1379,20/9872,0.3,2.1476432197244377,2.0701024457521244,0.05002286001362525,0.41128749864190695,0.3816234880186115,IL1RAP/PPFIA2/PTPRF/SLITRK5/PPFIA4/PPFIBP1,6,4.24329224075417,1.7012714263505035,10.583572239891936
R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,6/1379,20/9872,0.3,2.1476432197244377,2.0701024457521244,0.05002286001362525,0.41128749864190695,0.3816234880186115,GPC5/VCAN/CSPG5/NCAN/GPC6/GPC2,6,4.24329224075417,1.7012714263505035,10.583572239891936
R-HSA-2029485,Role of phospholipids in phagocytosis,7/1379,25/9872,0.28,2.004467005076142,2.026216548062971,0.0501299914169597,0.41128749864190695,0.3816234880186115,PLD4/PRKCD/FCGR2A/SYK/FCGR1A/FCGR3A/ITPR1,7,3.960406091370558,1.7099049747153272,9.172916998604732
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,7/1379,25/9872,0.28,2.004467005076142,2.026216548062971,0.0501299914169597,0.41128749864190695,0.3816234880186115,MAML3/PLXND1/HES5/FABP7/PBX1/STAT1/HES1,7,3.960406091370558,1.7099049747153272,9.172916998604732
R-HSA-9013148,CDC42 GTPase cycle,29/1379,153/9872,0.1895424836601307,1.3568987662746994,1.7927185735581181,0.051156244110816165,0.4174012225525385,0.38729626108188764,WIPF3/ARHGAP26/ARHGAP31/PREX2/TFRC/ARHGEF6/ARHGAP21/ABR/IQGAP1/GMIP/ARHGEF10/ARHGAP42/SRGAP2/ARHGDIB/FGD3/NGEF/ARHGAP4/DOCK8/OPHN1/DEF6/VAV3/IQGAP2/PAK5/VANGL1/PLEKHG2/GIT1/PLEKHG4/ARHGAP20/DIAPH3,29,2.6809471673610226,1.7958357456002294,4.002302399754712
R-HSA-9664407,Parasite infection,13/1379,58/9872,0.22413793103448276,1.604561026230902,1.8606438995596792,0.053782972874494996,0.42979215266989396,0.3987934983837612,WIPF3/DOCK1/CYFIP1/MYO10/NCKAP1L/SYK/FGR/FCGR3A/BTK/ACTG1/VAV3/ACTB/NCKIPSD,13,3.170275812057713,1.7330692958897878,5.799334595768724
R-HSA-9664417,Leishmania phagocytosis,13/1379,58/9872,0.22413793103448276,1.604561026230902,1.8606438995596792,0.053782972874494996,0.42979215266989396,0.3987934983837612,WIPF3/DOCK1/CYFIP1/MYO10/NCKAP1L/SYK/FGR/FCGR3A/BTK/ACTG1/VAV3/ACTB/NCKIPSD,13,3.170275812057713,1.7330692958897878,5.799334595768724
R-HSA-9664422,FCGR3A-mediated phagocytosis,13/1379,58/9872,0.22413793103448276,1.604561026230902,1.8606438995596792,0.053782972874494996,0.42979215266989396,0.3987934983837612,WIPF3/DOCK1/CYFIP1/MYO10/NCKAP1L/SYK/FGR/FCGR3A/BTK/ACTG1/VAV3/ACTB/NCKIPSD,13,3.170275812057713,1.7330692958897878,5.799334595768724
R-HSA-373760,L1CAM interactions,23/1379,117/9872,0.19658119658119658,1.4072875798764122,1.7857168950787539,0.05402697926805787,0.42979215266989396,0.3987934983837612,L1CAM/ITGB3/KCNQ3/EPHB2/SCN1B/CNTN1/NFASC/SCN1A/NCAN/SCN11A/LAMA1/TUBB4A/TUBA1A/CHL1/ACTG1/ANK1/KCNQ2/DCX/ACTB/CNTN6/CNTNAP1/TUBA1B/EZR,23,2.780504887103872,1.7722528913104798,4.362361300193298
R-HSA-9013423,RAC3 GTPase cycle,19/1379,93/9872,0.20430107526881722,1.4625527302782912,1.8058748386500048,0.05412197478065331,0.42979215266989396,0.3987934983837612,ERBIN/ARHGAP26/TFRC/ARHGAP21/ARHGAP15/CYFIP1/ABR/NCKAP1L/SLITRK5/CYBB/ARHGAP42/SRGAP2/ARHGDIB/OPHN1/NCF2/VANGL1/EPHA2/GIT1/DIAPH3,19,2.8896972248863517,1.7588927089331658,4.747503931937202
R-HSA-9927354,Co-stimulation by ICOS,4/1379,11/9872,0.36363636363636365,2.6032039026962885,2.143664281165689,0.05550902910586117,0.43846227777767993,0.40683829283075185,PIK3R5/PIK3CG/PIK3R3/PIK3CD,4,5.143384534247478,1.6356093535140193,16.174035939755594
R-HSA-451326,Activation of kainate receptors upon glutamate binding,8/1379,31/9872,0.25806451612903225,1.8474350277199465,1.9041440021395055,0.058089968448222604,0.4465468612162474,0.41433977765874025,GNB3/PLCB1/GNB4/NCALD/GRIK4/GRIK2/GNG2/PLCB2,8,3.65014386301434,1.674637870319835,7.956078419602813
R-HSA-5626467,RHO GTPases activate IQGAPs,8/1379,31/9872,0.25806451612903225,1.8474350277199465,1.9041440021395055,0.058089968448222604,0.4465468612162474,0.41433977765874025,CTNNA1/IQGAP1/TUBB4A/TUBA1A/ACTG1/IQGAP2/ACTB/TUBA1B,8,3.65014386301434,1.674637870319835,7.956078419602813
R-HSA-8941326,RUNX2 regulates bone development,8/1379,31/9872,0.25806451612903225,1.8474350277199465,1.9041440021395055,0.058089968448222604,0.4465468612162474,0.41433977765874025,MAF/ZNF521/GLI3/SMAD6/HDAC4/AR/WWTR1/HES1,8,3.65014386301434,1.674637870319835,7.956078419602813
R-HSA-1474228,Degradation of the extracellular matrix,24/1379,124/9872,0.1935483870967742,1.38557627078996,1.7409869988044613,0.0581485475743527,0.4465468612162474,0.41433977765874025,A2M/TLL2/SPP1/COL9A1/CTSS/COL4A1/ADAM9/ACAN/MMP2/COL5A3/COL10A1/COL5A2/COL4A2/COL12A1/BMP1/FN1/COL18A1/COL8A2/NID1/COL14A1/KLKB1/COL3A1/COL8A1/TLL1,24,2.7376078972607547,1.7622582498626047,4.252780203882584
R-HSA-8848021,Signaling by PTK6,12/1379,53/9872,0.22641509433962265,1.6208628073391986,1.8261317024787174,0.058336761667307745,0.4465468612162474,0.41433977765874025,SOCS3/STAT3/DOCK1/LRRK2/PXN/HIF1A/BCAR1/CCND1/UBC/KHDRBS2/NRG3/RPS27A,12,3.202484710003147,1.70738044623471,6.006809050918512
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,12/1379,53/9872,0.22641509433962265,1.6208628073391986,1.8261317024787174,0.058336761667307745,0.4465468612162474,0.41433977765874025,SOCS3/STAT3/DOCK1/LRRK2/PXN/HIF1A/BCAR1/CCND1/UBC/KHDRBS2/NRG3/RPS27A,12,3.202484710003147,1.70738044623471,6.006809050918512
R-HSA-3928662,EPHB-mediated forward signaling,10/1379,42/9872,0.23809523809523808,1.704478745813046,1.8435203169873764,0.059680523972017,0.45416858115607006,0.4214117829050475,EPHB2/GRIN1/EPHB1/LIMK2/ACTG1/EFNB1/ACTB/EPHB6/GRIN2B/EPHB3,10,3.3676922545668013,1.686089086248958,6.726424608263334
R-HSA-9013406,RHOQ GTPase cycle,13/1379,59/9872,0.22033898305084745,1.577365076633768,1.7922878650811385,0.060532436989727476,0.45416858115607006,0.4214117829050475,SLC4A7/ARHGAP26/TFRC/ARHGAP21/GJA1/IQGAP1/RHOQ/SRGAP2/TRIP10/OPHN1/VANGL1/GIT1/DIAPH3,13,3.1165423237177516,1.7052806730699248,5.695740419105641
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,7/1379,26/9872,0.2692307692307692,1.9273721202655212,1.9078443523011366,0.060643103555612414,0.45416858115607006,0.4214117829050475,SMAD7/PPP1R15A/TGFBR1/PMEPA1/TGFBR2/UBC/RPS27A,7,3.808082780163998,1.6499464228526841,8.789069911439382
R-HSA-9635486,Infection with Mycobacterium tuberculosis,7/1379,26/9872,0.2692307692307692,1.9273721202655212,1.9078443523011366,0.060643103555612414,0.45416858115607006,0.4214117829050475,TLR2/PGK1/ENO1/MRC1/UBC/LTF/RPS27A,7,3.808082780163998,1.6499464228526841,8.789069911439382
R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,5/1379,16/9872,0.3125,2.2371283538796227,1.9955221445864715,0.0611674856775852,0.45416858115607006,0.4214117829050475,PPFIA2/SYT1/PPFIA4/RIMS1/TSPOAP1,5,4.420096084118927,1.6168441995925458,12.083569584358818
R-HSA-844456,The NLRP3 inflammasome,5/1379,16/9872,0.3125,2.2371283538796227,1.9955221445864715,0.0611674856775852,0.45416858115607006,0.4214117829050475,NLRP3/HMOX1/CASP1/MEFV/TXN,5,4.420096084118927,1.6168441995925458,12.083569584358818
R-HSA-163560,Triglyceride catabolism,6/1379,21/9872,0.2857142857142857,2.045374494975655,1.9322954659146878,0.06205603889131826,0.45847372016720206,0.42540641481401215,MGLL/PLIN3/FABP7/PNPLA4/FABP1/FABP5,6,4.041230705480161,1.6284087725907064,10.02914371981251
R-HSA-397014,Muscle contraction,36/1379,200/9872,0.18,1.2885859318346629,1.6613615570565035,0.06310131986136867,0.46388841581253704,0.43043057685529756,ATP1A2/RYR1/SLC8A3/MYBPC1/SLC8A1/GUCY1A1/SCN1B/FGF11/PXN/TPM4/NPPC/ATP1B3/DMD/ATP2B4/SCN1A/CAMK2G/KCNK10/SCN11A/TRDN/KCNK2/FGF14/FGF12/FXYD6/KCNE3/CAMK2D/KCND2/ACTA2/FXYD7/DES/CACNG4/MYLK/WWTR1/ITPR1/RYR3/TNNI2/KCNA5,36,2.545975344452502,1.7779922436758098,3.6456798265661776
R-HSA-168898,Toll-like Receptor Cascades,30/1379,163/9872,0.18404907975460122,1.3175725274383054,1.6473338558279078,0.06638773598784742,0.48564427557612516,0.45061730053457233,TLR2/FOS/CD14/MEF2C/LY86/NFKBIA/NLRC5/CTSS/S100A9/TIFA/TLR7/TNIP2/IRF5/IKBKE/DUSP3/MAP2K3/S100A8/PELI2/GSDME/TLR10/MAP3K1/BTK/UBC/LY96/GSDMD/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,30,2.603246773468816,1.756919609143447,3.85725887986403
R-HSA-6806834,Signaling by MET,16/1379,78/9872,0.20512820512820512,1.468473996392778,1.6737280248072612,0.07067760223559849,0.5138531456943788,0.47679161276905324,STAT3/PTPN2/MUC20/LAMA1/COL5A3/SPINT2/TNS3/COL5A2/HPN/FN1/UBC/MET/RPS27A/LAMA4/LAMA2/COL3A1,16,2.9013964039344753,1.68963565257326,4.982199020210903
R-HSA-111885,Opioid Signalling,18/1379,90/9872,0.2,1.4317621464829586,1.6579985126193828,0.07093595613962805,0.5138531456943788,0.47679161276905324,PRKCD/PDE4D/PLA2G4A/CAMK2G/GNB3/ADCY3/PLCB1/GNB4/OPRM1/CAMK4/CAMK2D/PDYN/ADCY7/GNG2/PDE4A/PLCB2/PLCB4/ITPR1,18,2.8288614938361127,1.700404344275585,4.706208484028503
R-HSA-1483249,Inositol phosphate metabolism,11/1379,49/9872,0.22448979591836735,1.6070799603380148,1.7165403318644967,0.0716965640295927,0.516841735844394,0.47956465158271255,INPP5D/PLD4/IP6K3/PLCB1/PLCH2/ITPKC/PLCD4/PLCB2/PLCH1/PLCB4/PLCZ1,11,3.175252697162984,1.6473558263646255,6.12025011808785
R-HSA-112308,Presynaptic depolarization and calcium channel opening,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,CACNB4/CACNA1A/CACNG4/CACNG2,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-189483,Heme degradation,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,ABCG2/HMOX1/SLCO2B1/FABP1,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,ITGB3/APBB1IP/BCAR1/FN1,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,TNFRSF10D/TNFRSF10C/TNFRSF10A/TNFRSF10B,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-73621,Pyrimidine catabolism,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,NT5E/DPYS/TYMP/NT5C1A,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-75205,Dissolution of Fibrin Clot,4/1379,12/9872,0.3333333333333333,2.3862702441382644,1.9361197444491096,0.07434332778197057,0.5171524415240815,0.4798529476909607,PLAUR/SERPINB6/SERPINB8/S100A10,4,4.714769156393523,1.5185808858719487,14.638040294650533
R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",6/1379,22/9872,0.2727272727272727,1.952402927022216,1.8019639307419555,0.07564833346183598,0.5171524415240815,0.4798529476909607,CAMK2G/GRIN1/CAMK2D/GRIA1/GRIA4/GRIN2B,6,3.8575384006856086,1.5615344180784199,9.529474560718123
R-HSA-6783589,Interleukin-6 family signaling,6/1379,22/9872,0.2727272727272727,1.952402927022216,1.8019639307419555,0.07564833346183598,0.5171524415240815,0.4798529476909607,SOCS3/STAT3/OSM/LIFR/CNTFR/STAT1,6,3.8575384006856086,1.5615344180784199,9.529474560718123
R-HSA-70263,Gluconeogenesis,6/1379,22/9872,0.2727272727272727,1.952402927022216,1.8019639307419555,0.07564833346183598,0.5171524415240815,0.4798529476909607,PGK1/ENO1/PCK1/ENO2/GPI/TPI1,6,3.8575384006856086,1.5615344180784199,9.529474560718123
R-HSA-912631,Regulation of signaling by CBL,6/1379,22/9872,0.2727272727272727,1.952402927022216,1.8019639307419555,0.07564833346183598,0.5171524415240815,0.4798529476909607,BLNK/SYK/UBC/RPS27A/PIK3R3/PIK3CD,6,3.8575384006856086,1.5615344180784199,9.529474560718123
R-HSA-977068,Termination of O-glycan biosynthesis,6/1379,22/9872,0.2727272727272727,1.952402927022216,1.8019639307419555,0.07564833346183598,0.5171524415240815,0.4798529476909607,ST6GALNAC3/MUC20/ST6GAL1/MUC4/ST3GAL4/MUC15,6,3.8575384006856086,1.5615344180784199,9.529474560718123
R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),5/1379,17/9872,0.29411764705882354,2.105532568357292,1.838229936591575,0.0770601163156024,0.5171524415240815,0.4798529476909607,LTC4S/DPEP2/PTGR1/CYP4F3/ALOX5AP,5,4.160090432111931,1.5324965431211817,11.292914480643455
R-HSA-8963743,Digestion and absorption,5/1379,17/9872,0.29411764705882354,2.105532568357292,1.838229936591575,0.0770601163156024,0.5171524415240815,0.4798529476909607,SLC2A5/MGAM/PIR/PNLIPRP3/NPC1L1,5,4.160090432111931,1.5324965431211817,11.292914480643455
R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),5/1379,17/9872,0.29411764705882354,2.105532568357292,1.838229936591575,0.0770601163156024,0.5171524415240815,0.4798529476909607,LTC4S/PTGR1/CYP2E1/PTGS2/ALOX5AP,5,4.160090432111931,1.5324965431211817,11.292914480643455
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,5/1379,17/9872,0.29411764705882354,2.105532568357292,1.838229936591575,0.0770601163156024,0.5171524415240815,0.4798529476909607,SLC2A3/FKBP5/OPRM1/MET/GRIN2B,5,4.160090432111931,1.5324965431211817,11.292914480643455
R-HSA-913531,Interferon Signaling,44/1379,255/9872,0.17254901960784313,1.235245773436278,1.533572310713552,0.07744200657297381,0.5171524415240815,0.4798529476909607,SOCS3/STAT3/GBP2/PTAFR/SMAD7/IFNAR2/PTPN2/IRF1/FKBP5/PRKCD/IFNGR1/TRIM38/UBA7/OAS1/SAMHD1/CAMK2G/FCGR1A/ISG20/IRF5/TRIM34/EGR1/PPM1B/NUP205/TRIM3/TUBB4A/GBP1/NUP188/TUBA1A/CAMK2D/HLA-DRB5/EIF2AK3/FLNA/UBC/RPS27A/ICAM1/STAT1/HSPA1A/HSPA1B/RSAD2/HLA-DQA2/EIF4A1/IFITM2/IRF9/TUBA1B,44,2.4405863868389996,1.76411828392298,3.3764526822873164
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,16/1379,79/9872,0.20253164556962025,1.4498857179574265,1.61767033597241,0.07765992892920551,0.5171524415240815,0.4798529476909607,FGF20/FGFR3/CD86/PDGFRA/PIK3R5/PDGFA/PIK3CG/FGF22/KIT/PDGFRB/NRG3/MET/PDGFB/PIK3R3/PIK3CD/AREG,16,2.864669867175811,1.6692104428457561,4.916296493996586
R-HSA-168255,Influenza Infection,28/1379,153/9872,0.1830065359477124,1.3101091536445373,1.5576922424580566,0.07844886139072182,0.5200739248447407,0.4825637197389797,RPL9/NUP205/RPL18A/RPL37A/RPS3/RPL30/NUP188/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/HSPA1A/HSPA1B/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,28,2.5885007133140903,1.7237783235644093,3.8870055686584313
R-HSA-8979227,Triglyceride metabolism,8/1379,33/9872,0.24242424242424243,1.7354692684641926,1.7052111633057454,0.07968466153521399,0.5259187661324123,0.4879870032729596,MGLL/PLIN3/GK/FABP7/MOGAT1/PNPLA4/FABP1/FABP5,8,3.4289230228316523,1.5807684891353546,7.437846324312839
R-HSA-112043,PLC beta mediated events,11/1379,50/9872,0.22,1.5749383611312546,1.6422469764170846,0.08085364378077535,0.5312728363471301,0.49295491247803885,PRKCD/PLA2G4A/CAMK2G/ADCY3/PLCB1/CAMK4/CAMK2D/ADCY7/PLCB2/PLCB4/ITPR1,11,3.111747643219725,1.6163404045401972,5.990677067704709
R-HSA-936837,Ion transport by P-type ATPases,12/1379,56/9872,0.21428571428571427,1.5340308712317412,1.6148241995637722,0.08281371075754203,0.5417548919601317,0.5026809523840599,ATP1A2/ATP8B4/ATP13A4/ATP1B3/ATP2B4/CAMK2G/ATP2C2/FXYD6/ATP8B1/CAMK2D/FXYD7/ATP13A5,12,3.030923029110121,1.620921722656465,5.667450981738148
R-HSA-8982491,Glycogen metabolism,7/1379,28/9872,0.25,1.7897026831036984,1.6861219175634277,0.08542145320112209,0.556363412296782,0.5162358367510103,PYGL/AKR1E2/PYGM/GYS1/UBC/RPS27A/GBE1,7,3.536076867295141,1.541826943570843,8.109755549128723
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,20/1379,105/9872,0.19047619047619047,1.3635829966504367,1.5092103241746413,0.08940041418246987,0.5772157176563816,0.5355841746675197,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TLR7/TNIP2/IRF5/DUSP3/MAP2K3/PELI2/MAP3K1/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,20,2.694153803653441,1.6649322974294671,4.35961554049185
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",20/1379,105/9872,0.19047619047619047,1.3635829966504367,1.5092103241746413,0.08940041418246987,0.5772157176563816,0.5355841746675197,FGF20/PIP4K2A/FGFR3/PIP5K1B/CD86/IL1RAP/PDGFRA/PIK3R5/PDGFA/PIK3CG/FGF22/KIT/PDGFRB/NRG3/MET/PDGFB/PIK3R3/IL33/PIK3CD/AREG,20,2.694153803653441,1.6649322974294671,4.35961554049185
R-HSA-3371571,HSF1-dependent transactivation,6/1379,23/9872,0.2608695652173913,1.8675158432386418,1.678330207212671,0.09078647251011379,0.583627323279303,0.5415333447971701,CAMK2G/CAMK2D/HSPA1A/HSPA1B/CRYAB/DNAJB1,6,3.689819339786234,1.499939025554073,9.076880145332085
R-HSA-75105,Fatty acyl-CoA biosynthesis,8/1379,34/9872,0.23529411764705882,1.6844260546858338,1.610811532636863,0.09204989625493487,0.5873855679437076,0.5450205269809061,ELOVL5/ACSL1/HACD4/ELOVL2/TECR/HACD1/ACSL6/ACSBG1,8,3.328072345689545,1.5376759786290877,7.20312061323762
R-HSA-181429,Serotonin Neurotransmitter Release Cycle,5/1379,18/9872,0.2777777777777778,1.988558536781887,1.6914708253183892,0.09494523365156948,0.5873855679437076,0.5450205269809061,PPFIA2/SYT1/PPFIA4/RIMS1/TSPOAP1,5,3.9289742969946015,1.4565131233988193,10.598489487291316
R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,5/1379,18/9872,0.2777777777777778,1.988558536781887,1.6914708253183892,0.09494523365156948,0.5873855679437076,0.5450205269809061,PPFIA2/SYT1/PPFIA4/RIMS1/TSPOAP1,5,3.9289742969946015,1.4565131233988193,10.598489487291316
R-HSA-936964,"Activation of IRF3, IRF7 mediated by TBK1, IKK (IKBKE)",5/1379,18/9872,0.2777777777777778,1.988558536781887,1.6914708253183892,0.09494523365156948,0.5873855679437076,0.5450205269809061,CD14/IKBKE/UBC/LY96/RPS27A,5,3.9289742969946015,1.4565131233988193,10.598489487291316
R-HSA-9825892,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,5/1379,18/9872,0.2777777777777778,1.988558536781887,1.6914708253183892,0.09494523365156948,0.5873855679437076,0.5450205269809061,CDKN1A/CCND1/TCF7L2/MET/CDKN2A,5,3.9289742969946015,1.4565131233988193,10.598489487291316
R-HSA-5357801,Programmed Cell Death,33/1379,188/9872,0.17553191489361702,1.2565997562217457,1.4313304835227194,0.0951827616701417,0.5873855679437076,0.5450205269809061,STAT3/IL1B/CD14/LMNA/IRF1/PRKCD/CASP4/BCL2L1/PMAIP1/MLKL/FLOT1/TNFSF10/FLOT2/IL18/LMNB1/GSDME/CASP1/UBC/CHMP4C/LY96/TNFRSF10A/HMGB2/GSDMD/RPS27A/TFDP2/SFN/CASP8/DAPK1/CDKN2A/CASP5/BID/TRADD/TNFRSF10B,33,2.4827773749093542,1.7082010668133405,3.6085819246449167
R-HSA-2022857,Keratan sulfate degradation,4/1379,13/9872,0.3076923076923077,2.2027109945891676,1.748431696215325,0.09595374350432204,0.5873855679437076,0.5450205269809061,ACAN/OMD/OGN/GLB1L3,4,4.352094605901713,1.417159308118376,13.365277531054161
R-HSA-209560,NF-kB is activated and signals survival,4/1379,13/9872,0.3076923076923077,2.2027109945891676,1.748431696215325,0.09595374350432204,0.5873855679437076,0.5450205269809061,NGFR/NFKBIA/UBC/RPS27A,4,4.352094605901713,1.417159308118376,13.365277531054161
R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",4/1379,13/9872,0.3076923076923077,2.2027109945891676,1.748431696215325,0.09595374350432204,0.5873855679437076,0.5450205269809061,FZD5/WNT5A/ROR1/FZD2,4,4.352094605901713,1.417159308118376,13.365277531054161
R-HSA-1433557,Signaling by SCF-KIT,9/1379,40/9872,0.225,1.6107324147933286,1.5595244165316264,0.09651318422778764,0.5873855679437076,0.5450205269809061,STAT3/SOCS6/KIT/SH2B3/STAT1/PIK3R3/GRAP/GRAP2/SH2B2,9,3.182469180565627,1.5410906219808165,6.572040567109576
R-HSA-451927,Interleukin-2 family signaling,9/1379,40/9872,0.225,1.6107324147933286,1.5595244165316264,0.09651318422778764,0.5873855679437076,0.5450205269809061,CSF2RA/STAT3/INPP5D/JAK3/SYK/IL21R/STAT1/PIK3R3/PIK3CD,9,3.182469180565627,1.5410906219808165,6.572040567109576
R-HSA-8875878,MET promotes cell motility,9/1379,40/9872,0.225,1.6107324147933286,1.5595244165316264,0.09651318422778764,0.5873855679437076,0.5450205269809061,LAMA1/COL5A3/TNS3/COL5A2/FN1/MET/LAMA4/LAMA2/COL3A1,9,3.182469180565627,1.5410906219808165,6.572040567109576
R-HSA-9013420,RHOU GTPase cycle,9/1379,40/9872,0.225,1.6107324147933286,1.5595244165316264,0.09651318422778764,0.5873855679437076,0.5450205269809061,ARHGAP31/ARHGEF6/NCK2/IQGAP1/DLG5/SRGAP2/VANGL1/EPHA2/GIT1,9,3.182469180565627,1.5410906219808165,6.572040567109576
R-HSA-196807,Nicotinate metabolism,7/1379,29/9872,0.2413793103448276,1.727988797479433,1.581947620953462,0.09967815039078332,0.6041716462461765,0.5605959134759844,NAMPT/NT5E/PARP9/NNMT/CD38/BST1/NMNAT2,7,3.414143182215998,1.4929163356513595,7.807787610272416
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,15/1379,76/9872,0.19736842105263158,1.4129231708713408,1.4560752120244809,0.10200702176245427,0.6132810822560509,0.5690483336332949,CYSLTR1/DPEP2/FCGR2A/SYK/FCGR1A/GNB3/FGR/CD163/ADCY3/FCGR3A/GNB4/ADCY7/GNG2/ITPR1/PLK2,15,2.791639632075112,1.600280535557776,4.869928529535064
R-HSA-9664433,Leishmania parasite growth and survival,15/1379,76/9872,0.19736842105263158,1.4129231708713408,1.4560752120244809,0.10200702176245427,0.6132810822560509,0.5690483336332949,CYSLTR1/DPEP2/FCGR2A/SYK/FCGR1A/GNB3/FGR/CD163/ADCY3/FCGR3A/GNB4/ADCY7/GNG2/ITPR1/PLK2,15,2.791639632075112,1.600280535557776,4.869928529535064
R-HSA-5683057,MAPK family signaling cascades,49/1379,294/9872,0.16666666666666666,1.1931351220691322,1.354657963138003,0.10400009156255274,0.6227424837515759,0.5778273338513649,CSF2RA/FGF20/FGFR3/JAK3/RASAL2/ITGB3/RALGDS/SPRED3/RASA3/PDGFRA/BCL2L1/RASAL1/IQGAP1/DUSP1/CAMK2G/MARK3/PDGFA/CCND3/RASGRP3/APBB1IP/GRIN1/CDC14A/FGF22/RASGRF1/RGL1/ABHD17C/RGL3/RASAL3/CAMK2D/KIT/FN1/GDNF/CNKSR2/UBC/ACTG1/SHC3/ARRB2/PDGFRB/NRG3/MET/RPS27A/PDGFB/ACTB/KSR2/AREG/DNAJB1/GRIN2B/RGL2/DUSP6,49,2.357384578196761,1.7336457320272325,3.2055349872557612
R-HSA-114604,GPVI-mediated activation cascade,8/1379,35/9872,0.22857142857142856,1.636299595980524,1.5194852231385303,0.10545099042735705,0.6256399003121796,0.5805157749485331,PIK3R5/SYK/PIK3CG/PDPN/FCER1G/VAV3/RHOB/PIK3R3,8,3.2329845643841293,1.4968725586680214,6.982684753635155
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,19/1379,101/9872,0.18811881188118812,1.3467069694641691,1.4111913284723268,0.10548417366035083,0.6256399003121796,0.5805157749485331,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TLR7/TNIP2/DUSP3/MAP2K3/PELI2/MAP3K1/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,19,2.6608103159844627,1.6249379306236702,4.357035062214336
R-HSA-2024096,HS-GAG degradation,6/1379,24/9872,0.25,1.7897026831036984,1.5607285018115729,0.10743311419502075,0.6256399003121796,0.5805157749485331,GPC5/HPSE2/GPC6/HPSE/GPC2/GLB1L3,6,3.5360768672951415,1.4430210493412632,8.665043117096456
R-HSA-210991,Basigin interactions,6/1379,24/9872,0.25,1.7897026831036984,1.5607285018115729,0.10743311419502075,0.6256399003121796,0.5805157749485331,L1CAM/ATP1B3/SLC16A3/SLC7A11/SLC7A8/SLC3A2,6,3.5360768672951415,1.4430210493412632,8.665043117096456
R-HSA-354192,Integrin signaling,6/1379,24/9872,0.25,1.7897026831036984,1.5607285018115729,0.10743311419502075,0.6256399003121796,0.5805157749485331,ITGB3/SYK/APBB1IP/BCAR1/FN1/RAPGEF3,6,3.5360768672951415,1.4430210493412632,8.665043117096456
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,6/1379,24/9872,0.25,1.7897026831036984,1.5607285018115729,0.10743311419502075,0.6256399003121796,0.5805157749485331,MAF/ZNF521/GLI3/AR/WWTR1/HES1,6,3.5360768672951415,1.4430210493412632,8.665043117096456
R-HSA-9934037,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),6/1379,24/9872,0.25,1.7897026831036984,1.5607285018115729,0.10743311419502075,0.6256399003121796,0.5805157749485331,SS18L1/BCL11B/DPF1/ACTL6B/ACTB/SMARCD2,6,3.5360768672951415,1.4430210493412632,8.665043117096456
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,10/1379,47/9872,0.2127659574468085,1.5231512196627222,1.4485785118405559,0.11133328334957049,0.6416836545406384,0.5954023773125612,ITGB3/SMAD7/PPP1R15A/TGFB3/TGFBR1/PMEPA1/TGFBR2/UBC/RPS27A/LTBP4,10,3.009427121102248,1.517406156631912,5.968508535202089
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,10/1379,47/9872,0.2127659574468085,1.5231512196627222,1.4485785118405559,0.11133328334957049,0.6416836545406384,0.5954023773125612,CDKN1A/BTG2/RGCC/GADD45A/PLAGL1/PLK3/TFDP2/SFN/CCNA2/PLK2,10,3.009427121102248,1.517406156631912,5.968508535202089
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,20/1379,108/9872,0.18518518518518517,1.3257056911879246,1.3713726586876327,0.11148443291009072,0.6416836545406384,0.5954023773125612,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TLR7/TNIP2/IRF5/DUSP3/MAP2K3/PELI2/MAP3K1/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,20,2.619316197996401,1.6203959406266788,4.234037603447057
R-HSA-975155,MyD88 dependent cascade initiated on endosome,19/1379,102/9872,0.18627450980392157,1.3335039599596183,1.3642248182238363,0.11352051147952336,0.6465794721806044,0.5999450852981827,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TLR7/TNIP2/DUSP3/MAP2K3/PELI2/MAP3K1/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,19,2.6347239403375564,1.6096158318023701,4.312687601994322
R-HSA-418217,G beta:gamma signalling through PLC beta,5/1379,19/9872,0.2631578947368421,1.8838975611617874,1.553912791336496,0.11473403812663391,0.6465794721806044,0.5999450852981827,GNB3/PLCB1/GNB4/GNG2/PLCB2,5,3.7221861761001493,1.387708861984122,9.983844817234854
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,5/1379,19/9872,0.2631578947368421,1.8838975611617874,1.553912791336496,0.11473403812663391,0.6465794721806044,0.5999450852981827,STAT3/FOXP1/SALL1/PBX1/ZIC3,5,3.7221861761001493,1.387708861984122,9.983844817234854
R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,5/1379,19/9872,0.2631578947368421,1.8838975611617874,1.553912791336496,0.11473403812663391,0.6465794721806044,0.5999450852981827,BTG2/RGCC/PLAGL1/PLK3/PLK2,5,3.7221861761001493,1.387708861984122,9.983844817234854
R-HSA-9033658,Blood group systems biosynthesis,5/1379,19/9872,0.2631578947368421,1.8838975611617874,1.553912791336496,0.11473403812663391,0.6465794721806044,0.5999450852981827,B3GALT5/ST3GAL6/ST3GAL4/FUT3/B3GALT2,5,3.7221861761001493,1.387708861984122,9.983844817234854
R-HSA-376176,Signaling by ROBO receptors,34/1379,198/9872,0.1717171717171717,1.2292907318288029,1.313252393626427,0.11494746172099635,0.6465794721806044,0.5999450852981827,CXCL12/NCK2/NTN1/RPL9/SRGAP2/NELL2/RPL18A/RPL37A/RPS3/RPL30/RPL18/LHX2/MSI1/RPL21/RPS16/UBC/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/PAK5/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14/CAP2,34,2.428820474505754,1.6811448879766988,3.509018728586896
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,27/1379,153/9872,0.17647058823529413,1.2633195410143754,1.3226659113579948,0.11598742506564796,0.6499672687641027,0.6030885378785826,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/LHX2/MSI1/RPL21/RPS16/UBC/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,27,2.4960542592671584,1.6519375714604738,3.7715026117467274
R-HSA-168638,NOD1/2 Signaling Pathway,8/1379,36/9872,0.2222222222222222,1.5908468294255096,1.4310310160670507,0.11986769054727786,0.6582724265002556,0.6107946881366894,CASP4/CARD9/CASP1/UBC/RPS27A/CASP8/NOD2/CASP2,8,3.1431794375956814,1.4581804214825551,6.775277483755804
R-HSA-9013424,RHOV GTPase cycle,8/1379,36/9872,0.2222222222222222,1.5908468294255096,1.4310310160670507,0.11986769054727786,0.6582724265002556,0.6107946881366894,NCK2/SH3RF1/TPM4/IQGAP1/DLG5/VANGL1/EPHA2/GIT1,8,3.1431794375956814,1.4581804214825551,6.775277483755804
R-HSA-3322077,Glycogen synthesis,4/1379,14/9872,0.2857142857142857,2.045374494975655,1.5771523881816143,0.12012917682260557,0.6582724265002556,0.6107946881366894,GYS1/UBC/RPS27A/GBE1,4,4.041230705480162,1.3284228706003114,12.293935896734073
R-HSA-5682910,LGI-ADAM interactions,4/1379,14/9872,0.2857142857142857,2.045374494975655,1.5771523881816143,0.12012917682260557,0.6582724265002556,0.6107946881366894,LGI1/CACNG3/CACNG4/CACNG2,4,4.041230705480162,1.3284228706003114,12.293935896734073
R-HSA-877312,Regulation of IFNG signaling,4/1379,14/9872,0.2857142857142857,2.045374494975655,1.5771523881816143,0.12012917682260557,0.6582724265002556,0.6107946881366894,SOCS3/PTPN2/IFNGR1/STAT1,4,4.041230705480162,1.3284228706003114,12.293935896734073
R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),4/1379,14/9872,0.2857142857142857,2.045374494975655,1.5771523881816143,0.12012917682260557,0.6582724265002556,0.6107946881366894,TPST1/TPST2/KLKB1/GP1BA,4,4.041230705480162,1.3284228706003114,12.293935896734073
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",15/1379,78/9872,0.19230769230769232,1.3766943716182296,1.345824808675146,0.12081316501945993,0.6595865810805074,0.6120140596380537,ST6GAL2/ST6GALNAC3/ST6GAL1/PGM3/ST8SIA4/ST3GAL6/NEU4/ST3GAL4/ST8SIA3/GFPT2/NUDT14/HK1/ST8SIA6/NEU3/UAP1,15,2.7200591286885705,1.561066569206584,4.739529889056841
R-HSA-9696270,RND2 GTPase cycle,9/1379,42/9872,0.21428571428571427,1.5340308712317412,1.3974825597867642,0.12260860758417066,0.6620864809545216,0.614333654842792,ALDH3A2/PTPN13/TFRC/PLXND1/DLG5/PRAG1/VANGL1/EPHA2/CKAP4,9,3.030923029110121,1.4723509074996886,6.239337620941437
R-HSA-977606,Regulation of Complement cascade,9/1379,42/9872,0.21428571428571427,1.5340308712317412,1.3974825597867642,0.12260860758417066,0.6620864809545216,0.614333654842792,CD55/C3/PROS1/CD59/CR2/C3AR1/CR1/C5AR1/CFB,9,3.030923029110121,1.4723509074996886,6.239337620941437
R-HSA-9925563,Developmental Lineage of Pancreatic Ductal Cells,9/1379,42/9872,0.21428571428571427,1.5340308712317412,1.3974825597867642,0.12260860758417066,0.6620864809545216,0.614333654842792,PROM1/LAMA1/SLC4A4/COL5A3/COL5A2/FN1/LAMA4/LAMA2/COL3A1,9,3.030923029110121,1.4723509074996886,6.239337620941437
R-HSA-9679191,Potential therapeutics for SARS,18/1379,97/9872,0.18556701030927836,1.3284391049841884,1.309828666651817,0.12427831695839539,0.6650987576987425,0.6171286718608215,ATP1A2/JAK3/CYSLTR1/VEGFA/IFNAR2/BLNK/IFNGR1/ATP1B3/SYK/TLR7/GATAD2A/ITGA4/FXYD6/SAP30/BTK/FXYD7/S1PR1/IMPDH1,18,2.624716849951033,1.5824900978823966,4.35335333322815
R-HSA-917937,Iron uptake and transport,11/1379,54/9872,0.2037037037037037,1.458276260306717,1.3606451359182095,0.12441791770703135,0.6650987576987425,0.6171286718608215,TFRC/SLC40A1/SLC11A2/ABCG2/HMOX1/TFR2/HEPH/UBC/RPS27A/FTH1/CP,11,2.8812478177960412,1.503149219141623,5.522797658302409
R-HSA-9678108,SARS-CoV-1 Infection,24/1379,135/9872,0.17777777777777778,1.272677463540408,1.2853922934014683,0.12451007046481509,0.6650987576987425,0.6171286718608215,RUNX1/PARP9/NFKBIA/ST6GALNAC3/NLRP3/BCL2L1/TLR7/ST6GAL1/IKBKE/RPS3/ST3GAL4/CASP1/RPS16/UBC/CHMP4C/RPS3A/RPS6/RPS12/RPS27A/EEF1A1/RPS9/SFN/RPSA/RPS14,24,2.514543550076545,1.6233268403849224,3.895043874055741
R-HSA-3238698,WNT ligand biogenesis and trafficking,6/1379,25/9872,0.24,1.7181145757795502,1.448584801189609,0.12552883717756644,0.6681373591709181,0.6199481149422165,WNT11/WNT7A/WNT2B/WNT5A/WNT8B/WNT6,6,3.3946337926033356,1.3902670101972618,8.288723318155593
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,34/1379,200/9872,0.17,1.2169978245105149,1.2492356828163336,0.12707196679480895,0.673935252465326,0.6253278365955073,GABRB1/CAMK2G/GNB3/KCNJ16/ADCY3/PLCB1/GRIN1/GNB4/NCALD/CACNG3/RASGRF1/GRIK4/TUBB4A/TUBA1A/GABRG3/CAMK4/CAMK2D/GABRA2/GABRG2/GABRA4/GRIK2/KCNJ6/ADCY7/GNG2/PLCB2/CACNG4/GRIA1/GRIA4/GIT1/KCNJ3/GABRB3/GRIN2B/TUBA1B/CACNG2,34,2.404532269760696,1.6647724792529028,3.473012383599231
R-HSA-418346,Platelet homeostasis,16/1379,85/9872,0.18823529411764706,1.347540843748667,1.2966497088008695,0.1288131672853493,0.6807386242659919,0.6316405168627918,SLC8A3/KCNMB4/SLC8A1/GUCY1A1/PLA2G4A/ATP2B4/GNB3/PECAM1/FGR/KCNMB2/GNB4/KCNMA1/GNG2/PRKG1/ITPR1/PDE11A,16,2.662457876551636,1.5563361131657725,4.554724319795309
R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),7/1379,31/9872,0.22580645161290322,1.6165056492549532,1.3852572715484768,0.13179039481574145,0.6866973203557054,0.6371694434489588,A2M/PROS1/THBD/F2R/KLKB1/SERPINA5/GP1BA,7,3.193875880137547,1.4038552741328294,7.266306809315169
R-HSA-2022928,HS-GAG biosynthesis,7/1379,31/9872,0.22580645161290322,1.6165056492549532,1.3852572715484768,0.13179039481574145,0.6866973203557054,0.6371694434489588,HS3ST4/GPC5/GLCE/SLC35D2/HS3ST1/GPC6/GPC2,7,3.193875880137547,1.4038552741328294,7.266306809315169
R-HSA-399719,Trafficking of AMPA receptors,7/1379,31/9872,0.22580645161290322,1.6165056492549532,1.3852572715484768,0.13179039481574145,0.6866973203557054,0.6371694434489588,CAMK2G/CACNG3/CAMK2D/CACNG4/GRIA1/GRIA4/CACNG2,7,3.193875880137547,1.4038552741328294,7.266306809315169
R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",7/1379,31/9872,0.22580645161290322,1.6165056492549532,1.3852572715484768,0.13179039481574145,0.6866973203557054,0.6371694434489588,CAMK2G/CACNG3/CAMK2D/CACNG4/GRIA1/GRIA4/CACNG2,7,3.193875880137547,1.4038552741328294,7.266306809315169
R-HSA-4420097,VEGFA-VEGFR2 Pathway,18/1379,98/9872,0.1836734693877551,1.3148836039129213,1.2622897767102257,0.1334403489368336,0.6928633502489437,0.642890749938591,CTNNA1/VEGFA/ITGB3/DOCK1/NCK2/CYFIP1/PRKCD/NCKAP1L/PXN/SHB/CYBB/AXL/BCAR1/NCF2/ACTG1/VAV3/ACTB/ITPR1,18,2.5979340249515324,1.5669681348417905,4.3072102411848405
R-HSA-4086398,Ca2+ pathway,12/1379,61/9872,0.19672131147540983,1.4082906358848775,1.2888721696928302,0.1360253002617126,0.6940175483626425,0.6439617017945767,FZD5/GNB3/PLCB1/GNB4/WNT11/WNT5A/TCF7L2/GNG2/PLCB2/PRKG1/ITPR1/FZD2,12,2.782486715248636,1.4947830921550986,5.17950220414442
R-HSA-500657,Presynaptic function of Kainate receptors,5/1379,20/9872,0.25,1.7897026831036984,1.4244544189460784,0.1363044308309702,0.6940175483626425,0.6439617017945767,GNB3/PLCB1/GNB4/GNG2/PLCB2,5,3.5360768672951415,1.3251123601079977,9.436059905441338
R-HSA-9671555,Signaling by PDGFR in disease,5/1379,20/9872,0.25,1.7897026831036984,1.4244544189460784,0.1363044308309702,0.6940175483626425,0.6439617017945767,STAT3/ETV6/PDGFRA/BIN2/STAT1,5,3.5360768672951415,1.3251123601079977,9.436059905441338
R-HSA-9717207,"Sensory perception of sweet, bitter, and umami (glutamate) taste",5/1379,20/9872,0.25,1.7897026831036984,1.4244544189460784,0.1363044308309702,0.6940175483626425,0.6439617017945767,SCN1B/GNB3/GRM1/PLCB2/GRM4,5,3.5360768672951415,1.3251123601079977,9.436059905441338
R-HSA-977225,Amyloid fiber formation,9/1379,43/9872,0.20930232558139536,1.4983557346914684,1.3196269229242046,0.1369445069505438,0.6940175483626425,0.6439617017945767,SORL1/TSPAN15/MFGE8/SNCAIP/UBC/LTF/RPS27A/CST3/TGFBI,9,2.9604364470377926,1.4402323540461057,6.085256960328767
R-HSA-112040,G-protein mediated events,11/1379,55/9872,0.2,1.4317621464829586,1.2938045090899994,0.13701285108630662,0.6940175483626425,0.6439617017945767,PRKCD/PLA2G4A/CAMK2G/ADCY3/PLCB1/CAMK4/CAMK2D/ADCY7/PLCB2/PLCB4/ITPR1,11,2.828861493836113,1.4772879977840596,5.416992057955129
R-HSA-9013409,RHOJ GTPase cycle,11/1379,55/9872,0.2,1.4317621464829586,1.2938045090899994,0.13701285108630662,0.6940175483626425,0.6439617017945767,SLC4A7/ARHGAP26/TFRC/ARHGAP21/RHOJ/GJA1/DOCK8/OPHN1/VANGL1/GIT1/DIAPH3,11,2.828861493836113,1.4772879977840596,5.416992057955129
R-HSA-9012852,Signaling by NOTCH3,10/1379,49/9872,0.20408163265306123,1.460981782125468,1.3034425001157262,0.13740145401927065,0.6940175483626425,0.6439617017945767,MAML3/NEURL1B/PLXND1/HES5/FABP7/PBX1/UBC/RPS27A/STAT1/HES1,10,2.8865933610572587,1.4590274927386175,5.710941893534683
R-HSA-8878159,Transcriptional regulation by RUNX3,16/1379,86/9872,0.18604651162790697,1.3318717641701943,1.2455153116707076,0.1388791550696903,0.6991035433169156,0.6486808706020505,RUNX1/MAML3/CDKN1A/SPP1/TEAD3/TEAD4/HDAC4/ITGA4/CCND1/UBC/ZFHX3/TCF7L2/RPS27A/CDKN2A/WWTR1/HES1,16,2.631499064033594,1.5389925150636443,4.499558806316422
R-HSA-446652,Interleukin-1 family signaling,23/1379,131/9872,0.17557251908396945,1.2568904339354217,1.1926525896127538,0.1437660513305012,0.7201261629737161,0.6681872389385749,PTPN14/STAT3/PTPN13/IL1B/PTPN2/IL1RAP/NFKBIA/NLRC5/TIFA/TNIP2/IL18/PELI2/PTPN5/CASP1/UBC/IL1RN/GSDMD/RPS27A/IL33/CASP8/NOD2/MAP3K8/PTPN20,23,2.483351693062237,1.5890569886790333,3.880940504570369
R-HSA-9013106,RHOC GTPase cycle,14/1379,74/9872,0.1891891891891892,1.3543695980244206,1.2329224063606632,0.14402523259474323,0.7201261629737161,0.6681872389385749,ERBIN/ARHGAP26/TFRC/ARHGAP21/ABR/RTKN/IQGAP1/ARHGEF10/FLOT1/FLOT2/OPHN1/CAVIN1/VANGL1/DIAPH3,14,2.6759500617368635,1.5075127002123088,4.750015526835066
R-HSA-199418,Negative regulation of the PI3K/AKT network,20/1379,112/9872,0.17857142857142858,1.2783590593597844,1.1937726087810043,0.1457204890166542,0.7257010265384514,0.6733600168271011,FGF20/PIP4K2A/FGFR3/PIP5K1B/CD86/IL1RAP/PDGFRA/PIK3R5/PDGFA/PIK3CG/FGF22/KIT/PDGFRB/NRG3/MET/PDGFB/PIK3R3/IL33/PIK3CD/AREG,20,2.525769190925101,1.5645955293742049,4.077418020220259
R-HSA-3229121,Glycogen storage diseases,4/1379,15/9872,0.26666666666666666,1.9090161953106115,1.4196360495014957,0.14660626798756593,0.7257010265384514,0.6733600168271011,GYS1/UBC/RPS27A/GBE1,4,3.7718153251148174,1.2501348940475283,11.38004459719538
R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,4/1379,15/9872,0.26666666666666666,1.9090161953106115,1.4196360495014957,0.14660626798756593,0.7257010265384514,0.6733600168271011,CD14/UBC/LY96/RPS27A,4,3.7718153251148174,1.2501348940475283,11.38004459719538
R-HSA-9861718,Regulation of pyruvate metabolism,7/1379,32/9872,0.21875,1.5659898477157361,1.2921657579452497,0.14954949399812373,0.7361401690230593,0.6830462387036574,PDK1/LDHA/PDK3/PDPR/UBC/RPS27A/ME1,7,3.0940672588832485,1.3631966951496284,7.022649216034455
R-HSA-112310,Neurotransmitter release cycle,10/1379,50/9872,0.2,1.4317621464829586,1.2332801697173859,0.1515384065788943,0.7361401690230593,0.6830462387036574,SLC1A2/PPFIA2/SYT1/PPFIA4/RIMS1/ALDH5A1/SLC1A6/TSPOAP1/SLC32A1/NAAA,10,2.8288614938361136,1.4314922301283435,5.590290455569718
R-HSA-2172127,DAP12 interactions,8/1379,38/9872,0.21052631578947367,1.5071180489294302,1.2620248636709224,0.15161759772171735,0.7361401690230593,0.6830462387036574,TREM1/SYK/CLEC5A/TREM2/BTK/VAV3/KLRD1/GRAP2,8,2.977748940880119,1.3865063587100819,6.3952023726468585
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,8/1379,38/9872,0.21052631578947367,1.5071180489294302,1.2620248636709224,0.15161759772171735,0.7361401690230593,0.6830462387036574,RUNX1/NFKBIA/NLRP3/TLR7/IKBKE/CASP1/UBC/RPS27A,8,2.977748940880119,1.3865063587100819,6.3952023726468585
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",9/1379,44/9872,0.20454545454545456,1.4643021952666624,1.243731541664686,0.15210226759419768,0.7361401690230593,0.6830462387036574,CSF2RA/INPP5D/JAK3/BLNK/SYK/UBC/RPS27A/PIK3R3/PIK3CD,9,2.8931538005142063,1.4094862955612264,5.938574174002103
R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,3/1379,10/9872,0.3,2.1476432197244377,1.4630411557408562,0.15367235851659825,0.7361401690230593,0.6830462387036574,VEGFA/HIF1A/CA9,3,4.24329224075417,1.1664373556244116,15.436344655479516
R-HSA-2892247,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",3/1379,10/9872,0.3,2.1476432197244377,1.4630411557408562,0.15367235851659825,0.7361401690230593,0.6830462387036574,STAT3/SALL1/ZIC3,3,4.24329224075417,1.1664373556244116,15.436344655479516
R-HSA-399997,Acetylcholine regulates insulin secretion,3/1379,10/9872,0.3,2.1476432197244377,1.4630411557408562,0.15367235851659825,0.7361401690230593,0.6830462387036574,MARCKS/PLCB1/PLCB2,3,4.24329224075417,1.1664373556244116,15.436344655479516
R-HSA-5661231,Metallothioneins bind metals,3/1379,10/9872,0.3,2.1476432197244377,1.4630411557408562,0.15367235851659825,0.7361401690230593,0.6830462387036574,MT1M/MT1X/MT1A,3,4.24329224075417,1.1664373556244116,15.436344655479516
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,3/1379,10/9872,0.3,2.1476432197244377,1.4630411557408562,0.15367235851659825,0.7361401690230593,0.6830462387036574,CDKN1A/PIM1/BCL2L1,3,4.24329224075417,1.1664373556244116,15.436344655479516
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,24/1379,139/9872,0.17266187050359713,1.2360536516399643,1.1293457155357627,0.1569427881545727,0.7493891974583294,0.6953396841913545,TLR2/FOS/CD14/MEF2C/LY86/NFKBIA/NLRC5/S100A9/TIFA/TNIP2/IKBKE/DUSP3/MAP2K3/S100A8/PELI2/MAP3K1/BTK/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,24,2.4421825846067162,1.5780897920258123,3.779414711820647
R-HSA-194138,Signaling by VEGF,19/1379,107/9872,0.17757009345794392,1.2711906908026267,1.136482334411564,0.15910081520254046,0.7519618227570978,0.6977267595173071,CTNNA1/VEGFA/ITGB3/DOCK1/NCK2/CYFIP1/PRKCD/NCKAP1L/PXN/SHB/CYBB/AXL/BCAR1/NCF2/ACTG1/VAV3/VEGFD/ACTB/ITPR1,19,2.5116059992002873,1.537147582317963,4.103812000736057
R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,5/1379,21/9872,0.23809523809523808,1.704478745813046,1.3021755293537327,0.15950705331211165,0.7519618227570978,0.6977267595173071,A2M/PROS1/KLKB1/SERPINA5/GP1BA,5,3.3676922545668013,1.2679198457964753,8.944848650385213
R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,5/1379,21/9872,0.23809523809523808,1.704478745813046,1.3021755293537327,0.15950705331211165,0.7519618227570978,0.6977267595173071,CAMK2G/GRIN1/RASGRF1/CAMK2D/GRIN2B,5,3.3676922545668013,1.2679198457964753,8.944848650385213
R-HSA-5365859,RA biosynthesis pathway,5/1379,21/9872,0.23809523809523808,1.704478745813046,1.3021755293537327,0.15950705331211165,0.7519618227570978,0.6977267595173071,ALDH1A1/CYP26C1/DHRS9/RDH10/AKR1C3,5,3.3676922545668013,1.2679198457964753,8.944848650385213
R-HSA-9855142,Cellular responses to mechanical stimuli,18/1379,101/9872,0.1782178217821782,1.2758276552818442,1.1226933104003267,0.1631792925664023,0.7668393970288209,0.7115312923698223,ITGB3/CALCRL/SPP1/PDE4D/NFKBIA/GJA1/ADM/GNB3/PECAM1/ADCY3/IKBKE/GNB4/TRPV4/FN1/ADCY7/GNG2/STAT1/PIK3CD,18,2.5207676677747544,1.5221783345594404,4.174458071456963
R-HSA-3000170,Syndecan interactions,6/1379,27/9872,0.2222222222222222,1.5908468294255096,1.2387426145739024,0.1657342301486441,0.7721592871128081,0.7164674866777714,ITGB3/ITGB4/COL5A3/COL5A2/FN1/COL3A1,6,3.143179437595681,1.2955470551423547,7.625795556950059
R-HSA-389357,CD28 dependent PI3K/Akt signaling,6/1379,27/9872,0.2222222222222222,1.5908468294255096,1.2387426145739024,0.1657342301486441,0.7721592871128081,0.7164674866777714,CD86/PIK3R5/PIK3CG/PIK3R3/PIK3CD/MAP3K8,6,3.143179437595681,1.2955470551423547,7.625795556950059
R-HSA-9012999,RHO GTPase cycle,69/1379,441/9872,0.1564625850340136,1.1200860329628588,1.0395971194379525,0.1658712542686773,0.7721592871128081,0.7164674866777714,ERBIN/ALDH3A2/PTPN13/SLC4A7/WIPF3/ARHGAP26/ARHGAP31/ARHGEF3/PREX2/RASAL2/TFRC/ARHGEF6/DOCK1/ARHGAP21/NCK2/ARHGAP15/CYFIP1/RHOJ/ABR/NCKAP1L/SH3RF1/PLXND1/RTKN/TPM4/GJA1/IQGAP1/SLITRK5/RHOQ/GMIP/ARHGEF10/CYBB/DLG5/PRAG1/ARHGAP42/FLOT1/SRGAP2/TEX2/ARHGDIB/FLOT2/FGD3/RHOBTB2/NGEF/PCDH7/ARHGAP4/LMNB1/DOCK8/DIAPH2/TRIP10/OPHN1/NCF2/ACTG1/CAVIN1/DEF6/VAV3/IQGAP2/RHOB/ARHGAP8/PAK5/PIK3R3/ACTB/VANGL1/PLEKHG2/EPHA2/GIT1/CKAP4/PLEKHG4/ARHGAP20/DIAPH3/TUBA1B,69,2.213054910143898,1.7071376349986733,2.8689028552263287
R-HSA-1980145,Signaling by NOTCH2,7/1379,33/9872,0.21212121212121213,1.5185356099061682,1.2022429059883974,0.16835925658429207,0.7787631938543083,0.7225950882546799,MAML3/NEURL1B/CNTN1/HES5/UBC/RPS27A/HES1,7,3.0003076449776955,1.3248284262091312,6.794725857648993
R-HSA-5694530,Cargo concentration in the ER,7/1379,33/9872,0.21212121212121213,1.5185356099061682,1.2022429059883974,0.16835925658429207,0.7787631938543083,0.7225950882546799,TMED10/CD59/SEC24D/GOSR2/SERPINA1/GRIA1/AREG,7,3.0003076449776955,1.3248284262091312,6.794725857648993
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,8/1379,39/9872,0.20512820512820512,1.468473996392778,1.1811550753232238,0.16886313024989041,0.7787631938543083,0.7225950882546799,FCGR2A/SYK/FCGR1A/FGR/ADCY3/FCGR3A/ADCY7/ITPR1,8,2.9013964039344753,1.3532500916427943,6.220654367401261
R-HSA-140875,Common Pathway of Fibrin Clot Formation,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,PROS1/THBD/F2R/SERPINA5,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-1433559,Regulation of KIT signaling,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,SOCS6/KIT/SH2B3/SH2B2,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-193639,p75NTR signals via NF-kB,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,NGFR/NFKBIA/UBC/RPS27A,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,TGFBR1/TGFBR2/UBC/RPS27A,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-399956,CRMPs in Sema3A signaling,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,DPYSL5/PLXNA3/SEMA3A/PLXNA2,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-5423646,Aflatoxin activation and detoxification,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,ACY3/DPEP2/MGST2/MGST1,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,TNIP2/UBC/RPS27A/MAP3K8,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,CD14/UBC/LY96/RPS27A,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-9830364,Formation of the nephric duct,4/1379,16/9872,0.25,1.7897026831036984,1.2738122013216104,0.1750858620908929,0.7855060580210754,0.7288516249864171,ID4/PCDH19/PLAC8/EMX2,4,3.5360768672951415,1.180554535050483,10.59149682643431
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,17/1379,96/9872,0.17708333333333334,1.267706067198453,1.062051021704213,0.1785095794070266,0.7879335834617059,0.7311040657461445,FOS/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/DUSP3/MAP2K3/PELI2/TLR10/MAP3K1/UBC/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,17,2.5047211143340586,1.4911513682310338,4.207237436956726
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,17/1379,96/9872,0.17708333333333334,1.267706067198453,1.062051021704213,0.1785095794070266,0.7879335834617059,0.7311040657461445,FOS/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/DUSP3/MAP2K3/PELI2/TLR10/MAP3K1/UBC/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,17,2.5047211143340586,1.4911513682310338,4.207237436956726
R-HSA-975871,MyD88 cascade initiated on plasma membrane,17/1379,96/9872,0.17708333333333334,1.267706067198453,1.062051021704213,0.1785095794070266,0.7879335834617059,0.7311040657461445,FOS/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/DUSP3/MAP2K3/PELI2/TLR10/MAP3K1/UBC/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,17,2.5047211143340586,1.4911513682310338,4.207237436956726
R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",11/1379,58/9872,0.1896551724137931,1.35770548373384,1.1009021377011712,0.17863066927051338,0.7879335834617059,0.7311040657461445,RPS3/RPS16/RPS3A/RPS6/EIF4EBP1/RPS12/RPS27A/RPS9/EIF4A1/RPSA/RPS14,11,2.6825410717411415,1.404785496632047,5.122509179394635
R-HSA-9700206,Signaling by ALK in cancer,16/1379,90/9872,0.17777777777777778,1.272677463540408,1.0471015874307683,0.1833341970491925,0.7879335834617059,0.7311040657461445,STAT3/BCL2A1/CDKN1A/TPM4/JUNB/RRBP1/PPM1B/MCL1/EIF2AK3/FN1/IL10RA/UBC/RPS6/RPS27A/STAT1/PPFIBP1,16,2.514543550076545,1.4733214340533765,4.2916156102039595
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,16/1379,90/9872,0.17777777777777778,1.272677463540408,1.0471015874307683,0.1833341970491925,0.7879335834617059,0.7311040657461445,STAT3/BCL2A1/CDKN1A/TPM4/JUNB/RRBP1/PPM1B/MCL1/EIF2AK3/FN1/IL10RA/UBC/RPS6/RPS27A/STAT1/PPFIBP1,16,2.514543550076545,1.4733214340533765,4.2916156102039595
R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,5/1379,22/9872,0.22727272727272727,1.6270024391851803,1.1863001969465452,0.18417138267983976,0.7879335834617059,0.7311040657461445,CAMK2G/GRIN1/CAMK4/CAMK2D/GRIN2B,5,3.214615333904674,1.21546052998369,8.501922925554583
R-HSA-9824439,Bacterial Infection Pathways,13/1379,71/9872,0.18309859154929578,1.3107681622731313,1.0589187696167364,0.18480667749162139,0.7879335834617059,0.7311040657461445,TLR2/PGK1/ENO1/MRC1/CD9/SYT1/MAP2K3/ANTXR1/UBC/LTF/SV2C/MET/RPS27A,13,2.589802776047146,1.4301545799510775,4.6897576757408554
R-HSA-1296041,Activation of G protein gated Potassium channels,6/1379,28/9872,0.21428571428571427,1.5340308712317412,1.1402280578564175,0.18763771477069535,0.7879335834617059,0.7311040657461445,GNB3/KCNJ16/GNB4/KCNJ6/GNG2/KCNJ3,6,3.030923029110121,1.2528697574923109,7.332361846435943
R-HSA-1296059,G protein gated Potassium channels,6/1379,28/9872,0.21428571428571427,1.5340308712317412,1.1402280578564175,0.18763771477069535,0.7879335834617059,0.7311040657461445,GNB3/KCNJ16/GNB4/KCNJ6/GNG2/KCNJ3,6,3.030923029110121,1.2528697574923109,7.332361846435943
R-HSA-9682385,FLT3 signaling in disease,6/1379,28/9872,0.21428571428571427,1.5340308712317412,1.1402280578564175,0.18763771477069535,0.7879335834617059,0.7311040657461445,CDKN1A/ETV6/PIM1/BCL2L1/UBC/RPS27A,6,3.030923029110121,1.2528697574923109,7.332361846435943
R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,6/1379,28/9872,0.21428571428571427,1.5340308712317412,1.1402280578564175,0.18763771477069535,0.7879335834617059,0.7311040657461445,GNB3/KCNJ16/GNB4/KCNJ6/GNG2/KCNJ3,6,3.030923029110121,1.2528697574923109,7.332361846435943
R-HSA-9711097,Cellular response to starvation,25/1379,149/9872,0.16778523489932887,1.2011427403380526,0.9968492832167176,0.18813758372491254,0.7879335834617059,0.7311040657461445,ATF3/RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,25,2.3732059512047927,1.5482485767186662,3.637727540347845
R-HSA-76009,Platelet Aggregation (Plug Formation),7/1379,34/9872,0.20588235294117646,1.4738727978501043,1.1152698857003995,0.18814316481782908,0.7879335834617059,0.7311040657461445,ITGB3/SYK/APBB1IP/BCAR1/FN1/RAPGEF3/GP1BA,7,2.9120633024783515,1.2885621474442084,6.5810661088104725
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,7/1379,34/9872,0.20588235294117646,1.4738727978501043,1.1152698857003995,0.18814316481782908,0.7879335834617059,0.7311040657461445,RNF125/NLRC5/UBA7/IKBKE/RNF135/UBC/RPS27A,7,2.9120633024783515,1.2885621474442084,6.5810661088104725
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,21/1379,123/9872,0.17073170731707318,1.2222359787049648,0.999353269287764,0.19031497342695064,0.7879335834617059,0.7311040657461445,NAMPT/SLC2A3/SHMT1/NT5E/GSTO2/PARP9/MMAB/MTHFD2/FOLR2/NNMT/ENPP1/SLC23A2/ABCD4/VNN2/PANK1/CUBN/CD38/SLC2A1/ENPP3/BST1/NMNAT2,21,2.4148817630308286,1.515367936348327,3.8483419039944633
R-HSA-1059683,Interleukin-6 signaling,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,SOCS3/STAT3/STAT1,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-196025,Formation of annular gap junctions,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,GJA1/ACTG1/ACTB,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-2022923,Dermatan sulfate biosynthesis,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,VCAN/CSPG5/NCAN,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-2586552,Signaling by Leptin,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,SOCS3/STAT3/LEP,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-3270619,IRF3-mediated induction of type I IFN,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,IFI16/DTX4/NLRP4,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9020956,Interleukin-27 signaling,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,STAT3/IL27/STAT1,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,PIK3R5/PIK3CG/PIK3CD,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,TIFA/UBC/RPS27A,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9701898,STAT3 nuclear events downstream of ALK signaling,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,STAT3/HIF1A/PRDM1,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9708530,Regulation of BACH1 activity,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,BACH1/UBC/RPS27A,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9818030,NFE2L2 regulating tumorigenic genes,3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,BCL2L1/PDGFA/AREG,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-9828211,"Regulation of TBK1, IKK-mediated activation of IRF3, IRF7 upon TLR3 ligation",3/1379,11/9872,0.2727272727272727,1.952402927022216,1.2734700386529343,0.19048360704562456,0.7879335834617059,0.7311040657461445,IKBKE/UBC/RPS27A,3,3.8575384006856086,1.0749103289160258,13.843575703445106
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,68/1379,439/9872,0.1548974943052392,1.1088818446565056,0.9403617594755416,0.19108853895999336,0.7882402232099727,0.7313885891772847,ERBIN/FGF20/STAT3/FGFR3/BCL2A1/MAML3/CDKN1A/NEURL1B/ITGB3/DHH/LMNA/CD86/ETV6/SPRED3/PIM1/PDGFRA/TPM4/PIK3R5/BCL2L1/JUNB/BIN2/IQGAP1/RRBP1/HES5/FZD5/CAMK2G/MARK3/TGFBR1/PDGFA/APBB1IP/FGFR1OP2/PIK3CG/MPRIP/PPM1B/FGF22/HDAC4/MCL1/TGFBR2/TRAK1/CAMK2D/EIF2AK3/KIT/FN1/CNKSR2/IL10RA/UBC/ACTG1/KIAA1549/RPS6/TCF7L2/ARRB2/RNF43/PDGFRB/NRG3/MET/RPS27A/PDGFB/STAT1/PIK3R3/PPFIBP1/ACTB/PIK3CD/AGTRAP/KSR2/HES1/NR4A1/AREG/DUSP6,68,2.190917785658949,1.6872775176275328,2.8448910705964496
R-HSA-9860931,Response of endothelial cells to shear stress,16/1379,91/9872,0.17582417582417584,1.2586919969080956,0.99895104829324,0.19544069997760094,0.8039596661128459,0.7459742710910618,ITGB3/CALCRL/PDE4D/NFKBIA/ADM/GNB3/PECAM1/ADCY3/IKBKE/GNB4/TRPV4/FN1/ADCY7/GNG2/STAT1/PIK3CD,16,2.486911203372407,1.4577707709095937,4.242592495938273
R-HSA-2219528,PI3K/AKT Signaling in Cancer,18/1379,104/9872,0.17307692307692307,1.2390249344564064,0.987391078708925,0.19614029573185401,0.8046086717176885,0.7465764673247948,FGF20/FGFR3/CDKN1A/CD86/PDGFRA/PIK3R5/PDGFA/PIK3CG/FGF22/KIT/PDGFRB/NRG3/MET/PDGFB/PIK3R3/PIK3CD/NR4A1/AREG,18,2.4480532158197135,1.4798796724536354,4.049629614513811
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,10/1379,53/9872,0.18867924528301888,1.3507190061159988,1.031562992917931,0.19801733415564002,0.8100709124548909,0.7516447452797819,FKBP5/AR/TUBB4A/TUBA1A/DNAJA4/HSPA1A/HSPA1B/PGR/DNAJB1/TUBA1B,10,2.668737258335956,1.3547925928163485,5.257010255145359
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,12/1379,66/9872,0.18181818181818182,1.3016019513481443,0.9905863001652468,0.20391074348806426,0.8122513683363213,0.7536679363120642,CACNA1D/KCNMA1/PCDH15/USH1C/ACTG1/EPS8L2/ACTB/TMC1/EZR/BSN/RIPOR2/SLC17A8,12,2.571692267123739,1.3868726072151973,4.768715657355126
R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,GJA1/TUBB4A/TUBA1A/TUBA1B,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-190872,Transport of connexons to the plasma membrane,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,GJA1/TUBB4A/TUBA1A/TUBA1B,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-8964315,G beta:gamma signalling through BTK,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,GNB3/GNB4/BTK/GNG2,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,CDKN1A/CCND3/CCND1/TFDP2,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,CDKN1A/CCND3/CCND1/TFDP2,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-9671793,Diseases of hemostasis,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,TPST1/TPST2/KLKB1/GP1BA,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,4/1379,17/9872,0.23529411764705882,1.6844260546858338,1.138032925593696,0.20524763002175175,0.8122513683363213,0.7536679363120642,HMOX1/BACH1/SLC7A11/TXN,4,3.328072345689545,1.1183068428257925,9.904317056807024
R-HSA-9035034,RHOF GTPase cycle,8/1379,41/9872,0.1951219512195122,1.3968411185199596,1.0259870812001501,0.20581767094128472,0.8122513683363213,0.7536679363120642,SLC4A7/ARHGAP21/SRGAP2/LMNB1/DIAPH2/ACTB/VANGL1/DIAPH3,8,2.7598648720352323,1.2913076046131733,5.8985590146631015
R-HSA-9694548,Maturation of spike protein,8/1379,41/9872,0.1951219512195122,1.3968411185199596,1.0259870812001501,0.20581767094128472,0.8122513683363213,0.7536679363120642,MGAT4C/ZDHHC20/ST6GALNAC3/ST6GAL1/ST3GAL4/ZDHHC11/TUSC3/EDEM2,8,2.7598648720352323,1.2913076046131733,5.8985590146631015
R-HSA-416482,G alpha (12/13) signalling events,14/1379,79/9872,0.17721518987341772,1.2686500032127481,0.9659945261860505,0.20683419842363146,0.8122513683363213,0.7536679363120642,ARHGEF3/ARHGEF6/ABR/GNB3/ARHGEF10/GNB4/FGD3/NGEF/GNA12/BTK/VAV3/RHOB/GNG2/PLEKHG2,14,2.506586133778834,1.4161591047195838,4.436630054570336
R-HSA-1236975,Antigen processing-Cross presentation,16/1379,92/9872,0.17391304347826086,1.2450105621590946,0.9513524480247679,0.2079166082776253,0.8122513683363213,0.7536679363120642,TLR2/MRC2/CD14/CTSS/MRC1/FCGR1A/S100A9/CYBB/TAP1/S100A8/NCF2/BTK/UBC/LY96/PSMB9/RPS27A,16,2.4598795598574896,1.4425451832766092,4.194674467846038
R-HSA-375165,NCAM signaling for neurite out-growth,11/1379,60/9872,0.18333333333333332,1.3124486342760453,0.9781548961221733,0.20930878709195982,0.8122513683363213,0.7536679363120642,CACNB4/COL9A1/COL4A1/CACNA1D/NCAN/ST8SIA4/COL5A3/COL5A2/COL4A2/GDNF/COL3A1,11,2.593123036016437,1.3602817352217336,4.943304688879768
R-HSA-202040,G-protein activation,5/1379,23/9872,0.21739130434782608,1.556263202698868,1.0761686296875579,0.21011163550476358,0.8122513683363213,0.7536679363120642,GNB3/GNB4/OPRM1/PDYN/GNG2,5,3.074849449821862,1.1671702079416368,8.10053158891336
R-HSA-212676,Dopamine Neurotransmitter Release Cycle,5/1379,23/9872,0.21739130434782608,1.556263202698868,1.0761686296875579,0.21011163550476358,0.8122513683363213,0.7536679363120642,PPFIA2/SYT1/PPFIA4/RIMS1/TSPOAP1,5,3.074849449821862,1.1671702079416368,8.10053158891336
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,SMAD7/TGIF2/UBC/RPS27A/STAT1/WWTR1,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-2424491,DAP12 signaling,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,SYK/TREM2/BTK/VAV3/KLRD1/GRAP2,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-4090294,SUMOylation of intracellular receptors,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,RARA/HDAC4/AR/PPARG/RORA/PGR,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-9683701,Translation of Structural Proteins,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,PARP9/ST6GALNAC3/ST6GAL1/ST3GAL4/UBC/RPS27A,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-9860927,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,ITGB3/PDE4D/NFKBIA/IKBKE/FN1/STAT1,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-9932444,ATP-dependent chromatin remodelers,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,SS18L1/BCL11B/DPF1/ACTL6B/ACTB/SMARCD2,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-9932451,SWI/SNF chromatin remodelers,6/1379,29/9872,0.20689655172413793,1.481133254982371,1.0455210447142365,0.2105836880871944,0.8122513683363213,0.7536679363120642,SS18L1/BCL11B/DPF1/ACTL6B/ACTB/SMARCD2,6,2.926408441899427,1.2129156946442383,7.0605619225102965
R-HSA-5173105,O-linked glycosylation,19/1379,112/9872,0.16964285714285715,1.2144411063917953,0.9196536286478151,0.21317104674805376,0.8201010477224348,0.7609514594851442,GALNT15/SPON1/ADAMTS14/ADAMTS19/ADAMTS10/ST6GALNAC3/MUC20/ST6GAL1/GALNT7/MUC4/B3GLCT/B4GALT5/ST3GAL4/B3GNT5/THSD7A/MUC15/EMID1/ADAMTSL2/MMRN1,19,2.399480731378846,1.470927814667575,3.914201446764769
R-HSA-109606,Intrinsic Pathway for Apoptosis,10/1379,54/9872,0.18518518518518517,1.3257056911879246,0.9670364861560176,0.21474447425759657,0.8240194942442659,0.7645872890063754,STAT3/BCL2L1/PMAIP1/GSDME/GSDMD/TFDP2/SFN/CASP8/CDKN2A/BID,10,2.619316197996401,1.331021787721133,5.154549240574683
R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,9/1379,48/9872,0.1875,1.3422770123277739,0.9578253373460522,0.22014674524118857,0.8244238247293524,0.764962457253746,RPS3/RPS16/RPS3A/RPS6/RPS12/RPS27A/RPS9/RPSA/RPS14,9,2.652057650471356,1.2986050248068326,5.4161270340609295
R-HSA-8978868,Fatty acid metabolism,27/1379,166/9872,0.16265060240963855,1.1643848781638517,0.8606526526251067,0.2237802542442257,0.8244238247293524,0.764962457253746,ALDH3A2/ELOVL5/LTC4S/ACSF2/ACSL1/HACD4/DPEP2/PTGS1/TBXAS1/PLA2G4A/ALOX15B/HPGDS/ELOVL2/SLC27A1/AKR1C3/TECR/CYP8B1/ACOT11/HACD1/PTGR1/ACSL6/ACSBG1/ACBD7/PTGS2/CBR1/CYP4F3/ALOX5AP,27,2.3005801305293687,1.5262104663369656,3.4678499811951764
R-HSA-187037,Signaling by NTRK1 (TRKA),19/1379,113/9872,0.168141592920354,1.2036938399635495,0.8774989493766691,0.2249049029282197,0.8244238247293524,0.764962457253746,STAT3/FOS/VGF/SGK1/MEF2C/RALGDS/ID4/JUNB/EGR1/DUSP3/FOSL1/ID2/LYL1/ARC/SHC3/ADORA2A/EGR3/ASCL1/DUSP6,19,2.378246388623281,1.4583631246883937,3.878359092635587
R-HSA-9696264,RND3 GTPase cycle,8/1379,42/9872,0.19047619047619047,1.3635829966504367,0.951444802586152,0.22539627408413557,0.8244238247293524,0.764962457253746,PTPN13/RASAL2/ARHGAP21/DLG5/FLOT2/VANGL1/EPHA2/CKAP4,8,2.694153803653441,1.262416614219827,5.749658738629665
R-HSA-9696273,RND1 GTPase cycle,8/1379,42/9872,0.19047619047619047,1.3635829966504367,0.951444802586152,0.22539627408413557,0.8244238247293524,0.764962457253746,ALDH3A2/PTPN13/RASAL2/TFRC/DLG5/FLOT2/VANGL1/EPHA2,8,2.694153803653441,1.262416614219827,5.749658738629665
R-HSA-977444,GABA B receptor activation,8/1379,42/9872,0.19047619047619047,1.3635829966504367,0.951444802586152,0.22539627408413557,0.8244238247293524,0.764962457253746,GNB3/KCNJ16/ADCY3/GNB4/KCNJ6/ADCY7/GNG2/KCNJ3,8,2.694153803653441,1.262416614219827,5.749658738629665
R-HSA-991365,Activation of GABAB receptors,8/1379,42/9872,0.19047619047619047,1.3635829966504367,0.951444802586152,0.22539627408413557,0.8244238247293524,0.764962457253746,GNB3/KCNJ16/ADCY3/GNB4/KCNJ6/ADCY7/GNG2/KCNJ3,8,2.694153803653441,1.262416614219827,5.749658738629665
R-HSA-9694635,Translation of Structural Proteins,11/1379,61/9872,0.18032786885245902,1.290933082894471,0.9184035116870762,0.22543115419461415,0.8244238247293524,0.764962457253746,MGAT4C/PARP9/ZDHHC20/ST6GALNAC3/ST6GAL1/ST3GAL4/UBC/ZDHHC11/RPS27A/TUSC3/EDEM2,11,2.55061282231125,1.3390715346276967,4.858310852786012
R-HSA-9772573,Late SARS-CoV-2 Infection Events,13/1379,74/9872,0.17567567567567569,1.2576289124512476,0.8963422947630616,0.2274947623050031,0.8244238247293524,0.764962457253746,MGAT4C/PARP9/ZDHHC20/ST6GALNAC3/ANO2/ANO3/ST6GAL1/ST3GAL4/UBC/ZDHHC11/RPS27A/TUSC3/EDEM2,13,2.4848107716128016,1.3747160913843162,4.491316141142718
R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,CAMK2G/CAMK4/CAMK2D,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-190873,Gap junction degradation,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,GJA1/ACTG1/ACTB,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,ELOVL5/ACSL1/ELOVL2,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,ELOVL5/ACSL1/ELOVL2,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-210990,PECAM1 interactions,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,INPP5D/ITGB3/PECAM1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,MAML3/HES5/HES1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,ITGB3/APBB1IP/FN1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-419408,Lysosphingolipid and LPA receptors,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,LPAR5/PLPPR5/S1PR1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-451306,Ionotropic activity of kainate receptors,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,NCALD/GRIK4/GRIK2,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-451308,Activation of Ca-permeable Kainate Receptor,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,NCALD/GRIK4/GRIK2,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-6803207,TP53 Regulates Transcription of Caspase Activators and Caspases,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,CASP10/CASP1/CASP2,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,CASP10/RNF135/CASP8,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,STAT3/PDGFRA/STAT1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,STAT3/PDGFRA/STAT1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-9700645,ALK mutants bind TKIs,3/1379,12/9872,0.25,1.7897026831036984,1.1029299398631633,0.22919703346684264,0.8244238247293524,0.764962457253746,PPM1B/EIF2AK3/FN1,3,3.5360768672951415,0.9966706400368309,12.54560845793326
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,7/1379,36/9872,0.19444444444444445,1.391990975747321,0.9494021400744855,0.23028654031466,0.8244238247293524,0.764962457253746,SMAD7/JUNB/TGIF2/UBC/RPS27A/TFDP2/WWTR1,7,2.750282007896221,1.221680186614978,6.191514936422178
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,7/1379,36/9872,0.19444444444444445,1.391990975747321,0.9494021400744855,0.23028654031466,0.8244238247293524,0.764962457253746,WIPF3/CYFIP1/NCKAP1L/BTK/ACTG1/ACTB/NCKIPSD,7,2.750282007896221,1.221680186614978,6.191514936422178
R-HSA-3781865,Diseases of glycosylation,23/1379,140/9872,0.16428571428571428,1.1760903346110017,0.8455331386927358,0.2306827025395012,0.8244238247293524,0.764962457253746,GPC5/SPON1/ADAMTS14/ADAMTS19/VCAN/CSPG5/ADAMTS10/ACAN/CHSY1/MUC20/NCAN/MUC4/B3GLCT/GPC6/THSD7A/CHST3/MUC15/OMD/OGN/GPC2/ADAMTSL2/B3GAT3/GALK1,23,2.3237076556510927,1.490053302631186,3.6237745719543537
R-HSA-6794361,Neurexins and neuroligins,10/1379,55/9872,0.18181818181818182,1.3016019513481443,0.9037706704563392,0.23201816829566077,0.8244238247293524,0.764962457253746,NRXN1/EPB41L2/LRRTM2/NLGN4X/GRIN1/SYT1/EPB41/DLGAP1/GRM1/GRIN2B,10,2.571692267123739,1.3080713317018202,5.05599423861667
R-HSA-2871809,FCERI mediated Ca+2 mobilization,6/1379,30/9872,0.2,1.4317621464829586,0.9543235874201871,0.2344425193451592,0.8244238247293524,0.764962457253746,SYK/BTK/FCER1G/VAV3/ITPR1/GRAP2,6,2.8288614938361127,1.175432189548883,6.808097840488723
R-HSA-3928663,EPHA-mediated growth cone collapse,6/1379,30/9872,0.2,1.4317621464829586,0.9543235874201871,0.2344425193451592,0.8244238247293524,0.764962457253746,EFNA1/EPHA6/EFNA5/EPHA4/NGEF/EPHA2,6,2.8288614938361127,1.175432189548883,6.808097840488723
R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),6/1379,30/9872,0.2,1.4317621464829586,0.9543235874201871,0.2344425193451592,0.8244238247293524,0.764962457253746,GNB3/GNB4/F2R/GNA12/ARRB2/GNG2,6,2.8288614938361127,1.175432189548883,6.808097840488723
R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,6/1379,30/9872,0.2,1.4317621464829586,0.9543235874201871,0.2344425193451592,0.8244238247293524,0.764962457253746,CDH19/CTNNA1/ADAM19/CDH8/CDH24/ANGPTL4,6,2.8288614938361127,1.175432189548883,6.808097840488723
R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,6/1379,30/9872,0.2,1.4317621464829586,0.9543235874201871,0.2344425193451592,0.8244238247293524,0.764962457253746,CDH19/CTNNA1/ADAM19/CDH8/CDH24/ANGPTL4,6,2.8288614938361127,1.175432189548883,6.808097840488723
R-HSA-5635838,Activation of SMO,4/1379,18/9872,0.2222222222222222,1.5908468294255096,1.0109671172923425,0.23676260041323224,0.8244238247293524,0.764962457253746,DHH/CDON/ARRB2/SMO,4,3.1431794375956814,1.0622915664063766,9.300249846043586
R-HSA-9758274,Regulation of NF-kappa B signaling,4/1379,18/9872,0.2222222222222222,1.5908468294255096,1.0109671172923425,0.23676260041323224,0.8244238247293524,0.764962457253746,NLRC5/UBC/RPS27A/CASP8,4,3.1431794375956814,1.0622915664063766,9.300249846043586
R-HSA-189445,Metabolism of porphyrins,5/1379,24/9872,0.20833333333333334,1.4914189025864155,0.9712155017394942,0.23713229900732738,0.8244238247293524,0.764962457253746,ABCG2/HMOX1/ALAS1/SLCO2B1/FABP1,5,2.9467307227459516,1.1225709056841382,7.735121147722055
R-HSA-392451,G beta:gamma signalling through PI3Kgamma,5/1379,24/9872,0.20833333333333334,1.4914189025864155,0.9712155017394942,0.23713229900732738,0.8244238247293524,0.764962457253746,PIK3R5/GNB3/PIK3CG/GNB4/GNG2,5,2.9467307227459516,1.1225709056841382,7.735121147722055
R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,5/1379,24/9872,0.20833333333333334,1.4914189025864155,0.9712155017394942,0.23713229900732738,0.8244238247293524,0.764962457253746,PRKCD/S100A9/CYBB/S100A8/NCF2,5,2.9467307227459516,1.1225709056841382,7.735121147722055
R-HSA-912526,Interleukin receptor SHC signaling,5/1379,24/9872,0.20833333333333334,1.4914189025864155,0.9712155017394942,0.23713229900732738,0.8244238247293524,0.764962457253746,CSF2RA/INPP5D/JAK3/PIK3R3/PIK3CD,5,2.9467307227459516,1.1225709056841382,7.735121147722055
R-HSA-9620244,Long-term potentiation,5/1379,24/9872,0.20833333333333334,1.4914189025864155,0.9712155017394942,0.23713229900732738,0.8244238247293524,0.764962457253746,CAMK2G/GRIN1/CAMK2D/GRIA1/GRIN2B,5,2.9467307227459516,1.1225709056841382,7.735121147722055
R-HSA-73887,Death Receptor Signaling,25/1379,154/9872,0.16233766233766234,1.162144599417986,0.8171589621516077,0.23761171514085036,0.8244238247293524,0.764962457253746,NGFR/ARHGEF3/ARHGEF6/TNFRSF10D/ABR/NFKBIA/ARHGEF10/TNFSF10/IKBKE/FGD3/NGEF/SMPD3/CASP10/TNF/UBC/TNFRSF10A/VAV3/RPS27A/CASP8/PLEKHG2/RTN4R/CASP2/TRADD/TNFRSF10B/RACK1,25,2.29615380993191,1.4994511005531024,3.5161682277734996
R-HSA-5083635,Defective B3GALTL causes PpS,7/1379,37/9872,0.1891891891891892,1.3543695980244206,0.8701663461316015,0.25245712460033803,0.87255441198282635,0.8096216376292892,SPON1/ADAMTS14/ADAMTS19/ADAMTS10/B3GLCT/THSD7A/ADAMTSL2,7,2.6759500617368635,1.1907783264601783,6.013469151891714
R-HSA-8878166,Transcriptional regulation by RUNX2,17/1379,102/9872,0.16666666666666666,1.1931351220691322,0.7900347774860101,0.25265885330142446,0.87255441198282635,0.8096216376292892,RUNX1/CDKN1A/MAF/ZNF521/GLI3/BMP2/SMAD6/HDAC4/ITGBL1/AR/CCND1/PPARGC1B/UBC/RPS27A/STAT1/WWTR1/HES1,17,2.357384578196761,1.4066321301842315,3.950757223775392
R-HSA-166658,Complement cascade,9/1379,50/9872,0.18,1.2885859318346629,0.8243133630176871,0.25791161290477976,0.8844422032410264,0.8206520248396268,CD55/C3/PROS1/CD59/CR2/C3AR1/CR1/C5AR1/CFB,9,2.545975344452502,1.2494629938360289,5.187821077164842
R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",9/1379,50/9872,0.18,1.2885859318346629,0.8243133630176871,0.25791161290477976,0.8844422032410264,0.8206520248396268,RPS3/RPS16/RPS3A/RPS6/RPS12/RPS27A/RPS9/RPSA/RPS14,9,2.545975344452502,1.2494629938360289,5.187821077164842
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,13/1379,76/9872,0.17105263157894737,1.224533414755162,0.791763607758575,0.25798690248051326,0.8844422032410264,0.8206520248396268,PLAUR/LSAMP/FOLR2/OPCML/THY1/CD109/LYPD1/VNN2/FCGR3B/RAET1G/CNTN4/BST1/PSCA,13,2.419421014465097,1.3400863447746032,4.368075287133733
R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,6/1379,31/9872,0.1935483870967742,1.38557627078996,0.866370540957448,0.25907902923221987,0.8844422032410264,0.8206520248396268,NEURL1B/CNTN1/DTX4/UBC/ARRB2/RPS27A,6,2.7376078972607547,1.1401968938691438,6.572984928692999
R-HSA-2871796,FCERI mediated MAPK activation,6/1379,31/9872,0.1935483870967742,1.38557627078996,0.866370540957448,0.25907902923221987,0.8844422032410264,0.8206520248396268,FOS/SYK/MAP3K1/FCER1G/VAV3/GRAP2,6,2.7376078972607547,1.1401968938691438,6.572984928692999
R-HSA-5621480,Dectin-2 family,5/1379,25/9872,0.2,1.4317621464829586,0.870953054316247,0.26503316446476755,0.8926691345516579,0.8282855907340919,SYK/MUC20/MUC4/MUC15/FCER1G,5,2.8288614938361136,1.081255016826719,7.401082285652098
R-HSA-1236394,Signaling by ERBB4,10/1379,57/9872,0.17543859649122806,1.2559317074411918,0.7808156635997362,0.2680144946284832,0.8926691345516579,0.8282855907340919,GABRB1/CXCL12/MXD4/GABRG3/UBC/GABRG2/NRG3/RPS27A/PGR/GABRB3,10,2.4814574507334326,1.2644671664287663,4.8697437492121365
R-HSA-72649,Translation initiation complex formation,10/1379,57/9872,0.17543859649122806,1.2559317074411918,0.7808156635997362,0.2680144946284832,0.8926691345516579,0.8282855907340919,RPS3/RPS16/RPS3A/RPS6/RPS12/RPS27A/RPS9/EIF4A1/RPSA/RPS14,10,2.4814574507334326,1.2644671664287663,4.8697437492121365
R-HSA-72702,Ribosomal scanning and start codon recognition,10/1379,57/9872,0.17543859649122806,1.2559317074411918,0.7808156635997362,0.2680144946284832,0.8926691345516579,0.8282855907340919,RPS3/RPS16/RPS3A/RPS6/RPS12/RPS27A/RPS9/EIF4A1/RPSA/RPS14,10,2.4814574507334326,1.2644671664287663,4.8697437492121365
R-HSA-209543,p75NTR recruits signalling complexes,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,NGFR/UBC/RPS27A,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-425561,Sodium/Calcium exchangers,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,SLC8A3/SLC8A1/SLC24A3,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-5660526,Response to metal ions,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,MT1M/MT1X/MT1A,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-8935690,Digestion,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,MGAM/PIR/PNLIPRP3,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,IKBKE/UBC/RPS27A,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,3/1379,13/9872,0.23076923076923078,1.6520332459418754,0.9478882286100335,0.26917002045559923,0.8926691345516579,0.8282855907340919,TLR7/UBC/RPS27A,3,3.2640709544262845,0.9290274905719573,11.468077428979054
R-HSA-3000480,Scavenging by Class A Receptors,4/1379,19/9872,0.21052631578947367,1.5071180489294302,0.8915255088081534,0.2693035503563251,0.8926691345516579,0.8282855907340919,COL4A1/COL4A2/COL3A1/FTH1,4,2.977748940880119,1.0116178974358212,8.765156070674612
R-HSA-888590,"GABA synthesis, release, reuptake and degradation",4/1379,19/9872,0.21052631578947367,1.5071180489294302,0.8915255088081534,0.2693035503563251,0.8926691345516579,0.8282855907340919,SYT1/RIMS1/ALDH5A1/SLC32A1,4,2.977748940880119,1.0116178974358212,8.765156070674612
R-HSA-8964616,G beta:gamma signalling through CDC42,4/1379,19/9872,0.21052631578947367,1.5071180489294302,0.8915255088081534,0.2693035503563251,0.8926691345516579,0.8282855907340919,ARHGEF6/GNB3/GNB4/GNG2,4,2.977748940880119,1.0116178974358212,8.765156070674612
R-HSA-111996,Ca-dependent events,7/1379,38/9872,0.18421052631578946,1.3187282928132513,0.7931940721393749,0.2752273403471234,0.9042314168484031,0.8390139462375047,PRKCD/PLA2G4A/CAMK2G/ADCY3/CAMK4/CAMK2D/ADCY7,7,2.605530323270104,1.1614019965055598,5.845338897217501
R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,7/1379,38/9872,0.18421052631578946,1.3187282928132513,0.7931940721393749,0.2752273403471234,0.9042314168484031,0.8390139462375047,SPON1/ADAMTS14/ADAMTS19/ADAMTS10/B3GLCT/THSD7A/ADAMTSL2,7,2.605530323270104,1.1614019965055598,5.845338897217501
R-HSA-6803157,Antimicrobial peptides,7/1379,38/9872,0.18421052631578946,1.3187282928132513,0.7931940721393749,0.2752273403471234,0.9042314168484031,0.8390139462375047,SLC11A1/TLR2/S100A9/CD4/S100A8/LTF/RNASE6,7,2.605530323270104,1.1614019965055598,5.845338897217501
R-HSA-9607240,FLT3 Signaling,7/1379,38/9872,0.18421052631578946,1.3187282928132513,0.7931940721393749,0.2752273403471234,0.9042314168484031,0.8390139462375047,SOCS6/SYK/SLA/SH2B3/UBC/RPS27A/GRAP2,7,2.605530323270104,1.1614019965055598,5.845338897217501
R-HSA-166520,Signaling by NTRKs,21/1379,131/9872,0.16030534351145037,1.147595613593211,0.6852348998393528,0.2814104992795201,0.92250461684346,0.8559691961354522,STAT3/FOS/VGF/SGK1/MEF2C/RALGDS/ID4/JUNB/PTPRO/EGR1/DUSP3/FOSL1/ID2/LYL1/ARC/SHC3/ADORA2A/EGR3/ASCL1/GRIN2B/DUSP6,21,2.267408067578564,1.4257476509313913,3.605925173056979
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,6/1379,32/9872,0.1875,1.3422770123277739,0.7814250323512593,0.2843550758247035,0.9301041577085566,0.8630206219673936,VEGFA/CDKN1A/TFAP2E/KCTD15/KIT/HSPD1,6,2.652057650471356,1.1070133695276196,6.353500305443393
R-HSA-9679506,SARS-CoV Infections,59/1379,392/9872,0.15051020408163265,1.0774740643175327,0.6307065651163107,0.28513118518308767,0.9305929890041432,0.8634741964248972,MGAT4C/TLR2/ATP1A2/GPC5/JAK3/CYSLTR1/RUNX1/VEGFA/IFNAR2/PARP9/ZDHHC20/BLNK/IFNGR1/NFKBIA/GJA1/ST6GALNAC3/NLRP3/ATP1B3/SYK/BCL2L1/SEC24D/ANO2/ANO3/TLR7/ST6GAL1/IKBKE/NUP205/GATAD2A/ITGA4/FXYD6/RPS3/GPC6/RNF135/ST3GAL4/NUP188/SAP30/CASP1/BTK/RPS16/UBC/CHMP4C/RPS3A/RPS6/ZDHHC11/FXYD7/RPS12/RPS27A/TUSC3/EEF1A1/GPC2/RPS9/STAT1/SFN/EDEM2/S1PR1/NOD2/IMPDH1/RPSA/RPS14,59,2.1288626037797282,1.610414818400342,2.8142165198613784
R-HSA-114508,Effects of PIP2 hydrolysis,5/1379,26/9872,0.19230769230769232,1.3766943716182296,0.7749577690880948,0.29361378522681875,0.947625324997985,0.8792780793353624,MGLL/PRKCD/DAGLB/PRKCH/ITPR1,5,2.7200591286885705,1.0428728157175422,7.0945579864131165
R-HSA-191273,Cholesterol biosynthesis,5/1379,26/9872,0.19230769230769232,1.3766943716182296,0.7749577690880948,0.29361378522681875,0.947625324997985,0.8792780793353624,MVK/TM7SF2/DHCR7/SQLE/DHCR24,5,2.7200591286885705,1.0428728157175422,7.0945579864131165
R-HSA-9717189,Sensory perception of taste,5/1379,26/9872,0.19230769230769232,1.3766943716182296,0.7749577690880948,0.29361378522681875,0.947625324997985,0.8792780793353624,SCN1B/GNB3/GRM1/PLCB2/GRM4,5,2.7200591286885705,1.0428728157175422,7.0945579864131165
R-HSA-190828,Gap junction trafficking,7/1379,39/9872,0.1794871794871795,1.2849147468436808,0.7183504353712148,0.2984945113058931,0.947625324997985,0.8792780793353624,GJA1/GJB6/TUBB4A/TUBA1A/ACTG1/ACTB/TUBA1B,7,2.5387218534426657,1.1334409027890648,5.686320860035884
R-HSA-9830369,Kidney development,7/1379,39/9872,0.1794871794871795,1.2849147468436808,0.7183504353712148,0.2984945113058931,0.947625324997985,0.8792780793353624,ID4/PCDH19/WNT11/SALL1/GDNF/PLAC8/EMX2,7,2.5387218534426657,1.1334409027890648,5.686320860035884
R-HSA-199220,Vitamin B5 (pantothenate) metabolism,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,ENPP1/VNN2/PANK1/ENPP3,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-5689901,Metalloprotease DUBs,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,NLRP3/BARD1/UBC/RPS27A,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-901032,ER Quality Control Compartment (ERQC),4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,EDEM1/UBC/RPS27A/EDEM2,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,MAML3/HES5/ACTA2/HES1,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-9669938,Signaling by KIT in disease,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,STAT3/KIT/STAT1/PIK3R3,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,STAT3/KIT/STAT1/PIK3R3,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-9748787,Azathioprine ADME,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,ABCC4/HPRT1/VAV3/IMPDH1,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-9768919,NPAS4 regulates expression of target genes,4/1379,20/9872,0.2,1.4317621464829586,0.7788063921400322,0.3025533302376636,0.947625324997985,0.8792780793353624,NAMPT/FOS/RBFOX3/PLK2,4,2.828861493836113,0.9655569474283908,8.287918566193296
R-HSA-913709,O-linked glycosylation of mucins,10/1379,59/9872,0.1694915254237288,1.2133577512567446,0.6623166588598931,0.3056033244740174,0.947625324997985,0.8792780793353624,GALNT15/ST6GALNAC3/MUC20/ST6GAL1/GALNT7/MUC4/B4GALT5/ST3GAL4/B3GNT5/MUC15,10,2.3973402490136553,1.2236780465958934,4.696693125719546
R-HSA-418597,G alpha (z) signalling events,8/1379,46/9872,0.17391304347826086,1.2450105621590946,0.6711312937203241,0.3093271012377197,0.947625324997985,0.8792780793353624,RGS16/PRKCD/GNB3/ADCY3/GNB4/ADCY7/GNG2/PRKCH,8,2.4598795598574896,1.158725154718644,5.222124870909489
R-HSA-1834941,STING mediated induction of host immune responses,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,IFI16/DTX4/NLRP4,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-2024101,CS/DS degradation,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,VCAN/CSPG5/NCAN,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,TEAD3/TEAD4/WWTR1,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,PDK1/PDK3/PDPR,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-3296469,Defects in cobalamin (B12) metabolism,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,MMAB/ABCD4/CUBN,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-3371568,Attenuation phase,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,HSPA1A/HSPA1B/DNAJB1,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-3656237,Defective EXT2 causes exostoses 2,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,GPC5/GPC6/GPC2,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,GPC5/GPC6/GPC2,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,PLXNA3/SEMA3A/PLXNA2,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-418359,Reduction of cytosolic Ca++ levels,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,SLC8A3/SLC8A1/ATP2B4,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,SLC6A6/SLC6A15/SLC6A20,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-71240,Tryptophan catabolism,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,KYNU/SLC3A2/HAAO,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,DOCK1/PXN/BCAR1,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-937039,IRAK1 recruits IKK complex,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,PELI2/UBC/RPS27A,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,3/1379,14/9872,0.21428571428571427,1.5340308712317412,0.8056902746086833,0.3098175232645972,0.947625324997985,0.8792780793353624,PELI2/UBC/RPS27A,3,3.030923029110121,0.8699688435931318,10.559567133977072
R-HSA-2559585,Oncogene Induced Senescence,6/1379,33/9872,0.18181818181818182,1.3016019513481443,0.6992746486710495,0.3101319245447951,0.947625324997985,0.8792780793353624,UBC/ERF/RPS27A/ETS2/TFDP2/CDKN2A,6,2.571692267123739,1.0757074208703874,6.14814120314683
R-HSA-9709957,Sensory Perception,41/1379,271/9872,0.15129151291512916,1.083067306380098,0.5587128827995567,0.3136683432722534,0.9564630179862347,0.8874783558702685,GPC5/SCN1B/BCO2/RLBP1/CACNA1D/ANO2/GNB3/GUCA1B/DHRS9/ADCY3/OR2A5/CNGA1/KCNMA1/RDH10/LPL/GPC6/AKR1C3/RGS9/PCDH15/LHX2/GRK4/USH1C/ACTG1/HSD17B1/GRM1/EBF1/PLCB2/OR2T6/GPC2/EPS8L2/ACTB/OR2L2/GRM4/OR2L3/OR2K2/TMC1/OR5V1/EZR/BSN/RIPOR2/SLC17A8,41,2.1399136761490896,1.5339024684833462,2.9853466145716863
R-HSA-170834,Signaling by TGF-beta Receptor Complex,15/1379,93/9872,0.16129032258064516,1.1546468923249666,0.6037645298451736,0.3151227376616587,0.9589288225974656,0.889766314924744,ITGB3/SMAD7/PPP1R15A/JUNB/TGIF2/TGFB3/TGFBR1/PMEPA1/TGFBR2/UBC/RPS27A/LTBP4/TFDP2/STAT1/WWTR1,15,2.2813399143839623,1.318741884076214,3.946573524209564
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,9/1379,53/9872,0.16981132075471697,1.2156471055043987,0.6342786381375379,0.3179033112805387,0.9596460192986423,0.8904317839886039,PIP4K2A/PTPN13/INPP5D/PIP5K1B/PIK3R5/PIK3CG/PIK3R3/PLEKHA6/PIK3CD,9,2.40186353250236,1.182352913842418,4.879210226679908
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,9/1379,53/9872,0.16981132075471697,1.2156471055043987,0.6342786381375379,0.3179033112805387,0.9596460192986423,0.8904317839886039,KCNMA1/PCDH15/USH1C/ACTG1/EPS8L2/ACTB/TMC1/EZR/RIPOR2,9,2.40186353250236,1.182352913842418,4.879210226679908
R-HSA-9013408,RHOG GTPase cycle,12/1379,73/9872,0.1643835616438356,1.176790805328459,0.6108890946811009,0.31794332760601485,0.9596460192986423,0.8904317839886039,ERBIN/TFRC/DOCK1/ARHGAP21/CYFIP1/ARHGDIB/OPHN1/VAV3/IQGAP2/VANGL1/EPHA2/DIAPH3,12,2.325091638769408,1.2595852625524206,4.291929486155309
R-HSA-9659379,Sensory processing of sound,12/1379,73/9872,0.1643835616438356,1.176790805328459,0.6108890946811009,0.31794332760601485,0.9596460192986423,0.8904317839886039,CACNA1D/KCNMA1/PCDH15/USH1C/ACTG1/EPS8L2/ACTB/TMC1/EZR/BSN/RIPOR2/SLC17A8,12,2.325091638769408,1.2595852625524206,4.291929486155309
R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,7/1379,40/9872,0.175,1.2527918781725889,0.6455120061777785,0.32215533742266134,0.9699915402848378,0.9000311367945084,CAMK2G/GRIN1/TUBB4A/TUBA1A/CAMK2D/GRIN2B/TUBA1B,7,2.475253807106599,1.1067951371784073,5.535695996293579
R-HSA-9759475,Regulation of CDH11 Expression and Function,5/1379,27/9872,0.18518518518518517,1.3257056911879246,0.6828597521222654,0.3226773204718585,0.9699915402848378,0.9000311367945084,CTNNA1/ADAM19/CDH8/CDH24/ANGPTL4,5,2.619316197996401,1.0071225375852226,6.812296507172306
R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",10/1379,60/9872,0.16666666666666666,1.1931351220691322,0.6046307922030143,0.3248622319504292,0.9745866958512875,0.9042948678854053,PROS1/TPST1/STS/RPS6/FN3K/DPH1/TPST2/GAS6/ARSF/RPL8,10,2.357384578196761,1.2042552449352875,4.6146878520081085
R-HSA-211859,Biological oxidations,28/1379,183/9872,0.15300546448087432,1.0953371612437937,0.5245421960753225,0.33093628787043117,0.9810696934984446,0.9103102809069389,ACSM5/ACY3/AHR/ALDH1A1/MAT2A/DPEP2/GSTO2/SLC35D2/PTGS1/TBXAS1/CYP26C1/HPGDS/NNMT/AOC2/TPST1/ACSS1/MGST2/SULT1A1/CYP8B1/GSTK1/CYP2E1/TPST2/ALDH3A1/MGST1/CBR3/CYP4F3/AOC3/PODXL2,28,2.164156334082272,1.4485519823865847,3.233278953946771
R-HSA-70268,Pyruvate metabolism,8/1379,47/9872,0.1702127659574468,1.2185209757301776,0.6050732138849734,0.3313187557669169,0.9810696934984446,0.9103102809069389,PDK1/LDHA/PDK3/PDPR/UBC/GPT/RPS27A/ME1,8,2.407541696881798,1.1354116884957293,5.104982695663249
R-HSA-196854,Metabolism of vitamins and cofactors,29/1379,190/9872,0.15263157894736842,1.092660585473837,0.5196625837357296,0.3321182332563913,0.9810696934984446,0.9103102809069389,NAMPT/SLC2A3/GPC5/SHMT1/NT5E/TTPA/GSTO2/PARP9/MMAB/MTHFD2/BCO2/FOLR2/NNMT/ENPP1/SLC23A2/GCH1/LPL/GPC6/AKR1C3/ABCD4/VNN2/PANK1/CUBN/CD38/GPC2/SLC2A1/ENPP3/BST1/NMNAT2,29,2.1588679821380867,1.45503913296793,3.2031516257533528
R-HSA-1980143,Signaling by NOTCH1,12/1379,74/9872,0.16216216216216217,1.1608882268780747,0.5597621831654601,0.33544950153524317,0.9810696934984446,0.9103102809069389,MAML3/NEURL1B/CNTN1/HES5/HIF1A/TLE1/HDAC4/DTX4/UBC/ARRB2/RPS27A/HES1,12,2.2936714814887402,1.2432851697687728,4.231473995602459
R-HSA-422356,Regulation of insulin secretion,12/1379,74/9872,0.16216216216216217,1.1608882268780747,0.5597621831654601,0.33544950153524317,0.9810696934984446,0.9103102809069389,MARCKS/CACNA1A/CACNA1D/IQGAP1/GNB3/PLCB1/GNB4/RAPGEF3/GNG2/PLCB2/ITPR1/SLC2A1,12,2.2936714814887402,1.2432851697687728,4.231473995602459
R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,RLBP1/DHRS9/RDH10/HSD17B1,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-389977,Post-chaperonin tubulin folding pathway,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,TBCE/TUBB4A/TUBA1A/TUBA1B,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-392170,ADP signalling through P2Y purinoceptor 12,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,P2RY12/GNB3/GNB4/GNG2,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-4641263,Regulation of FZD by ubiquitination,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,FZD5/UBC/RNF43/RPS27A,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-6807004,Negative regulation of MET activity,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,PTPN2/UBC/MET/RPS27A,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-9613829,Chaperone Mediated Autophagy,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,PLIN3/UBC/RPS27A/EEF1A1,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-9753281,Paracetamol ADME,4/1379,21/9872,0.19047619047619047,1.3635829966504367,0.6720555927927774,0.33621127774955833,0.9810696934984446,0.9103102809069389,ABCC4/ABCG2/SULT1A1/CYP2E1,4,2.694153803653441,0.923506588451306,7.859678326618699
R-HSA-1296065,Inwardly rectifying K+ channels,6/1379,34/9872,0.17647058823529413,1.2633195410143754,0.6197282387639362,0.336272373057716,0.9810696934984446,0.9103102809069389,GNB3/KCNJ16/GNB4/KCNJ6/GNG2/KCNJ3,6,2.4960542592671584,1.0461240327767982,5.955590991125829
R-HSA-8956319,Nucleotide catabolism,6/1379,34/9872,0.17647058823529413,1.2633195410143754,0.6197282387639362,0.336272373057716,0.9810696934984446,0.9103102809069389,ENTPD1/NT5E/DPYS/SAMHD1/TYMP/NT5C1A,6,2.4960542592671584,1.0461240327767982,5.955590991125829
R-HSA-1660662,Glycosphingolipid metabolism,9/1379,54/9872,0.16666666666666666,1.1931351220691322,0.5734278363938256,0.3385350786851271,0.9857344938184583,0.9146386336405189,UGCG/NEU4/B4GALT5/STS/SMPD3/B3GNT5/ARSF/NEU3/GLB1L3,9,2.357384578196761,1.161557639647447,4.7843187973062165
R-HSA-2187338,Visual phototransduction,14/1379,88/9872,0.1590909090909091,1.1389017074296262,0.5273790157234809,0.34308220274715717,0.9919736781657822,0.9204278183370612,GPC5/BCO2/RLBP1/GUCA1B/DHRS9/CNGA1/RDH10/LPL/GPC6/AKR1C3/RGS9/GRK4/HSD17B1/GPC2,14,2.2502307337332716,1.2768948540241465,3.96550925009995
R-HSA-157858,Gap junction trafficking and regulation,7/1379,41/9872,0.17073170731707318,1.2222359787049648,0.5745655691616475,0.34610720993353244,0.9919736781657822,0.9204278183370612,GJA1/GJB6/TUBB4A/TUBA1A/ACTG1/ACTB/TUBA1B,7,2.414881763030828,1.081373982643089,5.39281878704459
R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,NEURL1B/UBC/RPS27A,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,NEURL1B/UBC/RPS27A,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-391903,Eicosanoid ligand-binding receptors,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,CYSLTR1/PTGDR/GPR17,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-392517,Rap1 signalling,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,RAP1GAP2/RAPGEF3/PRKG1,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-5083625,Defective GALNT3 causes HFTC,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,MUC20/MUC4/MUC15,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-5083636,Defective GALNT12 causes CRCS1,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,MUC20/MUC4/MUC15,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,OSM/LIFR/CNTFR,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,UBC/MET/RPS27A,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-9018677,Biosynthesis of DHA-derived SPMs,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,LTC4S/CYP2E1/PTGS2,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-912694,Regulation of IFNA/IFNB signaling,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,SOCS3/IFNAR2/STAT1,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-9933947,Formation of the non-canonical BAF (ncBAF) complex,3/1379,15/9872,0.2,1.4317621464829586,0.6742950357973652,0.3506203370838553,0.9919736781657822,0.9204278183370612,SS18L1/ACTB/SMARCD2,3,2.8288614938361127,0.8179606720075384,9.783425566987324
R-HSA-166166,MyD88-independent TLR4 cascade,17/1379,109/9872,0.1559633027522936,1.1165117656059769,0.49285995706940394,0.351127135580299,0.9919736781657822,0.9204278183370612,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/IKBKE/DUSP3/MAP2K3/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,17,2.2059929080373357,1.3193915122446807,3.6883704837783955
R-HSA-937061,TRIF (TICAM1)-mediated TLR4 signaling,17/1379,109/9872,0.1559633027522936,1.1165117656059769,0.49285995706940394,0.351127135580299,0.9919736781657822,0.9204278183370612,FOS/CD14/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/IKBKE/DUSP3/MAP2K3/UBC/LY96/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,17,2.2059929080373357,1.3193915122446807,3.6883704837783955
R-HSA-190861,Gap junction assembly,5/1379,28/9872,0.17857142857142858,1.2783590593597844,0.5943341981494071,0.35203375649385,0.9919736781657822,0.9204278183370612,GJA1/GJB6/TUBB4A/TUBA1A/TUBA1B,5,2.525769190925101,0.9737424306681872,6.551537454775166
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,5/1379,28/9872,0.17857142857142858,1.2783590593597844,0.5943341981494071,0.35203375649385,0.9919736781657822,0.9204278183370612,ADGRV1/UTRN/LAMA2/WWTR1/ADGRG6,5,2.525769190925101,0.9737424306681872,6.551537454775166
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,8/1379,48/9872,0.16666666666666666,1.1931351220691322,0.5404678280646157,0.3535531578720626,0.9924885433648638,0.9209055490091135,MAML3/HES5/HIF1A/TLE1/HDAC4/UBC/RPS27A/HES1,8,2.3573845781967613,1.1130183326903398,4.992965422309934
R-HSA-389356,Co-stimulation by CD28,8/1379,48/9872,0.16666666666666666,1.1931351220691322,0.5404678280646157,0.3535531578720626,0.9924885433648638,0.9209055490091135,CD86/PIK3R5/PIK3CG/CTLA4/PIK3R3/PIK3CD/MAP3K8/GRAP2,8,2.3573845781967613,1.1130183326903398,4.992965422309934
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,13/1379,82/9872,0.15853658536585366,1.1349334087974672,0.4943872013939261,0.35651838123141427,0.9970429305624298,0.9251314521397984,CEBPA/CEBPD/CCND3/PCK1/MED28/LPL/TNF/HELZ2/MED29/PPARG/EBF1/LEP/ANGPTL4,13,2.2423902085286262,1.2459355091775606,4.035773770204393
R-HSA-9833110,RSV-host interactions,13/1379,82/9872,0.15853658536585366,1.1349334087974672,0.4943872013939261,0.35651838123141427,0.9970429305624298,0.9251314521397984,TLR2/CX3CR1/GPC5/CD14/IFNAR2/TLR7/MED28/GPC6/MED29/UBC/LY96/RPS27A/GPC2,13,2.2423902085286262,1.2459355091775606,4.035773770204393
R-HSA-9840310,Glycosphingolipid catabolism,6/1379,35/9872,0.17142857142857143,1.227224696985393,0.5426132148793678,0.3626426140181857,0.9999999999999936,0.9278752436647114,NEU4/STS/SMPD3/ARSF/NEU3/GLB1L3,6,2.424738423288097,1.0181248010549813,5.77469129057406
R-HSA-156584,Cytosolic sulfonation of small molecules,4/1379,22/9872,0.18181818181818182,1.3016019513481443,0.570636463151135,0.36999792109838536,0.9999999999999936,0.9278752436647114,TPST1/SULT1A1/TPST2/PODXL2,4,2.571692267123739,0.8849650652312309,7.473290615213137
R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,4/1379,22/9872,0.18181818181818182,1.3016019513481443,0.570636463151135,0.36999792109838536,0.9999999999999936,0.9278752436647114,NEURL1B/CNTN1/UBC/RPS27A,4,2.571692267123739,0.8849650652312309,7.473290615213137
R-HSA-9637690,Response of Mtb to phagocytosis,4/1379,22/9872,0.18181818181818182,1.3016019513481443,0.570636463151135,0.36999792109838536,0.9999999999999936,0.9278752436647114,PGK1/ENO1/UBC/RPS27A,4,2.571692267123739,0.8849650652312309,7.473290615213137
R-HSA-1489509,DAG and IP3 signaling,7/1379,42/9872,0.16666666666666666,1.1931351220691322,0.5054070453855398,0.3702493971034118,0.9999999999999936,0.9278752436647114,PRKCD/CAMK2G/ADCY3/CAMK4/CAMK2D/ADCY7/ITPR1,7,2.357384578196761,1.0570948797793425,5.257108094857049
R-HSA-6806667,Metabolism of fat-soluble vitamins,7/1379,42/9872,0.16666666666666666,1.1931351220691322,0.5054070453855398,0.3702493971034118,0.9999999999999936,0.9278752436647114,GPC5/TTPA/BCO2/LPL/GPC6/AKR1C3/GPC2,7,2.357384578196761,1.0570948797793425,5.257108094857049
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",12/1379,76/9872,0.15789473684210525,1.1303385366970726,0.459607805625622,0.3709852690567736,0.9999999999999936,0.9278752436647114,NGFR/ARHGEF3/ARHGEF6/ABR/ARHGEF10/FGD3/NGEF/UBC/VAV3/RPS27A/PLEKHG2/CASP2,12,2.2333117056600895,1.211919402859804,4.1155221732309855
R-HSA-156580,Phase II - Conjugation of compounds,13/1379,83/9872,0.1566265060240964,1.1212595123059315,0.44701062514538115,0.37361565628027005,0.9999999999999936,0.9278752436647114,ACSM5/MAT2A/GSTO2/SLC35D2/HPGDS/NNMT/TPST1/MGST2/SULT1A1/GSTK1/TPST2/MGST1/PODXL2,13,2.215373459028281,1.2315157730251745,3.985234838617536
R-HSA-163359,Glucagon signaling in metabolic regulation,5/1379,29/9872,0.1724137931034483,1.2342777124853093,0.5090944684750107,0.3815025207452374,0.9999999999999936,0.9278752436647114,GNB3/ADCY3/GNB4/ADCY7/GNG2,5,2.4386737015828563,0.9425043377975182,6.309922601193879
R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,5/1379,29/9872,0.1724137931034483,1.2342777124853093,0.5090944684750107,0.3815025207452374,0.9999999999999936,0.9278752436647114,CAMK2G/GRIN1/RASGRF1/CAMK2D/GRIN2B,5,2.4386737015828563,0.9425043377975182,6.309922601193879
R-HSA-2559580,Oxidative Stress Induced Senescence,10/1379,63/9872,0.15873015873015872,1.136319163875364,0.4373679631128014,0.38384634630509845,0.9999999999999936,0.9278752436647114,FOS/MAP3K5/PHC2/MAP2K3/UBC/RPS27A/TFDP2/CBX2/CDKN2A/TXN,10,2.2451281697112013,1.1495201168320177,4.3849606671714865
R-HSA-450294,MAP kinase activation,10/1379,63/9872,0.15873015873015872,1.136319163875364,0.4373679631128014,0.38384634630509845,0.9999999999999936,0.9278752436647114,FOS/MEF2C/TNIP2/DUSP3/MAP2K3/UBC/RPS27A/NOD2/MAP3K8/DUSP6,10,2.2451281697112013,1.1495201168320177,4.3849606671714865
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,11/1379,70/9872,0.15714285714285714,1.1249559722366103,0.42274729351126766,0.3866509558683447,0.9999999999999936,0.9278752436647114,RNF125/NFKBIA/NLRC5/UBA7/IKBKE/CASP10/RNF135/MAP3K1/UBC/RPS27A/CASP8,11,2.222676888014089,1.1742963187879787,4.20702378903052
R-HSA-111933,Calmodulin induced events,6/1379,36/9872,0.16666666666666666,1.1931351220691322,0.4677732640819203,0.3891138287588909,0.9999999999999936,0.9278752436647114,PRKCD/CAMK2G/ADCY3/CAMK4/CAMK2D/ADCY7,6,2.357384578196761,0.9915857651909676,5.604418946503994
R-HSA-111997,CaM pathway,6/1379,36/9872,0.16666666666666666,1.1931351220691322,0.4677732640819203,0.3891138287588909,0.9999999999999936,0.9278752436647114,PRKCD/CAMK2G/ADCY3/CAMK4/CAMK2D/ADCY7,6,2.357384578196761,0.9915857651909676,5.604418946503994
R-HSA-9759194,Nuclear events mediated by NFE2L2,13/1379,84/9872,0.15476190476190477,1.10791118477848,0.40021307268337486,0.39081354419719083,0.9999999999999936,0.9278752436647114,BCL2L1/ABCG2/HMOX1/CCL2/PDGFA/BACH1/UBC/SLC7A11/RPS27A/ME1/CDKN2A/TXN/AREG,13,2.1889999654684207,1.2174261803601485,3.93594365401541
R-HSA-110312,Translesion synthesis by REV1,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,MAD2L2/UBC/RPS27A,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-197264,Nicotinamide salvage,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,NAMPT/PARP9/NNMT,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-205043,NRIF signals cell death from the nucleus,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,NGFR/UBC/RPS27A,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-399954,Sema3A PAK dependent Axon repulsion,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,PLXNA3/SEMA3A/PLXNA2,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-5083632,Defective C1GALT1C1 causes TNPS,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,MUC20/MUC4/MUC15,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,3/1379,16/9872,0.1875,1.3422770123277739,0.5521022580567493,0.39112829285146156,0.9999999999999936,0.9278752436647114,CDKN1A/PIM1/BCL2L1,3,2.652057650471356,0.7718132743519147,9.11283857786658
R-HSA-9645723,Diseases of programmed cell death,7/1379,43/9872,0.16279069767441862,1.16538779364892,0.4379405513558821,0.39448409248455574,0.9999999999999936,0.9278752436647114,LMNA/MLKL/LMNB1/GSDME/CASP8/CDKN2A/TRADD,7,2.302561681029394,1.0338825297500076,5.128039349138514
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,8/1379,50/9872,0.16,1.1454097171863669,0.41534655631798834,0.3984346419554803,0.9999999999999936,0.9278752436647114,SMAD7/JUNB/TGIF2/UBC/RPS27A/TFDP2/STAT1/WWTR1,8,2.2630891950688907,1.0707822472613673,4.783019813726361
R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian expression",4/1379,23/9872,0.17391304347826086,1.2450105621590946,0.47400705216244476,0.4036581917496739,0.9999999999999936,0.9278752436647114,NAMPT/KLF15/HELZ2/NOCT,4,2.4598795598574896,0.8495109302706217,7.1229306573807785
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,4/1379,23/9872,0.17391304347826086,1.2450105621590946,0.47400705216244476,0.4036581917496739,0.9999999999999936,0.9278752436647114,MAP2K3/UBC/RPS27A/NOD2,4,2.4598795598574896,0.8495109302706217,7.1229306573807785
R-HSA-937041,IKK complex recruitment mediated by RIP1,4/1379,23/9872,0.17391304347826086,1.2450105621590946,0.47400705216244476,0.4036581917496739,0.9999999999999936,0.9278752436647114,CD14/UBC/LY96/RPS27A,4,2.4598795598574896,0.8495109302706217,7.1229306573807785
R-HSA-9843745,Adipogenesis,16/1379,106/9872,0.1509433962264151,1.080575204892799,0.3360687558523237,0.4102028668856752,0.9999999999999936,0.9278752436647114,CEBPA/CEBPD/CCND3/PCK1/MED28/GATAD2A/LPL/TNF/HELZ2/MED29/PPARGC1B/PPARG/BMP7/EBF1/LEP/ANGPTL4,16,2.1349898066687647,1.2585377342994222,3.62180755519173
R-HSA-156590,Glutathione conjugation,5/1379,30/9872,0.16666666666666666,1.1931351220691322,0.42688643284555444,0.4109145210252525,0.9999999999999936,0.9278752436647114,GSTO2/HPGDS/MGST2/GSTK1/MGST1,5,2.357384578196761,0.9132084748275863,6.085425401433261
R-HSA-381042,PERK regulates gene expression,5/1379,30/9872,0.16666666666666666,1.1931351220691322,0.42688643284555444,0.4109145210252525,0.9999999999999936,0.9278752436647114,ATF3/CCL2/CXCL8/EIF2AK3/EXOSC6,5,2.357384578196761,0.9132084748275863,6.085425401433261
R-HSA-5339562,Uptake and actions of bacterial toxins,5/1379,30/9872,0.16666666666666666,1.1931351220691322,0.42688643284555444,0.4109145210252525,0.9999999999999936,0.9278752436647114,CD9/SYT1/MAP2K3/ANTXR1/SV2C,5,2.357384578196761,0.9132084748275863,6.085425401433261
R-HSA-6806003,Regulation of TP53 Expression and Degradation,6/1379,37/9872,0.16216216216216217,1.1608882268780747,0.39506639762149864,0.4155635134347401,0.9999999999999936,0.9278752436647114,SGK1/PRDM1/UBC/RPS27A/CDKN2A/CCNA2,6,2.2936714814887402,0.9663955718171396,5.443866899247567
R-HSA-9013407,RHOH GTPase cycle,6/1379,37/9872,0.16216216216216217,1.1608882268780747,0.39506639762149864,0.4155635134347401,0.9999999999999936,0.9278752436647114,SLC4A7/TFRC/ARHGDIB/PAK5/VANGL1/TUBA1B,6,2.2936714814887402,0.9663955718171396,5.443866899247567
R-HSA-159740,Gamma-carboxylation of protein precursors,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,PROS1/GAS6,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,PROS1/GAS6,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-168799,Neurotoxicity of clostridium toxins,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,SYT1/SV2C,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-170660,Adenylate cyclase activating pathway,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,ADCY3/ADCY7,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-193697,p75NTR regulates axonogenesis,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,NGFR/RTN4R,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,CABIN1/LMNB1,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-418890,Role of second messengers in netrin-1 signaling,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,TRPC5/NTN1,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-428542,Regulation of commissural axon pathfinding by SLIT and ROBO,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,NTN1/NELL2,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-430116,GP1b-IX-V activation signalling,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,FLNA/GP1BA,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,CAMK2G/CAMK4,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-879518,Transport of organic anions,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,SLCO1C1/SLCO2B1,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,VEGFA/KIT,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-937042,IRAK2 mediated activation of TAK1 complex,2/1379,10/9872,0.2,1.4317621464829586,0.5504200076634057,0.4173125422444557,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.828861493836113,0.619206075742087,12.923738420554338
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation,7/1379,44/9872,0.1590909090909091,1.1389017074296262,0.3720775746539108,0.4187173218143343,0.9999999999999936,0.9278752436647114,NFKBIA/NLRC5/TIFA/UBC/RPS27A/CASP8/NOD2,7,2.2502307337332716,1.0116681130802188,5.0051378407300575
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),8/1379,51/9872,0.1568627450980392,1.1229507031238892,0.35470752030292924,0.4209291865896424,0.9999999999999936,0.9278752436647114,STAT3/FOS/CDKN1A/CXCL8/UBC/RPS27A/CDKN2A/CCNA2,8,2.2187148971263633,1.0508444406019313,4.684514286349264
R-HSA-109581,Apoptosis,23/1379,156/9872,0.14743589743589744,1.0554656849073092,0.2813682395196487,0.4241523593712902,0.9999999999999936,0.9278752436647114,STAT3/CD14/LMNA/PRKCD/BCL2L1/PMAIP1/TNFSF10/LMNB1/GSDME/UBC/LY96/TNFRSF10A/HMGB2/GSDMD/RPS27A/TFDP2/SFN/CASP8/DAPK1/CDKN2A/BID/TRADD/TNFRSF10B,23,2.085378665327904,1.3414840290776189,3.241786024687116
R-HSA-388841,Regulation of T cell activation by CD28 family,11/1379,72/9872,0.1527777777777778,1.093707195230038,0.321557243054714,0.4244448286135398,0.9999999999999936,0.9278752436647114,CD86/PIK3R5/CD4/PIK3CG/CTLA4/HLA-DRB5/PIK3R3/PIK3CD/MAP3K8/GRAP2/HLA-DQA2,11,2.1609358633470306,1.1430429479687598,4.085274148095266
R-HSA-5619102,SLC transporter disorders,13/1379,86/9872,0.1511627906976744,1.0821458083882827,0.30829336262757334,0.42537391847753536,0.9999999999999936,0.9278752436647114,SLC29A3/SLC40A1/SLC11A2/NUP205/SLC4A4/NUP188/HEPH/SLC3A2/SLC6A20/HK1/SLC2A1/CP/SLC17A8,13,2.1380929895272947,1.1901930649754682,3.8409244402377607
R-HSA-1482801,Acyl chain remodelling of PS,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,OSBPL5/PLA2G4A/PLA2G5,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,STAT3/FGFR1OP2/STAT1,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-196757,Metabolism of folate and pterines,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,SHMT1/MTHFD2/FOLR2,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,CD4/HLA-DRB5/HLA-DQA2,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-432142,Platelet sensitization by LDL,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,PLA2G4A/PECAM1/FGR,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-5655862,Translesion synthesis by POLK,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,MAD2L2/UBC/RPS27A,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-5656121,Translesion synthesis by POLI,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,MAD2L2/UBC/RPS27A,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,TNFRSF13C/TNFRSF12A/TNFRSF11A,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-70221,Glycogen breakdown (glycogenolysis),3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,PYGL/AKR1E2/PYGM,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-8934593,Regulation of RUNX1 Expression and Activity,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,RUNX1/CCND3/CCND1,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,CDKN1A/GADD45A/CCNG2,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-9830674,Formation of the ureteric bud,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,WNT11/SALL1/GDNF,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-9841251,Mitochondrial unfolded protein response (UPRmt),3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,HSPD1/HSPA1A/HSPA1B,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-9856532,Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,3/1379,17/9872,0.17647058823529413,1.2633195410143754,0.4378359145958173,0.43095986345782844,0.9999999999999936,0.9278752436647114,ITGB3/SPP1/GJA1,3,2.4960542592671584,0.7305899750348428,8.527747543905994
R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,26/1379,178/9872,0.14606741573033707,1.0456689833864303,0.24774904242625662,0.4350918601422481,0.9999999999999936,0.9278752436647114,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/EXOSC6/RPL7A/PWP2/RPL19/RPL32/RPL8/RPSA/RPS14,26,2.0660224393185094,1.3641239994806649,3.129076771167902
R-HSA-418592,ADP signalling through P2Y purinoceptor 1,4/1379,24/9872,0.16666666666666666,1.1931351220691322,0.38170250166741565,0.43696337029814325,0.9999999999999936,0.9278752436647114,PLA2G4A/GNB3/GNB4/GNG2,4,2.3573845781967613,0.8167876038050876,6.80380312290595
R-HSA-525793,Myogenesis,4/1379,24/9872,0.16666666666666666,1.1931351220691322,0.38170250166741565,0.43696337029814325,0.9999999999999936,0.9278752436647114,CTNNA1/MEF2C/CDON/CTNNA2,4,2.3573845781967613,0.8167876038050876,6.80380312290595
R-HSA-5683826,Surfactant metabolism,4/1379,24/9872,0.16666666666666666,1.1931351220691322,0.38170250166741565,0.43696337029814325,0.9999999999999936,0.9278752436647114,CSF2RA/ADA2/ADORA2A/CKAP4,4,2.3573845781967613,0.8167876038050876,6.80380312290595
R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,5/1379,31/9872,0.16129032258064516,1.1546468923249666,0.3474838103664193,0.44011365406237435,0.9999999999999936,0.9278752436647114,BLNK/SYK/BTK/PIK3CD/ITPR1,5,2.2813399143839623,0.8856791534530871,5.876294801193036
R-HSA-5689896,Ovarian tumor domain proteases,6/1379,38/9872,0.15789473684210525,1.1303385366970726,0.3243632806078273,0.441876545888668,0.9999999999999936,0.9278752436647114,TNIP2/RNF135/UBC/YOD1/RPS27A/NOD2,6,2.2333117056600895,0.9424539114794492,5.292228207540457
R-HSA-975634,Retinoid metabolism and transport,6/1379,38/9872,0.15789473684210525,1.1303385366970726,0.3243632806078273,0.441876545888668,0.9999999999999936,0.9278752436647114,GPC5/BCO2/LPL/GPC6/AKR1C3/GPC2,6,2.2333117056600895,0.9424539114794492,5.292228207540457
R-HSA-3906995,Diseases associated with O-glycosylation of proteins,10/1379,66/9872,0.15151515151515152,1.0846682927901201,0.2780859026984842,0.4435221828473377,0.9999999999999936,0.9278752436647114,SPON1/ADAMTS14/ADAMTS19/ADAMTS10/MUC20/MUC4/B3GLCT/THSD7A/MUC15/ADAMTSL2,10,2.143076889269783,1.099546701075555,4.176974519435768
R-HSA-193648,NRAGE signals death through JNK,9/1379,59/9872,0.15254237288135594,1.0920219761310703,0.285659590119478,0.4435505208725776,0.9999999999999936,0.9278752436647114,NGFR/ARHGEF3/ARHGEF6/ABR/ARHGEF10/FGD3/NGEF/VAV3/PLEKHG2,9,2.1576062241122895,1.067671736022661,4.360202168196466
R-HSA-9614085,FOXO-mediated transcription,9/1379,60/9872,0.15,1.0738216098622189,0.23110668828385533,0.46449551303530934,0.9999999999999936,0.9278752436647114,CDKN1A/BCL6/ABCA6/GADD45A/PCK1/TRIM63/SFN/CCNG2/TXN,9,2.1216461203770844,1.0506876965383039,4.284224774823021
R-HSA-9013405,RHOD GTPase cycle,8/1379,53/9872,0.1509433962264151,1.080575204892799,0.23699428335714484,0.46566649446482367,0.9999999999999936,0.9278752436647114,SLC4A7/ARHGAP26/ARHGAP21/LMNB1/DIAPH2/PAK5/VANGL1/DIAPH3,8,2.1349898066687647,1.0131172418683099,4.499164841152734
R-HSA-437239,Recycling pathway of L1,7/1379,46/9872,0.15217391304347827,1.0893842418892077,0.24484071775796157,0.46682709934551403,0.9999999999999936,0.9278752436647114,L1CAM/TUBB4A/TUBA1A/ACTG1/ACTB/TUBA1B/EZR,7,2.1523946148753033,0.9699861885816842,4.776153137724878
R-HSA-156581,Methylation,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,MAT2A/NNMT,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,PROS1/GAS6,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-400451,Free fatty acids regulate insulin secretion,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,PLCB1/PLCB2,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-549132,Organic cation/anion/zwitterion transport,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,RUNX1/SLC22A4,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-5689877,Josephin domain DUBs,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-71288,Creatine metabolism,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,SLC6A8/CKMT2,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-71384,Ethanol oxidation,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,ALDH1A1/ACSS1,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-8851805,MET activates RAS signaling,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,MUC20/MET,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9020558,Interleukin-2 signaling,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,JAK3/SYK,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,PFKFB3/PFKFB4,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9664873,Pexophagy,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9926550,"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,PXN/ZEB1,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-9931521,The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex,2/1379,11/9872,0.18181818181818182,1.3016019513481443,0.4032757961401796,0.46771897228863957,0.9999999999999936,0.9278752436647114,PER1/CRY1,2,2.571692267123739,0.5694471177658236,11.614074266864197
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,6/1379,39/9872,0.15384615384615385,1.1013554972945838,0.25554579541920586,0.46794600672189923,0.9999999999999936,0.9278752436647114,IQGAP1/GNB3/GNB4/RAPGEF3/GNG2/ITPR1,6,2.1760473029508565,0.9196701824007756,5.148782634573001
R-HSA-202433,Generation of second messenger molecules,5/1379,32/9872,0.15625,1.1185641769398114,0.2706843067572687,0.46895783521749845,0.9999999999999936,0.9278752436647114,FYB1/CD4/HLA-DRB5/GRAP2/HLA-DQA2,5,2.2100480420594635,0.8597612550139577,5.681010070791775
R-HSA-375280,Amine ligand-binding receptors,5/1379,32/9872,0.15625,1.1185641769398114,0.2706843067572687,0.46895783521749845,0.9999999999999936,0.9278752436647114,HRH2/ADRB2/ADRB1/DRD1/HTR2C,5,2.2100480420594635,0.8597612550139577,5.681010070791775
R-HSA-392518,Signal amplification,5/1379,32/9872,0.15625,1.1185641769398114,0.2706843067572687,0.46895783521749845,0.9999999999999936,0.9278752436647114,P2RY12/PLA2G4A/GNB3/GNB4/GNG2,5,2.2100480420594635,0.8597612550139577,5.681010070791775
R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,ATF3/CCL2/CXCL8/EXOSC6,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-420029,Tight junction interactions,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,CLDN11/CLDN7/CLDN14/PARD6G,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-5357786,TNFR1-induced proapoptotic signaling,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,IKBKE/TNF/CASP8/TRADD,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-5654732,Negative regulation of FGFR3 signaling,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/UBC/RPS27A,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-901042,Calnexin/calreticulin cycle,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,EDEM1/UBC/RPS27A/EDEM2,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-9648002,RAS processing,4/1379,25/9872,0.16,1.1454097171863669,0.29332130744288526,0.46971198093307165,0.9999999999999936,0.9278752436647114,BCL2L1/ABHD17C/UBC/RPS27A,4,2.2630891950688907,0.7864913619023802,6.511924927502576
R-HSA-1369062,ABC transporters in lipid homeostasis,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,ABCD2/ABCA9/ABCA6,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,GNB3/GNB4/GNG2,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-420499,Class C/3 (Metabotropic glutamate/pheromone receptors),3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,GRM3/GRM1/GRM4,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,GADD45A/TFDP2/SFN,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-9909505,Modulation of host responses by IFN-stimulated genes,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,FKBP5/UBA7/EIF2AK3,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-9933937,Formation of the canonical BAF (cBAF) complex,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,SS18L1/DPF1/ACTB,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-9933946,Formation of the embryonic stem cell BAF (esBAF) complex,3/1379,18/9872,0.16666666666666666,1.1931351220691322,0.3304634092662956,0.46979931606674696,0.9999999999999936,0.9278752436647114,BCL11B/ACTB/SMARCD2,3,2.357384578196761,0.6935433563748873,8.0128545655277
R-HSA-1989781,PPARA activates gene expression,16/1379,110/9872,0.14545454545454545,1.0412815610785153,0.17543457934939385,0.4721777955708014,0.9999999999999936,0.9278752436647114,AHR/GLIPR1/ACSL1/MED28/ALAS1/SLC27A1/RGL1/HELZ2/MED29/PPARGC1B/TNFRSF21/PPARG/RORA/ME1/FABP1/ANGPTL4,16,2.0573538136989913,1.2142875175539658,3.485751647408887
R-HSA-9755511,KEAP1-NFE2L2 pathway,16/1379,110/9872,0.14545454545454545,1.0412815610785153,0.17543457934939385,0.4721777955708014,0.9999999999999936,0.9278752436647114,CDKN1A/PRKCD/BCL2L1/ABCG2/HMOX1/CCL2/PDGFA/BACH1/EIF2AK3/UBC/SLC7A11/RPS27A/ME1/CDKN2A/TXN/AREG,16,2.0573538136989913,1.2142875175539658,3.485751647408887
R-HSA-163685,Integration of energy metabolism,15/1379,103/9872,0.14563106796116504,1.0425452522934164,0.1748947640621195,0.47374746895066744,0.9999999999999936,0.9278752436647114,MARCKS/CACNA1A/CACNA1D/ADIPOR2/IQGAP1/GNB3/ADCY3/PLCB1/GNB4/RAPGEF3/ADCY7/GNG2/PLCB2/ITPR1/SLC2A1,15,2.0598506023078493,1.1950876812673963,3.5503541458383245
R-HSA-448424,Interleukin-17 signaling,10/1379,68/9872,0.14705882352941177,1.052766284178646,0.1759306325317304,0.483016754517838,0.9999999999999936,0.9278752436647114,FOS/MEF2C/TNIP2/DUSP3/MAP2K3/UBC/RPS27A/NOD2/MAP3K8/DUSP6,10,2.0800452160559657,1.0685781464751856,4.048920628883347
R-HSA-9856530,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,10/1379,68/9872,0.14705882352941177,1.052766284178646,0.1759306325317304,0.483016754517838,0.9999999999999936,0.9278752436647114,CALCRL/ADM/GNB3/PECAM1/ADCY3/GNB4/TRPV4/ADCY7/GNG2/PIK3CD,10,2.0800452160559657,1.0685781464751856,4.048920628883347
R-HSA-69231,Cyclin D associated events in G1,7/1379,47/9872,0.14893617021276595,1.0662058537639054,0.18332056490718207,0.4905410594717685,0.9999999999999936,0.9278752436647114,CDKN1A/CCND3/CCND1/UBC/RPS27A/TFDP2/CDKN2A,7,2.106598984771573,0.9504077071598017,4.66932164923454
R-HSA-69236,G1 Phase,7/1379,47/9872,0.14893617021276595,1.0662058537639054,0.18332056490718207,0.4905410594717685,0.9999999999999936,0.9278752436647114,CDKN1A/CCND3/CCND1/UBC/RPS27A/TFDP2/CDKN2A,7,2.106598984771573,0.9504077071598017,4.66932164923454
R-HSA-9707616,Heme signaling,7/1379,47/9872,0.14893617021276595,1.0662058537639054,0.18332056490718207,0.4905410594717685,0.9999999999999936,0.9278752436647114,MEF2C/HMOX1/BACH1/HELZ2/RORA/RAI1/LY96,7,2.106598984771573,0.9504077071598017,4.66932164923454
R-HSA-193704,p75 NTR receptor-mediated signalling,14/1379,97/9872,0.14432989690721648,1.033230414987702,0.13252426247393365,0.4918687012098023,0.9999999999999936,0.9278752436647114,NGFR/ARHGEF3/ARHGEF6/ABR/NFKBIA/ARHGEF10/FGD3/NGEF/UBC/VAV3/RPS27A/PLEKHG2/RTN4R/CASP2,14,2.0414464388508033,1.1625812278541048,3.5846988260674175
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,6/1379,40/9872,0.15,1.0738216098622189,0.18850580100085454,0.49367377189235384,0.9999999999999936,0.9278752436647114,SOX6/SOX4/TLE1/UBC/TCF7L2/RPS27A,6,2.121646120377085,0.8979623436912905,5.012885330588718
R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",6/1379,40/9872,0.15,1.0738216098622189,0.18850580100085454,0.49367377189235384,0.9999999999999936,0.9278752436647114,SLCO1C1/SLC29A3/SLC35D2/SLC27A1/SLCO2B1/SLC27A6,6,2.121646120377085,0.8979623436912905,5.012885330588718
R-HSA-9734767,Developmental Cell Lineages,13/1379,90/9872,0.14444444444444443,1.0340504391265812,0.13075619964784657,0.49422901768539007,0.9999999999999936,0.9278752436647114,TFRC/PROM1/ITGB4/ABCG2/LAMA1/SLC4A4/COL5A3/COL5A2/FN1/LAMA4/LAMA2/COL3A1/FABP5,13,2.0430666344371926,1.1392272263007215,3.663993605827566
R-HSA-3299685,Detoxification of Reactive Oxygen Species,5/1379,33/9872,0.15151515151515152,1.0846682927901201,0.19630639135370156,0.4973196049804808,0.9999999999999936,0.9278752436647114,ERO1A/CYBB/NCF2/GPX8/TXN,5,2.143076889269783,0.8353173058548143,5.498244225435113
R-HSA-390522,Striated Muscle Contraction,5/1379,33/9872,0.15151515151515152,1.0846682927901201,0.19630639135370156,0.4973196049804808,0.9999999999999936,0.9278752436647114,MYBPC1/TPM4/DMD/DES/TNNI2,5,2.143076889269783,0.8353173058548143,5.498244225435113
R-HSA-5357956,TNFR1-induced NF-kappa-B signaling pathway,5/1379,33/9872,0.15151515151515152,1.0846682927901201,0.19630639135370156,0.4973196049804808,0.9999999999999936,0.9278752436647114,TNF/UBC/RPS27A/TRADD/RACK1,5,2.143076889269783,0.8353173058548143,5.498244225435113
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,5/1379,33/9872,0.15151515151515152,1.0846682927901201,0.19630639135370156,0.4973196049804808,0.9999999999999936,0.9278752436647114,STAT3/BCL2A1/JUNB/IL10RA/RPS6,5,2.143076889269783,0.8353173058548143,5.498244225435113
R-HSA-9725554,Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,4/1379,26/9872,0.15384615384615385,1.1013554972945838,0.2085144774815739,0.5017298346978449,0.9999999999999936,0.9278752436647114,TFRC/ITGB4/ABCG2/FABP5,4,2.1760473029508565,0.7583618969810156,6.243960678312184
R-HSA-5668914,Diseases of metabolism,35/1379,248/9872,0.14112903225806453,1.010316030784346,0.06629683712982412,0.502077506376009,0.9999999999999936,0.9278752436647114,CSF2RA/GPC5/SPON1/ADAMTS14/ADAMTS19/TBXAS1/MMAB/VCAN/CSPG5/CYP26C1/ADAMTS10/ACAN/CHSY1/MUC20/NCAN/MUC4/B3GLCT/GYS1/HPRT1/GPC6/THSD7A/CHST3/MUC15/OMD/ABCD4/UBC/OGN/CUBN/RPS27A/PAH/GPC2/ADAMTSL2/B3GAT3/GALK1/GBE1,35,1.996172425085967,1.3953358156241058,2.8557314347236993
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,16/1379,112/9872,0.14285714285714285,1.0226872474878275,0.09729668824824715,0.5029073534874324,0.9999999999999936,0.9278752436647114,AHR/GLIPR1/ACSL1/MED28/ALAS1/SLC27A1/RGL1/HELZ2/MED29/PPARGC1B/TNFRSF21/PPARG/RORA/ME1/FABP1/ANGPTL4,16,2.020615352740081,1.193309710787861,3.421480917165478
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,15/1379,105/9872,0.14285714285714285,1.0226872474878275,0.09417334817957441,0.5054809833971965,0.9999999999999936,0.9278752436647114,FOS/MEF2C/NFKBIA/NLRC5/TIFA/TNIP2/IKBKE/DUSP3/MAP2K3/UBC/RPS27A/CASP8/NOD2/MAP3K8/DUSP6,15,2.020615352740081,1.173089714206083,3.480455377184953
R-HSA-111471,Apoptotic factor-mediated response,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,GSDME/GSDMD/CDKN2A,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-416700,Other semaphorin interactions,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,PLXND1/TREM2/PLXNA2,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-6804760,Regulation of TP53 Activity through Methylation,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,L3MBTL1/UBC/RPS27A,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-8854691,Interleukin-20 family signaling,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,STAT3/JAK3/STAT1,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-9694614,Attachment and Entry,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,GPC5/GPC6/GPC2,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-9703465,Signaling by FLT3 fusion proteins,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,CDKN1A/ETV6/PIM1,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-9840309,Glycosphingolipid biosynthesis,3/1379,19/9872,0.15789473684210525,1.1303385366970726,0.22913822627981073,0.5073922721374513,0.9999999999999936,0.9278752436647114,UGCG/B4GALT5/B3GNT5,3,2.2333117056600895,0.6600698193233069,7.556293332350313
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,8/1379,55/9872,0.14545454545454545,1.0412815610785153,0.12370299318901838,0.5096317888228028,0.9999999999999936,0.9278752436647114,PAX6/RARB/RARA/PBX1/MAFB/HOXD1/HOXB2/RARG,8,2.0573538136989913,0.9780061922616696,4.327891528941675
R-HSA-5619507,Activation of HOX genes during differentiation,8/1379,55/9872,0.14545454545454545,1.0412815610785153,0.12370299318901838,0.5096317888228028,0.9999999999999936,0.9278752436647114,PAX6/RARB/RARA/PBX1/MAFB/HOXD1/HOXB2/RARG,8,2.0573538136989913,0.9780061922616696,4.327891528941675
R-HSA-2559583,Cellular Senescence,18/1379,127/9872,0.14173228346456693,1.0146345919957975,0.06688422586550571,0.5125915508793015,0.9999999999999936,0.9278752436647114,STAT3/FOS/CDKN1A/MAP3K5/PHC2/CABIN1/MAP2K3/CXCL8/LMNB1/UBC/ERF/RPS27A/ETS2/TFDP2/CBX2/CDKN2A/CCNA2/TXN,18,2.0047049956318914,1.2200043273859096,3.2941212004736022
R-HSA-5357905,Regulation of TNFR1 signaling,7/1379,48/9872,0.14583333333333334,1.0439932318104908,0.12311031878317912,0.5139292377936695,0.9999999999999936,0.9278752436647114,IKBKE/TNF/UBC/RPS27A/CASP8/TRADD/RACK1,7,2.0627115059221657,0.9316042235561933,4.567152712577891
R-HSA-1296346,Tandem pore domain potassium channels,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,KCNK10/KCNK2,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-1482922,Acyl chain remodelling of PI,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,PLA2G4A/PLA2G5,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-1482925,Acyl chain remodelling of PG,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,PLA2G4A/PLA2G5,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-1663150,The activation of arylsulfatases,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,STS/ARSF,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-176974,Unwinding of DNA,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,GINS3/MCM7,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-193775,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,AKR1C3/CYP8B1,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-2033519,Activated point mutants of FGFR2,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-400511,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,DPP4/PAX6,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-428643,Organic anion transporters,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,SLC25A18/SLC17A8,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-4641265,Repression of WNT target genes,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,TLE1/TCF7L2,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-4755510,SUMOylation of immune response proteins,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,NFKBIA/IKBKE,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-71064,Lysine catabolism,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,CRYM/SLC25A21,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-75109,Triglyceride biosynthesis,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,GK/MOGAT1,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-8984722,Interleukin-35 Signalling,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,STAT3/STAT1,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-9827857,Specification of primordial germ cells,2/1379,12/9872,0.16666666666666666,1.1931351220691322,0.2697401352772169,0.5154233600529988,0.9999999999999936,0.9278752436647114,PDPN/PRDM1,2,2.3573845781967613,0.5270721265665259,10.543646247661126
R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,6/1379,41/9872,0.14634146341463414,1.0476308388899696,0.12314405712314494,0.5189708967995802,0.9999999999999936,0.9278752436647114,VASH1/AGTPBP1/TUBB4A/TUBA1A/AGBL1/TUBA1B,6,2.0698986540264244,0.8772559273915385,4.883957240026884
R-HSA-8856828,Clathrin-mediated endocytosis,20/1379,142/9872,0.14084507042253522,1.0082832017485623,0.040060663537360285,0.521249246658891,0.9999999999999936,0.9278752436647114,TFRC/SGIP1/CTTN/ADRB2/CD4/SYT1/AMPH/KIAA0319/TRIP10/UBC/ACTG1/WNT5A/SNX18/TACR1/STON2/ARRB2/RPS27A/ACTB/UBQLN2/AREG,20,1.9921559815747276,1.2434942247593102,3.191559217488237
R-HSA-71291,Metabolism of amino acids and derivatives,46/1379,329/9872,0.1398176291793313,1.0009279443497887,0.006897783606103622,0.5222679279707914,0.9999999999999936,0.9278752436647114,SHMT1/AZIN2/GLUL/BCAT1/GLDC/HNMT/SQOR/NNMT/RPL9/SLC6A8/BBOX1/RPL18A/RPL37A/KYNU/RPS3/RPL30/RPL18/CRYM/ODC1/RPL21/RPS16/RPS3A/RPL10/RPS6/GPT/RPL15/SLC3A2/RPS12/RPS27A/ARG2/PAH/RPL17/HAAO/CKMT2/RPS9/RPL13A/RPL13/SLC25A21/DMGDH/SLC45A2/RPL7A/RPL19/RPL32/RPL8/RPSA/RPS14,46,1.9776235367243344,1.4456675238111558,2.705321098101218
R-HSA-391251,Protein folding,13/1379,92/9872,0.14130434782608695,1.0115710817542642,0.044929397558241026,0.5280303392527762,0.9999999999999936,0.9278752436647114,STAT3/GNB3/TBCE/GNB4/KIFC3/TUBB4A/RGS9/TUBA1A/GNG2/ACTB/FBXO6/RGS7/TUBA1B,13,1.99865214238421,1.1153476063947374,3.581493664714284
R-HSA-1839124,FGFR1 mutant receptor activation,4/1379,27/9872,0.14814814814814814,1.0605645529503398,0.12697688967062826,0.5328694023893206,0.9999999999999936,0.9278752436647114,FGF20/STAT3/FGFR1OP2/STAT1,4,2.095452958397121,0.7321748305609461,5.997096482395056
R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",4/1379,27/9872,0.14814814814814814,1.0605645529503398,0.12697688967062826,0.5328694023893206,0.9999999999999936,0.9278752436647114,CACNA1D/GNB3/GNB4/GNG2,4,2.095452958397121,0.7321748305609461,5.997096482395056
R-HSA-5654687,Downstream signaling of activated FGFR1,4/1379,27/9872,0.14814814814814814,1.0605645529503398,0.12697688967062826,0.5328694023893206,0.9999999999999936,0.9278752436647114,FGF20/FLRT2/FGF22/FLRT1,4,2.095452958397121,0.7321748305609461,5.997096482395056
R-HSA-438064,Post NMDA receptor activation events,11/1379,78/9872,0.14102564102564102,1.009575872520035,0.03421194414668537,0.5361778573876206,0.9999999999999936,0.9278752436647114,CAMK2G/GRIN1/RASGRF1/TUBB4A/TUBA1A/CAMK4/CAMK2D/GRIA1/GIT1/GRIN2B/TUBA1B,11,1.9947100277049516,1.0585306650451203,3.758859545610884
R-HSA-189200,Cellular hexose transport,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,SLC2A3/SLC45A3/SLC2A1,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,CD4/HLA-DRB5/HLA-DQA2,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,BNIP3L/PMAIP1/BID,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-8876384,Listeria monocytogenes entry into host cells,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,UBC/MET/RPS27A,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-9603798,Class I peroxisomal membrane protein import,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,ALDH3A2/GDAP1/ABCD2,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-982772,Growth hormone receptor signaling,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,SOCS3/STAT3/STAT1,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-9931510,Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes,3/1379,20/9872,0.15,1.0738216098622189,0.13315836533398612,0.5435403207080026,0.9999999999999936,0.9278752436647114,PER1/CRY1/RORA,3,2.121646120377085,0.6296766179675466,7.148720679260057
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,6/1379,42/9872,0.14285714285714285,1.0226872474878275,0.059369288184927656,0.5437578134156082,0.9999999999999936,0.9278752436647114,COL4A1/CD163/COL4A2/HSPH1/COL3A1/FTH1,6,2.0206153527400805,0.8574831842604583,4.761476934676254
R-HSA-9006936,Signaling by TGFB family members,21/1379,151/9872,0.1390728476821192,0.9955961945742426,-0.02197319810787378,0.5449414004690324,0.9999999999999936,0.9278752436647114,ITGB3/SMAD7/CHRDL1/PPP1R15A/JUNB/BMP2/TGIF2/TGFB3/TGFBR1/RARA/SMAD6/PMEPA1/TGFBR2/UBC/INHBB/ARRB2/RPS27A/LTBP4/TFDP2/STAT1/WWTR1,21,1.96708911823041,1.2421191404921719,3.1151919915888926
R-HSA-390466,Chaperonin-mediated protein folding,12/1379,86/9872,0.13953488372093023,0.9989038231276455,-0.0041139537201381055,0.549186173426496,0.9999999999999936,0.9278752436647114,STAT3/GNB3/GNB4/KIFC3/TUBB4A/RGS9/TUBA1A/GNG2/ACTB/FBXO6/RGS7/TUBA1B,12,1.973624298025195,1.0761803962363379,3.619460903931973
R-HSA-75893,TNF signaling,8/1379,57/9872,0.14035087719298245,1.0047453659529533,0.014477518642078793,0.5523613256719111,0.9999999999999936,0.9278752436647114,IKBKE/SMPD3/TNF/UBC/RPS27A/CASP8/TRADD/RACK1,8,1.985165960586746,0.9452481942727723,4.16915251988841
R-HSA-8868773,rRNA processing in the nucleus and cytosol,26/1379,188/9872,0.13829787234042554,0.9900482927807693,-0.055511283859789366,0.5546925830742706,0.9999999999999936,0.9278752436647114,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/EXOSC6/RPL7A/PWP2/RPL19/RPL32/RPL8/RPSA/RPS14,26,1.9561276287164608,1.2933543239564849,2.9585359780779035
R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-1679131,Trafficking and processing of endosomal TLR,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,CTSS/TLR7,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-193807,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,AKR1C3/CYP8B1,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-202670,ERKs are inactivated,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,DUSP3/DUSP6,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-212300,PRC2 methylates histones and DNA,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,PHF19/AEBP2,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,WIF1/WNT5A,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-428540,Activation of RAC1,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,NCK2/PAK5,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-5210891,Uptake and function of anthrax toxins,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,MAP2K3/ANTXR1,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-5578768,Physiological factors,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,NPPC/WWTR1,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-918233,TRAF3-dependent IRF activation pathway,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,IKBKE/RNF135,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-9637687,Suppression of phagosomal maturation,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-9733458,Induction of Cell-Cell Fusion,2/1379,13/9872,0.15384615384615385,1.1013554972945838,0.14734476100474217,0.5601966945252532,0.9999999999999936,0.9278752436647114,ANO2/ANO3,2,2.1760473029508565,0.4905548206194983,9.652706824284923
R-HSA-211945,Phase I - Functionalization of compounds,13/1379,94/9872,0.13829787234042554,0.9900482927807693,-0.039063274717027155,0.5611182050002163,0.9999999999999936,0.9278752436647114,AHR/ALDH1A1/PTGS1/TBXAS1/CYP26C1/AOC2/ACSS1/CYP8B1/CYP2E1/ALDH3A1/CBR3/CYP4F3/AOC3,13,1.9561276287164608,1.0924489892188092,3.5026214840146443
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,4/1379,28/9872,0.14285714285714285,1.0226872474878275,0.04844033844239681,0.5630086767052324,0.9999999999999936,0.9278752436647114,CDKN1A/CABIN1/LMNB1/CCNA2,4,2.020615352740081,0.707735723142137,5.768942092681312
R-HSA-373755,Semaphorin interactions,9/1379,65/9872,0.13846153846153847,0.9912199475651252,-0.028616587756387802,0.5659668063809897,0.9999999999999936,0.9278752436647114,PLXND1/DPYSL5/PLXNA3/SEMA3A/TREM2/PLXNA2/LIMK2/RHOB/MET,9,1.9584425726557706,0.9732786720500942,3.94080073933146
R-HSA-3371556,Cellular response to heat stress,12/1379,87/9872,0.13793103448275862,0.9874221699882473,-0.04748069630825247,0.5662288936294846,0.9999999999999936,0.9278752436647114,HSPA12A/CAMK2G/HSPA6/NUP205/NUP188/CAMK2D/HSPH1/EEF1A1/HSPA1A/HSPA1B/CRYAB/DNAJB1,12,1.9509389612662849,1.0642610896487272,3.576343124451767
R-HSA-373752,Netrin-1 signaling,6/1379,43/9872,0.13953488372093023,0.9989038231276455,-0.0029026344282790826,0.5679643627557787,0.9999999999999936,0.9278752436647114,DOCK1/TRPC5/MYO10/NTN1/DSCAM/EZR,6,1.973624298025195,0.8385823426495145,4.644973631866036
R-HSA-9634597,GPER1 signaling,6/1379,43/9872,0.13953488372093023,0.9989038231276455,-0.0029026344282790826,0.5679643627557787,0.9999999999999936,0.9278752436647114,GNB3/ADCY3/GNB4/FN1/ADCY7/GNG2,6,1.973624298025195,0.8385823426495145,4.644973631866036
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,14/1379,102/9872,0.13725490196078433,0.9825818652334031,-0.07125028362072919,0.5721533298171173,0.9999999999999936,0.9278752436647114,TFRC/SGIP1/ADRB2/CD4/SYT1/KIAA0319/UBC/WNT5A/TACR1/STON2/ARRB2/RPS27A/UBQLN2/AREG,14,1.9413755349855677,1.1075026672717787,3.4030969669128663
R-HSA-1187000,Fertilization,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,HVCN1/CD9/OVGP1,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-1482788,Acyl chain remodelling of PC,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,PLA2G4A/LPCAT2/PLA2G5,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,NFKBIA/DTX4/NLRP4,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,MMAB/ABCD4/CUBN,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-389948,Co-inhibition by PD-1,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,CD4/HLA-DRB5/HLA-DQA2,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-5218921,VEGFR2 mediated cell proliferation,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,VEGFA/PRKCD/ITPR1,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,3/1379,21/9872,0.14285714285714285,1.0226872474878275,0.04193565623182218,0.5780951612010765,0.9999999999999936,0.9278752436647114,ALDH3A2/SGTA/HMOX1,3,2.0206153527400805,0.6019575533500577,6.782681571161529
R-HSA-6804757,Regulation of TP53 Degradation,5/1379,36/9872,0.1388888888888889,0.9942792683909435,-0.01385561191064492,0.5784581507906595,0.9999999999999936,0.9278752436647114,SGK1/UBC/RPS27A/CDKN2A/CCNA2,5,1.9644871484973008,0.769670547803167,5.014106058268969
R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,5/1379,36/9872,0.1388888888888889,0.9942792683909435,-0.01385561191064492,0.5784581507906595,0.9999999999999936,0.9278752436647114,RUNX1/PHC2/ACTL6B/CBX2/SMARCD2,5,1.9644871484973008,0.769670547803167,5.014106058268969
R-HSA-9845323,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),5/1379,36/9872,0.1388888888888889,0.9942792683909435,-0.01385561191064492,0.5784581507906595,0.9999999999999936,0.9278752436647114,GATAD2A/SS18L1/DPF1/ACTB/SMARCD2,5,1.9644871484973008,0.769670547803167,5.014106058268969
R-HSA-9006925,Intracellular signaling by second messengers,40/1379,293/9872,0.13651877133105803,0.9773120453808591,-0.15885511941303565,0.5894042472547041,0.9999999999999936,0.9278752436647114,FGF20/PIP4K2A/FGFR3/PIP5K1B/CDKN1A/PREX2/SGK1/PHC2/CD86/IL1RAP/FRK/PRKCD/PDGFRA/PIK3R5/CAMK2G/ADCY3/PDGFA/EGR1/PIK3CG/GATAD2A/FGF22/NR2E1/CAMK4/CAMK2D/KIT/PPARG/UBC/PDGFRB/NRG3/ADCY7/MET/RPS27A/PDGFB/PIK3R3/IL33/CBX2/PIK3CD/ITPR1/NR4A1/AREG,40,1.9309634770212376,1.381479368819863,2.6990051634105425
R-HSA-201451,Signaling by BMP,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,SMAD7/CHRDL1/BMP2/SMAD6,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-418360,Platelet calcium homeostasis,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,SLC8A3/SLC8A1/ATP2B4/ITPR1,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-499943,Interconversion of nucleotide di- and triphosphates,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,AK7/AK4/AK5/TXN,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,MOV10L1/ASZ1/MYBL1/TDRD9,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-5654726,Negative regulation of FGFR1 signaling,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,FGF20/FGF22/UBC/RPS27A,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-5654727,Negative regulation of FGFR2 signaling,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,FGF20/FGF22/UBC/RPS27A,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-8863795,Downregulation of ERBB2 signaling,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,ERBIN/UBC/NRG3/RPS27A,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/CHMP4C/TUBA1B,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-9843743,Transcriptional regulation of brown and beige adipocyte differentiation,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,GATAD2A/PPARGC1B/PPARG/BMP7,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-9844594,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,4/1379,29/9872,0.13793103448275862,0.9874221699882473,-0.027332107764214977,0.5920496616588318,0.9999999999999936,0.9278752436647114,GATAD2A/PPARGC1B/PPARG/BMP7,4,1.9509389612662849,0.6848752433808476,5.557454247868363
R-HSA-170670,Adenylate cyclase inhibitory pathway,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,ADCY3/ADCY7,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-174490,Membrane binding and targetting of GAG proteins,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-174495,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-189451,Heme biosynthesis,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,ABCG2/ALAS1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-190241,FGFR2 ligand binding and activation,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-190242,FGFR1 ligand binding and activation,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,SYK/FCER1G,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-391160,Signal regulatory protein family interactions,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,CD47/FYB1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-418885,DCC mediated attractive signaling,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,DOCK1/NTN1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-435354,Zinc transporters,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,SLC39A10/SLC39A14,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-5654704,SHC-mediated cascade:FGFR3,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,FGF20/FGFR3,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-5654710,PI-3K cascade:FGFR3,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,FGF20/FGFR3,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,BCL6/NDRG1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,CDKN1A/CCNA2,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-75892,Platelet Adhesion to exposed collagen,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,FCER1G/GP1BA,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-8941856,RUNX3 regulates NOTCH signaling,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,MAML3/HES1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-8983432,Interleukin-15 signaling,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,STAT3/JAK3,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,PPP1R15A/ATF3,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-9931530,Phosphorylation and nuclear translocation of the CRY:PER:kinase complex,2/1379,14/9872,0.14285714285714285,1.0226872474878275,0.03422816103575203,0.6019265564020291,0.9999999999999936,0.9278752436647114,PER1/CRY1,2,2.020615352740081,0.45876146961978637,8.899802346332066
R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,5/1379,37/9872,0.13513513513513514,0.9674068557317289,-0.08003355088860428,0.6039104378775222,0.9999999999999936,0.9278752436647114,GNB3/GNB4/RGS9/GNG2/RGS7,5,1.911392901240617,0.7500229564336492,4.8710813336767815
R-HSA-9694516,SARS-CoV-2 Infection,38/1379,280/9872,0.1357142857142857,0.9715528851134362,-0.19457847904542738,0.603935910714744,0.9999999999999936,0.9278752436647114,MGAT4C/TLR2/GPC5/IFNAR2/PARP9/ZDHHC20/GJA1/ST6GALNAC3/NLRP3/SEC24D/ANO2/ANO3/TLR7/ST6GAL1/IKBKE/NUP205/RPS3/GPC6/RNF135/ST3GAL4/NUP188/RPS16/UBC/CHMP4C/RPS3A/RPS6/ZDHHC11/RPS12/RPS27A/TUSC3/GPC2/RPS9/STAT1/SFN/EDEM2/NOD2/RPSA/RPS14,38,1.9195845851030766,1.3619158590496863,2.7056039878532023
R-HSA-9820448,Developmental Cell Lineages of the Exocrine Pancreas,9/1379,67/9872,0.13432835820895522,0.9616312924139274,-0.12697637370838924,0.6042265672827999,0.9999999999999936,0.9278752436647114,PROM1/LAMA1/SLC4A4/COL5A3/COL5A2/FN1/LAMA4/LAMA2/COL3A1,9,1.899981600337688,0.94541858572102,3.818340506674789
R-HSA-1592389,Activation of Matrix Metalloproteinases,3/1379,22/9872,0.13636363636363635,0.976201463511108,-0.04502727064427526,0.6109526201646591,0.9999999999999936,0.9278752436647114,MMP2/COL18A1/KLKB1,3,1.9287692003428043,0.5765747874509399,6.452156266905036
R-HSA-198753,ERK/MAPK targets,3/1379,22/9872,0.13636363636363635,0.976201463511108,-0.04502727064427526,0.6109526201646591,0.9999999999999936,0.9278752436647114,MEF2C/DUSP3/DUSP6,3,1.9287692003428043,0.5765747874509399,6.452156266905036
R-HSA-3296482,Defects in vitamin and cofactor metabolism,3/1379,22/9872,0.13636363636363635,0.976201463511108,-0.04502727064427526,0.6109526201646591,0.9999999999999936,0.9278752436647114,MMAB/ABCD4/CUBN,3,1.9287692003428043,0.5765747874509399,6.452156266905036
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,3/1379,22/9872,0.13636363636363635,0.976201463511108,-0.04502727064427526,0.6109526201646591,0.9999999999999936,0.9278752436647114,UBC/RPS27A/NOD2,3,1.9287692003428043,0.5765747874509399,6.452156266905036
R-HSA-8949215,Mitochondrial calcium ion transport,3/1379,22/9872,0.13636363636363635,0.976201463511108,-0.04502727064427526,0.6109526201646591,0.9999999999999936,0.9278752436647114,SLC8A3/MCUB/MAIP1,3,1.9287692003428043,0.5765747874509399,6.452156266905036
R-HSA-445717,Aquaporin-mediated transport,6/1379,45/9872,0.13333333333333333,0.9545080976553058,-0.12324293263705753,0.6144019891143963,0.9999999999999936,0.9278752436647114,GNB3/ADCY3/GNB4/ADCY7/GNG2/AQP11,6,1.8859076625574085,0.8031753763695266,4.428233006556215
R-HSA-381119,Unfolded Protein Response (UPR),12/1379,90/9872,0.13333333333333333,0.9545080976553058,-0.17469226294646067,0.6157121095427416,0.9999999999999936,0.9278752436647114,SRPRB/LMNA/XBP1/ATF3/GOSR2/CCL2/CXCL8/CREB3L1/EDEM1/EIF2AK3/PDIA5/EXOSC6,12,1.8859076625574085,1.0300370509341952,3.452931822663113
R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,14/1379,105/9872,0.13333333333333333,0.9545080976553058,-0.18883404701943896,0.6178564650984433,0.9999999999999936,0.9278752436647114,TLR2/CX3CR1/GPC5/CD14/IFNAR2/TLR7/MED28/GPC6/MED29/UBC/IGF1R/LY96/RPS27A/GPC2,14,1.8859076625574087,1.0768924064491032,3.3026955064343704
R-HSA-114452,Activation of BH3-only proteins,4/1379,30/9872,0.13333333333333333,0.9545080976553058,-0.1005507217290783,0.6199166063716898,0.9999999999999936,0.9278752436647114,PMAIP1/TFDP2/SFN/BID,4,1.8859076625574087,0.6634452430915259,5.3608760462573555
R-HSA-201556,Signaling by ALK,4/1379,30/9872,0.13333333333333333,0.9545080976553058,-0.1005507217290783,0.6199166063716898,0.9999999999999936,0.9278752436647114,STAT3/JAK3/HIF1A/PRDM1,4,1.8859076625574087,0.6634452430915259,5.3608760462573555
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,5/1379,38/9872,0.13157894736842105,0.9419487805808937,-0.1444675109237202,0.6284610275728031,0.9999999999999936,0.9278752436647114,GNB3/ADCY3/GNB4/ADCY7/GNG2,5,1.8610930880500747,0.7313536056566853,4.735968286199563
R-HSA-8853659,RET signaling,5/1379,38/9872,0.13157894736842105,0.9419487805808937,-0.1444675109237202,0.6284610275728031,0.9999999999999936,0.9278752436647114,DOK6/GDNF/SHC3/PIK3R3/PIK3CD,5,1.8610930880500747,0.7313536056566853,4.735968286199563
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,12/1379,91/9872,0.13186813186813187,0.9440189976810716,-0.21617321610017623,0.6315864778810681,0.9999999999999936,0.9278752436647114,CAMK2G/GRIN1/RASGRF1/TUBB4A/TUBA1A/CAMK4/CAMK2D/GRIA1/GRIA4/GIT1/GRIN2B/TUBA1B,12,1.8651834025293053,1.0191131958026807,3.4136631135766184
R-HSA-111447,Activation of BAD and translocation to mitochondria,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,SFN/BID,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,MAML3/HES1,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-4419969,Depolymerization of the Nuclear Lamina,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,LMNA/LMNB1,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-5099900,WNT5A-dependent internalization of FZD4,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,WNT5A/ARRB2,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-5576893,Phase 2 - plateau phase,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,KCNE3/CACNG4,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,SFN/CCNA2,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-8949664,Processing of SMDT1,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,MCUB/MAIP1,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-8963898,Plasma lipoprotein assembly,2/1379,15/9872,0.13333333333333333,0.9545080976553058,-0.07104597790676544,0.6405890516817487,0.9999999999999936,0.9278752436647114,A2M/BMP1,2,1.8859076625574087,0.43083261404431317,8.2552889353147485
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",9/1379,69/9872,0.13043478260869565,0.9337579216193209,-0.22249033055630305,0.6407428998760312,0.9999999999999936,0.9278752436647114,A2M/LPL/BMP1/UBC/CUBN/RPS27A/LIPG/NCEH1/ANGPTL4,9,1.844909669893117,0.9191096841370732,3.703248642473791
R-HSA-1266695,Interleukin-7 signaling,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,STAT3/JAK3/PIK3R3,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-1482839,Acyl chain remodelling of PE,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,PLA2G4A/PLAAT1/PLA2G5,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-166208,mTORC1-mediated signalling,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,RPS6/EIF4EBP1/EEF2K,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-428930,Thromboxane signalling through TP receptor,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,GNB3/GNB4/GNG2,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,LMNA/LMNB1/CDKN2A,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-9833109,Evasion by RSV of host interferon responses,3/1379,23/9872,0.13043478260869565,0.9337579216193209,-0.12815452536266833,0.6420467844269072,0.9999999999999936,0.9278752436647114,IFNAR2/UBC/RPS27A,3,1.844909669893117,0.5532450537995293,6.152231577471044
R-HSA-1251985,Nuclear signaling by ERBB4,4/1379,31/9872,0.12903225806451613,0.9237175138599732,-0.17140292022460946,0.6465540807878847,0.9999999999999936,0.9278752436647114,CXCL12/MXD4/NRG3/PGR,4,1.82507193150717,0.6433155459925611,5.177688578994527
R-HSA-182971,EGFR downregulation,4/1379,31/9872,0.12903225806451613,0.9237175138599732,-0.17140292022460946,0.6465540807878847,0.9999999999999936,0.9278752436647114,SPRY1/UBC/RPS27A/AREG,4,1.82507193150717,0.6433155459925611,5.177688578994527
R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",4/1379,31/9872,0.12903225806451613,0.9237175138599732,-0.17140292022460946,0.6465540807878847,0.9999999999999936,0.9278752436647114,GUCA1B/CNGA1/RGS9/GRK4,4,1.82507193150717,0.6433155459925611,5.177688578994527
R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,4/1379,31/9872,0.12903225806451613,0.9237175138599732,-0.17140292022460946,0.6465540807878847,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/ACTB/TUBA1B,4,1.82507193150717,0.6433155459925611,5.177688578994527
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,4/1379,31/9872,0.12903225806451613,0.9237175138599732,-0.17140292022460946,0.6465540807878847,0.9999999999999936,0.9278752436647114,FOS/MEF2C/DUSP3/DUSP6,4,1.82507193150717,0.6433155459925611,5.177688578994527
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA,8/1379,62/9872,0.12903225806451613,0.9237175138599732,-0.24278302978749214,0.6514084783659366,0.9999999999999936,0.9278752436647114,NFKBIA/IFI16/POLR3G/DTX4/UBC/RPS27A/NLRP4/TRIM56,8,1.82507193150717,0.8722150256731253,3.818883483008935
R-HSA-157118,Signaling by NOTCH,22/1379,167/9872,0.1317365269461078,0.9430768629528471,-0.29893821630048273,0.6514735123782873,0.9999999999999936,0.9278752436647114,RUNX1/MAML3/NEURL1B/PLXND1/CNTN1/HES5/HIF1A/ST3GAL6/TLE1/HDAC4/ST3GAL4/CCND1/FABP7/DTX4/PBX1/UBC/ACTA2/ARRB2/RPS27A/TFDP2/STAT1/HES1,22,1.8633219420477392,1.1906173213264586,2.9161079698122165
R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,5/1379,39/9872,0.1282051282051282,0.9177962477454863,-0.20725884453280308,0.652066177697936,0.9999999999999936,0.9278752436647114,UBA7/USP43/MAD2L2/UBC/RPS27A,5,1.813372752459047,0.7135912055686018,4.60812957572916
R-HSA-428157,Sphingolipid metabolism,13/1379,100/9872,0.13,0.9306453952139232,-0.28087670331382225,0.6543018632572066,0.9999999999999936,0.9278752436647114,ALDH3A2/SPTLC3/PPM1L/ABCG2/UGCG/NEU4/B4GALT5/STS/SMPD3/B3GNT5/ARSF/NEU3/GLB1L3,13,1.8387599709934734,1.0290695032201866,3.285529519967214
R-HSA-9748784,Drug ADME,11/1379,85/9872,0.12941176470588237,0.9264343300772087,-0.2744681846721628,0.6555076110453562,0.9999999999999936,0.9278752436647114,ACSM5/ABCC4/SLC29A3/ABCG2/PCK1/HPRT1/SLCO2B1/SULT1A1/CYP2E1/VAV3/IMPDH1,11,1.8304397901292497,0.9744794376460701,3.4382560532850492
R-HSA-9006931,Signaling by Nuclear Receptors,30/1379,227/9872,0.13215859030837004,0.9460983346803692,-0.33105194420319745,0.6588872786451867,0.9999999999999936,0.9278752436647114,PDK1/FOS/CXCL12/RUNX1/ALDH1A1/KDM3A/FKBP5/CYP26C1/GNB3/DHRS9/PCK1/RARB/MMP2/GNB4/CXXC5/RARA/PDK3/RDH10/KDM4B/AKR1C3/CCND1/IGF1R/GNG2/RARG/ARL4C/PIK3R3/PGR/RXRG/AREG/FABP5,30,1.8692917360150527,1.2723997296756766,2.7461901420120727
R-HSA-15869,Metabolism of nucleotides,12/1379,93/9872,0.12903225806451613,0.9237175138599732,-0.2978182017584497,0.6622967594406203,0.9999999999999936,0.9278752436647114,ENTPD1/NT5E/DPYS/SAMHD1/TYMP/AK7/HPRT1/AK4/AK5/NT5C1A/IMPDH1/TXN,12,1.8250719315071695,0.9979464327138782,3.337741832612284
R-HSA-5658442,Regulation of RAS by GAPs,7/1379,55/9872,0.12727272727272726,0.9111213659437009,-0.26633084544464203,0.6637943173686278,0.9999999999999936,0.9278752436647114,RASAL2/SPRED3/RASA3/RASAL1/RASAL3/UBC/RPS27A,7,1.8001845869866173,0.8182838808011201,3.9603182016141965
R-HSA-1236974,ER-Phagosome pathway,10/1379,78/9872,0.1282051282051282,0.9177962477454863,-0.29369127198542977,0.6648376018047093,0.9999999999999936,0.9278752436647114,TLR2/CD14/S100A9/TAP1/S100A8/BTK/UBC/LY96/PSMB9/RPS27A,10,1.813372752459047,0.9366807698891457,3.510609852436777
R-HSA-72312,rRNA processing,26/1379,198/9872,0.13131313131313133,0.9400458537514377,-0.34338468651031184,0.6654627119251944,0.9999999999999936,0.9278752436647114,RPL9/RPL18A/RPL37A/RPS3/RPL30/RPL18/RPL21/RPS16/RPS3A/RPL10/RPS6/RPL15/RPS12/RPS27A/RPL17/RPS9/RPL13A/RPL13/EXOSC6/RPL7A/PWP2/RPL19/RPL32/RPL8/RPSA/RPS14,26,1.8573333040338116,1.2295683053654023,2.8056082669176963
R-HSA-3858494,Beta-catenin independent WNT signaling,17/1379,131/9872,0.1297709923664122,0.92900597290879,-0.329600479707449,0.6672386395123506,0.9999999999999936,0.9278752436647114,PRICKLE1/FZD5/GNB3/PLCB1/GNB4/WNT11/UBC/WNT5A/ROR1/TCF7L2/ARRB2/RPS27A/GNG2/PLCB2/PRKG1/ITPR1/FZD2,17,1.8355208166112185,1.1041892765999382,3.0512311064888156
R-HSA-9020702,Interleukin-1 signaling,13/1379,101/9872,0.12871287128712872,0.9214310843702209,-0.3197967799596735,0.6687567924051294,0.9999999999999936,0.9278752436647114,IL1B/IL1RAP/NFKBIA/NLRC5/TIFA/TNIP2/PELI2/UBC/IL1RN/RPS27A/CASP8/NOD2/MAP3K8,13,1.8205544267262115,1.0192146784050662,3.2519335630634982
R-HSA-9856651,MITF-M-dependent gene expression,13/1379,101/9872,0.12871287128712872,0.9214310843702209,-0.3197967799596735,0.6687567924051294,0.9999999999999936,0.9278752436647114,TRPM1/BCL2A1/CDKN1A/PXN/SS18L1/DPF1/ZEB1/CCND1/TCF7L2/MET/ACTB/CDKN2A/SMARCD2,13,1.8205544267262115,1.0192146784050662,3.2519335630634982
R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/TUBA1B,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-5223345,Miscellaneous transport and binding events,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,LRRC8B/TUSC3/NIPAL2,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-5627123,RHO GTPases activate PAKs,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,CTTN/FLNA/MYLK,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-9006335,Signaling by Erythropoietin,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,PIK3R5/PIK3CG/PIK3CD,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-933542,TRAF6 mediated NF-kB activation,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,NFKBIA/RNF135/MAP3K1,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,ABCA6/PCK1/TRIM63,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,3/1379,24/9872,0.125,0.8948513415518492,-0.20781049840466298,0.6713444150167309,0.9999999999999936,0.9278752436647114,FOS/CCND1/AREG,3,1.7680384336475707,0.5317290738265742,5.878858344831641
R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,4/1379,32/9872,0.125,0.8948513415518492,-0.24005641883672188,0.6719249730122256,0.9999999999999936,0.9278752436647114,NUP205/NUP188/HSPA1A/HSPA1B,4,1.7680384336475707,0.6243713032768755,5.0065720292541345
R-HSA-192105,Synthesis of bile acids and bile salts,4/1379,32/9872,0.125,0.8948513415518492,-0.24005641883672188,0.6719249730122256,0.9999999999999936,0.9278752436647114,OSBPL3/OSBPL6/AKR1C3/CYP8B1,4,1.7680384336475707,0.6243713032768755,5.0065720292541345
R-HSA-2514856,The phototransduction cascade,4/1379,32/9872,0.125,0.8948513415518492,-0.24005641883672188,0.6719249730122256,0.9999999999999936,0.9278752436647114,GUCA1B/CNGA1/RGS9/GRK4,4,1.7680384336475707,0.6243713032768755,5.0065720292541345
R-HSA-5656169,Termination of translesion DNA synthesis,4/1379,32/9872,0.125,0.8948513415518492,-0.24005641883672188,0.6719249730122256,0.9999999999999936,0.9278752436647114,UBA7/USP43/UBC/RPS27A,4,1.7680384336475707,0.6243713032768755,5.0065720292541345
R-HSA-9634815,Transcriptional Regulation by NPAS4,4/1379,32/9872,0.125,0.8948513415518492,-0.24005641883672188,0.6719249730122256,0.9999999999999936,0.9278752436647114,NAMPT/FOS/RBFOX3/PLK2,4,1.7680384336475707,0.6243713032768755,5.0065720292541345
R-HSA-9646399,Aggrephagy,5/1379,40/9872,0.125,0.8948513415518492,-0.26850040417606946,0.6746936642415906,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/UBC/RPS27A/TUBA1B,5,1.7680384336475707,0.6966712293602725,4.4869943972358515
R-HSA-1295596,Spry regulation of FGF signaling,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,TFDP2/CCNA2,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-1461973,Defensins,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,TLR2/CD4,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-164378,PKA activation in glucagon signalling,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,ADCY3/ADCY7,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-175474,Assembly Of The HIV Virion,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-210745,Regulation of gene expression in beta cells,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,HNF4G/PAX6,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,IGF1/LEP,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-4655427,SUMOylation of DNA methylation proteins,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,PHC2/CBX2,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-5654706,FRS-mediated FGFR3 signaling,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,FGF20/FGFR3,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-8866427,VLDLR internalisation and degradation,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,2/1379,16/9872,0.125,0.8948513415518492,-0.16960768520811176,0.6762263029432181,0.9999999999999936,0.9278752436647114,LPL/ANGPTL4,2,1.7680384336475707,0.40610501890425,7.69741755787555
R-HSA-381038,XBP1(S) activates chaperone genes,6/1379,48/9872,0.125,0.8948513415518492,-0.2942471904982575,0.6784714358389984,0.9999999999999936,0.9278752436647114,SRPRB/LMNA/XBP1/GOSR2/EDEM1/PDIA5,6,1.7680384336475707,0.7553382558826894,4.138490111561944
R-HSA-5654736,Signaling by FGFR1,6/1379,48/9872,0.125,0.8948513415518492,-0.2942471904982575,0.6784714358389984,0.9999999999999936,0.9278752436647114,FGF20/FLRT2/FGF22/FLRT1/UBC/RPS27A,6,1.7680384336475707,0.7553382558826894,4.138490111561944
R-HSA-983189,Kinesins,7/1379,56/9872,0.125,0.8948513415518492,-0.3179527764417514,0.6827396243953521,0.9999999999999936,0.9278752436647114,KIF19/KIF26B/KIF21B/KIF25/TUBB4A/TUBA1A/TUBA1B,7,1.7680384336475705,0.8043079276906374,3.886521312590243
R-HSA-1257604,PIP3 activates AKT signaling,33/1379,252/9872,0.13095238095238096,0.9374633101971753,-0.4052096418956058,0.6848014079865122,0.9999999999999936,0.9278752436647114,FGF20/PIP4K2A/FGFR3/PIP5K1B/CDKN1A/PREX2/SGK1/PHC2/CD86/IL1RAP/FRK/PDGFRA/PIK3R5/PDGFA/EGR1/PIK3CG/GATAD2A/FGF22/NR2E1/KIT/PPARG/UBC/PDGFRB/NRG3/MET/RPS27A/PDGFB/PIK3R3/IL33/CBX2/PIK3CD/NR4A1/AREG,33,1.8522307400117408,1.2833302100052062,2.673324984869267
R-HSA-9730414,MITF-M-regulated melanocyte development,18/1379,140/9872,0.12857142857142856,0.9204185227390448,-0.38212646025635943,0.6854330689565045,0.9999999999999936,0.9278752436647114,TRPM1/BCL2A1/EDNRB/CDKN1A/PXN/MARK3/SS18L1/DPF1/ZEB1/CCND1/CSF1/KIT/TCF7L2/MET/EDN3/ACTB/CDKN2A/SMARCD2,18,1.8185538174660727,1.1098612127166385,2.979776164017347
R-HSA-2980736,Peptide hormone metabolism,9/1379,72/9872,0.125,0.8948513415518492,-0.3608187465059339,0.6918366828571194,0.9999999999999936,0.9278752436647114,DPP4/IGF1/FFAR4/GNB3/PAX6/CPE/TCF7L2/INHBB/LEP,9,1.7680384336475705,0.88228268365846,3.5430366715267456
R-HSA-1221632,Meiotic synapsis,4/1379,33/9872,0.12121212121212122,0.8677346342320963,-0.3066618659636464,0.6960084720510874,0.9999999999999936,0.9278752436647114,LMNA/LMNB1/SYCE2/SYNE1,4,1.7144615114158261,0.6065108026511498,4.846374147464111
R-HSA-5663084,Diseases of carbohydrate metabolism,4/1379,33/9872,0.12121212121212122,0.8677346342320963,-0.3066618659636464,0.6960084720510874,0.9999999999999936,0.9278752436647114,GYS1/UBC/RPS27A/GBE1,4,1.7144615114158261,0.6065108026511498,4.846374147464111
R-HSA-9615710,Late endosomal microautophagy,4/1379,33/9872,0.12121212121212122,0.8677346342320963,-0.3066618659636464,0.6960084720510874,0.9999999999999936,0.9278752436647114,PLIN3/UBC/CHMP4C/RPS27A,4,1.7144615114158261,0.6065108026511498,4.846374147464111
R-HSA-9931509,"Expression of BMAL (ARNTL), CLOCK, and NPAS2",4/1379,33/9872,0.12121212121212122,0.8677346342320963,-0.3066618659636464,0.6960084720510874,0.9999999999999936,0.9278752436647114,MEF2C/HELZ2/RORA/RAI1,4,1.7144615114158261,0.6065108026511498,4.846374147464111
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),5/1379,41/9872,0.12195121951219512,0.8730256990749747,-0.32827745491535765,0.6963218263863138,0.9999999999999936,0.9278752436647114,MVK/TM7SF2/DHCR7/HELZ2/SQLE,5,1.7249155450220204,0.6805351298867933,4.372050033557501
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,5/1379,41/9872,0.12195121951219512,0.8730256990749747,-0.32827745491535765,0.6963218263863138,0.9999999999999936,0.9278752436647114,GNB3/ADCY3/GNB4/ADCY7/GNG2,5,1.7249155450220204,0.6805351298867933,4.372050033557501
R-HSA-1643713,Signaling by EGFR in Cancer,3/1379,25/9872,0.12,0.8590572878897751,-0.28431043943047657,0.6988397469372299,0.9999999999999936,0.9278752436647114,UBC/RPS27A/AREG,3,1.6973168963016678,0.5118233426282183,5.628669907233527
R-HSA-400685,Sema4D in semaphorin signaling,3/1379,25/9872,0.12,0.8590572878897751,-0.28431043943047657,0.6988397469372299,0.9999999999999936,0.9278752436647114,LIMK2/RHOB/MET,3,1.6973168963016678,0.5118233426282183,5.628669907233527
R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,3/1379,25/9872,0.12,0.8590572878897751,-0.28431043943047657,0.6988397469372299,0.9999999999999936,0.9278752436647114,NEURL1B/UBC/RPS27A,3,1.6973168963016678,0.5118233426282183,5.628669907233527
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,17/1379,134/9872,0.12686567164179105,0.9082073317242648,-0.4310797828437899,0.7039186922624374,0.9999999999999936,0.9278752436647114,KIF19/DOCK1/KIF26B/IRF1/MAFF/CARMIL1/KIF21B/KIF25/CABLES1/TUBB4A/DOCK8/TUBA1A/SH2B3/MICAL1/ACTB/SH2B2/TUBA1B,17,1.7944270669855942,1.0801665398669522,2.9809926339017476
R-HSA-9009391,Extra-nuclear estrogen signaling,9/1379,73/9872,0.1232876712328767,0.8825931039963444,-0.4056918699801049,0.7078197954540957,0.9999999999999936,0.9278752436647114,FOS/GNB3/MMP2/GNB4/CCND1/IGF1R/GNG2/PIK3R3/AREG,9,1.743818729077056,0.870654410252275,3.4926645108233094
R-HSA-9818564,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,9/1379,73/9872,0.1232876712328767,0.8825931039963444,-0.4056918699801049,0.7078197954540957,0.9999999999999936,0.9278752436647114,ELOVL5/MGLL/ACSL1/CEBPA/PHLDA1/LPL/PPARGC1B/PPARG/ANGPTL4,9,1.743818729077056,0.870654410252275,3.4926645108233094
R-HSA-9841922,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,9/1379,73/9872,0.1232876712328767,0.8825931039963444,-0.4056918699801049,0.7078197954540957,0.9999999999999936,0.9278752436647114,ELOVL5/MGLL/ACSL1/CEBPA/PHLDA1/LPL/PPARGC1B/PPARG/ANGPTL4,9,1.743818729077056,0.870654410252275,3.4926645108233094
R-HSA-9851695,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,9/1379,73/9872,0.1232876712328767,0.8825931039963444,-0.4056918699801049,0.7078197954540957,0.9999999999999936,0.9278752436647114,ELOVL5/MGLL/ACSL1/CEBPA/PHLDA1/LPL/PPARGC1B/PPARG/ANGPTL4,9,1.743818729077056,0.870654410252275,3.4926645108233094
R-HSA-180292,GAB1 signalosome,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,PXN/AREG,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,GRIA1/GRIA4,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,ZFP36/EXOSC6,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-5654688,SHC-mediated cascade:FGFR1,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-5654689,PI-3K cascade:FGFR1,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-73929,"Base-Excision Repair, AP Site Formation",2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,NEIL2/MPG,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-74259,Purine catabolism,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,NT5E/NT5C1A,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-9933939,Formation of the polybromo-BAF (pBAF) complex,2/1379,17/9872,0.11764705882352941,0.8422130273429169,-0.2623610964020616,0.7089284948746033,0.9999999999999936,0.9278752436647114,ACTB/SMARCD2,2,1.6640361728447726,0.3840587901013314,7.209876341601999
R-HSA-1912422,Pre-NOTCH Expression and Processing,6/1379,50/9872,0.12,0.8590572878897751,-0.40258705708140924,0.7171426543566829,0.9999999999999936,0.9278752436647114,RUNX1/MAML3/ST3GAL6/ST3GAL4/CCND1/TFDP2,6,1.6973168963016678,0.7264922974486338,3.965471700923048
R-HSA-381070,IRE1alpha activates chaperones,6/1379,50/9872,0.12,0.8590572878897751,-0.40258705708140924,0.7171426543566829,0.9999999999999936,0.9278752436647114,SRPRB/LMNA/XBP1/GOSR2/EDEM1/PDIA5,6,1.6973168963016678,0.7264922974486338,3.965471700923048
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,7/1379,58/9872,0.1206896551724138,0.8639943987397165,-0.41858138601584544,0.7185412684646013,0.9999999999999936,0.9278752436647114,MAML3/NEURL1B/HES5/HDAC4/UBC/RPS27A/HES1,7,1.707071591107999,0.7777412974943206,3.746867276504981
R-HSA-2644603,Signaling by NOTCH1 in Cancer,7/1379,58/9872,0.1206896551724138,0.8639943987397165,-0.41858138601584544,0.7185412684646013,0.9999999999999936,0.9278752436647114,MAML3/NEURL1B/HES5/HDAC4/UBC/RPS27A/HES1,7,1.707071591107999,0.7777412974943206,3.746867276504981
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,7/1379,58/9872,0.1206896551724138,0.8639943987397165,-0.41858138601584544,0.7185412684646013,0.9999999999999936,0.9278752436647114,MAML3/NEURL1B/HES5/HDAC4/UBC/RPS27A/HES1,7,1.707071591107999,0.7777412974943206,3.746867276504981
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,7/1379,58/9872,0.1206896551724138,0.8639943987397165,-0.41858138601584544,0.7185412684646013,0.9999999999999936,0.9278752436647114,MAML3/NEURL1B/HES5/HDAC4/UBC/RPS27A/HES1,7,1.707071591107999,0.7777412974943206,3.746867276504981
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,7/1379,58/9872,0.1206896551724138,0.8639943987397165,-0.41858138601584544,0.7185412684646013,0.9999999999999936,0.9278752436647114,MAML3/NEURL1B/HES5/HDAC4/UBC/RPS27A/HES1,7,1.707071591107999,0.7777412974943206,3.746867276504981
R-HSA-1222556,ROS and RNS production in phagocytes,4/1379,34/9872,0.11764705882352941,0.8422130273429169,-0.3713550551089905,0.7187980857772192,0.9999999999999936,0.9278752436647114,SLC11A1/HVCN1/CYBB/NCF2,4,1.6640361728447726,0.5896436426674672,4.696084523203246
R-HSA-1912408,Pre-NOTCH Transcription and Translation,4/1379,34/9872,0.11764705882352941,0.8422130273429169,-0.3713550551089905,0.7187980857772192,0.9999999999999936,0.9278752436647114,RUNX1/MAML3/CCND1/TFDP2,4,1.6640361728447726,0.5896436426674672,4.696084523203246
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,4/1379,34/9872,0.11764705882352941,0.8422130273429169,-0.3713550551089905,0.7187980857772192,0.9999999999999936,0.9278752436647114,EDEM1/UBC/RPS27A/EDEM2,4,1.6640361728447726,0.5896436426674672,4.696084523203246
R-HSA-5655302,Signaling by FGFR1 in disease,4/1379,34/9872,0.11764705882352941,0.8422130273429169,-0.3713550551089905,0.7187980857772192,0.9999999999999936,0.9278752436647114,FGF20/STAT3/FGFR1OP2/STAT1,4,1.6640361728447726,0.5896436426674672,4.696084523203246
R-HSA-9705683,SARS-CoV-2-host interactions,23/1379,181/9872,0.1270718232044199,0.9096831317433164,-0.494146823137739,0.7210768725708437,0.9999999999999936,0.9278752436647114,TLR2/IFNAR2/GJA1/NLRP3/SEC24D/TLR7/IKBKE/NUP205/RPS3/RNF135/NUP188/RPS16/UBC/RPS3A/RPS6/RPS12/RPS27A/RPS9/STAT1/SFN/NOD2/RPSA/RPS14,23,1.7973429380726684,1.160681480844416,2.783228379494338
R-HSA-9711123,Cellular response to chemical stress,24/1379,189/9872,0.12698412698412698,0.9090553311002911,-0.5086690682318198,0.7254320086742836,0.9999999999999936,0.9278752436647114,STAT3/CDKN1A/ERO1A/PRKCD/NLRP3/BCL2L1/ABCG2/HMOX1/CCL2/CYBB/PDGFA/BACH1/HELZ2/EIF2AK3/NCF2/UBC/SLC7A11/RPS27A/GPX8/ME1/CDKN2A/FABP1/TXN/AREG,24,1.7961025357689608,1.1704585518886566,2.7561713430947474
R-HSA-4608870,Asymmetric localization of PCP proteins,6/1379,51/9872,0.11764705882352941,0.8422130273429169,-0.45520866807003674,0.7352268283386353,0.9999999999999936,0.9278752436647114,PRICKLE1/FZD5/UBC/WNT5A/RPS27A/FZD2,6,1.6640361728447723,0.7128802025164864,3.8842660727022214
R-HSA-5675221,Negative regulation of MAPK pathway,5/1379,43/9872,0.11627906976744186,0.8324198526063713,-0.4437458202124403,0.7365404562300912,0.9999999999999936,0.9278752436647114,DUSP1/MARK3/UBC/RPS27A/DUSP6,5,1.644686915020996,0.6504062988543947,4.158931199168542
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,5/1379,43/9872,0.11627906976744186,0.8324198526063713,-0.4437458202124403,0.7365404562300912,0.9999999999999936,0.9278752436647114,BARD1/EYA2/KDM4B/UBC/RPS27A,5,1.644686915020996,0.6504062988543947,4.158931199168542
R-HSA-1912420,Pre-NOTCH Processing in Golgi,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,ST3GAL6/ST3GAL4,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-5654695,PI-3K cascade:FGFR2,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-5654699,SHC-mediated cascade:FGFR2,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-5655332,Signaling by FGFR3 in disease,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,FGF20/FGFR3,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-933541,TRAF6 mediated IRF7 activation,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,IKBKE/RNF135,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-9824594,Regulation of MITF-M-dependent genes involved in apoptosis,2/1379,18/9872,0.1111111111111111,0.7954234147127548,-0.35004029875975123,0.738819642225585,0.9999999999999936,0.9278752436647114,TRPM1/BCL2A1,2,1.5715897187978407,0.3642806903683465,6.780195353570937
R-HSA-1483255,PI Metabolism,10/1379,83/9872,0.12048192771084337,0.8625073171584088,-0.506852525968216,0.7402583564650185,0.9999999999999936,0.9278752436647114,PIP4K2A/PTPN13/INPP5D/PIP5K1B/PIK3R5/PIK3CG/TPTE2/PIK3R3/PLEKHA6/PIK3CD,10,1.704133430021755,0.882236551295977,3.291714385503214
R-HSA-186712,Regulation of beta-cell development,4/1379,35/9872,0.11428571428571428,0.818149797990262,-0.4342587933797949,0.7402997319050864,0.9999999999999936,0.9278752436647114,MAML3/HNF4G/PAX6/HES1,4,1.6164922821920646,0.5736892032309105,4.554813448937709
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,4/1379,35/9872,0.11428571428571428,0.818149797990262,-0.4342587933797949,0.7402997319050864,0.9999999999999936,0.9278752436647114,CDKN1A/CCND3/CCND1/TFDP2,4,1.6164922821920646,0.5736892032309105,4.554813448937709
R-HSA-420092,Glucagon-type ligand receptors,3/1379,27/9872,0.1111111111111111,0.7954234147127548,-0.4289059727810089,0.748509777127802,0.9999999999999936,0.9278752436647114,GNB3/GNB4/GNG2,3,1.5715897187978405,0.47617017190370364,5.186999081350614
R-HSA-5654733,Negative regulation of FGFR4 signaling,3/1379,27/9872,0.1111111111111111,0.7954234147127548,-0.4289059727810089,0.748509777127802,0.9999999999999936,0.9278752436647114,FGF20/UBC/RPS27A,3,1.5715897187978405,0.47617017190370364,5.186999081350614
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,8/1379,68/9872,0.11764705882352941,0.8422130273429169,-0.5260852140136373,0.7516248563020199,0.9999999999999936,0.9278752436647114,HSPA12A/HSPA6/NUP205/NUP188/HSPH1/HSPA1A/HSPA1B/DNAJB1,8,1.6640361728447726,0.7982120901365467,3.4690233570155447
R-HSA-445355,Smooth Muscle Contraction,5/1379,44/9872,0.11363636363636363,0.8135012195925901,-0.4995763923568643,0.7551315807455269,0.9999999999999936,0.9278752436647114,GUCY1A1/PXN/TPM4/ACTA2/MYLK,5,1.607307666952337,0.6363207144293307,4.0599620249054125
R-HSA-5693606,DNA Double Strand Break Response,5/1379,44/9872,0.11363636363636363,0.8135012195925901,-0.4995763923568643,0.7551315807455269,0.9999999999999936,0.9278752436647114,BARD1/EYA2/KDM4B/UBC/RPS27A,5,1.607307666952337,0.6363207144293307,4.0599620249054125
R-HSA-75153,Apoptotic execution phase,5/1379,44/9872,0.11363636363636363,0.8135012195925901,-0.4995763923568643,0.7551315807455269,0.9999999999999936,0.9278752436647114,LMNA/PRKCD/LMNB1/HMGB2/CASP8,5,1.607307666952337,0.6363207144293307,4.0599620249054125
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,13/1379,108/9872,0.12037037037037036,0.8617086992721511,-0.5822707858153393,0.7598350685096052,0.9999999999999936,0.9278752436647114,TLR2/IFNAR2/NLRP3/SEC24D/TLR7/IKBKE/NUP205/RNF135/NUP188/UBC/RPS27A/STAT1/NOD2,13,1.7025555286976606,0.9551856499740569,3.0346931283753062
R-HSA-195258,RHO GTPase Effectors,33/1379,261/9872,0.12643678160919541,0.9051369891558936,-0.6258424488570129,0.7599740777620199,0.9999999999999936,0.9278752436647114,CTNNA1/WIPF3/CYFIP1/PRKCD/NCKAP1L/CENPP/RTKN/IQGAP1/RHOQ/CTTN/S100A9/CYBB/SRGAP2/RCC2/S100A8/LIMK2/AR/TUBB4A/DIAPH2/TUBA1A/FLNA/NCF2/BTK/ACTG1/IQGAP2/RHOB/TAX1BP3/ACTB/SFN/MYLK/NCKIPSD/DIAPH3/TUBA1B,33,1.7883607144940945,1.2399661874746601,2.5792913366931525
R-HSA-111465,Apoptotic cleavage of cellular proteins,4/1379,36/9872,0.1111111111111111,0.7954234147127548,-0.49548448790321015,0.7605299295443899,0.9999999999999936,0.9278752436647114,LMNA/PRKCD/LMNB1/CASP8,4,1.5715897187978407,0.5585753577149609,4.421774448366293
R-HSA-5654741,Signaling by FGFR3,4/1379,36/9872,0.1111111111111111,0.7954234147127548,-0.49548448790321015,0.7605299295443899,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/UBC/RPS27A,4,1.5715897187978407,0.5585753577149609,4.421774448366293
R-HSA-110320,Translesion Synthesis by POLH,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-163615,PKA activation,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,ADCY3/ADCY7,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-166663,Initial triggering of complement,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,C3/CFB,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,LMNA/LMNB1,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-5576886,Phase 4 - resting membrane potential,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,KCNK10/KCNK2,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-5654693,FRS-mediated FGFR1 signaling,2/1379,19/9872,0.10526315789473684,0.7535590244647151,-0.433249056248532,0.7660463916477183,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.4888744704400596,0.34643815640671605,6.398680825808696
R-HSA-177929,Signaling by EGFR,6/1379,53/9872,0.11320754716981132,0.8104314036695993,-0.5575744262036414,0.7688873260247995,0.9999999999999936,0.9278752436647114,PXN/ADAM12/SPRY1/UBC/RPS27A/AREG,6,1.6012423550015735,0.6871312831499249,3.7314224258533026
R-HSA-162588,Budding and maturation of HIV virion,3/1379,28/9872,0.10714285714285714,0.7670154356158706,-0.4974535212646135,0.7707699091785103,0.9999999999999936,0.9278752436647114,UBC/CHMP4C/RPS27A,3,1.5154615145550605,0.4601430191769124,4.991108212845731
R-HSA-196071,Metabolism of steroid hormones,3/1379,28/9872,0.10714285714285714,0.7670154356158706,-0.4974535212646135,0.7707699091785103,0.9999999999999936,0.9278752436647114,STS/TSPOAP1/HSD17B1,3,1.5154615145550605,0.4601430191769124,4.991108212845731
R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,3/1379,28/9872,0.10714285714285714,0.7670154356158706,-0.4974535212646135,0.7707699091785103,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/ACTB,3,1.5154615145550605,0.4601430191769124,4.991108212845731
R-HSA-9619483,Activation of AMPK downstream of NMDARs,3/1379,28/9872,0.10714285714285714,0.7670154356158706,-0.4974535212646135,0.7707699091785103,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/TUBA1B,3,1.5154615145550605,0.4601430191769124,4.991108212845731
R-HSA-9749641,Aspirin ADME,3/1379,28/9872,0.10714285714285714,0.7670154356158706,-0.4974535212646135,0.7707699091785103,0.9999999999999936,0.9278752436647114,ACSM5/SLCO2B1/CYP2E1,3,1.5154615145550605,0.4601430191769124,4.991108212845731
R-HSA-2428928,IRS-related events triggered by IGF1R,5/1379,45/9872,0.1111111111111111,0.7954234147127548,-0.5542221147103948,0.7727227796994185,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/IGF1/FGF22/IGF1R,5,1.5715897187978407,0.6228323444756463,3.9655844243452782
R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,MPG,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-110331,Cleavage of the damaged purine,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,MPG,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-1250342,PI3K events in ERBB4 signaling,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,NRG3,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-1433617,Regulation of signaling by NODAL,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,LEFTY1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-164940,Nef mediated downregulation of MHC class I complex cell surface expression,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,AP1B1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-1855167,Synthesis of pyrophosphates in the cytosol,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,IP6K3,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-190322,FGFR4 ligand binding and activation,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,FGF20,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-2453864,Retinoid cycle disease events,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,RLBP1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-2474795,Diseases associated with visual transduction,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,RLBP1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,XBP1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-390450,Folding of actin by CCT/TriC,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,ACTB,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-390666,Serotonin receptors,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,HTR2C,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-418889,Caspase activation via Dependence Receptors in the absence of ligand,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,DAPK1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-432047,Passive transport by Aquaporins,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,AQP11,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-450341,Activation of the AP-1 family of transcription factors,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,FOS,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-73927,Depurination,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,MPG,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-8875656,MET receptor recycling,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,MET,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-8963691,Phenylalanine and tyrosine metabolism,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,PAH,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,TXN,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-9675143,Diseases of the neuronal system,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,RLBP1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-9706019,RHOBTB3 ATPase cycle,1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,PLIN3,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-9821002,Chromatin modifications during the maternal to zygotic transition (MZT),1/1379,10/9872,0.1,0.7158810732414793,-0.36220114041404483,0.7780587055940538,0.9999999999999936,0.9278752436647114,UHRF1,1,1.4144307469180566,0.18092665402318758,11.057598719372615
R-HSA-4086400,PCP/CE pathway,9/1379,78/9872,0.11538461538461539,0.8260166229709377,-0.6215944881175449,0.7795057861603609,0.9999999999999936,0.9278752436647114,PRICKLE1/FZD5/WNT11/UBC/WNT5A/ROR1/ARRB2/RPS27A/FZD2,9,1.6320354772131422,0.8168278222330736,3.2608338335007336
R-HSA-8964043,Plasma lipoprotein clearance,4/1379,37/9872,0.10810810810810811,0.7739254845853831,-0.5551334993987072,0.7795141103524952,0.9999999999999936,0.9278752436647114,UBC/CUBN/RPS27A/NCEH1,4,1.5291143209924936,0.5442373833091071,4.296269749879213
R-HSA-9675126,Diseases of mitotic cell cycle,4/1379,37/9872,0.10810810810810811,0.7739254845853831,-0.5551334993987072,0.7795141103524952,0.9999999999999936,0.9278752436647114,CDKN1A/CCND3/CCND1/TFDP2,4,1.5291143209924936,0.5442373833091071,4.296269749879213
R-HSA-9772572,Early SARS-CoV-2 Infection Events,4/1379,37/9872,0.10810810810810811,0.7739254845853831,-0.5551334993987072,0.7795141103524952,0.9999999999999936,0.9278752436647114,GPC5/GPC6/CHMP4C/GPC2,4,1.5291143209924936,0.5442373833091071,4.296269749879213
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),6/1379,54/9872,0.1111111111111111,0.7954234147127548,-0.6073981128927505,0.7844765377882317,0.9999999999999936,0.9278752436647114,SEC24D/MVK/TM7SF2/DHCR7/HELZ2/SQLE,6,1.5715897187978405,0.674942099725959,3.6594164821455135
R-HSA-2428924,IGF1R signaling cascade,5/1379,46/9872,0.10869565217391304,0.778131601349434,-0.6077404341667635,0.7893306525188928,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/IGF1/FGF22/IGF1R,5,1.537424724910931,0.6099039929104755,3.875486654035405
R-HSA-167044,Signalling to RAS,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,RALGDS/SHC3,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-2028269,Signaling by Hippo,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,STK3/WWTR1,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-5627117,RHO GTPases Activate ROCKs,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,LIMK2/RHOB,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-5654700,FRS-mediated FGFR2 signaling,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,LMNA/LMNB1,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-8863678,Neurodegenerative Diseases,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,LMNA/LMNB1,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-9629569,Protein hydroxylation,2/1379,20/9872,0.1,0.7158810732414793,-0.51248966147206,0.7907692884187982,0.9999999999999936,0.9278752436647114,RPS6/RPL8,2,1.4144307469180566,0.33026054938960336,6.057684884024936
R-HSA-3214858,RMTs methylate histone arginines,3/1379,29/9872,0.10344827586206896,0.7405666274911855,-0.5637586840034406,0.7913914762000119,0.9999999999999936,0.9278752436647114,CCND1/ACTL6B/SMARCD2,3,1.4632042209497136,0.44515933986821415,4.809438779469109
R-HSA-8963899,Plasma lipoprotein remodeling,3/1379,29/9872,0.10344827586206896,0.7405666274911855,-0.5637586840034406,0.7913914762000119,0.9999999999999936,0.9278752436647114,LPL/LIPG/ANGPTL4,3,1.4632042209497136,0.44515933986821415,4.809438779469109
R-HSA-1169408,ISG15 antiviral mechanism,8/1379,71/9872,0.11267605633802817,0.8066265613988499,-0.6589052179036277,0.793390781860519,0.9999999999999936,0.9278752436647114,UBA7/PPM1B/NUP205/NUP188/UBC/RPS27A/STAT1/EIF4A1,8,1.593724785259782,0.7657292541864509,3.3170453881247064
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,8/1379,71/9872,0.11267605633802817,0.8066265613988499,-0.6589052179036277,0.793390781860519,0.9999999999999936,0.9278752436647114,TBC1D4/RHOQ/TUBB4A/TUBA1A/ACTG1/ACTB/SFN/TUBA1B,8,1.593724785259782,0.7657292541864509,3.3170453881247064
R-HSA-5689603,UCH proteinases,8/1379,71/9872,0.11267605633802817,0.8066265613988499,-0.6589052179036277,0.793390781860519,0.9999999999999936,0.9278752436647114,SMAD7/TGFBR1/BARD1/TGFBR2/UBC/RPS27A/ACTB/INO80C,8,1.593724785259782,0.7657292541864509,3.3170453881247064
R-HSA-5696394,DNA Damage Recognition in GG-NER,4/1379,38/9872,0.10526315789473684,0.7535590244647151,-0.6132983024552677,0.7972850612677529,0.9999999999999936,0.9278752436647114,UBC/RPS27A/ACTB/INO80C,4,1.4888744704400596,0.5306170348981916,4.177678142492147
R-HSA-8853884,Transcriptional Regulation by VENTX,4/1379,38/9872,0.10526315789473684,0.7535590244647151,-0.6132983024552677,0.7972850612677529,0.9999999999999936,0.9278752436647114,CSF1R/CCND1/TCF7L2/CDKN2A,4,1.4888744704400596,0.5306170348981916,4.177678142492147
R-HSA-381753,Olfactory Signaling Pathway,10/1379,88/9872,0.11363636363636363,0.8135012195925901,-0.7080945588427748,0.8033518287417754,0.9999999999999936,0.9278752436647114,ANO2/ADCY3/OR2A5/LHX2/EBF1/OR2T6/OR2L2/OR2L3/OR2K2/OR5V1,10,1.607307666952337,0.8337756031648624,3.0984810858431193
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),5/1379,47/9872,0.10638297872340426,0.7615756098313611,-0.6601847330484004,0.804976722927888,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/IGF1/FGF22/IGF1R,5,1.504713560551124,0.597501489872865,3.7893845248623643
R-HSA-2995410,Nuclear Envelope (NE) Reassembly,8/1379,72/9872,0.1111111111111111,0.7954234147127548,-0.7020067412862578,0.8060850442359442,0.9999999999999936,0.9278752436647114,LMNA/NUP205/LMNB1/TUBB4A/NUP188/TUBA1A/CHMP4C/TUBA1B,8,1.5715897187978407,0.755481429132484,3.2692984221561145
R-HSA-5632684,Hedgehog 'on' state,8/1379,72/9872,0.1111111111111111,0.7954234147127548,-0.7020067412862578,0.8060850442359442,0.9999999999999936,0.9278752436647114,DHH/GLI3/CDON/UBC/ARRB2/SMO/RPS27A/GPR161,8,1.5715897187978407,0.755481429132484,3.2692984221561145
R-HSA-1236977,Endosomal/Vacuolar pathway,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,CTSS,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-156588,Glucuronidation,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,SLC35D2,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-190373,FGFR1c ligand binding and activation,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,FGF20,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-193692,Regulated proteolysis of p75NTR,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,NGFR,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-211999,CYP2E1 reactions,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,CYP2E1,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,FGF20,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-73614,Pyrimidine salvage,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,TYMP,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-8851680,Butyrophilin (BTN) family interactions,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,BTN3A1,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,TFAP2E,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-8875555,MET activates RAP1 and RAC1,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,MET,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,SFN,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,ERBIN,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9683610,Maturation of nucleoprotein,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,PARP9,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9755088,Ribavirin ADME,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,SLC29A3,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9796292,Formation of axial mesoderm,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,TEAD4,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9819196,Zygotic genome activation (ZGA),1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,TEAD4,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-9845614,Sphingolipid catabolism,1/1379,11/9872,0.09090909090909091,0.6508009756740721,-0.46691844637257507,0.8090926789245954,0.9999999999999936,0.9278752436647114,ALDH3A2,1,1.2858461335618696,0.1658843130898626,9.96718887035649
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,3/1379,30/9872,0.1,0.7158810732414793,-0.627987876303711,0.8104442395142699,0.9999999999999936,0.9278752436647114,FZD5/WNT8B/FZD2,3,1.4144307469180564,0.431120470598243,4.640499522212491
R-HSA-111931,PKA-mediated phosphorylation of CREB,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,ADCY3/ADCY7,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,AP1B1/CD4,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-211981,Xenobiotics,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,AHR/CYP2E1,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-389513,Co-inhibition by CTLA4,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,CD86/CTLA4,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,LIMK2/RHOB,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-445144,Signal transduction by L1,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,L1CAM/ITGB3,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-5654708,Downstream signaling of activated FGFR3,2/1379,21/9872,0.09523809523809523,0.6817914983252183,-0.5881842803291331,0.8131560386522424,0.9999999999999936,0.9278752436647114,FGF20/FGFR3,2,1.3470769018267206,0.3155253966252469,5.751093886082065
R-HSA-447115,Interleukin-12 family signaling,6/1379,56/9872,0.10714285714285714,0.7670154356158706,-0.7045081716428562,0.813235671910066,0.9999999999999936,0.9278752436647114,STAT3/IL27/HNRNPF/LMNB1/IL12B/STAT1,6,1.5154615145550605,0.6518168491239464,3.523418587881276
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,17/1379,145/9872,0.11724137931034483,0.8393088444900103,-0.7854502167839008,0.8163797842318257,0.9999999999999936,0.9278752436647114,STAT3/PTPN2/UBA7/OAS1/PPM1B/NUP205/TUBB4A/NUP188/TUBA1A/FLNA/UBC/RPS27A/STAT1/HSPA1A/HSPA1B/EIF4A1/TUBA1B,17,1.658298117076342,1.0003683238031833,2.7489401450100077
R-HSA-9833482,PKR-mediated signaling,8/1379,73/9872,0.1095890410958904,0.7845272035523061,-0.7445521915338401,0.8181792287014026,0.9999999999999936,0.9278752436647114,STAT3/PTPN2/TUBB4A/TUBA1A/STAT1/HSPA1A/HSPA1B/TUBA1B,8,1.5500610925129388,0.7455043455694563,3.2229046078693235
R-HSA-446203,Asparagine N-linked glycosylation,37/1379,300/9872,0.12333333333333334,0.8829199903311579,-0.8298014301928016,0.8190012013250721,0.9999999999999936,0.9278752436647114,MGAT4C/CD55/ST6GAL2/TMED10/CD59/ST6GALNAC3/SEC24D/COPA/GOSR2/SERPINA1/ST6GAL1/PGM3/ST8SIA4/ST3GAL6/NEU4/B4GALT5/ST3GAL4/TUBB4A/TUBA1A/ST8SIA3/EDEM1/UBC/GFPT2/NUDT14/ANK1/FUT3/RPS27A/TUSC3/GRIA1/HK1/EDEM2/ST8SIA6/BET1L/NEU3/UAP1/AREG/TUBA1B,37,1.744464587865603,1.234410489316919,2.4652712567284554
R-HSA-73893,DNA Damage Bypass,5/1379,48/9872,0.10416666666666667,0.7457094512932078,-0.7116046997796941,0.8196866400312475,0.9999999999999936,0.9278752436647114,UBA7/USP43/MAD2L2/UBC/RPS27A,5,1.4733653613729758,0.5855933900876358,3.7070184275284466
R-HSA-1226099,Signaling by FGFR in disease,6/1379,57/9872,0.10526315789473684,0.7535590244647151,-0.7518606263155786,0.8264407408151755,0.9999999999999936,0.9278752436647114,FGF20/STAT3/FGFR3/FGFR1OP2/FGF22/STAT1,6,1.4888744704400594,0.6408385567140026,3.459135168293988
R-HSA-211897,Cytochrome P450 - arranged by substrate type,6/1379,57/9872,0.10526315789473684,0.7535590244647151,-0.7518606263155786,0.8264407408151755,0.9999999999999936,0.9278752436647114,AHR/TBXAS1/CYP26C1/CYP8B1/CYP2E1/CYP4F3,6,1.4888744704400594,0.6408385567140026,3.459135168293988
R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),3/1379,31/9872,0.0967741935483871,0.69278813539498,-0.6902896508156382,0.8280038993778112,0.9999999999999936,0.9278752436647114,UBC/CHMP4C/RPS27A,3,1.3688039486303774,0.41793980270525044,4.483000273385005
R-HSA-948021,Transport to the Golgi and subsequent modification,21/1379,178/9872,0.11797752808988764,0.8445787942736553,-0.8431423700768678,0.8290928309533423,0.9999999999999936,0.9278752436647114,MGAT4C/CD55/TMED10/CD59/SEC24D/COPA/GOSR2/SERPINA1/ST6GAL1/B4GALT5/ST3GAL4/TUBB4A/TUBA1A/ST8SIA3/ANK1/FUT3/GRIA1/ST8SIA6/BET1L/AREG/TUBA1B,21,1.6687104317572576,1.0581599898918306,2.6315439363192574
R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),4/1379,40/9872,0.1,0.7158810732414793,-0.7255066093529934,0.8293468207557162,0.9999999999999936,0.9278752436647114,MRC2/MRC1/FCGR1A/PSMB9,4,1.4144307469180566,0.5053239939625845,3.9590725192742418
R-HSA-1250196,SHC1 events in ERBB2 signaling,2/1379,22/9872,0.09090909090909091,0.6508009756740721,-0.6606910044396855,0.8333763805010006,0.9999999999999936,0.9278752436647114,PRKCD/NRG3,2,1.2858461335618696,0.3020481418231066,5.4739627571167695
R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,2/1379,22/9872,0.09090909090909091,0.6508009756740721,-0.6606910044396855,0.8333763805010006,0.9999999999999936,0.9278752436647114,AKR1C3/CYP8B1,2,1.2858461335618696,0.3020481418231066,5.4739627571167695
R-HSA-8956321,Nucleotide salvage,2/1379,22/9872,0.09090909090909091,0.6508009756740721,-0.6606910044396855,0.8333763805010006,0.9999999999999936,0.9278752436647114,TYMP/HPRT1,2,1.2858461335618696,0.3020481418231066,5.4739627571167695
R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,2/1379,22/9872,0.09090909090909091,0.6508009756740721,-0.6606910044396855,0.8333763805010006,0.9999999999999936,0.9278752436647114,ERBIN/NRG3,2,1.2858461335618696,0.3020481418231066,5.4739627571167695
R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,5/1379,49/9872,0.10204081632653061,0.730490891062734,-0.7620466586281259,0.8334894383200451,0.9999999999999936,0.9278752436647114,PLA2G4A/PAFAH1B3/TUBB4A/TUBA1A/TUBA1B,5,1.4432966805286294,0.5741507066029842,3.6281507347606445
R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,5/1379,49/9872,0.10204081632653061,0.730490891062734,-0.7620466586281259,0.8334894383200451,0.9999999999999936,0.9278752436647114,EDNRB/MARK3/CSF1/KIT/EDN3,5,1.4432966805286294,0.5741507066029842,3.6281507347606445
R-HSA-1474151,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,GCH1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-1475029,Reversible hydration of carbon dioxide,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,CA9,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-196108,Pregnenolone biosynthesis,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,TSPOAP1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-196791,Vitamin D (calciferol) metabolism,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,CUBN,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-211935,Fatty acids,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,CYP4F3,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,CASP8,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-3371511,HSF1 activation,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,EEF1A1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,XBP1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-389359,CD28 dependent Vav1 pathway,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,CD86,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-74217,Purine salvage,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,HPRT1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,SLC29A3,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-8956320,Nucleotide biosynthesis,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,IMPDH1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9664420,Killing mechanisms,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,WNT5A,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9673324,WNT5:FZD7-mediated leishmania damping,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,WNT5A,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,SFN,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9820865,Z-decay: degradation of maternal mRNAs by zygotically expressed factors,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,EIF4A1,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9823730,Formation of definitive endoderm,1/1379,12/9872,0.08333333333333333,0.5965675610345661,-0.5634496693087295,0.8357898897311041,0.9999999999999936,0.9278752436647114,TCF7L2,1,1.1786922890983806,0.15314685114000381,9.071786341267282
R-HSA-9707564,Cytoprotection by HMOX1,6/1379,58/9872,0.10344827586206896,0.7405666274911855,-0.7984522669450995,0.8388906799325496,0.9999999999999936,0.9278752436647114,STAT3/NLRP3/HMOX1/BACH1/HELZ2/FABP1,6,1.4632042209497136,0.6302240018003128,3.3971517842689627
R-HSA-9824585,Regulation of MITF-M-dependent genes involved in pigmentation,4/1379,41/9872,0.0975609756097561,0.6984205592599798,-0.7796989669538602,0.8437279012280839,0.9999999999999936,0.9278752436647114,SS18L1/DPF1/ACTB/SMARCD2,4,1.3799324360176162,0.4935606315892481,3.8581146997928313
R-HSA-5205685,PINK1-PRKN Mediated Mitophagy,3/1379,32/9872,0.09375,0.6711385061638869,-0.7507971444307124,0.8441499952087339,0.9999999999999936,0.9278752436647114,UBC/RPS27A/TOMM40,3,1.326028825235678,0.4055409963349269,4.335819217408368
R-HSA-1227986,Signaling by ERBB2,5/1379,50/9872,0.1,0.7158810732414793,-0.811553863781108,0.8464168587604186,0.9999999999999936,0.9278752436647114,ERBIN/PRKCD/UBC/NRG3/RPS27A,5,1.4144307469180568,0.5631466751548391,3.5525635257938735
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,5/1379,50/9872,0.1,0.7158810732414793,-0.811553863781108,0.8464168587604186,0.9999999999999936,0.9278752436647114,CDKN1A/CCND1/UBC/RPS27A/CCNA2,5,1.4144307469180568,0.5631466751548391,3.5525635257938735
R-HSA-5607764,CLEC7A (Dectin-1) signaling,9/1379,84/9872,0.10714285714285714,0.7670154356158706,-0.864076032446313,0.8475755086164036,0.9999999999999936,0.9278752436647114,IL1B/PRKCD/NFKBIA/SYK/CARD9/UBC/RPS27A/CASP8/ITPR1,9,1.5154615145550605,0.7604165236141981,3.020217907919534
R-HSA-8878171,Transcriptional regulation by RUNX1,18/1379,157/9872,0.11464968152866242,0.8207553705953267,-0.9122349828630557,0.848756527474478,0.9999999999999936,0.9278752436647114,SOCS3/RUNX1/PHC2/ELF2/LIFR/CCND3/NR4A3/LMO1/CTLA4/TAL1/CCND1/UBC/CR1/ACTL6B/RPS27A/CBX2/SMARCD2/GP1BA,18,1.621640346785033,0.9926762378399206,2.649118931307744
R-HSA-112409,RAF-independent MAPK1/3 activation,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,DUSP1/DUSP6,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-3214842,HDMs demethylate histones,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,KDM3A/KDM4B,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-373753,Nephrin family interactions,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,NCK2/IQGAP1,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-9013418,RHOBTB2 GTPase cycle,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,RHOBTB2/ACTG1,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-9820841,M-decay: degradation of maternal mRNAs by maternally stored factors,2/1379,23/9872,0.08695652173913043,0.6225052810795473,-0.7303161028877815,0.8515982467937714,0.9999999999999936,0.9278752436647114,ZFP36L2/EIF4A1,2,1.2299397799287448,0.28967440364961594,5.222248991253513
R-HSA-194068,Bile acid and bile salt metabolism,4/1379,42/9872,0.09523809523809523,0.6817914983252183,-0.8327062262162968,0.8570741450525277,0.9999999999999936,0.9278752436647114,OSBPL3/OSBPL6/AKR1C3/CYP8B1,4,1.3470769018267206,0.4823324691867807,3.762168826192739
R-HSA-9839373,Signaling by TGFBR3,4/1379,42/9872,0.09523809523809523,0.6817914983252183,-0.8327062262162968,0.8570741450525277,0.9999999999999936,0.9278752436647114,TGFBR1/RARA/TGFBR2/ARRB2,4,1.3470769018267206,0.4823324691867807,3.762168826192739
R-HSA-113501,Inhibition of replication initiation of damaged DNA by RB1/E2F1,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,TFDP2,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,SLC25A37,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-1461957,Beta defensins,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,TLR2,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-1483213,Synthesis of PE,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,ETNPPL,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-162594,Early Phase of HIV Life Cycle,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,CD4,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-171007,p38MAPK events,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,RALGDS,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-174430,Telomere C-strand synthesis initiation,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,STN1,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-179812,GRB2 events in EGFR signaling,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,AREG,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,CDKN1A,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-2168880,Scavenging of heme from plasma,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,CD163,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-429958,mRNA decay by 3' to 5' exoribonuclease,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,EXOSC6,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,ITPR1,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-71336,Pentose phosphate pathway,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,PGM2,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,NRG3,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-9679504,Translation of Replicase and Assembly of the Replication Transcription Complex,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,CHMP4C,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-9710421,Defective pyroptosis,1/1379,13/9872,0.07692307692307693,0.5506777486472919,-0.6531987066005491,0.8587559893315917,0.9999999999999936,0.9278752436647114,GSDME,1,1.0880236514754282,0.14222309950791123,8.323510528640076
R-HSA-4791275,Signaling by WNT in cancer,3/1379,33/9872,0.09090909090909091,0.6508009756740721,-0.8096301232809944,0.8589641475244986,0.9999999999999936,0.9278752436647114,FZD5/TCF7L2/RNF43,3,1.2858461335618696,0.39385650278888473,4.197976337799014
R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,3/1379,33/9872,0.09090909090909091,0.6508009756740721,-0.8096301232809944,0.8589641475244986,0.9999999999999936,0.9278752436647114,RUNX1/NR4A3/GP1BA,3,1.2858461335618696,0.39385650278888473,4.197976337799014
R-HSA-9022692,Regulation of MECP2 expression and activity,3/1379,33/9872,0.09090909090909091,0.6508009756740721,-0.8096301232809944,0.8589641475244986,0.9999999999999936,0.9278752436647114,CAMK2G/CAMK4/CAMK2D,3,1.2858461335618696,0.39385650278888473,4.197976337799014
R-HSA-8943724,Regulation of PTEN gene transcription,6/1379,60/9872,0.1,0.7158810732414793,-0.8894656234736216,0.8616210470514242,0.9999999999999936,0.9278752436647114,PHC2/EGR1/GATAD2A/NR2E1/PPARG/CBX2,6,1.4144307469180564,0.610016104930191,3.2796090491022647
R-HSA-5619115,Disorders of transmembrane transporters,17/1379,151/9872,0.11258278145695365,0.8059588241791489,-0.9681865534881586,0.862860884590696,0.9999999999999936,0.9278752436647114,SLC29A3/SLC40A1/SLC11A2/NUP205/SLC4A4/DERL3/NUP188/HEPH/ABCD4/UBC/SLC3A2/RPS27A/SLC6A20/HK1/SLC2A1/CP/SLC17A8,17,1.5924054766627127,0.961620567702058,2.636960239073279
R-HSA-204005,COPII-mediated vesicle transport,7/1379,69/9872,0.10144927536231885,0.7262561612594718,-0.9194360844042564,0.8656282328080613,0.9999999999999936,0.9278752436647114,TMED10/CD59/SEC24D/GOSR2/SERPINA1/GRIA1/AREG,7,1.4349297432502022,0.6581778483845806,3.128369289725748
R-HSA-211976,Endogenous sterols,2/1379,24/9872,0.08333333333333333,0.5965675610345661,-0.7973234984767416,0.8679849587735022,0.9999999999999936,0.9278752436647114,AHR/CYP8B1,2,1.1786922890983806,0.2782740551233883,4.9926160445103305
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,2/1379,24/9872,0.08333333333333333,0.5965675610345661,-0.7973234984767416,0.8679849587735022,0.9999999999999936,0.9278752436647114,CDKN1A/NR4A1,2,1.1786922890983806,0.2782740551233883,4.9926160445103305
R-HSA-9933387,"RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression",2/1379,24/9872,0.08333333333333333,0.5965675610345661,-0.7973234984767416,0.8679849587735022,0.9999999999999936,0.9278752436647114,HELZ2/RORA,2,1.1786922890983806,0.2782740551233883,4.9926160445103305
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,4/1379,43/9872,0.09302325581395349,0.6659358820850971,-0.8845890059966015,0.8694365746753416,0.9999999999999936,0.9278752436647114,UBC/RPS27A/HSPA1A/HSPA1B,4,1.315749532016797,0.47160379560827037,3.670871284590782
R-HSA-6807878,COPI-mediated anterograde transport,10/1379,95/9872,0.10526315789473684,0.7535590244647151,-0.9725323608836633,0.8715387994001766,0.9999999999999936,0.9278752436647114,CD55/TMED10/CD59/COPA/GOSR2/TUBB4A/TUBA1A/ANK1/BET1L/TUBA1B,10,1.4888744704400598,0.7742379241393526,2.863134341026136
R-HSA-1234174,Cellular response to hypoxia,6/1379,61/9872,0.09836065573770492,0.7041453179424387,-0.9339397783416932,0.8719531352800213,0.9999999999999936,0.9278752436647114,VEGFA/HIF1A/LIMD1/UBC/CA9/RPS27A,6,1.391243357624318,0.6003905257142157,3.2238318181841303
R-HSA-5625740,RHO GTPases activate PKNs,3/1379,34/9872,0.08823529411764706,0.6316597705071877,-0.8668967020454538,0.872528605112945,0.9999999999999936,0.9278752436647114,AR/RHOB/SFN,3,1.2480271296335792,0.38282633481358685,4.068611729806606
R-HSA-1250347,SHC1 events in ERBB4 signaling,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,NRG3,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-180336,SHC1 events in EGFR signaling,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,AREG,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-8964539,Glutamate and glutamine metabolism,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,GLUL,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,CAMK4,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-9005895,Pervasive developmental disorders,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,CAMK4,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-9675151,Disorders of Developmental Biology,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,CAMK4,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-9694676,Translation of Replicase and Assembly of the Replication Transcription Complex,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,CHMP4C,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-9697154,Disorders of Nervous System Development,1/1379,14/9872,0.07142857142857142,0.5113436237439137,-0.7372339525371792,0.8785120995569426,0.9999999999999936,0.9278752436647114,CAMK4,1,1.0103076763700405,0.13275196730411132,7.688937660667108
R-HSA-5621481,C-type lectin receptors (CLRs),13/1379,121/9872,0.10743801652892562,0.7691284257966307,-1.0296051782894007,0.8801108560042764,0.9999999999999936,0.9278752436647114,IL1B/PRKCD/NFKBIA/SYK/MUC20/MUC4/CARD9/MUC15/UBC/FCER1G/RPS27A/CASP8/ITPR1,13,1.5196363396640276,0.8553937731787804,2.6996860127304583
R-HSA-4551638,SUMOylation of chromatin organization proteins,5/1379,53/9872,0.09433962264150944,0.6753595030579994,-0.9548587809840345,0.8802923262468825,0.9999999999999936,0.9278752436647114,PHC2/NUP205/HDAC4/NUP188/CBX2,5,1.334368629167978,0.5325279599928614,3.3435608498969653
R-HSA-69563,p53-Dependent G1 DNA Damage Response,5/1379,53/9872,0.09433962264150944,0.6753595030579994,-0.9548587809840345,0.8802923262468825,0.9999999999999936,0.9278752436647114,CDKN1A/UBC/RPS27A/CDKN2A/CCNA2,5,1.334368629167978,0.5325279599928614,3.3435608498969653
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,5/1379,53/9872,0.09433962264150944,0.6753595030579994,-0.9548587809840345,0.8802923262468825,0.9999999999999936,0.9278752436647114,CDKN1A/UBC/RPS27A/CDKN2A/CCNA2,5,1.334368629167978,0.5325279599928614,3.3435608498969653
R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,2/1379,25/9872,0.08,0.5727048585931834,-0.8619421863038383,0.8826932380636129,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.1315445975344454,0.2677366434277408,4.78228590534696
R-HSA-180024,DARPP-32 events,2/1379,25/9872,0.08,0.5727048585931834,-0.8619421863038383,0.8826932380636129,0.9999999999999936,0.9278752436647114,PDE4D/PDE4A,2,1.1315445975344454,0.2677366434277408,4.78228590534696
R-HSA-5654696,Downstream signaling of activated FGFR2,2/1379,25/9872,0.08,0.5727048585931834,-0.8619421863038383,0.8826932380636129,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.1315445975344454,0.2677366434277408,4.78228590534696
R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,2/1379,25/9872,0.08,0.5727048585931834,-0.8619421863038383,0.8826932380636129,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,1.1315445975344454,0.2677366434277408,4.78228590534696
R-HSA-9664565,Signaling by ERBB2 KD Mutants,2/1379,25/9872,0.08,0.5727048585931834,-0.8619421863038383,0.8826932380636129,0.9999999999999936,0.9278752436647114,ERBIN/NRG3,2,1.1315445975344454,0.2677366434277408,4.78228590534696
R-HSA-9909396,Circadian clock,11/1379,105/9872,0.10476190476190476,0.7499706481577404,-1.037856232616479,0.8842263744844331,0.9999999999999936,0.9278752436647114,NAMPT/MEF2C/KLF15/PER1/CRY1/HELZ2/RORA/UBC/RAI1/NOCT/RPS27A,11,1.4817845920093926,0.7942986522439556,2.7643073180515403
R-HSA-1660661,Sphingolipid de novo biosynthesis,3/1379,35/9872,0.08571428571428572,0.6136123484926965,-0.9226947975093762,0.8849250619761817,0.9999999999999936,0.9278752436647114,SPTLC3/PPM1L/ABCG2,3,1.2123692116440485,0.3723970376287769,3.9469677704783925
R-HSA-5673000,RAF activation,3/1379,35/9872,0.08571428571428572,0.6136123484926965,-0.9226947975093762,0.8849250619761817,0.9999999999999936,0.9278752436647114,CAMK2G/MARK3/CAMK2D,3,1.2123692116440485,0.3723970376287769,3.9469677704783925
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,6/1379,63/9872,0.09523809523809523,0.6817914983252183,-1.0209437929792622,0.8906877820368613,0.9999999999999936,0.9278752436647114,CDKN1A/TUBB4A/TUBA1A/UBC/RPS27A/TUBA1B,6,1.3470769018267206,0.5820229122484581,3.117774474590512
R-HSA-4570464,SUMOylation of RNA binding proteins,4/1379,45/9872,0.08888888888888889,0.636338731770204,-0.9852012967837321,0.891417736933582,0.9999999999999936,0.9278752436647114,PHC2/NUP205/NUP188/CBX2,4,1.2572717750382725,0.451517278432653,3.5009342760814546
R-HSA-5620924,Intraflagellar transport,4/1379,45/9872,0.08888888888888889,0.636338731770204,-0.9852012967837321,0.891417736933582,0.9999999999999936,0.9278752436647114,DYNLRB2/TUBB4A/TUBA1A/TUBA1B,4,1.2572717750382725,0.451517278432653,3.5009342760814546
R-HSA-190236,Signaling by FGFR,8/1379,81/9872,0.09876543209876543,0.7070430353002264,-1.066755666461236,0.8949613337244576,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/HNRNPF/FLRT2/FGF22/FLRT1/UBC/RPS27A,8,1.396968638931414,0.6742696865450103,2.894274230475309
R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,NEIL2,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-110329,Cleavage of the damaged pyrimidine,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,NEIL2,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-139853,Elevation of cytosolic Ca2+ levels,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,ITPR1,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-1614558,Degradation of cysteine and homocysteine,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,SQOR,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-203615,eNOS activation,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,DDAH1,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,NRG3,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-73928,Depyrimidination,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,NEIL2,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-9694631,Maturation of nucleoprotein,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,PARP9,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/1379,15/9872,0.06666666666666667,0.4772540488276529,-0.816386991610896,0.8955066029765993,0.9999999999999936,0.9278752436647114,SFN,1,0.9429538312787044,0.12446212078102839,7.144036453368239
R-HSA-1227990,Signaling by ERBB2 in Cancer,2/1379,26/9872,0.07692307692307693,0.5506777486472919,-0.9243721057314679,0.8958718632780646,0.9999999999999936,0.9278752436647114,ERBIN/NRG3,2,1.0880236514754282,0.25796780921104,4.588927082764335
R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,2/1379,26/9872,0.07692307692307693,0.5506777486472919,-0.9243721057314679,0.8958718632780646,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,1.0880236514754282,0.25796780921104,4.588927082764335
R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,3/1379,36/9872,0.08333333333333333,0.5965675610345661,-0.9771133638957754,0.8962337103790718,0.9999999999999936,0.9278752436647114,STAT3/KIFC3/FBXO6,3,1.1786922890983804,0.362520823488663,3.832374369588255
R-HSA-1474165,Reproduction,9/1379,90/9872,0.1,0.7158810732414793,-1.0910376507293824,0.8978751107298795,0.9999999999999936,0.9278752436647114,LMNA/HVCN1/CD9/PDPN/LMNB1/OVGP1/PRDM1/SYCE2/SYNE1,9,1.4144307469180564,0.7112952587697424,2.812635559088974
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,5/1379,55/9872,0.09090909090909091,0.6508009756740721,-1.0463985227119628,0.8991509970166417,0.9999999999999936,0.9278752436647114,MEF2C/ALAS1/HELZ2/CAMK4/PPARGC1B,5,1.2858461335618696,0.5139006412294076,3.217353991309624
R-HSA-432722,Golgi Associated Vesicle Biogenesis,5/1379,55/9872,0.09090909090909091,0.6508009756740721,-1.0463985227119628,0.8991509970166417,0.9999999999999936,0.9278752436647114,TFRC/AP1B1/DTNBP1/TPD52L1/FTH1,5,1.2858461335618696,0.5139006412294076,3.217353991309624
R-HSA-69615,G1/S DNA Damage Checkpoints,5/1379,55/9872,0.09090909090909091,0.6508009756740721,-1.0463985227119628,0.8991509970166417,0.9999999999999936,0.9278752436647114,CDKN1A/UBC/RPS27A/CDKN2A/CCNA2,5,1.2858461335618696,0.5139006412294076,3.217353991309624
R-HSA-69202,Cyclin E associated events during G1/S transition,7/1379,73/9872,0.0958904109589041,0.6864613031082678,-1.0834125130875754,0.9003516205565399,0.9999999999999936,0.9278752436647114,CDKN1A/CABLES1/CCND1/UBC/RPS27A/TFDP2/CCNA2,7,1.3563034559488212,0.6233335716047386,2.951163146696673
R-HSA-5610787,Hedgehog 'off' state,10/1379,99/9872,0.10101010101010101,0.7231121951934135,-1.1156799363830556,0.9010357540807408,0.9999999999999936,0.9278752436647114,GLI3/ADCY3/TUBB4A/TUBA1A/UBC/ADCY7/SMO/RPS27A/GPR161/TUBA1B,10,1.4287179261798553,0.7438852439360588,2.7440185555866763
R-HSA-9752946,Expression and translocation of olfactory receptors,8/1379,82/9872,0.0975609756097561,0.6984205592599798,-1.104967383794447,0.9023098296045134,0.9999999999999936,0.9278752436647114,OR2A5/LHX2/EBF1/OR2T6/OR2L2/OR2L3/OR2K2/OR5V1,8,1.3799324360176162,0.6663114338255203,2.8578430915417066
R-HSA-5654743,Signaling by FGFR4,3/1379,37/9872,0.08108108108108109,0.5804441134390373,-1.03023344790881,0.906532498616711,0.9999999999999936,0.9278752436647114,FGF20/UBC/RPS27A,3,1.1468357407443701,0.35315484024483157,3.7242366983753565
R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,3/1379,37/9872,0.08108108108108109,0.5804441134390373,-1.03023344790881,0.906532498616711,0.9999999999999936,0.9278752436647114,ACSF2/ACOT11/ACBD7,3,1.1468357407443701,0.35315484024483157,3.7242366983753565
R-HSA-1538133,G0 and Early G1,2/1379,27/9872,0.07407407407407407,0.5302822764751699,-0.984788835232646,0.9076608301700855,0.9999999999999936,0.9278752436647114,TFDP2/CCNA2,2,1.0477264791985605,0.2488864600039448,4.410568478479758
R-HSA-1963640,GRB2 events in ERBB2 signaling,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,NRG3,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-1963642,PI3K events in ERBB2 signaling,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,NRG3,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,GATAD2A,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,GALK1,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-5654719,SHC-mediated cascade:FGFR4,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,FGF20,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-5654720,PI-3K cascade:FGFR4,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,FGF20,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,BCL6,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-9665348,Signaling by ERBB2 ECD mutants,1/1379,16/9872,0.0625,0.4474256707759246,-0.8913176284729729,0.9101252896454916,0.9999999999999936,0.9278752436647114,ERBIN,1,0.8840192168237854,0.11714576269566335,6.6710904238508055
R-HSA-8957322,Metabolism of steroids,15/1379,143/9872,0.1048951048951049,0.7509242027008525,-1.2089200855762843,0.9126368063990484,0.9999999999999936,0.9278752436647114,OSBPL3/SEC24D/MVK/OSBPL6/TM7SF2/STS/DHCR7/AKR1C3/HELZ2/CYP8B1/SQLE/CUBN/TSPOAP1/HSD17B1/DHCR24,15,1.4836686156483112,0.8691595102918552,2.5326450841234087
R-HSA-5358351,Signaling by Hedgehog,14/1379,135/9872,0.1037037037037037,0.7423951870652378,-1.2143403308443987,0.9143313396990727,0.9999999999999936,0.9278752436647114,GPC5/DHH/GLI3/CDON/ADCY3/TUBB4A/TUBA1A/UBC/ARRB2/ADCY7/SMO/RPS27A/GPR161/TUBA1B,14,1.4668170708779844,0.8437218815741008,2.5500729166879
R-HSA-72766,Translation,30/1379,265/9872,0.11320754716981132,0.8104314036695993,-1.2604556895521564,0.9146190804984445,0.9999999999999936,0.9278752436647114,SRPRB/RPL9/RPL18A/RPL37A/RPS3/RPL30/MRPS22/RPL18/RPL21/RPS16/MRPL39/RPS3A/RPL10/RPS6/EIF4EBP1/RPL15/RPS12/RPS27A/RPL17/EEF1A1/RPS9/RPL13A/RPL13/RPL7A/RPL19/RPL32/EIF4A1/RPL8/RPSA/RPS14,30,1.6012423550015735,1.0934002592065544,2.3449574461520446
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,7/1379,75/9872,0.09333333333333334,0.668155668358714,-1.1623866899155293,0.9146442582962384,0.9999999999999936,0.9278752436647114,ZFP36/PRKCD/UBC/RPS27A/HSPA1A/HSPA1B/EXOSC6,7,1.320135363790186,0.6072594857692499,2.8698726319965138
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,7/1379,75/9872,0.09333333333333334,0.668155668358714,-1.1623866899155293,0.9146442582962384,0.9999999999999936,0.9278752436647114,CDKN1A/CABLES1/CCND1/UBC/RPS27A/TFDP2/CCNA2,7,1.320135363790186,0.6072594857692499,2.8698726319965138
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,5/1379,57/9872,0.08771929824561403,0.6279658537205959,-1.1350296987944073,0.9153753495757473,0.9999999999999936,0.9278752436647114,RUNX1/LMO1/TAL1/UBC/RPS27A,5,1.2407287253667163,0.49653249547344397,3.100316261239439
R-HSA-8939902,Regulation of RUNX2 expression and activity,5/1379,57/9872,0.08771929824561403,0.6279658537205959,-1.1350296987944073,0.9153753495757473,0.9999999999999936,0.9278752436647114,BMP2/PPARGC1B/UBC/RPS27A/STAT1,5,1.2407287253667163,0.49653249547344397,3.100316261239439
R-HSA-109704,PI3K Cascade,3/1379,38/9872,0.07894736842105263,0.5651692683485363,-1.0821290939868153,0.9158965646751932,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/FGF22,3,1.1166558528300448,0.34426055031947994,3.6220249241524494
R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,AP1B1/CD4,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-1839126,FGFR2 mutant receptor activation,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-350054,Notch-HLH transcription pathway,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,MAML3/HDAC4,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,MIS18BP1/CENPP,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-73863,RNA Polymerase I Transcription Termination,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,CAVIN1/GTF2H2,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-774815,Nucleosome assembly,2/1379,28/9872,0.07142857142857142,0.5113436237439137,-1.0433473809716238,0.9181909010155913,0.9999999999999936,0.9278752436647114,MIS18BP1/CENPP,2,1.0103076763700405,0.24042251885013285,4.245532431046929
R-HSA-9932298,Degradation of CRY and PER proteins,4/1379,48/9872,0.08333333333333333,0.5965675610345661,-1.1289622090611307,0.9183038694051732,0.9999999999999936,0.9278752436647114,PER1/CRY1/UBC/RPS27A,4,1.1786922890983806,0.42440299989662034,3.273576088572422
R-HSA-195721,Signaling by WNT,28/1379,251/9872,0.11155378486055777,0.7985924323012519,-1.3023709039231164,0.9218598685380655,0.9999999999999936,0.9278752436647114,WIF1/SOX6/PIP5K1B/SOX4/PRICKLE1/FZD5/GNB3/PLCB1/TLE1/GNB4/WNT11/WNT7A/UBC/WNT2B/WNT5A/ROR1/TCF7L2/WNT8B/ARRB2/RNF43/RPS27A/GNG2/PLCB2/PRKG1/ITPR1/FZD2/WNT6/CCDC88C,28,1.577851032418549,1.0636902695063093,2.3405440022120216
R-HSA-1502540,Signaling by Activin,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,INHBB,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,NFKBIA,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-2142845,Hyaluronan metabolism,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,HAS1,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,GLDC,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-450385,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,EXOSC6,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-450604,KSRP (KHSRP) binds and destabilizes mRNA,1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,EXOSC6,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-9034015,Signaling by NTRK3 (TRKC),1/1379,17/9872,0.058823529411764705,0.42110651367145846,-0.9625581073999405,0.922700089318672,0.9999999999999936,0.9278752436647114,PTPRO,1,0.8320180864223863,0.11064108435931236,6.256754442914174
R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,9/1379,94/9872,0.09574468085106383,0.6854180488482249,-1.2348234235743634,0.9230403894061674,0.9999999999999936,0.9278752436647114,KIF19/KIF26B/TMED10/COPA/KIF21B/KIF25/TUBB4A/TUBA1A/TUBA1B,9,1.3542422044960114,0.6819286046294925,2.6893899683745577
R-HSA-180534,Vpu mediated degradation of CD4,3/1379,39/9872,0.07692307692307693,0.5506777486472919,-1.1328681244368208,0.9243978196394339,0.9999999999999936,0.9278752436647114,CD4/UBC/RPS27A,3,1.0880236514754282,0.33580320112654793,3.5252655787632268
R-HSA-5205647,Mitophagy,3/1379,39/9872,0.07692307692307693,0.5506777486472919,-1.1328681244368208,0.9243978196394339,0.9999999999999936,0.9278752436647114,UBC/RPS27A/TOMM40,3,1.0880236514754282,0.33580320112654793,3.5252655787632268
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,3/1379,39/9872,0.07692307692307693,0.5506777486472919,-1.1328681244368208,0.9243978196394339,0.9999999999999936,0.9278752436647114,CCND1/UBC/RPS27A,3,1.0880236514754282,0.33580320112654793,3.5252655787632268
R-HSA-9917777,Epigenetic regulation by WDR5-containing histone modifying complexes,10/1379,103/9872,0.0970873786407767,0.6950301681956109,-1.2536681275655832,0.9246596139798631,0.9999999999999936,0.9278752436647114,ELOVL5/MGLL/ACSL1/CEBPA/YEATS2/PHLDA1/LPL/PPARGC1B/PPARG/ANGPTL4,10,1.3732337348718997,0.7158231653782187,2.634408862129859
R-HSA-9816359,Maternal to zygotic transition (MZT),4/1379,49/9872,0.08163265306122448,0.5843927128501871,-1.1751444903768964,0.9258429299460735,0.9999999999999936,0.9278752436647114,ZFP36L2/TEAD4/UHRF1/EIF4A1,4,1.1546373444229034,0.4160743610351474,3.204204637409405
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,11/1379,112/9872,0.09821428571428571,0.7030974826478815,-1.2732982124176992,0.9265291255916488,0.9999999999999936,0.9278752436647114,FOS/NFKBIA/SYK/MAP3K1/BTK/UBC/FCER1G/VAV3/RPS27A/ITPR1/GRAP2,11,1.3891730550088055,0.7460236616505757,2.5867836048159867
R-HSA-5218920,VEGFR2 mediated vascular permeability,2/1379,29/9872,0.06896551724137931,0.49371108499412364,-1.1001852602426663,0.9275834510019305,0.9999999999999936,0.9278752436647114,CTNNA1/VAV3,2,0.9754694806331424,0.23251511613497577,4.092382136111616
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,2/1379,29/9872,0.06896551724137931,0.49371108499412364,-1.1001852602426663,0.9275834510019305,0.9999999999999936,0.9278752436647114,TBXAS1/CYP26C1,2,0.9754694806331424,0.23251511613497577,4.092382136111616
R-HSA-917977,Transferrin endocytosis and recycling,2/1379,29/9872,0.06896551724137931,0.49371108499412364,-1.1001852602426663,0.9275834510019305,0.9999999999999936,0.9278752436647114,TFRC/TFR2,2,0.9754694806331424,0.23251511613497577,4.092382136111616
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",2/1379,29/9872,0.06896551724137931,0.49371108499412364,-1.1001852602426663,0.9275834510019305,0.9999999999999936,0.9278752436647114,SEC24D/TAP1,2,0.9754694806331424,0.23251511613497577,4.092382136111616
R-HSA-983705,Signaling by the B Cell Receptor (BCR),9/1379,95/9872,0.09473684210526316,0.6782031220182436,-1.2699100739591944,0.928430090685864,0.9999999999999936,0.9278752436647114,BLNK/NFKBIA/SYK/RASGRP3/BTK/UBC/RPS27A/PIK3CD/ITPR1,9,1.3399870233960536,0.6749620358949251,2.660246247019056
R-HSA-165159,MTOR signalling,3/1379,40/9872,0.075,0.5369108049311094,-1.1825128145299175,0.9321046573867626,0.9999999999999936,0.9278752436647114,RPS6/EIF4EBP1/EEF2K,3,1.0608230601885424,0.32775137161024775,3.4335342656201355
R-HSA-5696400,Dual Incision in GG-NER,3/1379,40/9872,0.075,0.5369108049311094,-1.1825128145299175,0.9321046573867626,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,1.0608230601885424,0.32775137161024775,3.4335342656201355
R-HSA-202424,Downstream TCR signaling,7/1379,78/9872,0.08974358974358974,0.6424573734218404,-1.2774009203817753,0.9327565030640999,0.9999999999999936,0.9278752436647114,INPP5D/NFKBIA/CD4/HLA-DRB5/UBC/RPS27A/HLA-DQA2,7,1.2693609267213328,0.5846451045728303,2.7559918823986687
R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,1/1379,18/9872,0.05555555555555555,0.3977117073563774,-1.030544006785798,0.9335165862065006,0.9999999999999936,0.9278752436647114,TPTE2,1,0.7857948593989204,0.1048202227099942,5.890786578140854
R-HSA-210993,Tie2 Signaling,1/1379,18/9872,0.05555555555555555,0.3977117073563774,-1.030544006785798,0.9335165862065006,0.9999999999999936,0.9278752436647114,ANGPT4,1,0.7857948593989204,0.1048202227099942,5.890786578140854
R-HSA-3232118,SUMOylation of transcription factors,1/1379,18/9872,0.05555555555555555,0.3977117073563774,-1.030544006785798,0.9335165862065006,0.9999999999999936,0.9278752436647114,CDKN2A,1,0.7857948593989204,0.1048202227099942,5.890786578140854
R-HSA-5654712,FRS-mediated FGFR4 signaling,1/1379,18/9872,0.05555555555555555,0.3977117073563774,-1.030544006785798,0.9335165862065006,0.9999999999999936,0.9278752436647114,FGF20,1,0.7857948593989204,0.1048202227099942,5.890786578140854
R-HSA-73780,RNA Polymerase III Chain Elongation,1/1379,18/9872,0.05555555555555555,0.3977117073563774,-1.030544006785798,0.9335165862065006,0.9999999999999936,0.9278752436647114,POLR3G,1,0.7857948593989204,0.1048202227099942,5.890786578140854
R-HSA-3700989,Transcriptional Regulation by TP53,40/1379,351/9872,0.11396011396011396,0.8158188868848767,-1.4157596026587673,0.9355723181794096,0.9999999999999936,0.9278752436647114,SESN3/PIP4K2A/FOS/CDKN1A/SGK1/BNIP3L/TNFRSF10D/BTG2/L3MBTL1/BCL6/NDRG1/RGCC/DDIT4/GADD45A/PMAIP1/TNFRSF10C/BARD1/GATAD2A/PLAGL1/NUAK1/PLK3/CASP10/PRDM1/CASP1/GPI/UBC/CTDP1/TNFRSF10A/RPS27A/GTF2H2/TFDP2/SFN/CDKN2A/SCO2/BID/CCNA2/TXN/CASP2/PLK2/TNFRSF10B,40,1.6118868910747084,1.1569555614416192,2.2457036693622348
R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,TLE1/TCF7L2,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,PIP4K2A/GATAD2A,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,2/1379,30/9872,0.06666666666666667,0.4772540488276529,-1.1554250308783438,0.9359505375367634,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.9429538312787044,0.22511112610625011,3.949879969520085
R-HSA-2980766,Nuclear Envelope Breakdown,4/1379,51/9872,0.0784313725490196,0.5614753515619446,-1.2651248564430027,0.9390684225508832,0.9999999999999936,0.9278752436647114,LMNA/NUP205/LMNB1/NUP188,4,1.1093574485631816,0.4003606985475187,3.0739129818371613
R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,TFDP2,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,CDC14A,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,DDAH1,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-5620916,VxPx cargo-targeting to cilium,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,PKD1,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-8876725,Protein methylation,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,EEF1A1,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-8964038,LDL clearance,1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,NCEH1,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-9912633,"Antigen processing: Ub, ATP-independent proteasomal degradation",1/1379,19/9872,0.05263157894736842,0.37677951223235756,-1.0956363387768746,0.9428204859042107,0.9999999999999936,0.9278752436647114,PSMB9,1,0.7444372352200298,0.09958080983274914,5.565196729297801
R-HSA-69190,DNA strand elongation,2/1379,31/9872,0.06451612903225806,0.4618587569299866,-1.209176381406667,0.9433951332718635,0.9999999999999936,0.9278752436647114,GINS3/MCM7,2,0.912535965753585,0.21816397382084923,3.8169541662164543
R-HSA-199992,trans-Golgi Network Vesicle Budding,6/1379,71/9872,0.08450704225352113,0.6049699210491375,-1.3460348129117732,0.9440267549957159,0.9999999999999936,0.9278752436647114,TFRC/CLVS1/AP1B1/DTNBP1/TPD52L1/FTH1,6,1.1952935889448364,0.5185665685627006,2.755146302108517
R-HSA-5358346,Hedgehog ligand biogenesis,4/1379,52/9872,0.07692307692307693,0.5506777486472919,-1.308989012641135,0.9448422560496605,0.9999999999999936,0.9278752436647114,GPC5/DHH/UBC/RPS27A,4,1.0880236514754282,0.39294069971828544,3.012656787700112
R-HSA-9610379,HCMV Late Events,4/1379,52/9872,0.07692307692307693,0.5506777486472919,-1.308989012641135,0.9448422560496605,0.9999999999999936,0.9278752436647114,CEBPD/NUP205/NUP188/CHMP4C,4,1.0880236514754282,0.39294069971828544,3.012656787700112
R-HSA-112399,IRS-mediated signalling,3/1379,42/9872,0.07142857142857142,0.5113436237439137,-1.278743983416909,0.9453900485352756,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/FGF22,3,1.0103076763700403,0.31275295966543504,3.2636672791974184
R-HSA-3214841,PKMTs methylate histone lysines,3/1379,42/9872,0.07142857142857142,0.5113436237439137,-1.278743983416909,0.9453900485352756,0.9999999999999936,0.9278752436647114,DOT1L/SETD7/AEBP2,3,1.0103076763700403,0.31275295966543504,3.2636672791974184
R-HSA-5696395,Formation of Incision Complex in GG-NER,3/1379,42/9872,0.07142857142857142,0.5113436237439137,-1.278743983416909,0.9453900485352756,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,1.0103076763700403,0.31275295966543504,3.2636672791974184
R-HSA-6782315,tRNA modification in the nucleus and cytosol,3/1379,42/9872,0.07142857142857142,0.5113436237439137,-1.278743983416909,0.9453900485352756,0.9999999999999936,0.9278752436647114,NSUN2/TRIT1/OSGEP,3,1.0103076763700403,0.31275295966543504,3.2636672791974184
R-HSA-6811438,Intra-Golgi traffic,3/1379,42/9872,0.07142857142857142,0.5113436237439137,-1.278743983416909,0.9453900485352756,0.9999999999999936,0.9278752436647114,GOSR2/STX6/BET1L,3,1.0103076763700403,0.31275295966543504,3.2636672791974184
R-HSA-9842860,Regulation of endogenous retroelements,7/1379,81/9872,0.08641975308641975,0.6186626558876982,-1.388578602601117,0.947402385591533,0.9999999999999936,0.9278752436647114,ZNF708/GATAD2A/SS18L1/DPF1/ZNF649/ACTB/SMARCD2,7,1.222347559064987,0.5636548084649426,2.650795367507384
R-HSA-9013694,Signaling by NOTCH4,6/1379,72/9872,0.08333333333333333,0.5965675610345661,-1.3843827308469057,0.9487135439833196,0.9999999999999936,0.9278752436647114,MAML3/HES5/UBC/ACTA2/RPS27A/HES1,6,1.1786922890983804,0.5115944570835814,2.7156578675616916
R-HSA-180746,Nuclear import of Rev protein,2/1379,32/9872,0.0625,0.4474256707759246,-1.2615378700247029,0.9500114758094054,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8840192168237854,0.2116326559843445,3.6926719653868045
R-HSA-180910,Vpr-mediated nuclear import of PICs,2/1379,32/9872,0.0625,0.4474256707759246,-1.2615378700247029,0.9500114758094054,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8840192168237854,0.2116326559843445,3.6926719653868045
R-HSA-3214815,HDACs deacetylate histones,2/1379,32/9872,0.0625,0.4474256707759246,-1.2615378700247029,0.9500114758094054,0.9999999999999936,0.9278752436647114,GATAD2A/SAP30,2,0.8840192168237854,0.2116326559843445,3.6926719653868045
R-HSA-68962,Activation of the pre-replicative complex,2/1379,32/9872,0.0625,0.4474256707759246,-1.2615378700247029,0.9500114758094054,0.9999999999999936,0.9278752436647114,MCM7/CDC7,2,0.8840192168237854,0.2116326559843445,3.6926719653868045
R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,2/1379,32/9872,0.0625,0.4474256707759246,-1.2615378700247029,0.9500114758094054,0.9999999999999936,0.9278752436647114,MIS18BP1/CCNA2,2,0.8840192168237854,0.2116326559843445,3.6926719653868045
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,4/1379,53/9872,0.07547169811320754,0.5402876024463995,-1.3521431357644276,0.9501116380743772,0.9999999999999936,0.9278752436647114,HIF1A/LIMD1/UBC/RPS27A,4,1.0674949033343824,0.38579072691761207,2.953791496622051
R-HSA-202403,TCR signaling,9/1379,100/9872,0.09,0.6442929659173314,-1.4405650408772077,0.9507474288251321,0.9999999999999936,0.9278752436647114,INPP5D/NFKBIA/FYB1/CD4/HLA-DRB5/UBC/RPS27A/GRAP2/HLA-DQA2,9,1.272987672226251,0.6421609302196236,2.5235070172920473
R-HSA-1181150,Signaling by NODAL,1/1379,20/9872,0.05,0.35794053662073966,-1.1581376882781063,0.9508231805087062,0.9999999999999936,0.9278752436647114,LEFTY1,1,0.7072153734590283,0.09483992505415222,5.273660688483383
R-HSA-5625900,RHO GTPases activate CIT,1/1379,20/9872,0.05,0.35794053662073966,-1.1581376882781063,0.9508231805087062,0.9999999999999936,0.9278752436647114,RHOB,1,0.7072153734590283,0.09483992505415222,5.273660688483383
R-HSA-9854311,Maturation of TCA enzymes and regulation of TCA cycle,1/1379,20/9872,0.05,0.35794053662073966,-1.1581376882781063,0.9508231805087062,0.9999999999999936,0.9278752436647114,SDHA,1,0.7072153734590283,0.09483992505415222,5.273660688483383
R-HSA-113418,Formation of the Early Elongation Complex,2/1379,33/9872,0.06060606060606061,0.43386731711604815,-1.3125983805983423,0.9558854969890769,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.8572307557079131,0.20548093225983186,3.5762178049802915
R-HSA-159227,Transport of the SLBP independent Mature mRNA,2/1379,33/9872,0.06060606060606061,0.43386731711604815,-1.3125983805983423,0.9558854969890769,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8572307557079131,0.20548093225983186,3.5762178049802915
R-HSA-165054,Rev-mediated nuclear export of HIV RNA,2/1379,33/9872,0.06060606060606061,0.43386731711604815,-1.3125983805983423,0.9558854969890769,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8572307557079131,0.20548093225983186,3.5762178049802915
R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,2/1379,33/9872,0.06060606060606061,0.43386731711604815,-1.3125983805983423,0.9558854969890769,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.8572307557079131,0.20548093225983186,3.5762178049802915
R-HSA-4085377,SUMOylation of SUMOylation proteins,2/1379,33/9872,0.06060606060606061,0.43386731711604815,-1.3125983805983423,0.9558854969890769,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8572307557079131,0.20548093225983186,3.5762178049802915
R-HSA-69541,Stabilization of p53,3/1379,44/9872,0.06818181818181818,0.488100731755554,-1.3712303593676394,0.9562245701728034,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CDKN2A,3,0.9643846001714022,0.29906703529228773,3.109796625157299
R-HSA-70895,Branched-chain amino acid catabolism,1/1379,21/9872,0.047619047619047616,0.3408957491626092,-1.2183042168900882,0.9577065376015294,0.9999999999999936,0.9278752436647114,BCAT1,1,0.6735384509133603,0.09052968938637214,5.011107935238977
R-HSA-9839394,TGFBR3 expression,1/1379,21/9872,0.047619047619047616,0.3408957491626092,-1.2183042168900882,0.9577065376015294,0.9999999999999936,0.9278752436647114,RARA,1,0.6735384509133603,0.09052968938637214,5.011107935238977
R-HSA-8939211,ESR-mediated signaling,15/1379,156/9872,0.09615384615384616,0.6883471858091148,-1.5809631453532798,0.9607941521775039,0.9999999999999936,0.9278752436647114,FOS/CXCL12/RUNX1/FKBP5/GNB3/MMP2/GNB4/CXXC5/KDM4B/CCND1/IGF1R/GNG2/PIK3R3/PGR/AREG,15,1.3600295643442852,0.7984023199134263,2.316727256117034
R-HSA-8941858,Regulation of RUNX3 expression and activity,3/1379,45/9872,0.06666666666666667,0.4772540488276529,-1.4161804788570695,0.9608536296898906,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CDKN2A,3,0.9429538312787042,0.2926635769623661,3.0381707800883104
R-HSA-1483166,Synthesis of PA,2/1379,34/9872,0.058823529411764705,0.42110651367145846,-1.3624383489819172,0.9610953027313351,0.9999999999999936,0.9278752436647114,PLA2G4A/PLA2G5,2,0.8320180864223863,0.1996766534097987,3.466875492515634
R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,2/1379,34/9872,0.058823529411764705,0.42110651367145846,-1.3624383489819172,0.9610953027313351,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8320180864223863,0.1996766534097987,3.466875492515634
R-HSA-187687,Signalling to ERKs,2/1379,34/9872,0.058823529411764705,0.42110651367145846,-1.3624383489819172,0.9610953027313351,0.9999999999999936,0.9278752436647114,RALGDS/SHC3,2,0.8320180864223863,0.1996766534097987,3.466875492515634
R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,2/1379,34/9872,0.058823529411764705,0.42110651367145846,-1.3624383489819172,0.9610953027313351,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8320180864223863,0.1996766534097987,3.466875492515634
R-HSA-8953750,Transcriptional Regulation by E2F6,2/1379,34/9872,0.058823529411764705,0.42110651367145846,-1.3624383489819172,0.9610953027313351,0.9999999999999936,0.9278752436647114,CDC7/TFDP2,2,0.8320180864223863,0.1996766534097987,3.466875492515634
R-HSA-5654738,Signaling by FGFR2,5/1379,66/9872,0.07575757575757576,0.5423341463950601,-1.5031650909684222,0.9632123668067261,0.9999999999999936,0.9278752436647114,FGF20/HNRNPF/FGF22/UBC/RPS27A,5,1.0715384446348915,0.43098658116232863,2.6641076277456106
R-HSA-8948751,Regulation of PTEN stability and activity,4/1379,56/9872,0.07142857142857142,0.5113436237439137,-1.4776189620450657,0.9632667073140557,0.9999999999999936,0.9278752436647114,PREX2/FRK/UBC/RPS27A,4,1.0103076763700405,0.365821196566487,2.790219950381463
R-HSA-113510,E2F mediated regulation of DNA replication,1/1379,22/9872,0.045454545454545456,0.32540048783703607,-1.276354738235096,0.9636270212729832,0.9999999999999936,0.9278752436647114,TFDP2,1,0.6429230667809348,0.08659400490341176,4.773425946288765
R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,1/1379,22/9872,0.045454545454545456,0.32540048783703607,-1.276354738235096,0.9636270212729832,0.9999999999999936,0.9278752436647114,SMO,1,0.6429230667809348,0.08659400490341176,4.773425946288765
R-HSA-211000,Gene Silencing by RNA,6/1379,76/9872,0.07894736842105263,0.5651692683485363,-1.533327007172096,0.9641257153998308,0.9999999999999936,0.9278752436647114,MOV10L1/NUP205/NUP188/ASZ1/MYBL1/TDRD9,6,1.1166558528300448,0.4854853004534701,2.568399686859524
R-HSA-199977,ER to Golgi Anterograde Transport,14/1379,149/9872,0.09395973154362416,0.6726399345893095,-1.6223734747273355,0.9649573577039166,0.9999999999999936,0.9278752436647114,CD55/TMED10/CD59/SEC24D/COPA/GOSR2/SERPINA1/TUBB4A/TUBA1A/ANK1/GRIA1/BET1L/AREG/TUBA1B,14,1.328995332674684,0.7663002531124122,2.304877999318627
R-HSA-5387390,Hh mutants abrogate ligand secretion,3/1379,46/9872,0.06521739130434782,0.46687896080966046,-1.4603215860914887,0.9650196748030239,0.9999999999999936,0.9278752436647114,DHH/UBC/RPS27A,3,0.9224548349465586,0.28652855820692674,2.9697665316200648
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,3/1379,46/9872,0.06521739130434782,0.46687896080966046,-1.4603215860914887,0.9650196748030239,0.9999999999999936,0.9278752436647114,GLI3/UBC/RPS27A,3,0.9224548349465586,0.28652855820692674,2.9697665316200648
R-HSA-9020591,Interleukin-12 signaling,3/1379,46/9872,0.06521739130434782,0.46687896080966046,-1.4603215860914887,0.9650196748030239,0.9999999999999936,0.9278752436647114,HNRNPF/LMNB1/IL12B,3,0.9224548349465586,0.28652855820692674,2.9697665316200648
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,3/1379,46/9872,0.06521739130434782,0.46687896080966046,-1.4603215860914887,0.9650196748030239,0.9999999999999936,0.9278752436647114,KDM3A/PCK1/ARL4C,3,0.9224548349465586,0.28652855820692674,2.9697665316200648
R-HSA-9663891,Selective autophagy,7/1379,86/9872,0.08139534883720931,0.58269389682446,-1.5661505354586953,0.9655854439555077,0.9999999999999936,0.9278752436647114,PLIN3/TUBB4A/TUBA1A/UBC/RPS27A/TOMM40/TUBA1B,7,1.151280840514697,0.5318316527978912,2.492231454753087
R-HSA-176033,Interactions of Vpr with host cellular proteins,2/1379,35/9872,0.05714285714285714,0.409074898995131,-1.4111308016389574,0.9657116809589201,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8082461410960323,0.19419120000926424,3.3640135318462545
R-HSA-177243,Interactions of Rev with host cellular proteins,2/1379,35/9872,0.05714285714285714,0.409074898995131,-1.4111308016389574,0.9657116809589201,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.8082461410960323,0.19419120000926424,3.3640135318462545
R-HSA-432720,Lysosome Vesicle Biogenesis,2/1379,35/9872,0.05714285714285714,0.409074898995131,-1.4111308016389574,0.9657116809589201,0.9999999999999936,0.9278752436647114,CLVS1/AP1B1,2,0.8082461410960323,0.19419120000926424,3.3640135318462545
R-HSA-9706574,RHOBTB GTPase Cycle,2/1379,35/9872,0.05714285714285714,0.409074898995131,-1.4111308016389574,0.9657116809589201,0.9999999999999936,0.9278752436647114,RHOBTB2/ACTG1,2,0.8082461410960323,0.19419120000926424,3.3640135318462545
R-HSA-1500620,Meiosis,4/1379,57/9872,0.07017543859649122,0.5023726829764766,-1.518198771273236,0.9668811494075131,0.9999999999999936,0.9278752436647114,LMNA/LMNB1/SYCE2/SYNE1,4,0.992582980293373,0.3596163008625715,2.739644922671567
R-HSA-9018519,Estrogen-dependent gene expression,7/1379,87/9872,0.08045977011494253,0.5759962658264777,-1.6005934662057546,0.9684507634977988,0.9999999999999936,0.9278752436647114,FOS/CXCL12/RUNX1/CXXC5/KDM4B/CCND1/PGR,7,1.1380477274053327,0.5258934670923199,2.4627661511244443
R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/1379,23/9872,0.043478260869565216,0.31125264053977364,-1.3324776804128946,0.9687192382947655,0.9999999999999936,0.9278752436647114,CTDP1,1,0.6149698899643724,0.08298610654453839,4.557244354629652
R-HSA-171319,Telomere Extension By Telomerase,1/1379,23/9872,0.043478260869565216,0.31125264053977364,-1.3324776804128946,0.9687192382947655,0.9999999999999936,0.9278752436647114,CCNA2,1,0.6149698899643724,0.08298610654453839,4.557244354629652
R-HSA-5654716,Downstream signaling of activated FGFR4,1/1379,23/9872,0.043478260869565216,0.31125264053977364,-1.3324776804128946,0.9687192382947655,0.9999999999999936,0.9278752436647114,FGF20,1,0.6149698899643724,0.08298610654453839,4.557244354629652
R-HSA-73980,RNA Polymerase III Transcription Termination,1/1379,23/9872,0.043478260869565216,0.31125264053977364,-1.3324776804128946,0.9687192382947655,0.9999999999999936,0.9278752436647114,POLR3G,1,0.6149698899643724,0.08298610654453839,4.557244354629652
R-HSA-9733709,Cardiogenesis,1/1379,23/9872,0.043478260869565216,0.31125264053977364,-1.3324776804128946,0.9687192382947655,0.9999999999999936,0.9278752436647114,MEF2C,1,0.6149698899643724,0.08298610654453839,4.557244354629652
R-HSA-74751,Insulin receptor signalling cascade,3/1379,47/9872,0.06382978723404255,0.4569453658988165,-1.503690031003983,0.9687651685197747,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/FGF22,3,0.9028281363306743,0.2806454474021078,2.904371516785904
R-HSA-6790901,rRNA modification in the nucleus and cytosol,4/1379,58/9872,0.06896551724137931,0.49371108499412364,-1.5581940288036078,0.9701619097749031,0.9999999999999936,0.9278752436647114,RPS6/RPS9/PWP2/RPS14,4,0.9754694806331424,0.35361838204189544,2.6908689026634294
R-HSA-68949,Orc1 removal from chromatin,4/1379,58/9872,0.06896551724137931,0.49371108499412364,-1.5581940288036078,0.9701619097749031,0.9999999999999936,0.9278752436647114,MCM7/UBC/RPS27A/CCNA2,4,0.9754694806331424,0.35361838204189544,2.6908689026634294
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,7/1379,88/9872,0.07954545454545454,0.5694508537148131,-1.6346997397674667,0.9710968092820473,0.9999999999999936,0.9278752436647114,TNFRSF13C/TNFRSF12A/TNF/UBC/TNFRSF1B/TNFRSF11A/RPS27A,7,1.1251153668666358,0.5200864395963956,2.4339888379743435
R-HSA-5678895,Defective CFTR causes cystic fibrosis,3/1379,48/9872,0.0625,0.4474256707759246,-1.5463197183425672,0.9721292551274148,0.9999999999999936,0.9278752436647114,DERL3/UBC/RPS27A,3,0.8840192168237854,0.2749990429226426,2.8417916201023745
R-HSA-73864,RNA Polymerase I Transcription,3/1379,48/9872,0.0625,0.4474256707759246,-1.5463197183425672,0.9721292551274148,0.9999999999999936,0.9278752436647114,GATAD2A/CAVIN1/GTF2H2,3,0.8840192168237854,0.2749990429226426,2.8417916201023745
R-HSA-9843940,Regulation of endogenous retroelements by KRAB-ZFP proteins,3/1379,48/9872,0.0625,0.4474256707759246,-1.5463197183425672,0.9721292551274148,0.9999999999999936,0.9278752436647114,ZNF708/GATAD2A/ZNF649,3,0.8840192168237854,0.2749990429226426,2.8417916201023745
R-HSA-264876,Insulin processing,1/1379,24/9872,0.041666666666666664,0.29828378051728305,-1.3868364985488202,0.9730989895782987,0.9999999999999936,0.9278752436647114,CPE,1,0.5893461445491903,0.07966669973341614,4.359774902904736
R-HSA-429947,Deadenylation of mRNA,1/1379,24/9872,0.041666666666666664,0.29828378051728305,-1.3868364985488202,0.9730989895782987,0.9999999999999936,0.9278752436647114,EIF4A1,1,0.5893461445491903,0.07966669973341614,4.359774902904736
R-HSA-9006115,Signaling by NTRK2 (TRKB),1/1379,24/9872,0.041666666666666664,0.29828378051728305,-1.3868364985488202,0.9730989895782987,0.9999999999999936,0.9278752436647114,GRIN2B,1,0.5893461445491903,0.07966669973341614,4.359774902904736
R-HSA-9709603,Impaired BRCA2 binding to PALB2,1/1379,24/9872,0.041666666666666664,0.29828378051728305,-1.3868364985488202,0.9730989895782987,0.9999999999999936,0.9278752436647114,BARD1,1,0.5893461445491903,0.07966669973341614,4.359774902904736
R-HSA-201681,TCF dependent signaling in response to WNT,14/1379,153/9872,0.0915032679738562,0.6550545768222686,-1.732676392942807,0.9733774272077518,0.9999999999999936,0.9278752436647114,WIF1/SOX6/PIP5K1B/SOX4/FZD5/TLE1/UBC/WNT5A/TCF7L2/WNT8B/RNF43/RPS27A/FZD2/CCDC88C,14,1.2942503566570451,0.7467234457598622,2.2432454682098952
R-HSA-176187,Activation of ATR in response to replication stress,2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,MCM7/CDC7,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-3232142,SUMOylation of ubiquitinylation proteins,2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-73933,Resolution of Abasic Sites (AP sites),2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,NEIL2/MPG,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,HNRNPF/LMNB1,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,2/1379,37/9872,0.05405405405405406,0.38696274229269156,-1.505333396418913,0.9734138273641126,0.9999999999999936,0.9278752436647114,KDM3A/ARL4C,2,0.7645571604962468,0.18407718623571198,3.1755572953921987
R-HSA-8856688,Golgi-to-ER retrograde transport,11/1379,127/9872,0.08661417322834646,0.6200544728863207,-1.7364585537715986,0.9750654870966095,0.9999999999999936,0.9278752436647114,KIF19/KIF26B/TMED10/PLA2G4A/COPA/KIF21B/KIF25/PAFAH1B3/TUBB4A/TUBA1A/TUBA1B,11,1.2250974973306001,0.6600633386776672,2.273817965670452
R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,3/1379,49/9872,0.061224489795918366,0.4382945346376404,-1.5882423221256667,0.9751479285088066,0.9999999999999936,0.9278752436647114,PLIN3/STX6/USP6NL,3,0.8659780083171775,0.26957534204272693,2.781849056395245
R-HSA-382556,ABC-family proteins mediated transport,7/1379,90/9872,0.07777777777777778,0.5567963902989284,-1.701934575917997,0.9757890636323183,0.9999999999999936,0.9278752436647114,ABCC4/ABCD2/ABCA9/ABCA6/DERL3/UBC/RPS27A,7,1.1001128031584884,0.5088488513456904,2.3784040712141366
R-HSA-5655253,Signaling by FGFR2 in disease,2/1379,38/9872,0.05263157894736842,0.37677951223235756,-1.5509598855183628,0.9766092308468303,0.9999999999999936,0.9278752436647114,FGF20/FGF22,2,0.7444372352200298,0.17940514843429592,3.089023932805382
R-HSA-6803529,FGFR2 alternative splicing,1/1379,25/9872,0.04,0.2863524292965917,-1.4395739331772002,0.9768658958914106,0.9999999999999936,0.9278752436647114,HNRNPF,1,0.5657722987672227,0.07660252663123941,4.178691071030648
R-HSA-9701192,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,1/1379,25/9872,0.04,0.2863524292965917,-1.4395739331772002,0.9768658958914106,0.9999999999999936,0.9278752436647114,BARD1,1,0.5657722987672227,0.07660252663123941,4.178691071030648
R-HSA-9701193,Defective homologous recombination repair (HRR) due to PALB2 loss of function,1/1379,25/9872,0.04,0.2863524292965917,-1.4395739331772002,0.9768658958914106,0.9999999999999936,0.9278752436647114,BARD1,1,0.5657722987672227,0.07660252663123941,4.178691071030648
R-HSA-9704331,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,1/1379,25/9872,0.04,0.2863524292965917,-1.4395739331772002,0.9768658958914106,0.9999999999999936,0.9278752436647114,BARD1,1,0.5657722987672227,0.07660252663123941,4.178691071030648
R-HSA-9704646,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,1/1379,25/9872,0.04,0.2863524292965917,-1.4395739331772002,0.9768658958914106,0.9999999999999936,0.9278752436647114,BARD1,1,0.5657722987672227,0.07660252663123941,4.178691071030648
R-HSA-5628897,TP53 Regulates Metabolic Genes,6/1379,81/9872,0.07407407407407407,0.5302822764751699,-1.7104015387409979,0.9774146070985237,0.9999999999999936,0.9278752436647114,SESN3/DDIT4/GPI/SFN/SCO2/TXN,6,1.0477264791985603,0.45637201749156847,2.4053419866701007
R-HSA-9609690,HCMV Early Events,5/1379,71/9872,0.07042253521126761,0.5041416008742812,-1.689599610415846,0.9774585008963741,0.9999999999999936,0.9278752436647114,NUP205/TUBB4A/NUP188/TUBA1A/TUBA1B,5,0.9960779907873638,0.40153909532310716,2.4709209521245232
R-HSA-168276,NS1 Mediated Effects on Host Pathways,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-169911,Regulation of Apoptosis,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-6783310,Fanconi Anemia Pathway,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-69610,p53-Independent DNA Damage Response,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,2/1379,39/9872,0.05128205128205128,0.3671184990981945,-1.5956727643888298,0.9794314692904733,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.7253491009836188,0.17496435663123833,3.0070771466135753
R-HSA-1483257,Phospholipid metabolism,19/1379,201/9872,0.0945273631840796,0.67670350206906,-1.8659305886920743,0.9799078287376609,0.9999999999999936,0.9278752436647114,ETNPPL/PIP4K2A/PTPN13/INPP5D/MGLL/PIP5K1B/OSBPL5/PLD4/PLA2G4A/PIK3R5/LPCAT2/PIK3CG/PLAAT1/PLA2G5/TPTE2/PIK3R3/PLEKHA6/PLA2G15/PIK3CD,19,1.337024089126521,0.8326510006152805,2.146917992752842
R-HSA-174411,Polymerase switching on the C-strand of the telomere,1/1379,26/9872,0.038461538461538464,0.27533887432364595,-1.4908153973379887,0.9801056571959444,0.9999999999999936,0.9278752436647114,STN1,1,0.5440118257377141,0.07376525023684227,4.012036366612479
R-HSA-1169091,Activation of NF-kappaB in B cells,3/1379,51/9872,0.058823529411764705,0.42110651367145846,-1.6700829506294856,0.9802783199284217,0.9999999999999936,0.9278752436647114,NFKBIA/UBC/RPS27A,3,0.8320180864223862,0.25934535250111185,2.6692365583493594
R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,3/1379,51/9872,0.058823529411764705,0.42110651367145846,-1.6700829506294856,0.9802783199284217,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,0.8320180864223862,0.25934535250111185,2.6692365583493594
R-HSA-5693607,Processing of DNA double-strand break ends,4/1379,62/9872,0.06451612903225806,0.4618587569299866,-1.712733394744329,0.9804775903906457,0.9999999999999936,0.9278752436647114,BARD1/UBC/RPS27A/CCNA2,4,0.912535965753585,0.33150230794265606,2.5119640763945266
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,5/1379,73/9872,0.0684931506849315,0.49032950222019134,-1.7611331561950458,0.9815565281431552,0.9999999999999936,0.9278752436647114,PHC2/NUP205/NUP188/CBX2/CDKN2A,5,0.9687881828205867,0.39085690755152136,2.401263800228727
R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,2/1379,40/9872,0.05,0.35794053662073966,-1.6395190197068414,0.9819223541275107,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.7072153734590283,0.17073806012358186,2.9293619951800842
R-HSA-2871837,FCERI mediated NF-kB activation,4/1379,63/9872,0.06349206349206349,0.45452766555014557,-1.7500996710252938,0.9824708976689491,0.9999999999999936,0.9278752436647114,NFKBIA/UBC/FCER1G/RPS27A,4,0.8980512678844804,0.32639887866411715,2.470891085930637
R-HSA-8873719,RAB geranylgeranylation,4/1379,63/9872,0.06349206349206349,0.45452766555014557,-1.7500996710252938,0.9824708976689491,0.9999999999999936,0.9278752436647114,RAB40B/RAB27B/RAB42/RAB3C,4,0.8980512678844804,0.32639887866411715,2.470891085930637
R-HSA-1614635,Sulfur amino acid metabolism,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,SQOR,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-5693554,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,BARD1,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,POLR3G,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-77387,Insulin receptor recycling,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,PTPRF,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-8978934,Metabolism of cofactors,1/1379,27/9872,0.037037037037037035,0.26514113823758495,-1.5406716976842831,0.982891996696939,0.9999999999999936,0.9278752436647114,GCH1,1,0.5238632395992803,0.07113057709146058,3.858153624292742
R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,2/1379,41/9872,0.04878048780487805,0.3492102796299899,-1.6825419910308654,0.9841193071743021,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.6899662180088081,0.16671108758457717,2.8555592125920426
R-HSA-180585,Vif-mediated degradation of APOBEC3G,2/1379,41/9872,0.04878048780487805,0.3492102796299899,-1.6825419910308654,0.9841193071743021,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6899662180088081,0.16671108758457717,2.8555592125920426
R-HSA-1268020,Mitochondrial protein import,4/1379,64/9872,0.0625,0.4474256707759246,-1.7869920094893297,0.9842704828727897,0.9999999999999936,0.9278752436647114,HSPD1/CHCHD7/TOMM40/TIMM10B,4,0.8840192168237854,0.32145019924098944,2.4311385637930814
R-HSA-9609646,HCMV Infection,7/1379,95/9872,0.07368421052631578,0.5274913171253005,-1.8646655001102566,0.9846197945999964,0.9999999999999936,0.9278752436647114,CEBPD/NUP205/TUBB4A/NUP188/TUBA1A/CHMP4C/TUBA1B,7,1.0422121293080417,0.4827708219704872,2.249941531352954
R-HSA-9758941,Gastrulation,8/1379,105/9872,0.0761904761904762,0.5454331986601748,-1.8868784182135192,0.9849286934338113,0.9999999999999936,0.9278752436647114,MAML3/ZNF521/PAX6/EPHA4/TEAD4/TCF7L2/OTX2/DLL3,8,1.0776615214613765,0.5240559031369973,2.2160886803995234
R-HSA-5687128,MAPK6/MAPK4 signaling,5/1379,75/9872,0.06666666666666667,0.4772540488276529,-1.831078243357801,0.9849474689693128,0.9999999999999936,0.9278752436647114,CCND3/CDC14A/UBC/RPS27A/DNAJB1,5,0.9429538312787045,0.3807283740683355,2.335423331920082
R-HSA-390918,Peroxisomal lipid metabolism,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,ALDH3A2,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,ACTB,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-69205,G1/S-Specific Transcription,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,TFDP2,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-73772,RNA Polymerase I Promoter Escape,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,POLR3G,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,1/1379,28/9872,0.03571428571428571,0.25567181187195687,-1.589241240678634,0.9852883335740259,0.9999999999999936,0.9278752436647114,POLR3G,1,0.5051538381850202,0.06867756113787268,3.71562990888354
R-HSA-5619084,ABC transporter disorders,4/1379,65/9872,0.06153846153846154,0.4405421989178334,-1.8234257004060825,0.9858938778423281,0.9999999999999936,0.9278752436647114,DERL3/ABCD4/UBC/RPS27A,4,0.8704189211803426,0.31664933620960695,2.3926438861922534
R-HSA-168325,Viral Messenger RNA Synthesis,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-4641257,Degradation of AXIN,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,2/1379,42/9872,0.047619047619047616,0.3408957491626092,-1.7247817406175212,0.9860557701062533,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6735384509133603,0.1628696652416307,2.7853808392479693
R-HSA-6807070,PTEN Regulation,10/1379,126/9872,0.07936507936507936,0.568159581937682,-1.9657464665333568,0.9871384911860456,0.9999999999999936,0.9278752436647114,PREX2/PHC2/FRK/EGR1/GATAD2A/NR2E1/PPARG/UBC/RPS27A/CBX2,10,1.1225640848556007,0.5882349597150057,2.1422564296726314
R-HSA-5669034,TNFs bind their physiological receptors,1/1379,29/9872,0.034482758620689655,0.24685554249706182,-1.636611836481892,0.987349222237315,0.9999999999999936,0.9278752436647114,TNFRSF1B,1,0.4877347403165712,0.06638804656052434,3.5832531492668513
R-HSA-72086,mRNA Capping,1/1379,29/9872,0.034482758620689655,0.24685554249706182,-1.636611836481892,0.987349222237315,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.4877347403165712,0.06638804656052434,3.5832531492668513
R-HSA-5663220,RHO GTPases Activate Formins,11/1379,136/9872,0.08088235294117647,0.5790214562982554,-1.9919171921099734,0.9877318880442463,0.9999999999999936,0.9278752436647114,CENPP/SRGAP2/RCC2/TUBB4A/DIAPH2/TUBA1A/ACTG1/RHOB/ACTB/DIAPH3/TUBA1B,11,1.144024868830781,0.61738234562171,2.1199065859023207
R-HSA-167169,HIV Transcription Elongation,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-427413,NoRC negatively regulates rRNA expression,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,SAP30/GTF2H2,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,GATAD2A/ACTB,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-5362768,Hh mutants are degraded by ERAD,2/1379,43/9872,0.046511627906976744,0.33296794104254857,-1.7662753775649238,0.9877615852785209,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6578747660083984,0.15920125960243986,2.7185664788796187
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),4/1379,67/9872,0.05970149253731343,0.4273916855173011,-1.8949746265281593,0.9886752480593848,0.9999999999999936,0.9278752436647114,NFKBIA/RASGRP3/UBC/RPS27A,4,0.8444362668167502,0.307465336368983,2.319196749579815
R-HSA-2132295,MHC class II antigen presentation,9/1379,118/9872,0.07627118644067797,0.5460109880655352,-1.9990659256562082,0.9887437663848733,0.9999999999999936,0.9278752436647114,HLA-DMB/CTSS/SEC24D/AP1B1/TUBB4A/TUBA1A/HLA-DRB5/HLA-DQA2/TUBA1B,9,1.0788031120561448,0.5465467723871258,2.1293990073326747
R-HSA-8949613,Cristae formation,1/1379,30/9872,0.03333333333333333,0.23862702441382644,-1.6828621854529764,0.9891215906752652,0.9999999999999936,0.9278752436647114,MICOS10,1,0.4714769156393522,0.06424621828875068,3.4599776905424364
R-HSA-3899300,SUMOylation of transcription cofactors,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,PHC2/CBX2,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-4615885,SUMOylation of DNA replication proteins,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-4641258,Degradation of DVL,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-73762,RNA Polymerase I Transcription Initiation,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,GATAD2A/GTF2H2,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-73884,Base Excision Repair,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,NEIL2/MPG,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-9604323,Negative regulation of NOTCH4 signaling,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-9824272,Somitogenesis,2/1379,44/9872,0.045454545454545456,0.32540048783703607,-1.8070573428730268,0.9892633479026026,0.9999999999999936,0.9278752436647114,EPHA4/DLL3,2,0.6429230667809348,0.15569444094844606,2.65488007973176
R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,6/1379,89/9872,0.06741573033707865,0.48261645387066027,-1.975621467714161,0.9895758150943195,0.9999999999999936,0.9278752436647114,BARD1/NUAK1/PLK3/UBC/RPS27A/CCNA2,6,0.9535488181470043,0.4164181387167171,2.183515231568962
R-HSA-453279,Mitotic G1 phase and G1/S transition,11/1379,138/9872,0.07971014492753623,0.5706298409895849,-2.0467173786494763,0.9895788483774917,0.9999999999999936,0.9278752436647114,CDKN1A/CCND3/MCM7/CDC7/CABLES1/CCND1/UBC/RPS27A/TFDP2/CDKN2A/CCNA2,11,1.127444798268016,0.6086367696925858,2.088489944147868
R-HSA-1483206,Glycerophospholipid biosynthesis,9/1379,119/9872,0.07563025210084033,0.5414226604347322,-2.02791200410465,0.9896849779650412,0.9999999999999936,0.9278752436647114,ETNPPL/MGLL/OSBPL5/PLD4/PLA2G4A/LPCAT2/PLAAT1/PLA2G5/PLA2G15,9,1.069737539685925,0.5420629915754812,2.111080117252294
R-HSA-112382,Formation of RNA Pol II elongation complex,3/1379,57/9872,0.05263157894736842,0.37677951223235756,-1.9013678437520647,0.9902827940339183,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2/EAF2,3,0.7444372352200297,0.23283752682480896,2.380143805594627
R-HSA-75955,RNA Polymerase II Transcription Elongation,3/1379,57/9872,0.05263157894736842,0.37677951223235756,-1.9013678437520647,0.9902827940339183,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2/EAF2,3,0.7444372352200297,0.23283752682480896,2.380143805594627
R-HSA-9793380,Formation of paraxial mesoderm,3/1379,57/9872,0.05263157894736842,0.37677951223235756,-1.9013678437520647,0.9902827940339183,0.9999999999999936,0.9278752436647114,MAML3/EPHA4/DLL3,3,0.7444372352200297,0.23283752682480896,2.380143805594627
R-HSA-69206,G1/S Transition,9/1379,120/9872,0.075,0.5369108049311094,-2.0565561510828796,0.990552284235793,0.9999999999999936,0.9278752436647114,CDKN1A/MCM7/CDC7/CABLES1/CCND1/UBC/RPS27A/TFDP2/CCNA2,9,1.0608230601885422,0.5376521905501919,2.093073523751835
R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,2/1379,45/9872,0.044444444444444446,0.318169365885102,-1.8471596609304068,0.9905847301450543,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.6286358875191362,0.15233876446579644,2.5941071562629072
R-HSA-5578749,Transcriptional regulation by small RNAs,2/1379,45/9872,0.044444444444444446,0.318169365885102,-1.8471596609304068,0.9905847301450543,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.6286358875191362,0.15233876446579644,2.5941071562629072
R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,1/1379,31/9872,0.03225806451612903,0.2309293784649933,-1.7280631119976957,0.9906458059220452,0.9999999999999936,0.9278752436647114,CTDP1,1,0.4562679828767925,0.06223823665630875,3.34489669667328
R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,1/1379,31/9872,0.03225806451612903,0.2309293784649933,-1.7280631119976957,0.9906458059220452,0.9999999999999936,0.9278752436647114,CTDP1,1,0.4562679828767925,0.06223823665630875,3.34489669667328
R-HSA-351202,Metabolism of polyamines,2/1379,46/9872,0.043478260869565216,0.31125264053977364,-1.8866121620538512,0.9917467781151466,0.9999999999999936,0.9278752436647114,AZIN2/ODC1,2,0.6149698899643724,0.14912466641161926,2.5360523826347032
R-HSA-5250941,Negative epigenetic regulation of rRNA expression,2/1379,46/9872,0.043478260869565216,0.31125264053977364,-1.8866121620538512,0.9917467781151466,0.9999999999999936,0.9278752436647114,SAP30/GTF2H2,2,0.6149698899643724,0.14912466641161926,2.5360523826347032
R-HSA-5610780,Degradation of GLI1 by the proteasome,2/1379,46/9872,0.043478260869565216,0.31125264053977364,-1.8866121620538512,0.9917467781151466,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6149698899643724,0.14912466641161926,2.5360523826347032
R-HSA-5610783,Degradation of GLI2 by the proteasome,2/1379,46/9872,0.043478260869565216,0.31125264053977364,-1.8866121620538512,0.9917467781151466,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6149698899643724,0.14912466641161926,2.5360523826347032
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,2/1379,46/9872,0.043478260869565216,0.31125264053977364,-1.8866121620538512,0.9917467781151466,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6149698899643724,0.14912466641161926,2.5360523826347032
R-HSA-195253,Degradation of beta-catenin by the destruction complex,4/1379,70/9872,0.05714285714285714,0.409074898995131,-1.9992000593989168,0.9918876595496313,0.9999999999999936,0.9278752436647114,TLE1/UBC/TCF7L2/RPS27A,4,0.8082461410960323,0.2946465746435687,2.217103067927643
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,13/1379,160/9872,0.08125,0.5816533720087019,-2.149681278628955,0.9919685610323272,0.9999999999999936,0.9278752436647114,PHC2/NFKBIA/IKBKE/NUP205/RARA/HDAC4/AR/NUP188/PPARG/RORA/CBX2/CDKN2A/PGR,13,1.1492249818709208,0.6512879402117382,2.027855849022544
R-HSA-5688426,Deubiquitination,20/1379,224/9872,0.08928571428571429,0.6391795296798922,-2.2010437599085546,0.9921797131884008,0.9999999999999936,0.9278752436647114,SMAD7/NFKBIA/NLRP3/ADRB2/HIF1A/TGFBR1/TNIP2/BARD1/TGFBR2/AR/RNF135/UBC/ARRB2/YOD1/RPS27A/IL33/ACTB/NOD2/CCNA2/INO80C,20,1.2628845954625505,0.7967079723082594,2.0018344950607894
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,3/1379,59/9872,0.05084745762711865,0.3640073253770234,-1.9742828223230129,0.9923576219329545,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.7192020747040965,0.22516601061487865,2.297201175462393
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,3/1379,59/9872,0.05084745762711865,0.3640073253770234,-1.9742828223230129,0.9923576219329545,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.7192020747040965,0.22516601061487865,2.297201175462393
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,2/1379,47/9872,0.0425531914893617,0.3046302439325444,-1.9254426799817743,0.992768182986052,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.6018854242204495,0.14604337314305474,2.480537501240661
R-HSA-73854,RNA Polymerase I Promoter Clearance,2/1379,47/9872,0.0425531914893617,0.3046302439325444,-1.9254426799817743,0.992768182986052,0.9999999999999936,0.9278752436647114,GATAD2A/GTF2H2,2,0.6018854242204495,0.14604337314305474,2.480537501240661
R-HSA-1592230,Mitochondrial biogenesis,6/1379,93/9872,0.06451612903225806,0.4618587569299866,-2.1009836649656966,0.9930133781408361,0.9999999999999936,0.9278752436647114,MICOS10/MEF2C/ALAS1/HELZ2/CAMK4/PPARGC1B,6,0.9125359657535848,0.3989547252926585,2.0872591198988144
R-HSA-167287,HIV elongation arrest and recovery,1/1379,33/9872,0.030303030303030304,0.21693365855802407,-1.8155666379156903,0.9930838124448669,0.9999999999999936,0.9278752436647114,CTDP1,1,0.42861537785395654,0.05857659033928072,3.1362553038478165
R-HSA-167290,Pausing and recovery of HIV elongation,1/1379,33/9872,0.030303030303030304,0.21693365855802407,-1.8155666379156903,0.9930838124448669,0.9999999999999936,0.9278752436647114,CTDP1,1,0.42861537785395654,0.05857659033928072,3.1362553038478165
R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,1/1379,33/9872,0.030303030303030304,0.21693365855802407,-1.8155666379156903,0.9930838124448669,0.9999999999999936,0.9278752436647114,STN1,1,0.42861537785395654,0.05857659033928072,3.1362553038478165
R-HSA-71403,Citric acid cycle (TCA cycle),1/1379,33/9872,0.030303030303030304,0.21693365855802407,-1.8155666379156903,0.9930838124448669,0.9999999999999936,0.9278752436647114,SDHA,1,0.42861537785395654,0.05857659033928072,3.1362553038478165
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,3/1379,60/9872,0.05,0.35794053662073966,-2.0100379352310984,0.9932273880163313,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.7072153734590282,0.22151674017946346,2.257859085735866
R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),5/1379,83/9872,0.060240963855421686,0.4312536585792044,-2.0966244444908777,0.9934736513548407,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2/ACTB/INO80C,5,0.8520667150108775,0.3449707422537438,2.1045775710897954
R-HSA-5620920,Cargo trafficking to the periciliary membrane,2/1379,48/9872,0.041666666666666664,0.29828378051728305,-1.9636772276240038,0.9936655276755579,0.9999999999999936,0.9278752436647114,PKD1/SMO,2,0.5893461445491903,0.14308682118794538,2.427399499208782
R-HSA-69473,G2/M DNA damage checkpoint,3/1379,61/9872,0.04918032786885246,0.35207265897121937,-2.045345752358955,0.9940009671677609,0.9999999999999936,0.9278752436647114,BARD1/SFN/CCNA2,3,0.695621678812159,0.21798386455907376,2.2198410006732954
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),1/1379,34/9872,0.029411764705882353,0.21055325683572923,-1.8579799959183805,0.9940531612240648,0.9999999999999936,0.9278752436647114,BARD1,1,0.41600904321119314,0.056902685279552584,3.0413946755458494
R-HSA-9709570,Impaired BRCA2 binding to RAD51,1/1379,34/9872,0.029411764705882353,0.21055325683572923,-1.8579799959183805,0.9940531612240648,0.9999999999999936,0.9278752436647114,BARD1,1,0.41600904321119314,0.056902685279552584,3.0413946755458494
R-HSA-74752,Signaling by Insulin receptor,4/1379,73/9872,0.0547945205479452,0.39226360177615305,-2.099993477748781,0.9942160355503087,0.9999999999999936,0.9278752436647114,FGF20/FGFR3/PTPRF/FGF22,4,0.7750305462564694,0.28285390268204424,2.1236134341261557
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,3/1379,62/9872,0.04838709677419355,0.34639406769749,-2.080220985983538,0.9946885964954107,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.6844019743151887,0.21456190279106763,2.1830812290224912
R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,3/1379,62/9872,0.04838709677419355,0.34639406769749,-2.080220985983538,0.9946885964954107,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,0.6844019743151887,0.21456190279106763,2.1830812290224912
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,3/1379,62/9872,0.04838709677419355,0.34639406769749,-2.080220985983538,0.9946885964954107,0.9999999999999936,0.9278752436647114,FOS/CTDP1/GTF2H2,3,0.6844019743151887,0.21456190279106763,2.1830812290224912
R-HSA-9033241,Peroxisomal protein import,3/1379,62/9872,0.04838709677419355,0.34639406769749,-2.080220985983538,0.9946885964954107,0.9999999999999936,0.9278752436647114,UBC/GSTK1/RPS27A,3,0.6844019743151887,0.21456190279106763,2.1830812290224912
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,4/1379,74/9872,0.05405405405405406,0.38696274229269156,-2.132878709615352,0.9948379281072627,0.9999999999999936,0.9278752436647114,CDC14A/UBC/RPS27A/CCNA2,4,0.7645571604962468,0.2791300183699056,2.0941769540939728
R-HSA-453276,Regulation of mitotic cell cycle,4/1379,74/9872,0.05405405405405406,0.38696274229269156,-2.132878709615352,0.9948379281072627,0.9999999999999936,0.9278752436647114,CDC14A/UBC/RPS27A/CCNA2,4,0.7645571604962468,0.2791300183699056,2.0941769540939728
R-HSA-5633007,Regulation of TP53 Activity,12/1379,156/9872,0.07692307692307693,0.5506777486472919,-2.279337414680628,0.9948440005844379,0.9999999999999936,0.9278752436647114,PIP4K2A/SGK1/L3MBTL1/BARD1/GATAD2A/NUAK1/PLK3/PRDM1/UBC/RPS27A/CDKN2A/CCNA2,12,1.0880236514754282,0.6033043975168798,1.96218603915746
R-HSA-5693568,Resolution of D-loop Structures through Holliday Junction Intermediates,1/1379,35/9872,0.02857142857142857,0.2045374494975655,-1.8995668057685389,0.9948867341730397,0.9999999999999936,0.9278752436647114,BARD1,1,0.40412307054801616,0.05532177183721516,2.952100967223432
R-HSA-9930044,Nuclear RNA decay,1/1379,35/9872,0.02857142857142857,0.2045374494975655,-1.8995668057685389,0.9948867341730397,0.9999999999999936,0.9278752436647114,EXOSC6,1,0.40412307054801616,0.05532177183721516,2.952100967223432
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,16/1379,194/9872,0.08247422680412371,0.5904173799929726,-2.321569678110737,0.9950176888680639,0.9999999999999936,0.9278752436647114,KIF19/KIF26B/TMED10/PLIN3/PLA2G4A/COPA/GOSR2/STX6/KIF21B/USP6NL/KIF25/PAFAH1B3/TUBB4A/TUBA1A/BET1L/TUBA1B,16,1.1665408222004592,0.6985977809737958,1.947927014545108
R-HSA-2990846,SUMOylation,13/1379,166/9872,0.0783132530120482,0.5606297561529657,-2.3003646690334314,0.9950427059556226,0.9999999999999936,0.9278752436647114,PHC2/NFKBIA/IKBKE/NUP205/RARA/HDAC4/AR/NUP188/PPARG/RORA/CBX2/CDKN2A/PGR,13,1.1076867295141406,0.6282275696319903,1.9530659748990005
R-HSA-5689880,Ub-specific processing proteases,11/1379,147/9872,0.07482993197278912,0.5356933201126716,-2.285340631971699,0.9951132733034176,0.9999999999999936,0.9278752436647114,SMAD7/NFKBIA/ADRB2/HIF1A/TGFBR1/AR/UBC/ARRB2/RPS27A/IL33/CCNA2,11,1.0584175657209947,0.5721645411808817,1.9579118641548352
R-HSA-180786,Extension of Telomeres,2/1379,50/9872,0.04,0.2863524292965917,-2.0384542838802044,0.9951451482146927,0.9999999999999936,0.9278752436647114,STN1/CCNA2,2,0.5657722987672227,0.1375188238784102,2.3276689330572546
R-HSA-212165,Epigenetic regulation of gene expression,22/1379,249/9872,0.08835341365461848,0.6325053659161665,-2.3666148202473845,0.995220651659493,0.9999999999999936,0.9278752436647114,ZNF708/ELOVL5/MGLL/ACSL1/CEBPA/YEATS2/PHF19/GATAD2A/SS18L1/DPF1/PHLDA1/LPL/SAP30/PPARGC1B/PPARG/ZNF649/UHRF1/GTF2H2/ACTB/SMARCD2/ANGPTL4/AEBP2,22,1.2496978486826202,0.8053736910405657,1.9391553639952537
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,3/1379,63/9872,0.047619047619047616,0.3408957491626092,-2.1146776100483096,0.9952994814367339,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.6735384509133603,0.21124571270214193,2.1475183522347967
R-HSA-6782135,Dual incision in TC-NER,3/1379,63/9872,0.047619047619047616,0.3408957491626092,-2.1146776100483096,0.9952994814367339,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,0.6735384509133603,0.21124571270214193,2.1475183522347967
R-HSA-5685938,HDR through Single Strand Annealing (SSA),1/1379,36/9872,0.027777777777777776,0.1988558536781887,-1.9403711158809058,0.995603537423561,0.9999999999999936,0.9278752436647114,BARD1,1,0.3928974296994602,0.05382631187692354,2.8678983359924985
R-HSA-5693537,Resolution of D-Loop Structures,1/1379,36/9872,0.027777777777777776,0.1988558536781887,-1.9403711158809058,0.995603537423561,0.9999999999999936,0.9278752436647114,BARD1,1,0.3928974296994602,0.05382631187692354,2.8678983359924985
R-HSA-76046,RNA Polymerase III Transcription Initiation,1/1379,36/9872,0.027777777777777776,0.1988558536781887,-1.9403711158809058,0.995603537423561,0.9999999999999936,0.9278752436647114,POLR3G,1,0.3928974296994602,0.05382631187692354,2.8678983359924985
R-HSA-191859,snRNP Assembly,2/1379,51/9872,0.0392156862745098,0.2807376757809723,-2.0750410448159684,0.9957519575324996,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.5546787242815908,0.13489420863316598,2.280813166763392
R-HSA-194441,Metabolism of non-coding RNA,2/1379,51/9872,0.0392156862745098,0.2807376757809723,-2.0750410448159684,0.9957519575324996,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.5546787242815908,0.13489420863316598,2.280813166763392
R-HSA-9907900,Proteasome assembly,2/1379,51/9872,0.0392156862745098,0.2807376757809723,-2.0750410448159684,0.9957519575324996,0.9999999999999936,0.9278752436647114,PSMD5/PSMB9,2,0.5546787242815908,0.13489420863316598,2.280813166763392
R-HSA-429914,Deadenylation-dependent mRNA decay,2/1379,52/9872,0.038461538461538464,0.27533887432364595,-2.111120578922531,0.9962841208394086,0.9999999999999936,0.9278752436647114,EXOSC6/EIF4A1,2,0.5440118257377141,0.13236789093370643,2.2358055602072
R-HSA-3214847,HATs acetylate histones,4/1379,77/9872,0.05194805194805195,0.3718862718137555,-2.2295313064037043,0.996340655467453,0.9999999999999936,0.9278752436647114,YEATS2/MORF4L2/KAT6B/ACTB,4,0.7347692191782113,0.26852432772442203,2.01056570936033
R-HSA-9609507,Protein localization,12/1379,161/9872,0.07453416149068323,0.5335759552110405,-2.4043297972581485,0.9966226580916198,0.9999999999999936,0.9278752436647114,ALDH3A2/GDAP1/ABCD2/SGTA/HMOX1/HSPD1/UBC/GSTK1/CHCHD7/RPS27A/TOMM40/TIMM10B,12,1.0542340970817812,0.584947628274563,1.9000154504911753
R-HSA-69052,Switching of origins to a post-replicative state,4/1379,78/9872,0.05128205128205128,0.3671184990981945,-2.2611105687781206,0.9967400860109787,0.9999999999999936,0.9278752436647114,MCM7/UBC/RPS27A/CCNA2,4,0.7253491009836188,0.2651659544236306,1.9841586354528524
R-HSA-350562,Regulation of ornithine decarboxylase (ODC),1/1379,38/9872,0.02631578947368421,0.18838975611617878,-2.0197906770499103,0.9967499368372408,0.9999999999999936,0.9278752436647114,ODC1,1,0.3722186176100149,0.051065464027696725,2.713119364202115
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,2/1379,53/9872,0.03773584905660377,0.27014380122319975,-2.1467118453252136,0.9967506334579384,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.5337474516671912,0.12993445067527426,2.1925389354451843
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,3/1379,67/9872,0.04477611940298507,0.3205437641379758,-2.2485742770921133,0.9971287146676623,0.9999999999999936,0.9278752436647114,UBC/RPS27A/CCNA2,3,0.6333272001125626,0.19894630282024042,2.0161387103777355
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,2/1379,54/9872,0.037037037037037035,0.26514113823758495,-2.1818327119415186,0.9971594363966254,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.5238632395992803,0.12758885900435843,2.150914240827863
R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,1/1379,39/9872,0.02564102564102564,0.18355924954909725,-2.058477404340839,0.9972056859832084,0.9999999999999936,0.9278752436647114,BARD1,1,0.3626745504918094,0.04978857438678262,2.6418275918611966
R-HSA-68875,Mitotic Prophase,4/1379,80/9872,0.05,0.35794053662073966,-2.323360970888031,0.9974162406685309,0.9999999999999936,0.9278752436647114,LMNA/NUP205/LMNB1/NUP188,4,0.7072153734590283,0.25869507193480734,1.9333711334974117
R-HSA-983169,Class I MHC mediated antigen processing & presentation,34/1379,364/9872,0.09340659340659341,0.6686801233574258,-2.5952891032623198,0.9974389832102797,0.9999999999999936,0.9278752436647114,TLR2/SOCS3/FBXO7/MRC2/CD14/ZBTB16/SH3RF1/CTSS/UBA7/MRC1/SEC24D/FCGR1A/S100A9/CYBB/HECTD2/LNX1/TRIM63/TAP1/UBE3D/TRIM36/S100A8/NCF2/BTK/FBXL8/UBC/RNF182/LY96/RNF6/CCNF/PSMB9/KLHL3/DTX3L/RPS27A/FBXO6,34,1.3211715767915913,0.9257191554998865,1.8855549493079422
R-HSA-5685942,HDR through Homologous Recombination (HRR),3/1379,68/9872,0.04411764705882353,0.31582988525359385,-2.2811248303770566,0.997464120951934,0.9999999999999936,0.9278752436647114,BARD1/UBC/RPS27A,3,0.6240135648167896,0.19609201510750637,1.9857663702516144
R-HSA-6799198,Complex I biogenesis,3/1379,68/9872,0.04411764705882353,0.31582988525359385,-2.2811248303770566,0.997464120951934,0.9999999999999936,0.9278752436647114,LYRM2/NDUFB9/MT-ND6,3,0.6240135648167896,0.19609201510750637,1.9857663702516144
R-HSA-9675136,Diseases of DNA Double-Strand Break Repair,1/1379,40/9872,0.025,0.17897026831036983,-2.0965252248837656,0.9975975662872005,0.9999999999999936,0.9278752436647114,BARD1,1,0.35360768672951415,0.04857397456937363,2.5741849873869733
R-HSA-9701190,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,1/1379,40/9872,0.025,0.17897026831036983,-2.0965252248837656,0.9975975662872005,0.9999999999999936,0.9278752436647114,BARD1,1,0.35360768672951415,0.04857397456937363,2.5741849873869733
R-HSA-9772755,Formation of WDR5-containing histone-modifying complexes,1/1379,40/9872,0.025,0.17897026831036983,-2.0965252248837656,0.9975975662872005,0.9999999999999936,0.9278752436647114,YEATS2,1,0.35360768672951415,0.04857397456937363,2.5741849873869733
R-HSA-6784531,tRNA processing in the nucleus,2/1379,56/9872,0.03571428571428571,0.25567181187195687,-2.250729752447275,0.9978311057337322,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.5051538381850202,0.12314285784780438,2.072230616479943
R-HSA-74158,RNA Polymerase III Transcription,1/1379,41/9872,0.024390243902439025,0.17460513981499495,-2.133963503069368,0.9979345227650229,0.9999999999999936,0.9278752436647114,POLR3G,1,0.34498310900440404,0.04741721579295999,2.509918465436648
R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,1/1379,41/9872,0.024390243902439025,0.17460513981499495,-2.133963503069368,0.9979345227650229,0.9999999999999936,0.9278752436647114,POLR3G,1,0.34498310900440404,0.04741721579295999,2.509918465436648
R-HSA-4839726,Chromatin organization,17/1379,215/9872,0.07906976744186046,0.5660454997723325,-2.5922355230421648,0.9979889302623048,0.9999999999999936,0.9278752436647114,KDM3A/YEATS2/DOT1L/MORF4L2/KAT6B/SETD7/GATAD2A/SS18L1/BCL11B/DPF1/KDM4B/CCND1/SAP30/ACTL6B/ACTB/SMARCD2/AEBP2,17,1.1183871022142773,0.6804986591044131,1.8380487509635666
R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,1/1379,42/9872,0.023809523809523808,0.1704478745813046,-2.170819497818133,0.9982242484396271,0.9999999999999936,0.9278752436647114,BARD1,1,0.33676922545668014,0.046314263009876566,2.4487815166249485
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,4/1379,84/9872,0.047619047619047616,0.3408957491626092,-2.444437413858423,0.9983848432781637,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/UBC/RPS27A,4,0.6735384509133603,0.24665667471493238,1.83921252235752
R-HSA-68867,Assembly of the pre-replicative complex,3/1379,72/9872,0.041666666666666664,0.29828378051728305,-2.4079467151878773,0.9984627578503191,0.9999999999999936,0.9278752436647114,MCM7/UBC/RPS27A,3,0.5893461445491902,0.18544939507112515,1.8729038073258986
R-HSA-6809371,Formation of the cornified envelope,1/1379,43/9872,0.023255813953488372,0.16648397052127428,-2.207118563349085,0.9984733594672726,0.9999999999999936,0.9278752436647114,KAZN,1,0.3289373830041992,0.04526144791046282,2.390551052447426
R-HSA-8854214,TBC/RABGAPs,1/1379,43/9872,0.023255813953488372,0.16648397052127428,-2.207118563349085,0.9984733594672726,0.9999999999999936,0.9278752436647114,TBC1D14,1,0.3289373830041992,0.04526144791046282,2.390551052447426
R-HSA-1632852,Macroautophagy,9/1379,140/9872,0.06428571428571428,0.4602092613695224,-2.591913738364731,0.9985192500145863,0.9999999999999936,0.9278752436647114,PLIN3/ATG16L2/TUBB4A/TUBA1A/UBC/CHMP4C/RPS27A/TOMM40/TUBA1B,9,0.9092769087330363,0.4624018591429675,1.7880215669709876
R-HSA-9837999,Mitochondrial protein degradation,5/1379,97/9872,0.05154639175257732,0.3690108624956079,-2.516410646926304,0.9985977722478385,0.9999999999999936,0.9278752436647114,PDK1/ALAS1/HSPD1/ARG2/MT-ND6,5,0.729088013875287,0.2962758020044361,1.7941705950344593
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,2/1379,60/9872,0.03333333333333333,0.23862702441382644,-2.383562039150257,0.9987396310329087,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.4714769156393522,0.11511978466002674,1.9309494248731263
R-HSA-69481,G2/M Checkpoints,7/1379,121/9872,0.05785123966942149,0.414146075428955,-2.612700314193608,0.9988201678523967,0.9999999999999936,0.9278752436647114,BARD1/MCM7/CDC7/UBC/RPS27A/SFN/CCNA2,7,0.8182657213575533,0.381188799864543,1.7565017413594717
R-HSA-167161,HIV Transcription Initiation,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-167162,RNA Polymerase II HIV Promoter Escape,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-73776,RNA Polymerase II Promoter Escape,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-75953,RNA Polymerase II Transcription Initiation,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,GTF2H2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-9864848,Complex IV assembly,1/1379,45/9872,0.022222222222222223,0.159084682942551,-2.2781388430037444,0.9988717006835862,0.9999999999999936,0.9278752436647114,SCO2,1,0.3143179437595681,0.043293152121191496,2.282018400801166
R-HSA-69002,DNA Replication Pre-Initiation,4/1379,88/9872,0.045454545454545456,0.32540048783703607,-2.5613049206921588,0.9989964716383521,0.9999999999999936,0.9278752436647114,MCM7/CDC7/UBC/RPS27A,4,0.6429230667809348,0.23568887171706643,1.753795445612765
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,4/1379,88/9872,0.045454545454545456,0.32540048783703607,-2.5613049206921588,0.9989964716383521,0.9999999999999936,0.9278752436647114,DENND3/RAB27B/RIN2/DENND1B,4,0.6429230667809348,0.23568887171706643,1.753795445612765
R-HSA-8852135,Protein ubiquitination,2/1379,62/9872,0.03225806451612903,0.2309293784649933,-2.4477085772227474,0.9990406526133333,0.9999999999999936,0.9278752436647114,UBC/RPS27A,2,0.4562679828767925,0.11148789455960509,1.8672921667487132
R-HSA-9612973,Autophagy,10/1379,155/9872,0.06451612903225806,0.4618587569299866,-2.720997685152426,0.99905271487552,0.9999999999999936,0.9278752436647114,PLIN3/ATG16L2/TUBB4A/TUBA1A/UBC/CHMP4C/RPS27A/EEF1A1/TOMM40/TUBA1B,10,0.912535965753585,0.48030047831485,1.7337519456892072
R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),3/1379,76/9872,0.039473684210526314,0.28258463417426816,-2.529794413570955,0.9990732064420809,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2,3,0.5583279264150224,0.1759024938956894,1.772175405311509
R-HSA-157579,Telomere Maintenance,2/1379,64/9872,0.03125,0.2237128353879623,-2.510465808606729,0.9992704566331023,0.9999999999999936,0.9278752436647114,STN1/CCNA2,2,0.4420096084118927,0.10807814391543598,1.8076966059048978
R-HSA-674695,RNA Polymerase II Pre-transcription Events,3/1379,78/9872,0.038461538461538464,0.27533887432364595,-2.589013784910236,0.9992817415166336,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2/EAF2,3,0.5440118257377141,0.17148838661180388,1.7257662305285826
R-HSA-73886,Chromosome Maintenance,4/1379,91/9872,0.04395604395604396,0.3146729992270239,-2.6464217448870087,0.9993003144047246,0.9999999999999936,0.9278752436647114,MIS18BP1/CENPP/STN1/CCNA2,4,0.6217278008431018,0.22808245793016624,1.6947618937864621
R-HSA-69242,S Phase,9/1379,148/9872,0.060810810810810814,0.43533308507927804,-2.7888995474481817,0.9993258104383538,0.9999999999999936,0.9278752436647114,GINS3/CDKN1A/MCM7/CABLES1/CCND1/UBC/RPS27A/TFDP2/CCNA2,9,0.8601268055582776,0.437887532235591,1.689516296257214
R-HSA-6805567,Keratinization,1/1379,49/9872,0.02040816326530612,0.14609817821254678,-2.414437985623208,0.9993838125812456,0.9999999999999936,0.9278752436647114,KAZN,1,0.28865933610572586,0.03982899342004847,2.0920491623334887
R-HSA-162909,Host Interactions of HIV factors,6/1379,116/9872,0.05172413793103448,0.37028331374559276,-2.7489728285118793,0.9993930102158044,0.9999999999999936,0.9278752436647114,AP1B1/CD4/NUP205/NUP188/UBC/RPS27A,6,0.7316021104748568,0.32144346131802864,1.665119103236973
R-HSA-3247509,Chromatin modifying enzymes,14/1379,201/9872,0.06965174129353234,0.498623633103518,-2.8937322409204924,0.9994281450423927,0.9999999999999936,0.9278752436647114,KDM3A/YEATS2/DOT1L/MORF4L2/KAT6B/SETD7/GATAD2A/KDM4B/CCND1/SAP30/ACTL6B/ACTB/SMARCD2/AEBP2,14,0.9851756446195419,0.5715238620495253,1.698216146690696
R-HSA-72306,tRNA processing,5/1379,105/9872,0.047619047619047616,0.3408957491626092,-2.7359006038105593,0.9994379472284253,0.9999999999999936,0.9278752436647114,NSUN2/NUP205/TRIT1/NUP188/OSGEP,5,0.6735384509133603,0.2741617885474004,1.6546946504192936
R-HSA-380259,Loss of Nlp from mitotic centrosomes,2/1379,66/9872,0.030303030303030304,0.21693365855802407,-2.5719156871685662,0.9994457006541082,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.42861537785395654,0.104870758549229,1.751786147772081
R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,2/1379,66/9872,0.030303030303030304,0.21693365855802407,-2.5719156871685662,0.9994457006541082,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.42861537785395654,0.104870758549229,1.751786147772081
R-HSA-9675135,Diseases of DNA repair,1/1379,50/9872,0.02,0.14317621464829586,-2.447421090579903,0.999470315935665,0.9999999999999936,0.9278752436647114,BARD1,1,0.28288614938361134,0.039047868324914504,2.0493967262747392
R-HSA-69239,Synthesis of DNA,5/1379,106/9872,0.04716981132075472,0.3376797515289997,-2.76245207412862,0.999499433951955,0.9999999999999936,0.9278752436647114,GINS3/MCM7/UBC/RPS27A/CCNA2,5,0.667184314583989,0.2716275108025412,1.6387696088357437
R-HSA-5696398,Nucleotide Excision Repair,5/1379,107/9872,0.04672897196261682,0.3345238660006913,-2.7888194392821357,0.9995543419740739,0.9999999999999936,0.9278752436647114,UBC/RPS27A/GTF2H2/ACTB/INO80C,5,0.6609489471579704,0.26913965738448226,1.623148052556067
R-HSA-167172,Transcription of the HIV genome,2/1379,68/9872,0.029411764705882353,0.21055325683572923,-2.6321327536497403,0.9995792007602712,0.9999999999999936,0.9278752436647114,CTDP1/GTF2H2,2,0.41600904321119314,0.10184824348391215,1.6992293446948772
R-HSA-8854518,AURKA Activation by TPX2,2/1379,69/9872,0.028985507246376812,0.20750176035984907,-2.6618004690241395,0.9996334697383455,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.40997992664291494,0.10040138869348957,1.6741156914000848
R-HSA-162599,Late Phase of HIV Life Cycle,7/1379,132/9872,0.05303030303030303,0.37963390247654205,-2.891263610001226,0.9996341318126571,0.9999999999999936,0.9278752436647114,NUP205/NUP188/UBC/CHMP4C/CTDP1/RPS27A/GTF2H2,7,0.7500769112444239,0.3500293902988544,1.6073375218624228
R-HSA-162587,HIV Life Cycle,8/1379,144/9872,0.05555555555555555,0.3977117073563774,-2.9336346966404596,0.9996651747036722,0.9999999999999936,0.9278752436647114,CD4/NUP205/NUP188/UBC/CHMP4C/CTDP1/RPS27A/GTF2H2,8,0.7857948593989204,0.38477185920202445,1.6047783804624975
R-HSA-69306,DNA Replication,6/1379,122/9872,0.04918032786885246,0.35207265897121937,-2.901590101617696,0.9996896002539057,0.9999999999999936,0.9278752436647114,GINS3/MCM7/CDC7/UBC/RPS27A/CCNA2,6,0.695621678812159,0.30593773961447623,1.5816601137316828
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),4/1379,98/9872,0.04081632653061224,0.29219635642509356,-2.837408147329039,0.9997017882918747,0.9999999999999936,0.9278752436647114,BARD1/UBC/RPS27A/CCNA2,4,0.5773186722114517,0.21210975810509766,1.5713414237116299
R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,5/1379,113/9872,0.04424778761061947,0.316761536832513,-2.9433439602812084,0.999779530843378,0.9999999999999936,0.9278752436647114,CENPP/RCC2/TUBB4A/TUBA1A/TUBA1B,5,0.6258543127956002,0.25511973183265174,1.5353325202685155
R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,2/1379,73/9872,0.0273972602739726,0.19613180088807652,-2.7777141208562517,0.9997894148117887,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.3875152731282347,0.09500292583409586,1.580668022476378
R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,3/1379,89/9872,0.033707865168539325,0.24130822693533013,-2.8970533861352794,0.9998267195716777,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A/TUBA1B,3,0.47677440907350216,0.15069040477654577,1.5084824908690369
R-HSA-5693538,Homology Directed Repair,4/1379,103/9872,0.038834951456310676,0.2780120672782444,-2.9679435975188264,0.999839260242757,0.9999999999999936,0.9278752436647114,BARD1/UBC/RPS27A/CCNA2,4,0.5492934939487598,0.20200511914201028,1.4936420610327388
R-HSA-9007101,Rab regulation of trafficking,5/1379,119/9872,0.04201680672268908,0.3007903669081846,-3.0920315636980806,0.999892091840054,0.9999999999999936,0.9278752436647114,DENND3/RAB27B/RIN2/TBC1D14/DENND1B,5,0.5942986331588473,0.24248815481610808,1.4565283225579326
R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,2/1379,78/9872,0.02564102564102564,0.18355924954909725,-2.916917001042351,0.9998950787499383,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.3626745504918094,0.08901977908522753,1.4775685912285463
R-HSA-380287,Centrosome maturation,2/1379,78/9872,0.02564102564102564,0.18355924954909725,-2.916917001042351,0.9998950787499383,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.3626745504918094,0.08901977908522753,1.4775685912285463
R-HSA-1428517,Aerobic respiration and respiratory electron transport,17/1379,250/9872,0.068,0.486799129804206,-3.3117447701538407,0.9998952657964206,0.9999999999999936,0.9278752436647114,PDK1/PM20D1/LDHA/PDK3/ETFDH/SLC25A18/LYRM2/SDHA/PDPR/UBC/NDUFB9/GPT/RPS27A/ME1/SCO2/UCP2/MT-ND6,17,0.9618129079042785,0.5867077977269813,1.5767373015924409
R-HSA-5693532,DNA Double-Strand Break Repair,6/1379,133/9872,0.045112781954887216,0.32295386762773504,-3.1675176686595092,0.9999118364569186,0.9999999999999936,0.9278752436647114,BARD1/EYA2/KDM4B/UBC/RPS27A/CCNA2,6,0.6380890587600255,0.2810802759002858,1.4485457779104212
R-HSA-2500257,Resolution of Sister Chromatid Cohesion,5/1379,122/9872,0.040983606557377046,0.2933938824760161,-3.164369191605127,0.9999247865944002,0.9999999999999936,0.9278752436647114,CENPP/RCC2/TUBB4A/TUBA1A/TUBA1B,5,0.5796847323434658,0.23663010733407275,1.4200829839362101
R-HSA-72202,Transport of Mature Transcript to Cytoplasm,2/1379,82/9872,0.024390243902439025,0.17460513981499495,-3.024192886020495,0.9999400806205117,0.9999999999999936,0.9278752436647114,NUP205/NUP188,2,0.34498310900440404,0.08474981974217774,1.4042902493527631
R-HSA-5368286,Mitochondrial translation initiation,2/1379,83/9872,0.024096385542168676,0.17250146343168177,-3.050487595604475,0.9999479306523744,0.9999999999999936,0.9278752436647114,MRPS22/MRPL39,2,0.340826686004351,0.08374557349431366,1.3870921774820246
R-HSA-5389840,Mitochondrial translation elongation,2/1379,83/9872,0.024096385542168676,0.17250146343168177,-3.050487595604475,0.9999479306523744,0.9999999999999936,0.9278752436647114,MRPS22/MRPL39,2,0.340826686004351,0.08374557349431366,1.3870921774820246
R-HSA-5419276,Mitochondrial translation termination,2/1379,83/9872,0.024096385542168676,0.17250146343168177,-3.050487595604475,0.9999479306523744,0.9999999999999936,0.9278752436647114,MRPS22/MRPL39,2,0.340826686004351,0.08374557349431366,1.3870921774820246
R-HSA-8951664,Neddylation,14/1379,228/9872,0.06140350877192982,0.43957609760441707,-3.4497499701498238,0.9999533829209302,0.9999999999999936,0.9278752436647114,SOCS3/FBXO7/SOCS6/CDKN1A/FEM1C/ZBTB16/HIF1A/FBXL8/UBC/CCNF/KLHL3/RPS27A/FBXO6/ANKRD9,14,0.8685101077567013,0.5048936365662134,1.4939974534153873
R-HSA-611105,Respiratory electron transport,7/1379,154/9872,0.045454545454545456,0.32540048783703607,-3.399774270655852,0.9999686152313653,0.9999999999999936,0.9278752436647114,ETFDH/SLC25A18/LYRM2/SDHA/NDUFB9/SCO2/MT-ND6,7,0.6429230667809348,0.30084610100117526,1.3739585403414871
R-HSA-5368287,Mitochondrial translation,2/1379,89/9872,0.02247191011235955,0.16087215129022006,-3.204197358942319,0.9999776430768379,0.9999999999999936,0.9278752436647114,MRPS22/MRPL39,2,0.3178496060490015,0.07818669819478145,1.292142709669361
R-HSA-68882,Mitotic Anaphase,12/1379,216/9872,0.05555555555555555,0.3977117073563774,-3.6063246087617418,0.9999817361188259,0.9999999999999936,0.9278752436647114,LMNA/CENPP/RCC2/NUP205/LMNB1/TUBB4A/NUP188/TUBA1A/UBC/CHMP4C/RPS27A/TUBA1B,12,0.7857948593989202,0.4382669778640049,1.4088982110109425
R-HSA-2555396,Mitotic Metaphase and Anaphase,12/1379,217/9872,0.055299539170506916,0.3958789345114172,-3.6258501754694916,0.9999835211841306,0.9999999999999936,0.9278752436647114,LMNA/CENPP/RCC2/NUP205/LMNB1/TUBB4A/NUP188/TUBA1A/UBC/CHMP4C/RPS27A/TUBA1B,12,0.7821736849316442,0.4362779360133928,1.4023071599494459
R-HSA-6807505,RNA polymerase II transcribes snRNA genes,1/1379,73/9872,0.0136986301369863,0.09806590044403826,-3.116574442409987,0.9999837439693648,0.9999999999999936,0.9278752436647114,ELL2,1,0.19375763656411735,0.026909341313052684,1.39512971685793
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,19/1379,292/9872,0.06506849315068493,0.4658130271091817,-3.733654359401604,0.9999855005541316,0.9999999999999936,0.9278752436647114,SOCS3/FBXO7/ZBTB16/SH3RF1/UBA7/HECTD2/LNX1/TRIM63/UBE3D/TRIM36/FBXL8/UBC/RNF182/RNF6/CCNF/KLHL3/DTX3L/RPS27A/FBXO6,19,0.9203487736795573,0.5768005129962122,1.4685178777207977
R-HSA-69275,G2/M Transition,9/1379,185/9872,0.04864864864864865,0.34826646806342243,-3.605731861745357,0.9999863768512811,0.9999999999999936,0.9278752436647114,CDKN1A/MIS18BP1/PHLDA1/TUBB4A/TUBA1A/UBC/RPS27A/CCNA2/TUBA1B,9,0.688101444446622,0.3516633535432178,1.346411541262114
R-HSA-141424,Amplification of signal from the kinetochores,2/1379,93/9872,0.021505376344086023,0.15395291897666222,-3.3030939737705274,0.9999873085174189,0.9999999999999936,0.9278752436647114,CENPP/RCC2,2,0.3041786552511949,0.07487338121570569,1.2357483101219557
R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,2/1379,93/9872,0.021505376344086023,0.15395291897666222,-3.3030939737705274,0.9999873085174189,0.9999999999999936,0.9278752436647114,CENPP/RCC2,2,0.3041786552511949,0.07487338121570569,1.2357483101219557
R-HSA-5620912,Anchoring of the basal body to the plasma membrane,2/1379,94/9872,0.02127659574468085,0.1523151219662722,-3.3274036840747017,0.9999889869776842,0.9999999999999936,0.9278752436647114,TUBB4A/TUBA1A,2,0.3009427121102248,0.07408846825597554,1.2224104250522563
R-HSA-453274,Mitotic G2-G2/M phases,9/1379,187/9872,0.0481283422459893,0.3445416930039205,-3.6462648396607116,0.9999890814930006,0.9999999999999936,0.9278752436647114,CDKN1A/MIS18BP1/PHLDA1/TUBB4A/TUBA1A/UBC/RPS27A/CCNA2/TUBA1B,9,0.680742070709225,0.3479598124899118,1.331791058046161
R-HSA-2467813,Separation of Sister Chromatids,7/1379,173/9872,0.04046242774566474,0.28966286200522284,-3.798011190728915,0.9999965929122449,0.9999999999999936,0.9278752436647114,CENPP/RCC2/TUBB4A/TUBA1A/UBC/RPS27A/TUBA1B,7,0.5723130189841846,0.2682892731525446,1.2208545941848257
R-HSA-69618,Mitotic Spindle Checkpoint,2/1379,109/9872,0.01834862385321101,0.13135432536540906,-3.6744844409684734,0.9999987052541777,0.9999999999999936,0.9278752436647114,CENPP/RCC2,2,0.25952857741615715,0.06402121058591381,1.0520744903014063
R-HSA-162906,HIV Infection,9/1379,213/9872,0.04225352112676056,0.30248496052456875,-4.14676516688824,0.9999994317885689,0.9999999999999936,0.9278752436647114,AP1B1/CD4/NUP205/NUP188/UBC/CHMP4C/CTDP1/RPS27A/GTF2H2,9,0.5976467944724183,0.30605791919395364,1.1670395325298066
R-HSA-69620,Cell Cycle Checkpoints,11/1379,241/9872,0.04564315352697095,0.3267506973301358,-4.263643545604213,0.9999996380548767,0.9999999999999936,0.9278752436647114,CDKN1A/CENPP/RCC2/BARD1/MCM7/CDC7/UBC/RPS27A/SFN/CDKN2A/CCNA2,11,0.6455907973484906,0.35192021833841736,1.184323764030699
R-HSA-5617833,Cilium Assembly,6/1379,184/9872,0.03260869565217391,0.23343948040483023,-4.229318979672052,0.9999998227400337,0.9999999999999936,0.9278752436647114,DYNLRB2/TUBB4A/TUBA1A/PKD1/SMO/TUBA1B,6,0.4612274174732793,0.20416958534736437,1.041931540719646
R-HSA-73894,DNA Repair,14/1379,283/9872,0.04946996466431095,0.35414611397104984,-4.441943012116246,0.999999835927321,0.9999999999999936,0.9278752436647114,UBA7/USP43/BARD1/EYA2/KDM4B/MAD2L2/UBC/RPS27A/NEIL2/GTF2H2/ACTB/CCNA2/MPG/INO80C,14,0.699718390701512,0.4080025303432299,1.200006837884156
R-HSA-1852241,Organelle biogenesis and maintenance,12/1379,277/9872,0.04332129963898917,0.31012898479775275,-4.692642186101063,0.9999999764327043,0.9999999999999936,0.9278752436647114,MICOS10/MEF2C/DYNLRB2/ALAS1/TUBB4A/TUBA1A/HELZ2/CAMK4/PPARGC1B/PKD1/SMO/TUBA1B,12,0.6127497820583638,0.3429048016451263,1.0949461588500589
R-HSA-68877,Mitotic Prometaphase,5/1379,196/9872,0.025510204081632654,0.1826227227656835,-4.6573064262199075,0.9999999941708153,0.9999999999999936,0.9278752436647114,CENPP/RCC2/TUBB4A/TUBA1A/TUBA1B,5,0.36082417013215734,0.14827425716493378,0.8780626134362475
R-HSA-69278,"Cell Cycle, Mitotic",25/1379,478/9872,0.05230125523012552,0.3744147872601879,-5.649464603425347,0.9999999999220976,0.9999999999999936,0.9278752436647114,GINS3/CDKN1A/LMNA/MIS18BP1/CENPP/CCND3/RCC2/NUP205/CDC14A/MCM7/CDC7/CABLES1/PHLDA1/LMNB1/TUBB4A/NUP188/TUBA1A/CCND1/UBC/CHMP4C/RPS27A/TFDP2/CDKN2A/CCNA2/TUBA1B,25,0.7397650349989835,0.49300553001894093,1.1100327961554959
R-HSA-68886,M Phase,12/1379,332/9872,0.03614457831325301,0.2587521951475226,-5.535927855592285,0.9999999999650178,0.9999999999999936,0.9278752436647114,LMNA/CENPP/RCC2/NUP205/LMNB1/TUBB4A/NUP188/TUBA1A/UBC/CHMP4C/RPS27A/TUBA1B,12,0.5112400290065264,0.28666597143830935,0.9117453527784344
R-HSA-72163,mRNA Splicing - Major Pathway,2/1379,201/9872,0.009950248756218905,0.07123194758621684,-5.360456206268696,0.9999999999981928,0.9999999999999936,0.9278752436647114,NKAP/HNRNPF,2,0.14073937780279172,0.03491903327516027,0.5672428646072254
R-HSA-72172,mRNA Splicing,2/1379,209/9872,0.009569377990430622,0.06850536586042864,-5.484406763857365,0.9999999999994515,0.9999999999999936,0.9278752436647114,NKAP/HNRNPF,2,0.13535222458545995,0.03359123441211874,0.545387063644895
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,4/1379,278/9872,0.014388489208633094,0.10300447096999703,-6.112867274081199,0.9999999999999936,0.9999999999999936,0.9278752436647114,NKAP/HNRNPF/NUP205/NUP188,4,0.20351521538389303,0.0757323769984196,0.546905359825385
